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Abstract 
Since the late 19th century, scientists and clinicians have generated an astonishing 
array of meters, scales, experimental designs, and questionnaires to quantify pain 
with more precision, accuracy, and objectivity. In this thesis, I fol1ow the 
development and implementation ofpain-measuring technologies in the United 
States until the mid-1970s. Focussing on how these technologies work, I analyse 
the relationship between practices of objectification; the social, material and 
technical resources on which these practices depend; and changing conceptions of 
pain, subjectivity and objectivity. 
Surprisingly, as efforts to objectify pain were intensified, pain was 
increasingly conceptualised as a subjective experience, that is, as a phenomenon 
inextricably tied to the unique emotional, psychological, and social condition of 
the experiencing self. largue that this transformation was not solely due to the 
development of new theoretical models of pain, but also, importantly, enabled by 
the implementation of new technologies that could measure pain as an individual 
and psychological phenomenon. I also argue that the successful implementation 
of these technologies depended on the availability of specific social, material, and 
technical resources, and examine the social settings in which these resources were 
made available. 
The main motivation for the direct investment of new resources towards 
pain-measuring technologies was a desire to make analgesic drug testing more 
objective. Beginning in the late 1930s, professional, industrial and public heaIth 
interests in drug addiction, opiate pharmacology, new drug development and 
therapeutic testing converged on the goal of better pain-measurement. By the 
1950s, the organisation and funding of analgesic testing made it possible to 
implement and validate the analgesic clinical trial, a technology that determined 
analgesic efficacy by measuring collective pain and its relief. The validity of the 
clinical was based on procedural and statistical control of data collection and 
analysis, rather than on the standardisation of individual experiences and 
evaluations of pain. It became possible to think of pain relief as an inevitably 
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idiosyncratic experience, open to multiple sources of psychological variation, and 
yet still measure it consistently and objectively on a collective level. 
Keywords: pain; measurement; objectivity; subjectivity; clinical trials; analgesics; 
psychophysics; psychosomatics; history of medicine; history of science. 
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Résumé 
Depuis la fin du 1ge siècle, une gamme surprenante d'outils et de techniques ont 
été créées dans le but de quantifier la douleur de façon plus précise, plus juste et 
plus objective. Dans cette thèse, j'examine la conception et l'application des 
technologies à mesurer la douleur aux Etats-Unis jusqu'à la première moitié des 
années 1970. En portant mon attention sur le fonctionnement de ces technologies, 
j'analyse la relation entre les pratiques de l' objectification de la douleur, les 
ressources-à la fois techniques, matérielles et sociales-qui alimentent ces 
pratiques, et la transformation des représentations de l'objectivité, de la 
subjectivité et de la douleur. 
Etonnamment, j'ai constaté que plus on a multiplié les efforts pour 
objectiver la douleur, plus cette dernière a été conçue comme étant une expérience 
subjective, c'est-à-dire, en tant que phénomène indissociablement lié au soi dans 
sa condition affective, psychologique et sociale. Je soutiens que cette 
transformation n'était pas uniquement le résultat de l'application de nouveaux 
modèles théoriques, mais s'est aussi réalisée grâce a l'application de nouvelles 
technologies capables de mesurer la douleur en tant qu'expérience individuelle et 
psychologique. Je demontre également qu'une application valable de ces 
technologies repose sur des ressources materielles, sociales et techniques 
specifiques, et qu'il faut donc examiner les conditions sociales donnant lieu a 
l'investissement de ces ressources. 
C'est le désir de rendre plus objective l'évaluation des thérapies 
analgésiques qui a été le principal moteur de la mise en oeuvre de technologies a 
mesurer la douleur. A partir de la fin des années 1930, des intérêts professionnels, 
industriels et de santé publique, s'étant orientés vers les problèmes de 
toxicomanie, la pharmacologie des opiacées, le développement de nouveaux 
médicaments et les méthodes d'évaluation thérapeutique, ont partagé le but de 
mieux mesurer la douleur. Dans les années 1950, l'organisation et le financement 
des tests analgésiques ont permi l'application et la validation de l'essai clinique 
analgésique, une technologie qui calculait l'efficacité analgésique a partir de la 
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quantification de la douleur, et de son soulagement, au nIveau collectif. La 
vali<:iité de l'essai clinique se fondait sur le contrôle procédural et statistique de la 
collecte et de l'analyse des données plutôt que sur la standardisation de 
l'expérience et de l'évaluation individuelles de la douleur. Cette nouvelle forme 
d'objectivité permettait une conception de la douleur analgésiée comme étant 
inévitablement variable et personnelle, tout en permettant de la mesurer de façon 
constante et certaine à un niveau collectif. 
Mots-clé: douleur; objectivité; subjectivité; quantification; eSSaIS cliniques; 
analgésiques; psychophysique; psychosomatique; histoire de la médecine; histoire 
des sciences. 
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1. Introduction: Pain and the Pursuit of Objectivity 
In February of2006, a BBC1 News article predicted an imminent victory in the 
fight against pain. Finally, a technology had been developed to me as ure pain 
objectively using functional magnetic resonance imaging (fMRI) of the brain. 
"Doctors hope they will soon be able to assess how much pain their patients are 
suffering," proclaimed the article's by-line. Following the headline "Studying the 
Brain to Relieve Pain," this announcement took for granted that there existed a 
connection between the alleviation of pain and its measurement. Aiso assumed in 
the article was the superiority of visible, objective images of pain obtained by 
fMRI over patients' own descriptions oftheir experience. These two assumptions 
gave sense to the otherwise non-sequitur opening sentences of the article: "As 
many as one in four people suffer from chronic pain-people like Malcolm 
Pankhurst who was plagued for years by chronic pain. Until now, doctors have 
had to rely on patients' descriptions oftheir pain." The power ofthis technology's 
ability to excavate images of pain from a subject's body was thus pitted against a 
high prevalence of persistent suffering and the inadequacy of verbal 
communication-unmediated by technology-for obtaining information about 
pain? 
A few years earlier, Americans had announced another kind of triumph in 
the twin battle for the better evaluation and alleviation ofpain. In 2001, the Joint 
Commission on Accreditation of Healthcare Organizations (JCAHO), the largest 
healthcare accrediting body in the U.S., instituted new "pain standards." The text 
of these standards proclaimed that every patient had the right to have their pain 
"appropriately" treated and assessed. T 0 remain competitive in the American 
healthcare market, hospitals, clinics and cafe institutions have, since then, had to 
make the evaluation oftheir patients' pain routine.3 
1 British Broadcasting Corporation 
2 Jane Elliott, "Studying the Brain to Relieve Pain," BBC News, February 5, 2006 
<htU}j/ncws.bbc.co.uk/go/pr/fr/-!l Ihilhealth/4674136.stm> (Accessed February 4,2006) 
3 June Dahl, "New JCAHO Pain Standards are Approved," 1998-1999 APS (American Pain 
Society) Annual Report (American Pain Society) 
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Though the text of the JCAHO standards does not specify exactly how this 
assessment should be carried out, the requirements indicate clearly that pain 
should be assessed, recorded, and reassessed, thus indirectly encouraging 
clinicians to choose from a wide range of available scales and questionnaires. 
These measuring instruments can now easily be found in manuals and on websites 
run by numerous organisations concerned with pain research and management.4 
The great majority of these tools depend on patients' own subjective judgments of 
the intensity and character of the pain they have or had. They do not "objectif y" in 
the usual way we have come to expect from the use of blood pressure gauges or 
the analysis of blood samples. Many of my friends who have been presented with 
such scales-asked to give their pain a number, a pre-selected word, or a metered 
length-have found the task absurd and confusing. From what 1 have heard, many 
healthcare practitioners aiso take this exercise with a grain of salt. Pain specialists 
and health workers are aware that there is no common reference point, a universal 
understanding of what a "5" pain is, or exactly how much worse a "6" pain would 
be, and that the numbers themselves are somewhat arbitrary. 
hltp://www.ampainsoe.org/abolltiannual!1999/annllaI16.htm (Aecessed Mareh 14, 2006); "Pain 
Assessment and Management Standards-Hospital s," Joint Commission Resources 
http:/\vww. jcrînc.com/subscribers/pers pectîves.asp?durki=3 24 3&s ite~ 1 0& return=2897 (Accessed 
March 14, 2006). 
4 For example, The American Academy of Pain Management sells a Pain Outcomes Profile (POP), 
a "23-item questionnaire that utilizes Il-point, 0 t6 10, numerical rating scales (NRS) to assess a 
number of relevant dimensions in the pain patient's experience." It also promises to "assist you in 
preparing to comply with standards put in place by the Joint Commission on Accreditation of 
Healthcare Organizations (JCAHO) in 2001," as weil as the standards of the Pain Program 
Accreditation and the Commission on Accreditation of Rehabilitation Facilities, see: "Pain 
outcomes profile," American Academy of Pain Management 
http://www.aapainmanage.org/programs/NPDBMain.php (Accessed March 14,2006). 
Various hospitals and academie medieal researeh centres offer a variety ofscales for adults and 
children. For example, see: "UCLA Pain Assessment Tools," UeLA Pain Management Resource 
Guide (UCLA Department of Anesthesiology) 
http://www.anes.uela.edu/pain/assessmenttools.html(AccessedMarchI4.2006); .. II1.Pain and 
Symptom Management: A. Pain Assessment Tools," City of Hope Pain/Palliative Care Resource 
Center Website (City of Hope Beckman Research Institute) 
http://eitvofl1ope.org/pre/pain assessmenLillUl (Accessed Mareh 14,2006), whieh offers a list of 
other institutions offering pain assessment tools. 
The NIH Pain Consortium also offers a selection of scales: "Pain Intensity Scales," NIH Pain 
Consortium http://paineonsortiul1l.nih.gov/painscales/ (Accessed March 14, 2006). 
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Yet, for the pain activists who have created and publicised these tools -
campaigning for the creation of the JCAHO standards5 or for pain to be 
considered as a "5th Vital Sign,,6-they are weapons in a fight against the 
invisibility of pain. They may depend on the patient' s imperfect and idiosyncratic 
judgment, but they standardise the evaluation process itself, putting each voice on 
the same level of eloquence and insistence. Thus, these measurement instruments 
offer sorne protection against insufficient and inequitable access to relief, against 
the fickleness ofhealthcare professionals in their attentiveness to pain, and against 
the ignorance of patients who, not knowing they are entitled to relief, fail to 
complain. 
To understand the significance of the JCAHO standards and the 
concomitant growing use of pain assessment tools, one must be aware of the 
emergence and convergence of multiple strands of activism for the reform of 
attitudes, practices, and policies in matters of pain treatment. Denunciations of 
variable and insufficient responses to pain as a form of inequity have been 
articulated since the 1970s, but have become more frequent in the past two 
decades. A range of actors-including pain specialists, professional pain societies, 
pain policy groups, journal editors, patient groups, and journalists-have 
moralised social and medical responsibility towards pain sufferers in new ways.7 
Articles, lectures, and editorials have pointed to the undertreatment of pain in 
healthcare institutions; the needless suffering of children and the elderly; 
5 June Dahl, heading a group from the University of Wisconsin-Madison Medical School was at 
the forefront ofthis initiative. She received support from the American Pain Society and the 
Robert Johnson Wood Foundation, among others. See Dahl, "New JCAHO Pain Standards." 
6 James Campbell, "Pain: the Fifth Vital Sign™'' American Pain Society 
http://www.ampainsoc.org/advocacy/fifth.htm (Accessed March 14,2006): ln his presidential 
address to the American Pain Society in 1995, James Campbell explained: "APS has created the 
phrase "Pain: The 5th Vital Sign" ™ to elevate awareness of pain treatment among health care 
professiona1s ... Quality care means that pain is measured and treated." Among the tools ofthis 
education campaign were buttons and counter cards. 
7 There are now a large number of organisations who do education and advocacy work for better 
pain management in the U. S. run by various patient and profession al groups. They include: the 
American Pain Society, the American Academy of Pain Management, the American Pain 
Foundation, the American Chronic Pain Association, the American Society for Pain Management 
Nursing, the Pain & Policy Studies Group, the American Alliance of Cancer Pain Initiatives (an 
umbrella organisation for various state initiatives), Partners Against Pain, as weil as many groups 
formed around specifie painful diseases, such as the American Fibromyalgia Syndrome 
Association and the Sickle Cell Disease Association of America. 
13 
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discrimination against African Americans, minority groups, and AIDS patients in 
the provision of pain relief; irrational fears of addiction; and the lack of 
compassion and validation encountered by sufferers of mysterious ailments.8 Pain 
societies, both lay and professional, have created courses and materials to educate 
ignorant doctors, nurses, and even patients as weIl as their families about pain 
relief.9 These societies have also lobbied governments and organisations for 
funding for pain research,1 0 the reform of narcotics legislation, Il and the 
institution of standards of pain treatment. 12 
8 There is a voluminous lite rature on the undertreatment ofpain in the professionalliterature, 
which has received fairly wide coverage in the news and popular media. Many articles identity 
lack ofprofessional education on pain, especially of nurses, and fears of causing addiction, or of 
narcotics regulation, as the main barri ers to adequate treatment. Myths and prejudices about pain 
in certain cultural or ethnie groups, children, AIDS patients, the elderly, etc. have also been 
emphasized. A cross-section ofthese articles includes: R. M. Marks, and E. J. Sachar, 
"Undertreatment of Medical Inpatients with Narcotic Analgesies," Annals of Internai Medicine 78, 
no. 2 (1973): 173-81; D. E. Joranson, "Fear of Addiction is an Impediment to Cancer Pain Relief: 
A Proposai to the World Health Organization Programme on Substance Abuse," Symptom Control 
in Cancer Patients 5 (1993):52-58; Ronald Melzack, "The Tragedy ofNeedless Pain," Scientific 
American 262 (1990): 27-33; Marcia Angell, "The Quality of Mercy," New England Journal of 
Medicine 306 (1982): 98-9; B. R. Ferell, et al., "Pain and Addiction: an Urgent Need for Change 
in Nursing Education," Journal of Pain and Symptom Management 7 (1992): 117-124; N. L. 
Schechter, "The Undertreatment of Pain in children: an Overview," Pediatrie Clinics of North 
America 36 (1989): 78 J -94; M. McCaffery and L. L. Hart, "Undertreatment of Acute Pain with 
Narcotics," AmericanJournal ofNursing 76 (1976):1586-91. W. O. Evans, "The Undertreatment 
of Pain," Indiana Medicine 81 (1988):842-3; J. Streltzer and T. C. Wade, "The influence of 
cultural group on the undertreatment ofpostoperative pain," Psychosomatic Medicine 43 
(1981 ):397-403; W. Breitbart, et al. "The undertreatment of pain in ambulatory AIDS patients," 
Pain 65 (1996):243-9; C. S. Cleeland, "Undertreatment of cancer pain in elderly patients," Journal 
of the American Medical Association 279 (1998): 1914-5; B. J. Primm, "Managing Pain: the 
Challenge in Underserved Populations: Appropriate Use versus Abuse and Diversion," Journal of 
the National Medical Association 96 (2004): 1152-6 J. 
9 The websites of the groups listed in n.6 include descriptions oftheir education and advocacy 
initiatives. Two particularly visible and well-organised initiatives have been the American Pain 
Society's "Pain: the Fifth Vital Sign™'' campaign, see: 
http://www.ampainsoc.org/advocacy/fifth.htm and the Power Over Pain Campaign, ajoint 
initiative ofthe American Pain Foundation and divisions of the American Alliance Cancer Pain 
Initiatives, with support of the American Cancer Society and the American Society of Pain 
Management Nursing, which is described as a "grassroots effort" to provide "tools to implement 
action-oriented public awareness campaigns on the state or community level." See: "Power over 
Pain Campaign," http://www.poweroverpaincampaign.org! (Aeeessed Mareh 14,2006). 
10 As a result, an NIH Pain Consortium was established in 1996 to "enhance pain research" by 
developing a research agenda, identitying opportunities and increasing the visibility ofpain 
research, see http://painconsortium.nih.gov!(AccessedMarchI4,2006).Neverthe1ess,pain 
researchers have continued to bemoan the lack ofbalance between the magnitude of the problem 
ofpain and the amount offunding for research on it, see for example: "News Release : Study 
Assesses NIH Support for Pain Research: Only 1 Percent of2003 Grants were Dedicated to Pain," 
American Pain Society May 25, 2005 http://www.ampainsoc.org/decaclcofpain/news/053105.ht111 
(Accessed March 14,2006). 
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Pain-measuring instruments have taken on a particular significance within 
this broader political climate. Such instruments have not always been associated 
with the same kinds of debates about entitlement to pain relief and the imposition 
of common healthcare standards. In the past, different interests and resistances-
both social and material-have framed the creation and use of technologies for 
eliciting, exchanging, and interpreting information about pain. My fascination 
with these technologies stems from an interest in the changing configurations of 
goals and values, and of authority and trust, that have motivated and guided 
efforts to reform the evaluation and communication ofpain. 13 
Since the late 19th century, scientists and clinicians have generated an 
astonishing array of meters, scales, and questionnaires in their quest to better 
objectifY pain. Using these technologies, these actors have attempted to 
reconfigure hum an (and non-human) interactions with tools and rules in order to 
make the evaluation of pain more precise, accurate, consistent, or unbiased. From 
sets of horsehairs to balloons that were inflated in the stomach, lie-detecting 
machines to machines measuring heat auras, some of them instrumentally 
sophisticated, such as fMRI images of the brain in pain, others relying on little 
Il The Pain & Policy Studies Group, based at the University of Wisconsin Comprehensive Cancer 
Center as a collaborating centre of the World Health Organisation sponsors research on the 
regulatory barriers to the adequate relief of pain, and cancer pain in particular, with narcotic 
analgesics. See: Pain & Policy Studies Group http://ww\V.medsch.wisc.edu/painpolicy! (Accessed 
March 14,2006). 
The same centre houses the American Alliance of Cancer Pain Initiatives, an umbrella 
organisation for state initiatives that "work to remove the barriers that impede pain reliefthrough 
education, advocacy and institution al improvement," ofwhich regulatory barriers are an important 
focus. See: American Alliance of Cancer Pain Initiatives \Vvi\v.aacpi.org!about.htl11 (Accessed 
March 14,2006); Project on Legal Constraints on Access to Effective Pain Relief, "The Pain 
Relief Act" 
Journal of Law, Medicine & Ethics, 24, no. 4 (1996): 317-18. 
12 Dahl, "New JCAHO Pain Standards." 
13 ln this respect, 1 build on the work of several historians who have shown that historically-
specific codes of behaviour, artistic conventions and processes of adjudication have operated to 
make pain publicly inteIIigible under particular conditions: Esther Cohen, "The Animated Pain of 
the Body," American Historical Review 105 (2000): 36-68; Mitchell B. Merback, The Thiel, the 
Cross and the Wheel: Pain and the Spectacle ofPunishment in Medieval and Renaissance Europe 
(London: Reaktion, 1999); Greg Eghigian, Making Security Social: Disability, Insurance and the 
Birth of the Social Entitlement State in Germany (Ann Arbor: University of Michigan Press, 
2000); Silvia De Renzi, "Witnesses of the Body: Medico-Legal Cases in Seventeenth-Century 
Rome," Studies in the History and Philosophy of Science 33 (2002): 219-42. For more comments 
and references, see my bibliographical essay in chapter 2. 
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morè material than bowls of ice-cold water and a timer, these technologies 
constitute a long list of ever-more imaginative means for eliciting and quantifying 
various dimensions of the experience of pain. 
By following the trajectory of these technologies-from design, through 
implementation, validation, and diffusion-my dissertation examines how and 
why specific actors have attempted to make the evaluation of pain quantitative 
and objective in the United States from the turn of the 20th Century to the mid-
1970s. Given that pain is often defined as inherently subjective, or, at the very 
least, as particularly difficult to objectif y, these technologies make me curious: In 
what contexts do they make sense? What, exactly, do they measure? How do the y 
work? What kind of objectivity do they produce? 
On a generallevel, technologies of pain-measurement are useful because 
they make practices of pain evaluation more explicit, open to collective scrutiny, 
and thus to collective standardisation and validation. Assessments of pain that are 
carried out with the use of measuring technologies are meant to be more precise 
and less vulnerable to irrelevant personal and incidental factors than unmediated 
verbal or visual evaluations of pain. Because they convert information about pain 
into numerical form, measuring technologies make pain recordable, 
communicable and comparable. But when, for whom, and for what reasons did 
these qualities-precision, consistency, communicability, and impersonality-
become valuable in pain assessment? 
Pain-measuring technologies were not always considered important to the 
same extent, or for the same reasons. Before the mid-1970s and to a large extent 
afterwards, the main force driving the objectification of pain was a desire to better 
evaluate the efficacy of pain-relieving therapies. This was not the first use for 
which pain-measuring technologies were developed, nor the only context in 
which they have been considered useful. It was the only reason, however, that 
motivated significant investments into the development of pain-measuring 
technologies and supported their diffusion on a larger scale. As we will see, 
successfully implementing such technologies-making them collectively valid-
requires a collective effort to mobilise and coordinate the necessary labour and 
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resources. Making pain measurable has to be a collective goal, a goal that is 
important for those who have access to the right kinds of resources, for it to 
become possible to create effective pain-measuring technologies. 
It was not until the mid-1970s that pain-measuring instruments became 
important in clinical contexts. Though we can assume that pain was frequently 
evaluated in the clinic before this, technologies were seldom used. It was only 
with the expansion of specialised pain clinics in the 1970s, when persistent pain 
was redefined as a pathology-chronic pain-requiring special treatment 
approaches, and subsequently with the articulation of a new kind of "right" to 
adequate pain management, that pain-measuring technologies entered the clinic. 
Surprisingly, even the area of medical examinations for disability insurance, 
where one might expect to find a demand for the quantification and 
standardisation of pain evaluation, seems to have been relatively untouched by 
such technologies until the 1980s and 1990s. Before this, official evaluation 
guidelines deemed pain inadmissible as evidence of disability and rejected as 
subjective. Clinical pain evaluation did not become a collective issue before the 
1970s. 
Much earlier, however, from the mid-1930s onwards, the desire to 
improve the accuracy and precision of analgesic-testing motivated an important 
investment of resources-time, money, work, as weIl as systems of 
communication and of coordination-towards making pain into an objectively 
measurable quantity. To understand the history ofpain-measurement in the 
United States, it is crucial to know why analgesic testing became important, and 
to whom, from the late 1930s to the 1960s. Different actors were interested in 
analgesics-and analgesic testing-for different reasons. Public health 
researchers and regulatory authorities were concerned about the addictive 
properties of analgesic drugs; pharmaceutical companies were interested in 
potentially lucrative new analgesics; pharmacologists had ambitions for opiate 
research; the medical profession wanted a non-addictive analgesic while the 
military wanted a synthetic one; clinical researchers were interested in reforming, 
and taking over, therapeutic evaluation, and so on. These interests converged in 
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different configurations around the goal of better analgesic testing during the 
middle decades of the century, both generating a demand for pain-measuring 
technologies and creating the conditions under which they could be implemented 
effectively. 
To understand how pain-measuring technologies work, it is necessary to 
examine how specifie resources are translated into measurement practices. 
Objectivity is expensive in time, power, work and money. Different kinds of 
practices pro duce different kinds of objectivity. Like other historians of 
objectivity, 1 believe that both the forms and functions of objectivity vary in time 
and space, and that they are specifie to particular social arrangements. However, 
unlike studies that trace shifts in the values ascribed to objectivity over time, my 
approach to the history of objectivity focuses on changing practices of 
objectification. In other words, my attention is on the social, material, and 
technical conditions that enable, or constrain, the pursuit of objectivity in 
practice. 
Changing practices of pain-measurement created new ways of objectifying 
pain, but also opened up new possibilities for measuring pain as a subjective 
phenomenon. Pain-measurers have not been attempting to measure the same thing 
since the end of the 19th century; they have identified new dimensions of pain to 
render measurable, while they have also worked with changing models of pain. 
How they have considered what they measured as being subjective-that is, the 
way in which pain was seen to be tied to the personal or the self-and what that 
subjectivity implied for practices of objectification, has also shifted. Indeed, over 
the course of the 20th century, pain has increasingly been thought of as a 
subjective phenomenon, that is, as an experience rather than an event, primarily 
located in thinking, feeling, interacting selves rather than in external forces and 
objective matter. This process of subjectification has two main implications for 
my study. 
To pain-measurers, subjectivity was not only something to eliminate or 
control in order to objectif y pain, but also something to measure and dc:fine 
through these use of pain-measuring technologies. This is important, and caUs for 
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an approach towards the history of objectification that allows a close exarnination 
of changing conceptualisations of subjectivity. Subjectivity has usually been 
defined by historians of objectivity as that which objectification seeks to 
elirninate, or at least control. But to study the objectification ofpain, we need a 
more dynamic vision of the interaction between objectification and subjectivity 
that is not only oppositional but potentially collaborative. To sorne extent, this has 
been recognised by historians of sciences of the subjective that have expanded 
since the 19th century. Drawing on their studies, l emphasise the need to pay 
attention to the role given to subjects, and to their judgment and experience, in the 
operation of technologies of objectification of the subjective. Such an approach is 
particularly important for defining the nature ofthose forms of objectivity that 
have been associated with the expansion of the "psy sciences" in Western 
societies in the 20th century as it has been described by Nikolas Rose.1 4 But even 
the objectification of non-psychological phenomena may have been affected by 
changing conceptions of the personal, the self, and ofinterindividual variation-
and of the ways in which these factors can influence judgment-as a result ofthis 
process of "psychologisation." 
This second implication of this process of "subjectification" is that the 
conceptualisation of pain has changed during the 20th century. Pain-measurers 
have not simply been attempting to measure the same thing in new ways, but have 
actually been measuring new kinds of events, experiences, and persons. Indeed, it 
is possible to use these technologies as windows into changing conceptions of 
pain. Throughout my thesis, l examine how designers and users of pain-
measuring technologies defined what they were measuring; how they identified 
which dimensions should and could be measured; and how they developed 
appropriate strategies to do so. l conclude that pain-measurers did not simply 
work with definitions ofpain that were transformed outside the sphere oftheir 
activities, but actively transformed pain through their measurement practices. 
14 Nikolas Rose, Inventing Our Selves: Psychology, Power, and Personhood. Cambridge Studies 
in the History of Psychology (New York and Cambridge: Cambridge University Press, 1996). 
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Pain-measurers have been well-aware that they had to create a 
"measurable pain," which would only be one dimension or approximation of 
sorne abstract total, indivisible experience of pain. The creation and use of new 
techniques thus enabled new "versions" of pain-ones which increasingly 
involved affective, cognitive and experiential dimensions of the self-to become 
measurable, and to sorne extent, thinkable. 1 do not argue that new conceptions of 
pain were exclusively or dominantly produced by m~asurement practices. New 
definitions of pain were the product of an interaction between various theoretical 
and practical fields of activity, including measurement. 1 do insist, however, that 
measuring-practices played an important role in making increasingly subjective 
definitions of pain operational or usable in social processes-such as therapeutic 
evaluation-in which collective agreement about the validity of judgments about 
pain was considered to be necessary. 
So far, 1 have identified three central dimensions of my topic: the history 
of pain-measuring technologies first as a history of practices of objectification; 
second as a history of the dynamic interaction between objectification and 
subjectivity; and finally as a history of changing notions of pain. In the following 
sections, 1 will elaborate on the first two, situating my approach within two bodies 
ofhistoricalliterature: on objectivity and on the sciences of the subjective. 1 will 
discuss the social study and history of pain in a separate bibliographical essay in 
the following chapter. 
1.1 The History of Objectivity as a History of Practices 
U sing measuring-technologies to make the evaluation of pain more objective has 
meant different things over time. The history of these technologies is not a 
progressive story of increasingly successful objectification, but rather a history of 
the (sometimes unsuccessful) pursuit of changing types of objectivity, for 
different reasons and with different means. My study therefore shares sorne of the 
methods and preoccupations of social historians of objectivity who have usefully 
demonstrated that objectivity, as a term and as a concept, is neither fixed nor 
unitary. Encouraging us to look closely at the terminology of objectivity, these 
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scholars have argued that apparent confusion in the use of the adjective 
"objective" as a qualifier for different things-knowledge, persons, or 
processes-and to mean different things-such as impartial, consistent, detached, 
or true-in fact holds cIues about the historically distinct strands of a plural, 
layered concept. 
Lorraine Daston and Peter Galison have discussed this issue in depth, and 
have added sorne historical precision to the vocabulary of objectivity. They have 
shown that the ontological notion of objectivity, which refers to the fit between 
theory and reality, was joined by two new types of objectivity in the 19th century: 
mechanical and aperspectival. Those who pursued mechanical objectivity sought 
to eliminate human interpretation or judgment frbm the process of representing 
nature by mechanising, literally or figuratively, the production of 
representations. 1S Aperspectival objectivity, on the other hand, was about 
eliminating individual viewpoints or perspectives, and privileging types and forms 
of information that could be easily be communicated, to make possible the 
production and exchange of knowledge on a larger scale. 16 Even before the 
emergence ofthese objectivities, as Peter Dear has pointed out for the 1 i h 
century, the characterisation of objectivity shifted away from references to truth 
and became defined negatively as being not subjective, or more precisely, as 
being characterized by disinterestedness. 17 Alberto Cambrosio and his colleagues 
have identified a new form of objectivity in post-World War II medicine: 
regulatory objectivity. Regulatory objectivity refers to the way in which 
biomedical judgment is informed by the collective production of evidence, which 
depends on various forms of social (and material) regulation, both tacit and 
explicit. For example, the use of entities such as cell-surface markers in the cIinic 
is made possible by complex networks of regulation for the production of 
standards applying to substances, instruments, practices, and terminologies, which 
15 Lorraine Daston and Peter Galison, "The Image of Objectivity," Representations 40 (1992): 81-
128. 
16 Lorraine Daston, "Objectivity and the Escape from Perspective," Social Studies afScience 22 
(1992): 597-618. 
17 Peter Dear, "From Truth to Disinterestedness in the Seventeenth Century," Social Studies of 
Science 22 (1992): 619-31. 
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give these markers meaning and validity as diagnostic tests. Thus, regulatory 
objectivity depends on the establishment of conventions for making diverse 
practices and entities compatible, and for articulating biology and medicine in 
novel ways, rather than with reference to absolute accuracy.18 
These studies show, in various ways, that objectivity has often not been 
defined by its relationship to truth or nature, but instead with reference to 
processes and qualities that, within specifie social (and material) settings, have 
been identified as liable to make knowledge coIlectively useful and usable. Being 
aware of the dissociability oftruth and objectivity, and of the existence of 
different forms of objectivity, is particularly useful for understanding 
quantification, as weIl as standardisation, as technologies of objectivity that have 
been highly valued in the 19th and 20th centuries. Theodore Porter has argued that 
we have placed our trust in numbers, in science as in govemment and business, 
because they do not require intimate knowledge and personal trust. 19 
Quantification, ev en though it may poorly translate our notions of reality, is 
valuable, according to Porter, because it allows knowledge to travel across social 
and geographical distances, and represents the kind of impersonality that is 
considered to be authoritative in pluralistic democratic societies. In one example, 
Porter presents an extreme case-that of calculating the cost human life-to 
demonstrate how quantification could pro duce objectivity through a process of 
standardisation and de-personalisation, despite a widely shared opinion that there 
was no truth, rationality, or meaning in the concept of a life measurable in dollars 
and cents?O Measuring pain can be seen as a different type of extreme case, in 
which neither absolute truth nor removal of the private self have generally been 
attained, and yet it has still been considered possible, within a certain milieu, to 
18 Alberto Cambrosio, Peter Keating, Thomas Schlich, and George Weisz, "Regulatory Objectivity 
and the Generation and Management of Evidence in Medicine," Social Science and Medicine 
(Forthcoming). 
19 Theodore M. Porter, Trust in Numbers: the Pursuit ofObjectivity in Science and Public L(ie 
(Princeton, NJ: Princeton University Press, 1995). 
20 Theodore M. Porter, "Objectivity as Standardization: The Rhetoric ofimpersonality in 
Measurement, Statistics and Cost-Benefit Analysis," Annals ofScholarship 9 (1992): 19-59. 
22 
23 
produce collectively valid quantitative data about pain. My goal is to understand 
how this has been accepted as a form of objectivity. 
It is also useful, in analysing objectivity, to be attentive to changing 
distributions oftrustworthiness. Historians of science and objectivity have 
usefully focused on notions of trust, and more specifically on the way in which 
trust has been selectively attributed to varying actors, stances, procedures, and 
instruments in the production ofvalid or reliable knowledge.21 The emergence of 
new forms of objectivity has often entailed a shi ft of trust from certain types of 
persons, judgments, or procedures to others. For example, mechanical objectivity 
placed new trust in the ideal of the machine as a means of producing images that 
were free of interpretation and aestheticism.22 Conversely, the promotion of new 
processes of objectification has often been motivated by, or strategically 
depended on, the identification of specific targets of mistrust. Harry Marks has 
shown how advocates of the randomized clinical trial depicted specific figures, 
such as physicians, nurses, and pharmaceutical firrns, as untrustworthy in order to 
persuade their colleagues to adopt the techniques of the randomized clinical trial 
in the 1950s.23 Porter argues that a suspiciousness ofpersonal authority and trust 
led to the valorisation of impersonality and numbers as trustworthy.24 In designing 
and using pain-measuring technologies, it mattered whether pain-measurers were 
mistrustful of dishonesty, unconscious influences, personal quirks, or other forms 
of interested bias. 
Why have new forms of objectivity been adopted? It is possible to 
approach this question from at least two directions within the perspective of social 
history. One can identifY the advantages that are conferred to those who have laid 
claim to being objective or who have benefited from the implementation of 
objective methods within specifie social orders. This is one way of explaining 
how new social arrangements promote new types of objectivity. Porter has argued 
21 A good study of historically-specific means of attributing trustworthiness in scientific 
know1edge-making is Ste ven Shapin, A Social History of Truth: Civility and Science in 
Seventeenth-Century England (Chicago: University of Chicago, 1994). 
22 Daston and Ga1ison, "Image of Objectivity," 119-120. 
23 Harry Marks, "Trust and Mistrust in the Marketp1ace," History o(Science 28 (2000):343-355. 
24 Porter, Trust in Numbers. 
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that quantification can be seen as a response to suspicion of the personal and 
arbitrary, and has been especially appealing to groups who have been vulnerable 
to outside criticism and did not have access to other forms of authority and 
personal trust. Thus, quantitative objectivity has been compatible with the 
political order of suspicious, open, pluralist democratic societies?5 Similarly, 
Daston has shown that aperspectival objectivity was necessary for the circulation 
of knowledge along increasingly large and heterogeneous networks of scientists, 
whose labour was evaluated and organized in new ways?6 
While these authors have paid attention to the types of tools and 
procedures underlying the se forms of objectivity, their primary focus has been on 
the ideals of objectivity to which people have aspired rather than on the details of 
the actual practices by which objective methods, claims and status are pursued. 
However, we can also reverse this strategy by focusing first on these practices and 
what makes them possible. Changing social and material conditions can either 
enable or constrain practices of objectification, leading to the rejection of sorne 
forms of objectivity and the adoption of others. Of course, these conditions are 
not isolated from the actions of those who value certain ideals of objectivity, and 
who may be willing (though not al ways able) to mobilise resources in order to 
pursue specifie ideals of objectivity. It is important to investigate not only what 
these actors have hoped to gain from being objective but also what kinds of 
resources they have contributed towards the production of objectivity. 
The two different economies of values-of values necessary for the 
production of objectivity and of values generated by objectivity-that underlie the 
historical emergence of particular types of objectivity are well-described in the 
edited volume The Values of Precision. By emphasising two types ofhistorical 
processes, its contributors suggest that the title has a double meaning. Precision 
has become valuable at specifie times in history because it was useful to emerging 
states, industrial economies, and international trade. Producing precision, 
25 Theodore Porter, "Quantification and the Accounting Ideal in Science," Social Studies of 
Science 22 (1992): 633-52. 
26 Daston, "Objectivity and the Escape," 608. 
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however, is also costly in many ways; it depends on the exercise of power, the 
mobilisation of labour, the investment of funding, and the formation of systems of 
organisation and communication. As M. Norton Wise pointed out in a 
commentary on the essays in this volume, precision has not only helped to 
achieve standardisation, but has also required the standardisation of quantities and 
measurement processes. It has not only facilitated profitable commerce, but has 
also been expensive. Precision has helped to generate agreement but also 
depended on agreement. Being precise gave certain actors authority, but 
becoming precise has also necessitated the use of authority.27 1 similarly explore 
the double meaning of the value of objectively measured pain; 1 ask why, and to 
whom, pain-measuring technologies have become valuable, but also examine, in 
as much detail as possible, what it took-in material and social terms-to make 
these technologies work. 
When 1 speak of resources invested towards the objectification of pain, 1 
do not only mean money, though money is important in many ways, including for 
the production of social resources such as labour, agreement and collaboration 
through salaries, meetings, and publications. Other social goods include authority, 
expertise, coordination, and communication, while technical resources include 
instruments but also models, rules and definitions. 1 find it useful not to 
distinguish too sharply between material, social and technical resources, but rather 
to see them as interacting with, and sometimes turning into, each other within a 
continuous system. 
1 particularly focus on the relationship between resources, practices and 
objectivity in chapters 5, 6 and 7. In Chapter 5,1 compare the practices oftwo 
widely used pain-measuring/analgesic testing technologies on the basis of what 
kind of work and materials they required to control variability and subjectivity in 
the measurement process. Though both technologies worked, they did so under 
different conditions, and with different types of resources. 1 show that the 
27 M. Norton Wise, "Introduction," "Precision: Agent ofUnity and Product of Agreement Part I-
Traveling," "Precision: Agent of Unit y and Product of Agreement Part II- The Age of Steam and 
Telegraphy," The Values of Precision, ed. M. Norton Wise (Princeton, N.J: Princeton University 
Press, 1995), 3-13, 92- 100, 222-236. 
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investment of more, and increasingly concentrated resources for analgesic testing 
in the late 1940s and early 1950s made it possible to implement a more expensive, 
time-consuming, and labour-intensive technology: the analgesic clinical trial. In 
Chapter 6, 1 examine in detail how resources such as money, skills, people, 
labour, authority were mobilised and translated into pain-measuring practices, 
while in Chapter 7, 1 show how a lack of such resources impeded the effective 
implementation of such practices. Throughout these chapters, 1 show that shifts in 
the type of control exercised by technologies of pain-measurement brought about 
a new form of objectification, and was also associated with new conceptions of 
pain. 
Pain-measuring technologies did not only benefit from a direct investment 
of resources towards the objectification of pain for the purposes of analgesic 
testing. As 1 show in chapters 3 and 4, pain-measurers also drew, in designing 
their instruments and experimental designs, on techniques and definitions 
developed in other areas of research: psychophysics, psychosomatics, the 
physiology of the emotions, personality, anthropology, etc. Though it faIls outside 
the scope of my study to give a full account of the origins of these techniques, 1 
do point out sorne of the reasons why their development was supported sociaIly 
and financially. My point, however, is that measuring pain in new ways-whether 
as a psycho-physiological event, as an emotional response correlated with 
personality characteristics and past experience, or as an indivisible, psychological 
experience unique to each person-depended on the possibility of implementing 
certain practices, and that such conditions of possibility were historically-specific. 
Ifpracticing certain forms of objectivity depends on having access to 
certain types of resources, it is clear that not everyone at a given time has the 
means to be objective in the same way. Historians of objectivity have generally 
been concerned with the emergence of radically new forms of objectivity 
(mechanical, aperspectival, regulatory) in association with broad social 
transformations in the longue durée. These authors nevertheless recognise that 
new types of objectivity have not swept away older ones, but that these continue 
to coexist. They also suggest that yet unnamed types of objectivity may have been 
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formed, perhaps, we can suppose, through processes of adaptation or 
hybridisation,28 Specific actors, pursuing specific goals of objectification, may 
thus draw on multiple co-existing types of objectivity, shifting from one to 
another, or combining them, depending on the means available to them. Focusing 
on practices of objectification may thus highlight frequent variations in forms of 
objectivity over a relatively small time-frame. 
The case of pain, which has very often been defined as resistant to 
objectification and measurement, may particularly highlight difficult, shifting, and 
failed attempts at objectification. With respect to sorne issues, however, 1 have 
tried not to make a special case out of pain. Many phenomena have resisted 
objectification and measurement. Take electricity, for example, for which 
considerable effort and investment were necessary in developing both technical 
and social strategies for the realisation of reliable, standard, and objective 
measurements.29 The measurability of pain has likewise been sensitive to the 
investment ofwork, techniques and, money, as well as to the formation of 
agreements and networks. 
On the other hand, it is important for a historian to take seriously how 
actors have defined pain as subjective, making it different, in important ways, 
from electricity or other material phenomena. This reveals that the 
conceptualisation of pain as subjective has changed over the course of the 20th 
century. Most notably, from the 1940s, pain-measuring instruments were designed 
to produce and collect information that were seen to originate in subjects' 
psychological selves-selves that were shaped by broader social and temporal 
spaces that came to include families, cultures, pasts, and futures-rather than in 
their bodies. Pain-measurers also conceptualised sources of variation, which the y 
28 Daston and Galison, "The Image ofObjectivity," 123, " ... the emergence ofmechanical 
objectivity in the latter half of the nineteenth century by no means exhausts the history of modern 
objectivity as a whole." They also suggest that mechanical objectivity became "fused with other 
varieties of objectivity," but do not explore this aspect. Cambrosio et al., "Regulatory 
Objectivity," note that this new form of objectivity "now co-exists," with previous forms, and also 
suggest ways in which older medical technologies such as blood tests, that could be described as 
producing mechanical objectivity, had become embedded within networks ofrules and evidence 
that they cali regulatory objectivity. 
29For example: Simon Schaffer, "Accurate Measurement is an English Science," in Values of 
Precision, 135-172. 
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tried to neutralise, but also to measure, as forces that acted on individuals' 
experiences or expressions of pain through psychological processes. Thus, the 
subjectivity of pain and its evaluation were not only seen as bothersome variables 
but also became the very thing that needed to be measured. Understanding how 
pain-measurers tried to eliminate and control sorne aspects of subjectivity in pain 
evaluation, and tried to measure and use other dimensions ofthat subjectivity, can 
also be useful for developing finer distinctions between different practices of 
objectification over time. 
1.2 Objectification and the Place of Subjectivity 
We have seen that subjectivity was not only considered to be an obstacle in the 
application of pain-measuring technologies, but has also been conceptualised as a 
positive source of information for the production of useful and meaningful 
numbers about pain. What did this mean for the pursuit of objectivity? Historians 
of objectivity have generally defined subjectivity as that which objectification has 
aimed to eliminate, at least in the modern period. Their work has not generally 
been very helpful understanding how subjectivity could participate in processes of 
objectification, not as a negative value or as a residue, but potentially as a positive 
source of information and even as a product of objectification. For Dear and 
Porter, modern objectivity has been defined negatively by virtue of not being 
subjective, while Porter has given a puzzlingly general definition of subjectivity 
as "the fundamentally personal.,,30 Daston and Galison have been more attentive 
to the changing nature of subjectivity against which objectivity was defined, 
suggesting that "the history of the various forms of objectivity might be told as 
how, why and when various forms of subjectivity came to be seen as dangerously 
subjective.,,3l Picking up on this suggestion, Harry Marks has shown that 
advocates of a particular technology of objectification, the randomized clinical 
trial, rhetorically constructed "figures of mistrust" whose Cbad) judgment would 
30 Dear, "From Truth to Disinterestedness," 619-620; Porter, "Objectivity as Standardisation," 19. 
31 Daston and Galison, "The Image ofObjectivity," 82. 
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be eliminated by the adoption of these new practices.32 These are important points 
in tracing the history of pain-measuring technologies, and indeed sorne of the 
ways in which pain was seen as subjective were considered to pose threats to the 
measurement of pain. Examining only the threatening aspects ofpain's 
subjectivity would tell only part of the story, and would neglect those forms of 
subjectivity that were seen as constitutive of any pain defined as worth measuring. 
It is necessary to situate the objectification of pain within a positive pro cess of 
"subjectification" by focusing, as Nikolas Rose has put it, on those "processes and 
practices by which humans relate to themselves as selves." 33 
Can we sirnply say that psychological processes were objectified? One 
might argue that a definition of objectivity as a negation of the subjective might 
still be applicable to the ideal configuration pursued by scientists between 
experimenter, technology, and phenomenon, even if that phenomenon was 
defined as psychological. Surely these technologies were meant to eliminate the 
subjectivity of the scientist, while the subjectivity of the subject was irrelevant, or 
transformed into an object. But the subjectivity of the subject was not irrelevant or 
objectified because subjects were usually recognised as being active participants, 
even collaborators, in the operation of experimental technologies for the study of 
subjective phenomena. Certainly, in the case of pain-measuring technologies, 
subjects' judgments, experiences, and selves were very often seen as crucial 
sources of information that rendered their pain measurable. 
Similar cases can be found in the scientific study of emotions, sensations, 
cognition, and other phenomena defined as subjective or psychological. The work 
of historians who have studied these sciences is helpful in formulating an 
integrative approach that pays attention to the interplay of notions of objectivity 
and subjectivity in shaping methods of evaluation and investigation, as weIl as 
conceptions of the self. In particular, they describe sorne of the ways in which 
investigators have dealt with the participation of observing subjects in the 
production of knowledge about the self. Practices of objectification have sought to 
32 Marks, "Trust and Mistrust," 343-355. 
33 Rose, lnventing Our Selves, 24. 
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eliminate sorne forms of subjectivity. Other forms of subjectivity have instead 
been managed, controlled, purified, framed, or channelled by techniques of 
objectification. 
In Techniques afthe Observer, Jonathan Crary described how vision was 
relocated from the realm of images transmitted in reality, as modelled by the 
camera obscura, to that of images produced by the subjective observer in the early 
19t1l century. This shift was accompanied by a new scientific study of the 
observing subject, a science of vision focusing on the physiological apparatus of 
perception rather than on the physics of what was perceptible. Crary sees this 
increasingly objectified observer as intimately bound up with the romantic notion 
of the observer as "active, autonomous producer ofhis or her own visual 
experience," and thus as simultaneously subjectified.34 This twin process of 
objectification and subjectification of the observer was, according to Crary, part 
ofthe "strategic appropriation of subjectivity" described by Michel Foucault as 
the work of the "psy" sciences, which dissolved the boundaries that had kept the 
subject separated from the exterior, knowable world.35 For Foucault, this process 
of subj ectification was the product of the exercise of new forms of power 
predicated on obtaining individualised knowledge and control of personal abilities 
and proclivities.36 This line of analysis was continued by Rose into the 20tll 
century.37 
Othniel Dror has also written about a process of "appropriation of the 
subjective" in the use of technologies of inscription to study emotions in early 20111 
century physiology. While these technologies represented an ideal of mechanical 
objectivity in that they supposedly produced representations of emotions 
independently of the subject's will, consciousness, and verbal expression, the 
operation ofthese technologies in fact "depended on the subject's ability to 
34 Jonathan Crary, Techniques of the Observer: on Vision and Modernity in the Nineteenth 
Century (Cambridge, Mass. MIT Press, 1990),69. 
35 Crary, Techniques of the Observer, 148. 
36 Michel Foucault, Surveiller Et Punir: Naissance De La Prison (Paris: Gallimard, 1975). 
37 Rose, Inventing Our Selves. 
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manipulate the self." 38 Those subjects who were not sufficiently neutral to create 
a sharp delineation between "backdrop" and the "emotion" under study were 
excluded.39 Dror also suggested that "emotion-gauging" technologies should not 
be seen as replacing the interaction between experimenter and subject, but instead 
as mediating this interaction in a "trialogue. ,,40 This notion of "trialogue," or of 
mediated interactions in which the machine and the subject are part of the 
"discussion," is useful for better understanding the role of subjects in operating 
other technologies of objectification, especially ones in which their participation 
was seen as crucial. 41 
Historians ofpsychology such as Kurt Danziger, Deborah Coon, as well as 
Ruth Benschop and Douwe Draaisma have emphasized the function of subjects' 
training in early psychological experimentation. Training was seen as a means of 
making the subject capable of channelling his (he was usually male, as well as 
white) subjective judgment to make it more precise and consistent, thus, to sorne 
extent, calibrating, standardising, and mechanising his own mind as a too1 of 
investigation. The subject was thought of as a scientist, and indeed was often a 
faculty member or graduate student in psychology who was called an "observer," 
and was also thought of as a kind of instrument. This enabled him to represent a 
"universa1" or "generalized" mind, rather than his own idiosyncratic judgment.42 
Another means of making psychology more "objective" was/ to select mental 
phenomena and re-define them in quantitative terms, while rejecting others from 
the domain of 1egitimate psycho1ogical enquiry.43 
38 Othniel E. Dror, "The Scientific Image of Emotion: Experience and Technologies of 
Inscription," Configurations 7 (1999), 368 and 382. 
39 Dror, "Scientific Image," 383-4. 
40 Dror, "Scientific Image," 388-391. 
41 This is not exactly the way in which Dror uses the concept, but seems to be compatible with it. 
42 Deborah J. Coon, "Standardizing the Subject: Experimental Psychologists, Introspection, and 
the Quest for a Technoscientific Ideal," Technology and Culture 34 (1993): 757-83; Kurt 
Danziger, Constructing the Subject (New York: Cambridge University Press, 1990); Ruth 
Benschop and Douwe Draaisma, "In Pursuit of Precision: the Calibration ofMinds and Machines 
in Late Nineteenth Century Psychology," Annals of Science 57 (2000), 1-25. 
43 Gail A. Hornstein, "Quantifying Psychological Phenomena: Debates, Dilemmas, and 
Implications," The Rise of Experimentation in American Psychology, ed. J. G. Morawski (New 
Haven and London: Yale University Press, 1988), 1-34. 
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These scientists of the subjective clearly strove for forms of objectivity 
that were in sorne ways analogous to those in the physical and physiological 
sciences, but they also developed novel ways of managing subjectivity without 
eliminating it from the production of knowledge. The objectification of subjective 
phenomena is different from that of bodily processes, and the measurement of 
pain different from the measurement of matter, in that the first require the 
participation-and are open to the interference of- subjects' consciousness. To 
objectif y the subjective, scientists have had to find ways to involve subjects, 
eliciting and isolating certain aspects oftheir subjectivity, without allowing them 
to influence the measurement or experimental process in irrelevant ways. 
In the 19th and early 20th centuries, making the study of the mind scientific 
seemed to involve sorne form of "mechani sati on" of the subject, both literally 
through the use of instruments and figuratively by transforming the subject into a 
machine, and to depend on the subjects' own ability to manipulate their minds in 
order to isolate and purify particular forms of judgment. As untrained and naïve 
subjects replaced expert observers in psychological experimentation and new 
models of the mind were developed in the later 20th century, practices of 
objectification increasingly depended on new techniques for illuminating and 
containing subjectivity.44 Psychological instruments made out ofbrass and glass 
were replaced or joined by paper-based questionnaires and computers able to 
manipulate information and practices in new ways.45 Much more work is needed 
on the history of20th century practices of the "objectification of the subjective," 
in psychology or in other fields. 
More generally, historians of objectivity have not go ne far enough in 
distinguishing between different forms of subjectivity, and especially the 
dangerous from the valuable ones, and in identifying the practices through which 
they have been managed. Considering the development of psychology and its 
44 Danzinger, Constructing the Subject; Gerd Gigerenzer, "From Tools to Theories: Discovery in 
Cognitive Psychology," in Historical Dimensions of Psychological DÎscourse ed. Carl F. 
Graumann and Kenneth J. Gergen, (New York: Cambridge University Press, 1996): 36-59 
45 Ryan D. Tweeny, "Whatever Happened to the Brass and Glass? The Rise of Statistical 
"Instruments" in Psychology," in Thick Description and Fine Texture: Studies in the History of 
Psych%gy, ed. David B. Baker (Akron, OH: University of Akron Press, 2003) 123-142. 
32 
33 
widespread influence on conceptions of the self in the 20th century, it has become 
increasingly clear that subjectivity, even as it is defined within the sphere of 
scientific practice, does not only map onto negative values-bias, prejudice, 
corruption, vested interest, (poor) judgment, arbitrary opinion, fickleness, 
injustice, suspicion-but also positive ones-the richness of full experience, 
(good) judgment, identity, selfhood, personal meaning, personality. 
1 aim to contribute to this history of the objectification of the subjective by 
paying close attention to the ways in which investigators have characterised as 
subjective, in positive and negative ways, both pain itself and the process of its 
evaluation. What obstacles stood in the way of the reliable communication of 
information about pain? How did the use of technologies ofmeasurement propose 
to make that communication more reliable (what would it eliminate, control, 
stabilize, isolate)? Though what channels (minds, bodies, personalities, cultures) 
was the experience and evaluation of pain influenced by the personal, the social 
and the idiosyncratic? Was the "personal" and "social" a constitutive or 
corrupting influence on the experience of pain? What exactly was the "personal" 
aspect of pain-was it a physical constitution, the delicacy of nerves, a 
personality type, a particular meaning, an ability to express oneself, a 
susceptibility to emotion, a set of memories, a cultural identity-and how was it 
forrned by minds, bodies, souls, the "social" and the past? 
This examination reveals important shifts in thinking about pain's 
subjectivity that occurred around the middle of the 20th century. At the turn of the 
century, technologies ofpain-measurement had been meant to eliminate the 
emotional and idiosyncratic dimensions of pain responses, thereby isolating a 
psycho-physiological transmission of impulses that began in the external stimulus, 
travelled through the body and manifested itself in a mental perception. Variations 
in responses to pain were conceptualised as physiological variations in sensitivity, 
that is, in the delicacy or receptiveness ofthe nerves that transmitted pain 
impulses through the body. Around 1940, attention was refocused on the ways in 
which emotions, personal psychological characteristics and past experiences 
modulated responses to pain. By 1950, sorne pain-measurers suggested that pain 
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should not be measured as an event produced by bodily stimulation nor a response 
to stimulation, but rather as an experience produced by mental processes in which 
sensation, perception, response and interpretation were integrated, and shaped by 
social and psychological processes. 
These were conceptual shifts but also shifts in practices, enabled by new 
models of pain but also by new technologies of measurement. Nikolas Rose has 
argued that the psychologisation of Western societies should be studied as a 
history of practices, that is, of the "ways in which persons are understood and 
acted upon in particular activities of life.,,46 Thus, Rose showed that changing 
concepts of selfuood are not only the product of broad cultural influences, but of 
the development and deployment of specific techniques of measurement and 
differentiation within specific realms. 1 similarly argue that the psychologisation 
of pain required techniques for attaching pain to the personal and emotional in 
new ways. Pain was subjectified through the application of new techniques of 
investigation that have enabled researchers to outline, stabilise and quantify 
categories and variables such as personality, anxiety, stress, or upbringing. These 
were techniques to measure physiological emotional responses and personality 
characteristics, and experimental designs for modelling personality types and past 
experience, that were generated and circulated thanks to new philanthropic and 
military funding for psychosomatic research in the 1930s and 1940s. In the late 
1940s and early 1950s, pain was also subjectified through the application of the 
analgesic clinical trial. The techniques of the clinical trial, which were adapted for 
the evaluation of analgesics, entailed new forms of procedural and statistical 
control that enabled highly individual and variable experiences of pain to manifest 
themselves in regular and reliable collective patterns. That is, the clinical trial 
measured the pain and pain relief of groups rather than individuals. It was no 
longer necessary to standardise individual experiences or evaluations of pain, and 
thus possible to measure analgesia reliably while still conceptualising every 
person's pain as unique. 
46 Rose, Inventing Our Selves, 23. 
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These changing conceptions of pain' s positive subjectivity-that which 
needed to be measured-were associated with shifts in ideas about what kinds of 
subjectivity needed to be eliminated from the measurement process. In the late 
1 9th and 20th centuries, technologies of measurement were aimed towards the 
elimination of the will and emotionality of subjects whose pain was being 
measured, ideally bypassing their verbal and conscious participation but in reality 
attempting to isolate sensory judgment from emotionality and expressivity. 
Beginning in the 1940s, sorne researchers began turning their efforts towards the 
standardisation and comparison of emotionality and personal characteristics in 
pain responses by using autonomic measurements, personality questionnaires, or 
choosing certain categories of subjects in their experiments. The implementation 
of the analgesic c1inical trial brought new ways of controlling subjectivity and 
variation through the standardisation of the interrogation process, the 
neutralisation of subjects' and investigators' expectations of future changes in 
pain levels, and the collection, and statistical analysis, of large quantities of data. 
Along with the use of the se new controls, pain-measurers described new ways in 
which pain could be influenced by subjective processes: trust in medicines, an 
excessive desire to please, personality characteristics, political indoctrination, the 
influence of the media, cultural conditioning, etc. With the c1inial trial, it was no 
longer necessary to directly target and eliminate the factors that influenced pain-
measurement. The hypothetical sources of subjective influence on pain-
measurement were multiplied. 
1.3 Methodology 
1 define technologies ofpain-measurement broadly, encompassing not only 
material technologies but also organisational or procedural ones. That is, 1 define 
these technologies as the combination oftools and rules that are used to formalise 
and mediate interactions (between both people and tools) in order to pro duce 
information about pain that is expressed in numbers. Certain technologies are 
often embedded within others, in which case their use is usually considered to be 
meaningless without the operation of a broader set of rules about how they should 
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be used. 47 Two examples will help to illustrate these points. Take the simple pain-
scales 1 described earlier. In the triage procedure of a hospital emergency room, 
the number produced by this scale instrument may mean something immediate: 
give the pers on an analgesic or priority to consult a doctor. This meaning may be 
given by another technology, such as a protocol or guideline, which provide rules 
that guide the production and use of this number. In a clinical trial, however, both 
the rules for using this instrument and its meaning are quite different. The use of 
the scale means little if it is not used within the specific conditions prescribed by 
the design of the trial, which dictates how subjects should be recruited, what 
drugs they should receive, and what information they should be given. In 
addition, the number produced by the scale becomes valid only as part of the 
calculation of a change in pain experienced by a group of subjects. Individual 
measurements were not considered to be reliable. Thus, the real technology for 
measuring pain was not only the scale itself, but consisted of the whole clinical 
trial method that measured pain-and its change over time-collectively. 
1 have looked for these pain-measuring technologies in various places. 
Published journal articles make up the majority of my sources. 1 searched for 
these articles quite broadly, identifying as potentially relevant articles on topics 
such as the diagnosis of psychogenic pain, experiments on differences (racial, 
gender, age) in pain or other psychological and physiological aspects of pain 
using human subjects, the treatment of ill-defined painful conditions such as low 
back pain, pain in disability evaluation, etc. Analgesic evaluation appeared early 
on as one of the areas in which pain-measuring technologies were used the most 
extensively, while other areas, such as clinièal diagnosis, seemed hardly to 
involve their use at aIl. 1 therefore collected articles on the topic of analgesic 
47 Cambrosio et al., "Regulatory Objectivity," explain, for example, that traditional measures such 
as blood pressure, which can be seen as embodying the ideal ofmechanical objectivity, "now 
function as part of an expanding set of embedded regulations that set the parameters of use," such 
as clinical guidelines. Thus their actual use in the current socio-epistemic c\imate ofmedicine is 
characteristic of regulatory objectivity. They suggest that, in order to figure out what kind of 
objectivity is at work, we must pay attention to how the meaning and function of particular 
measurements are determined, which may be the product of multiple technologies. 
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evaluation more systematically and extensively, and selected my case studies 
within this area. 
These articles served as a departure point to map out the "territory" of my 
topic and to identify potentially useful archivaI sources. They also contained 
useful information in themselves, such as: descriptions of specific technologies 
and their use, discussions of their advantages and disadvantages, information 
about the identity and quantity of subjects used in specific experiments, mentions 
of difficulties encountered in running experiments, and the identification of 
sources of funding. 
To obtain additional information about why and how specific technologies 
were designed and implemented, archivaI sources are invaluable. 1 was aware 
from the work of Marcia Meldrum that a Committee on Drug Addiction had 
formed in the late 1920s, and had been active in sponsoring the development and 
use of pain-measuring technologies for the purpose of analgesic evaluation.48 
Documents pertaining to this committee and its successors have been conserved 
in the archives of the National Academies of Science. They include 
correspondence between members and researchers, transcripts of meetings at 
which pain-measuring technologies were discussed, and information about 
funding for researchers who developed or used these technologies to evaluate 
analgesics. In addition, minutes of the meetings, research proposais, reports, and 
budgets were published for limited circulation and are now available at the 
National Library of Medicine, while an institutional history written by an active 
member of the committee has also been published.49 1 used information obtained 
from the se sources extensively in chapters 5 and 6. 
48 Marcia Meldrum, "Each Patient His Own Control: James Hardy and Henry Beecher on the 
Problem of Pain Measurement," American Pain Society Bulletin 9, no. January/February, n. 1 
(1999): http://www.ampainsoc.org/pub/bulletin/jan99/historv.htm (Accessed September 29, 
2003). On the work ofthis committee, see also Caroline J. Acker, "Addiction and the Laboratory: 
The Work of the National Research Council's Committee on Drug Addiction, 1928-1939," Isis 86 
(1995): 167-93; Caroline J. Acker, Creating the American Junkie: Addiction Research in the 
Classic Era ofNarcotic Control (Baltimore: Johns Hopkins University Press, 2002). 
49 Nathan B. Eddy, The National Research Councillnvolvement in the Opiate Problem, 1928-
1971. (Washington, OC: National Academies of Science, 1973). 
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The National Academies of Science also formed a committee for the study 
of acupuncture anaesthesia in the 1970s. The evaluation of the efficacy of 
acupuncture on the relief of pain was a contentious issue during these years. 
Drawing on the records of this committee and those of other committees on 
acupuncture collected in the papers of John J. Bonica and conserved in the John 
C. Liebeskind History of Pain Collection at UCLA, 1 was able to examine the use 
of pain-measuring technologies to resolve the se issues. Bonica' s papers also 
included correspondence, newspaper clippings, and other useful information. The 
issues was also extensively covered in the press, and 1 was able to supplement 
archived clippings with articles obtained from the systematic search of JAMA, the 
use ofmedline, and the digitized archives of the New York Times and the Wall 
Street Journal through ProQuest. 
Finally, 1 consulted the collected papers of individual researchers whom 1 
knew to have used or designed particular pain-measuring technologies: Harold G. 
Wolff, co-creator of the Hardy-Wolff-Goodell dolorimeter;50 Janet Trave1l51 and 
William K Livingston52, who used the dolorimeter; Henry K. Beecher, pioneer of 
the analgesic clinical trial;53 John Adriani, who ran analgesic clinical trials;54 John 
J. Bonica, who also ran analgesic clinical trials, as weIl as a pain clinic and who 
was active in the debate on the evaluation of acupuncture;55 and Emmanuel 
Libman, inventor of the Libman pain test.56 1 was also fortunate to have access to 
oral histories collected by the John C. Liebeskind History of Pain Collection at 
UCLA. The oral histories of Louis Lasagna, Ada Rogers, and Raymond Houde 
50 Harold G. WolffPapers, Medical Center Archives ofNewYork-Presbyterian/Weill Cornell, 
New York, NY. 
51 Janet Travell Papers, Special Colletions and University Archives, The George Washington 
University, Washington, OC. 
52 William K. Livingston Papers, Manuscript Collection 136, History & Special Collections 
Division, Louise M. Darling Biomedical Library, University ofCalifornia, Los Angeles, CA. 
53 Henry K. Beecher Papers, Harvard Manuscript Collection 64, Harvard Medical Library in the 
Francis A. Countway Library of Medicine, Boston, MA. 
54John Adriani Papers, Modern Manuscripts Collection 453, History of Medicine Division, 
National Library of Medicine, Washington, oc. 
55 John J. Bonica Papers, Manuscript Collection 118, Louise M. Darling Biomedical Library, 
History & Special Collections Division, University ofCalifornia, Los Angeles. 
56 Emanuel Libman Papers, Modern Manuscripts Collection 406, History of Medicine Division, 
National Library of Medicine, Washington, Oc. 
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were especially helpful for understanding the appeal and operation of analgesic 
clinical trials. 
These sources enabled me to follow certain lines of analysis by asking particular 
sets of questions. 1 summarise them here: 
1. Changing lobbies to transform pain into a measurable entity: 
Who invested resources to create, promote and implement particular pain-
measuring technologies? Were these investments made within the context of 
larger projects, and if so which ones? It is in answering these questions that my 
study tells an American story: it is the story of American campaigns against drug 
addiction; of the interest in analgesics of the American pharmaceutical industry, 
American military, and public health institutions; of the professional ambitions of 
American psychologists, physiologists, anaesthesiologists, and pharmacologists; 
of the goals of American therapeutic reformers ... 1 also ask: What kinds of 
demands did they make for quantitative data about pain, or for certain kinds of 
pain-measuring technologies and how might these demands have shaped the 
design and use of these technologies? 
2. Changing availability of resources to create and implement pain-measuring 
technologies: 
What resources were available to make pain-measuring technologies work? ln 
answering this question, 1 have included both those resources-including social, 
material, and technical ones-that were specifically mobilized towards the use of 
pain-measuring technologies, and those which were available for other reasons. 1 
also invert the question to ask: What kinds of resources did it take to make 
specifie pain-measuring technologies work? 
3. Changing notions of objectivity and subjectivity: 
How were pain-measuring technologies supposed to improve the evaluation of 
pain? What types of variables were they meant to eliminate, control or manage? 
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With what expectations about interactions and abilities were these technologies 
designed? On what abilities, materials, and practices did their actual use depend? 
How did they propose to reconfigure interactions and transform judgment? 1 have 
paid particular attention to the issue of variation by asking: What information 
about inter- and intra-individual variations in the experience and expression of 
pain entered into the design of pain-measuring technologies? How was the use of 
technologies ofpain-measurement supposed to deal with this variation? How did 
they manage variation in practice? Aiso key in my analysis of these questions are 
notions of trustworthiness: What kinds of impulses, idiosyncrasies, prejudices, 
bias, or variables were thought likely to corrupt the validity of measurement? 
What kinds of people, instruments and practices were thought to be able to protect 
against such corruption? Who was entrusted with the operation ofpain-measuring 
technologies: who made good subjects, good observers, good experimenters and 
what qualities of trustworthiness did they possess? What kinds of people were 
excluded from their operation? 
4. Changing notions of pain, communicability and difference: 
What, exactly, did pain-measuring technologies measure? For what reasons was 
pain seen to be difficult to communicate accurately, precisely, or reliably? How 
was it made more measurable or communicable through the use of technologies? 
What variables were thought to influence pain and through what channels or 
mechanisms did these variables operate? How did the use of pain-measuring 
technologies help to define and explain differences in the experience or 
expression of pain? 
5. The utility ofpain-measuring technologies 
Wcre pain-measuring technologies uscful for resolving particular debates? On 
what did the validity of the numbers produced by pain-measuring technologies 
depend? What did these numbers mean? How widely did their meaning and 
validity extend? What kinds of mechanisms existed to generate agreement about 
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the meaning and validity of pain-measurement? How were these instruments, and 
information about how to use them, diffused? 
I chose analgesic testing technologies and debates about them as my case studies. 
This was a practical choice, since the se were the technologies and debates about 
which the most written sources were generated, and the richest information could 
be drawn. But it was also justified since they were the technologies in which the 
most resources were invested, and which were central to investigating why, when, 
and by whom, the quantification of pain was defined as important and how it was 
achieved in practice. 
As a consequence of these choices, much of my thesis deals with the 
measurement of pain as part of the evaluation of analgesic therapies. This is not 
because 1 wanted to write a history of analgesic evaluation, but because those who 
invested the most time, effort and money into making pain measurable were also 
ultimately trying to make the evaluation of analgesic therapies more accurate and 
impersonal. As a result, I have had to situate the history of pain-measuring 
technologies within the history oftherapeutic evaluation. I have also, however, 
paid sorne attention to the function of pain-measurement in the development of 
psychophysics, psychology, psychosomatic research, anaesthesiology, and clinical 
pharmacology, as weIl as in the measurement of individual and collective 
differences. 
1.4 Summary of Chapters 
The first pain-measuring instruments were created in the last decade of the 191h 
century. In chapter 3, I examine their emergence in experimental psychophysics, 
and follow attempts to extend their use to applied psychophysics, clinical 
diagnosis, and the evaluation of analgesic drugs. Though these instruments 
worked weIl in limited experimental settings, they did not become widely used. 
Cri minai and psychological anthropologists obtained sorne support in the United 
States and elsewhere for the psychophysical study of hum an differences in 
correlation with sociological and biological data, but failed to realise any large-
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scale projects involving the measurement of pain. There was also sorne interest in 
using pain-measuring techniques for clinical diagnosis-to enhance the diagnostic 
judgment of the clinician rather than replace it-but there is little evidence that 
these techniques were widely used. Finally, sorne attempts were made to measure 
analgesic drug effects more objectively but they received little material support. 
Laboratory psycho-physiologists, criminal and psychological 
anthropologists, clinicians, and pharmacologists used pain-measuring 
technologies for very different reasons. However, these groups shared a 
conception of sensitivity to pain as a nervous and physiological phenomenon and 
as the primary mechanism modulating individual experiences of pain, which 
could be differentiated according to gender, race, class, etc. They also shared a 
distrust of patients' or subjects' spontaneous verbal accounts of pain, and saw 
algometers as a means of digging beyond superficial differences in emotionality 
and expressiveness to reveal a "true" inner sensitivity. While the appeal of 
algometers seems to have been generally associated with a desire for mechanical 
objectivity (except perhaps in the clinic), algometers themselves did not fully 
mechanise the evaluation of pain because they still depended on the subjects' 
consciousjudgment ofpainfulness. Instead, they rendered thatjudgment as easy, 
emotionally-neutral, and automatic as possible. 
During the 1930s, two trends that would influence the future of pain 
evaluation began to take shape. One was a new investment into psychosomatic 
research and its institutionalisation by specific actors and American 
philanthropies, which would be bolstered by the interest in neurotic conditions 
provoked by W orld War II. This led to the creation and implementation of new 
techniques to define and measure psychological influences on physical experience 
and vice versa. The second was the launch of a systematic search for a non-
addictive analgesic hy the Committee on Drug Addiction of the National 
Academies of Science, which created a demand for precise methods to isolate and 
quanti:fy the pain-relieving potency of new drugs. This demand was stimulated by 
the American discovery of fully synthetic analgesics developed by the German 
pharmaceutical industry just before and after the war. 
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The reception of a new algometer, which was introduced in 1940, can be 
seen to reflect the influence of both these trends. The Hardy-Wolff-Goodell 
dolorimeter was acclaimed as the most precise algometer yet, and its precision 
was welcomed for two different types ofuses. In Chapter 4, l describe how the 
algometer was adopted to measure the psychological dimensions of individuals' 
reaetions to pain. An individual's reactivity to pain was conceptualised as an 
emotional and cognitive phenomenon, which was different from the sensory 
sensitivity that had previously been measured with algometers. The measurement 
of pain reactions was made possible not so much by the dolorimeter itself but by 
the development of new techniques to measure psychological influences on pain 
reactions, though it was also based on a theoretical distinction between reaction 
and sensation made by Hardy, Wolff and Goodell. The techniques used to 
standardise psychosomatic variables were the productof the development of 
psychosomatic research in the 1930s and 40s, as weIl as of the development of 
new methods in psychiatry, anthropology, and psychology. They included: the 
rneasurement of autonomic responses (the psychogalvanic reflex, heart rate, blood 
pressure, finger tremor, etc.) and their correlation with emotional fluctuations; the 
development of personality tests and questionnaires; the creation of new 
categories of subjects through psychiatric diagnostic and therapeutic techniques 
(psychoneurotics, lobotomized patients), which were also correlated with 
personality measures; and a new way of conceptualising culture and personality 
and of investigating it through ethnographic methods. Drawing on these new 
techniques, researchers were able to measure new dimensions of pain in the 
1940s, 50s and 60s. These measurement practices thus contributed towards 
defining pain as a psychological reaction that was susceptible to the influence of 
personality, early experience, culture, meaning, and emotion. 
ln chapter 5, 1 turn back to 1940 when the Hardy-Wolff-Goodell 
dolorimeter was introduced to examine how it was received as an instrument for 
evaluating the potency of analgesics. It turns out that the dolorimeter responded to 
the demands formulated by members of the Committee on Drug Addiction, who 
desired a pain-measuring technology that would enable them, along with 
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addiction-measuring techniques, to calculate precise ratios between the analgesic 
potency and addictive liability of opiate drugs. While World War II interrupted 
the activities of the Committee, it brought news of promising fully-synthetic 
strong analgesics from Germany. Pharmaceutical firms' interests in Demerol 
(early forties) and Methadone (post-war) made them eager for a method such as 
the Hardy-Wolff-Goodell dolorimeter to test the efficacy of these new drugs and 
pursue research on similar synthetics. Soon, however, sponsors of analgesic tests 
would begin favouring the analgesic clinical trial instead ofthe dolorimeter. By 
1950, it seems that the dolorimeter, as an analgesic-testing method, was being 
abandoned. The aim of chapter 5 is to explain why this shift took place. 1 suggest 
that the involvement ofnew actors in analgesic testing at the end of the decade, 
and the investment of new resources for operating analgesic-measuring 
technologies, were important factors in the displacement of the dolorimeter by the 
analgesic clinical trial. 
In Chapter 6, 1 examine in detail the design and operation of analgesic 
clinical trials under the sponsorship of the Committee on Drug Addiction and 
Narcotics. While the basic design ofthe trial was first described in 1949, 
researchers spent the next decade, and even longer, making it into a reliable and 
useful analgesic-measuring technology. 1 argue that producing effective practices 
of analgesic-measurement was largely due to the Committee's activities of 
sponsorship and coordination, which enabled four sets of relationships that were 
crucial to making analgesic clinical trials work. The first was the collaboration 
between the Committee and its grantees (the principal investigators), whose 
professional aspirations made them interested in workable analgesic clinical trials. 
The second was the relationship between investigators and their collaborators, 
including observers and consultants who were paid by Committee grants, and 
patients whose behaviours were investigated as part of Committee-funded 
research. The third was the alliance between the Committee and its sponsors. 
Finally, the diffusion of the analgesic clinical trial was facilitated by the 
communication, coordinated by the Committee, among different research teams, 
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as weIl as the development of techniques ofmulti-trial standardisation that were 
partly sponsored by the Committee. 
While Committee-sponsored researchers succeeded in pro vi ding sponsors 
and regulators with definitive information about the efficacy of analgesic drugs, it 
proved to be more difficult to resolve debates about the efficacy of acupuncture 
analgesia in the early 1970s. Sorne commentators suggested that the efficacy of 
acupuncture was controversial because ofthe "inherently subjective" nature of 
pain. In chapter 7, 1 instead examine why it was so difficult to make technologies 
of pain-measurement work under the social and material conditions within which 
this particular debate took place in the early 1970s. Elite medical researchers 
pushed for the use of technologies of objectification, mainly clinical trials, to 
determine the efficacy of acupuncture analgesia. They portrayed pain as a 
phenomenon that was vulnerable to multiple, intangible influences that traveIled 
through social interactions and acted upon the mind, thus invalidating-for 
therapeutic evaluation purposes-any experience of pain or relief that took place 
under uncontroIled conditions. They encountered several forms of resistance, 
however, in attempting to implement technologies of analgesic-measurement that 
would ensure the appropriate control and quantification of experiences of pain. 
These were a lack of agreement about methodological details, including 
disagreement about how to measure pain and what pain was; a lack of 
mechanisms to coordinate the use of technologies of measurement in multiple 
settings; a lack of material resources to implement the use of technologies of 
measurement on a scale considered to be adequate for resolving the issue; and a 
conflict for authority over the determination of the efficacy of acupuncture. This 
conflict took place within the medical community, with different groups 
competing to control the definition, evaluation and treatment of chronic pain, and 
outside the medical establishment, between elite medical researchers and lay 
people who argued for the validity of individual experiences in determining the 
pain-relieving efficacy of acupuncture. 
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Before beginning this history of pain measurement, 1 first review the 
historicalliterature on pain and situate my own approach in relation to other 
studies of pain and social change. 
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2. Bibliographical Essay: Pain in History 
F ollowing the publication of pioneering studies in the 1970s and 1980s, a growing 
number of historians, as well as other scholars, have been using pain as a focus of 
analysis for understanding social change. Perhaps stimulated by efforts within 
healthcare to redefine pain as an experience that affects the whole person within 
its social and psychological environment, scholars have begun exp10ring the ways 
in which ideas of pain, as weIl as practices of pain infliction, representation, and 
management, can help explain social relations and vice versa. Historians, as well 
as anthropologists, sociologists, literary, and art theorists, have begun referring to 
each other' s work on pain, thus constituting the social and historical study of pain 
as an interdisciplinary and dynamic field of study. Now, in 2006, it is possible to 
define and review their work as a coherent literature. 
1 will not encapsulate the history of pain in the Western world, but rather 
will begin with a review of the ways in which historians have analysed significant 
shifts in the meaning of pain. 1 will then focus on a theme that has especially 
preoccupied historians and other social scientists of pain, and which is also at the 
heart of my own concerns: the communication of pain. Though my focus here is 
on the work ofhistorians, 1 also include the work of anthropologists, sociologists, 
literary scholars, and art historians. 
2.1 Trends: Modernising Pain 
Undeniably, pain has undergone major transformations in Western societies 
during the 18t\ 19th , and 20th centuries. The broad outlines of these 
transformations are well-known. A religious valorisation of pain as redemptive 
was eroded. Instead, a new sensibility, representing pain as useless, cruel, and 
unjust, entered into artistic discourses and movements of humanitarian reform. 
Various forms of 1egal and public practices of painful infliction were abolished. 
New therapeutic tools were discovered and as they were made widely available, 
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they transformed various kinds of physical and mental suffering into relievable, 
and therefore unnecessary, pain. 
Since the 1970s, many historical examinations of the se shifts have rejected 
narratives that explain modern societies' supposed growing intolerance of pain as 
the natural product of the march oftechnological, moral, and evolutionary 
progress. Instead, many authors have revisited landmarks in the history of pain-
the abolition of torture, the appearance ofvarious movements against cruelty, or 
the discovery of anaesthetics and analgesics-by paying attention to the shifting 
function of pain and its representations within particular sets of social relations. 
Historians of torture have explained the disappearance of painful legal practices 
not as evidence of the rationalisation of the law, but as the result of changing 
strategies of power and knowledge that rendered the public punitive infliction of 
pain obsolete. Historians who have analysed the discourses of humanitarian 
reformers have shown that the linkage between higher civilisation and sensibility 
to pain was a tool of reform, rather than its driving cause. Thus, this association, 
which ascribed to reformers and their followers the quality ofbeing civilized 
because they were sensitive, was produced or at least reproduced by these 
discourses. Historians of anaesthesia and analgesia have examined the 
professional politics and concerns that motivated or restricted medical recourse to 
painkillers, while also pointing to commercial strategies and consumer demand, 
rather than a process of medicalisation led by healthcare professionals, as factors 
driving the expansion of the market for pain remedies. 
Perhaps the best~known reinterpretation of the modern "disappearance" of 
pain is Michel Foucault's work on the history of criminal punishment.57 Foucault 
sought to understand a double shift that occurred with the generalisation of 
incarceration in the early 19th century-the disappearance of the public spectacle 
ofpunishment, and the displacement of the physical body as the target ofpainful 
punitive practices-by placing the se shifts within the framework of a history of 
the body and of power. That is, he looked at how the body was targeted by 
57 Michel Foucault, Surveiller Et Punir: Naissance De La Prison (Paris: Gallimard, 1975). 
Translated and published in 1977 under the title Discipline and Punish. 
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strategies or technologies of power [technologie politique du corps ]58 and thus 
saw changing ways of using the body as evidence of transformations in the 
exercise of power. 
Foucault argued that the function of reforms for less painful punishments 
was not to "soften" power but to make it more fine-grained, more extensively 
distributed, and better adapted to a new society and its crimes. Old Regime crimes 
were committed against the sovereign, and the function of spectacular and painful 
punishment was to pro duce the truth of the crime publicly, thus re-establishing the 
right balance of power between the criminal and the sovereign. Both the nature of 
crimes and the society in which they were committed changed; the new crimes 
were committed against property, as weIl as against the whole society. Reformers 
were not so much concerned with cruelty involved in painful punishment, but 
with its inefficiency and poor distribution as a form of power. Their goal was not 
to punish less, but to punish better; by targeting the soul rather than the body, and 
by depriving the criminal of goods and liberty rather than life and bodily integrity. 
Having lost its function and collective intelligibility, painful punishment became 
repulsive. 
While Foucault's study explained the function ofbodily pain in punitive 
practices, Lisa Silverman studied torture as a means of extracting confessions in 
early modern France. She argued that torture had made both cultural and legal 
sense because there was a consensus-created in the religious arena-about the 
value of pain. In religion as in law, pain was seen as a means of crushing or 
bypassing the will to elicit truth from the body.59 Indeed, TalaI Asad has shown 
that the origins of inquisitorial torture depended on the emergence of religious 
rituals of sacramental penance linking the infliction of pain to the production of 
58 The concept oftechnology of power of the body is quite broad, and en compasses the various 
means by which bodies are disciplined and made productive within a political and economic order. 
Technologies of the body require knowledge about the body, not necessarily of its material 
composition and function, but of its capacities and behaviours, which it aims to reform in order to 
make it more productive. 
59 Lisa Silverman, Tortured Subjects: Pain, Truth and the Body in Early Modern France (Chicago: 
University of Chicago Press, 2001). 
49 
50 
truth in the middle Ages.60 It was when these associations broke down in the 18th 
century, Silverman argued, that torture lost its consensual foundations and became 
criticised as indefensible by the philosophes. For them, personal agency was 
essential in the production oftruth, and pain was to be rejected not only as 
useless, but as being opposed to personhood. Thus, for both Foucault and 
Silverman, as the meaning ofbodily pain shifted, it lost its utility in legal and 
punitive practices. Pain was not rejected because of concerns about cruel and 
arbitrary power. Others have also argued against a progressive narrative of the 
disappearance of corporal punishment by pointing out that torture only 
disappeared for certain people, continuing to be frequently practised on enslaved 
and colonized peoples, dissidents, soldiers, and prisoners ofwar. 61 
The pains inflicted not only on criminals but also on various other 
groups-animaIs, slaves, the insane, schoolchildren-were redefined as cruel by 
18th and 19th century reformers. Several historians have analysed the central role 
of representations of pain and suffering in these campaigns of reform, mainly in 
the Anglo-American context. Karen Halttunen and Elizabeth Clarke, for example, 
have argued that the strategic use of images of suffering in these campaigns made 
sense because it drew on and consolidated the emergence of a new sensibility. 
Where did this sensibility come from? While both place the intellectual and 
cultural roots of this sensibility in religious and literary movements of the 18th 
century, they also point out that sorne scholarship has instead emphasised social 
origins in industrialisation, consumerism, and a growing social distance between 
the increasingly comfortable middle classes and the suffering working classes. 
Halttunen also points out that, while humanitarian representations of 
suffering claimed to demolish social distance, for example, as Clark shows, by 
newly incorporating slaves as sentient beings into a universalising "web of 
sympathy,,,62 they also rested on and created social distance. First, these images 
60 TalaI Asad, "Notes on Body Pain and Truth in Medieval Christian Ritual," Economy and Society 
12 (1983): 287-327. 
61 Marcus Wood, Blind Memory: Visual Representations ofSlavery in England and America, 
1780-1865. (New York, NY: Routledge, 2000), 228-230. 
62 Elizabeth R. Clark, "'The Sacred Rights of the Weak': Pain, Sympathy and the Origins of 
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moved real pain into textual and visual representations, away from the immediate 
environment of white middle class people. They became a "spectatorial exercise 
of sympathy.,,63 These representations also emphasised social difference by 
defining appropriate responses to suffering according to white middle-class values 
of sympathy, virtue, and civilisation, and in line with their desire for prosperity 
and social order, rejecting brutality and insensibility as savage.64 
The dissolution of the religious definition of pain as redemptive, sorne 
historians have suggested, led to a more narrow, rational, and individualistic view 
of pain as something to be avoided or eliminated. Analyses of reformist 
discourses on pain, however, show that the religious implications, collective 
meanings, and valorisation of suffering did not disappear but instead shifted. The 
shi ft towards evangelical and liberal forms ofProtestantism in Anglo-American 
societies produced new notions of pain that overtook pre-existing Catholic and 
Calvinist ones. The suffering self, expiating human sins in the image of the 
Crucifixion, was replaced with an emphasis on a Jesus-like sympathy for the pain 
of others. Suffering was re-valorised within the exercise of "spectatorial 
sympathy"-a strategy much used by reformers-for the affective response it 
evoked in the virtuous Christian, at the same time forming and confirming this 
virtue. In addition, as Karen Halttunen has argued, as pain was made obscene by 
reformist discourses, it also became titillating in pornographic representations.65 
Suffering took on value in other realms as weIl. Rebecca Herzig has shown that, 
towards the end of the 19th century, science became characterized as an activity 
both worthy of, and made worthy by, painful self-sacrifice. Painful sacrifice for 
Humanitarian Sensibility," Journal of American History 82, no. 2 (1995): 463-93. 
63 Karen Halttunen, "Humanitarianism and the Pornography of Pain in Anglo-American Culture," 
American Historical Review 100 (1995): 303-334. Referring to J. S. Mill's essay "On 
Civilisation," Halttunen argued that the em~ct ofhumanitarian campaigns was to distance tht: 
middle classes From actual scenes ofsuffering, which were relegated to the indirect representations 
of its literature. She also notes, as other historians have, that there seemed to be a great concern in 
humanitarian movements about the effects of observing pain rather than those of suffering it. 
64 Halttunen and Clark suggest this. See also James Turner, Reckoning With the Beast: Anima/s, 
Pain and Humanity in the Victorian Mind (Baltimore: Johns Hopkins University Press, 1980); 
Lucy Bending, The Representation of Bodily Pain in Late Nineteenth-Century English Culture 
(Oxford, New York: Clarendon Press. Oxford University Press, 2000). 
6S Halttunen, , "Humanitarianism," 303-334. 
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science was both literaI, in the heroic exploits of arctic explorers and of 
researchers who self-experimented with yellow fever and x-ray, and figurative, in 
appeals to a general aesthetic of asceticism. While characterising science and 
scientists as rational, the valorisation of self-sacrifice rested on moral values.66 
If the 19th century did not bring a radical secularisation and de-valorisation 
of pain, it was nevertheless a period of "great discoveries" in physiology and 
pharmacology, associated with a growing tendency to think of pain in terms of 
nervous transmission and psychological processes, and leading to the creation of 
increasingly effective painkillers: nitrous oxide, ether, chloroform, morphine, 
aspirin, and heroin.67 Popular histories ofthese discoveries were published in the 
1930s and 1940s under evocative and self-explanatory titles such as The Conques! 
of Pain, Vic!ory over Pain, and Triumph over Pain. 68 
The first critiques of such triumphant narratives of "man' s" increasing 
power to prevent and annihilate pain were formulated by critics of medicalisation. 
In the 1970s, Ivan Illich complained that the medicalisation of pain had not only 
failed to relieve human suffering, but had also stripped individuals of the spiritual 
and communitarian resources they might have used to deal with this suffering.69 
Using similar terms, Philippe Aries criticised the medicalisation of death.70 Illich 
and Aries participated in a broader climate of discontent with medical authority, 
which also included various other "lay" health movements, in particular the 
women's health movement, which criticised both the limitations and unjustified 
dominance of medical expertise. These were also contemporary with nascent 
movements from within me di cine to better medicalise, by humanising, 
broadening, and improving, the care of chronic pain sufferers and the dying. 
Reformers, such as the American anaesthesiologist John Bonica and the British 
66 Rebecca M. Herzig, Sufferingfor Science: Reason and Sacrifice in Modern America (New 
Brunswick, NJ and London: Rutgers University Press, 2005). 
67 Roselyne Rey, The History of Pain (Cambrige, Mass: Harvard University Press, 1995). 
68 René Füllop-Miller, Triumph over Pain (Indianapolis and New York: Bobbs-Merrill, 1938), 
translated by Eden and Cedar Paul; Victor Robinson, Victory over Pain: A History of Anesthesia 
(New York: Schuman, 1946); George Sava, The Conquest of Pain: The Story of Anaesthesia 
(London: Macdonald, 1946). 
69 Ivan Illich, Medical Nemesis: The Expropriation of Health (London: Calder & Boyars, 1975), 
93-108. 
70 Philippe Ariès, L'Homme Devant La Mort (Paris: Éditions du Seuil, 1977). 
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physician Cicely Saunders, published extensively in the 1960s and 70s on the 
extensive amounts of pain that remained unrelieved by modern biomedicine.7I 
Despite their different agendas, Illich, Aries, Bonica, and Saunders similarly 
questioned the ability of medicine and science-despite its "great discoveries"-
to deal with the human problem of pain. 
Echoing Illich, David Morris has denounced the way in which medical 
discourse has dominated the definition of pain, and has argued for the recovery of 
alternative ways of giving meaning to pain that were swept away by its 
medicalisation. Morris presented history as a tool capable of providing post-
modern sufferers with new strategies to deal with their pain. Morris' approach, 
however, seems to caricature the modern medically-dominated view of pain as a 
powerful "myth," in which pain is defined as nothing more than "a matter of 
nerves," that is, of the physiological transmission of impulses. Morris also seems 
to exaggerate the medicalisation of pain as a powerful process that stripped pain 
of its broader cultural associations. 72 Recent scholarship and my own findings 
suggest that Morris may have overestimated the power exercised by the medical 
establishment over the definition and management of pain, oversimplified the 
medical view of pain, as weIl as ignored the broader social and cultural meanings 
given to "nerves" from the 18th to the 20th centuries.73 
The discovery of anaesthesia in the mid-19th century has often been taken 
as a defining moment in the medicalisation of pain. Sorne histories have 
suggested that a shift in the characterisation of pain from inevitable to avoidable 
71 1sabelle Baszanger, Inventing Pain Medicine From the Laboratory to the Clinie (New 
Brunswick, N.J: Rutgers University Press, 1998); Noémi Tousignant, "Exposing Relief: Place, 
Cancer Pain and Appropriate Care for the Dying in Britain 1950-1980," (Msc dissertation, Centre 
for the History of Science Technology and Medicine, University of Manchester, 2001). See also : 
John J. Bonica, The Management of Pain With Special Emphasis on the Use of Analgesie Block in 
Diagnosis, Prognosis, and Therapy (Philadelphia: Lea & Febiger, 1953); Cicely Saunders, The 
Management o.fTerminallllness (London: Hospital Medicine Publishers, 1967). 
72 David B. Morris The Culture of Pain (Berkeley: University ofCalifornia Press, 1991),2-5. 
73 For example: G. 1. Barker-Benfield, The Culture ofSensibility: Sex and Society in Eighteenth-
Century Britain (Chicago: University of Chicago Press, 1992), explains how the concept of 
"nerves" was popularised in 18th century literature, becoming associated with the definition of 
gender roles and constitutions. Lucy Bending, in The Representation of Bodily Pain, explains how 
nervous sensitivity was mapped onto hierarchical models of society. 1 also review these notions in 
Chapter 3. 
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enabled the discovery of anaesthetics, while others claim that anaesthetics 
themselves brought about this transformation. 74 Others have instead emphasised, 
by paying close attention to professional politics, the way in which doctors and 
surgeons had to redefine their own relationship to pain in order to incorporate 
anaesthetics in their practices and values. American doctors, according to Martin 
Pernick, saw both benefits and drawbacks to painful and anaesthetic surgery, and, 
though they used anaesthetics, they did so selectively. For Pernick, the utility of 
both pain and anaesthesia was contested within a larger debate about the 
professional values of American physicians with respect to the risk and value of 
intervening on patients' lives and bodies. Settling this debate in favour of 
selective anaesthesia depended on adopting a new way of calculating medical 
risk.75 In her study ofmesmerism, Alison Winter explained how ether "won" over 
mesmeric anaesthesia within the context of movements for medical reform in 19th 
century Britain. Mesmerists tried to claim an orthodox status for mesmeric 
anaesthesia by making painless surgery, rather than speed and skill, a symbol of 
surgeons' mastery. While mesmeric anaesthesia obtained limited success on these 
grounds, it was soon replaced by ether, which, for various reasons, was seen as 
more easily incorporated into the "social relations that surgeons wished to 
establish with patients.,,76 Mary Poovey placed pain and anaesthesia within the 
debate amongst obstetricians about how to best establish their positions as experts 
over the female body and as specialists within the medical profession. The 
adoption of obstetrical anaesthesia was dependent upon redefining pain as weIl as 
74 For example : Clark, '''The Sacred Rights'," 473, writes: "In the early nineteenth century, 
doctors began characterizing pain as a treatable pathology rather than as divine punishment or 
common biological medium; this was most dramatically marked by the first use of anesthesia at 
Massachusetts General Hospital in 1846," and describes this as a "reassignment of physical agony 
as a medical or therapeutic problem"; while Morris, The Culture of Pain, 61, writes of the official 
date of the discovery of anaesthesia: "The year 1846 effectively divided human history into 
periods so different that we really cannot recapture what life was like before that date." 
75 M. Pernick, A Calculus ofSuffering: Pain, Professionalism, and Anesthesia in Nineteenth-
Century America (New York: Columbia University Press, 1985). 
76 Allison Winter, "Ethereal Epidemie: Mesmerism and the Introduction of Inhalation Anaesthesia 
to Early Victorian London," Social History of Medicine 4 (1991): 1-27, see also, Allison Winter, 
Mesmerized: Powers of Mind in Victorian Britain (Chicago &London: University of Chicago 
Press, 1998), 180. 
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painlessness in relation to the obstetricians' proper realm of intervention over 
women's bodies and the birthing process. 77 
Analgesics have attracted less attention than the more dramatic 
anaesthetics, but a few studies have questioned the "medicalisation" of pain led 
by doctors and have instead emphasized the role of lay people who marketed and 
bought analgesic remedies in a process of "commercialisation." Jan R. McTavish 
has presented the history headache remedies as a "kind of counterexample to the 
general notion that with the advent of modern medicine, American doctors 
became all-powerful.,,78 American doctors did not seize on the new synthetic pain 
remedies such as aspirin to "enhance their image as compassionate" and raise 
their status despite the fact that the se remedies were both effective and appealing 
to American sufferers.79 McTavish explained this as a result of physicians'-both 
orthodox and sectarian-preference for treating the root causes of disease rather 
than symptoms such as headache, viewing the latter as a form of empiricism. 
Working together, consumer demand and industrial marketing strategies 
transformed the headache into "the very model of an ailment suitable for self-
treatment" in the early 20th century.80 Thus, as the headache lost its importance as 
a medical problem, it increasingly became a marketing issue. Patricia Stokes has 
similarly shown that labour pain was transformed in Germany by consumerist 
responses to patent medicines, as well as by women's desire for self-
determination. 81 
Self-medication for pain was not new in the 20th century, of course, but 
followed 19th century practices of recourse to opium and patent medicines. 82 
77 Mary Poovey, "'Scenes of an Indelicate Character': The Medical 'Treatment' of Victorian 
Women," Representations 14 (1986): 137-168. 
78 Jan R. McTavish, Pain and Profits: the History of the Headache and Its Remedies in America 
(New Brunswick, N. J. Rutgers University Press, 2004), 7. 
79 McTavish, Pain and Profits, 81. 
80 Janice Rae McTavish, "The Role of the Headache and Its Treatment in American Medical 
Practice Prior to World War Il,'' (PhD Thesis, York University, 1996), 15. 
81 Patricia R. Stokes "Purchasing Comfort: Patent Remedies and the Alleviation of Labor Pain in 
Germany between 1914 and 1933," in Pain and Prosperity: Reconsidering 20th-Century German 
History ed. Paul Betts and Greg Eghigian (Stanford: Stanford University Press, 2003), 61-87. 
82 Virginia Berridge and Griffith Edwards, Opium and the People: Opiate Use in Nineteenth-
Century England (London and New York: A. Lane and St-Martin's Press, 1981), 21-48; James 
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While the medical profession fought for control over the dispensation of opium-
based remedies and against the patent medicine industry in the19th century, the 
medical use of narcotics was also policed in the early 20th century because of 
concerns about iatrogenic (medically-induced) addiction. Caroline Acker shows 
that the American Medical Association engaged in a campaign of self-regulation 
to limit the use of opiates in response to accusations that medical treatment was 
contributing to growing rates of addiction.83 Though Acker does not investigate 
the impact of this trend on medical definition of pain, it seems likely that doctors 
concerned about their liability to produce addiction would have become more 
conservative in their judgment ofwhose pain was deserving of relief. 
This type of statement became commonplace in the last decadesofthe 
century. Studies denouncing the "undertreatment" of pain in the 1970s onwards 
have continued to point to fears of addiction-among both patients and healthcare 
professionals-as the cause of under-evaluations of sufferers' need and 
deservingness of relief. 84 Such studies and accusations have been generated as 
part of a broader critique of medicine' s neglect of pain, and a renewed emphasis 
on society's moral and medical dut y to alleviate suffering. This critique was 
associated with several interrelated trends. One of these was a new 
institutionalisation of pain in medicine. In the 1970s, a significant number of 
interdisciplinary pain clinics were founded in the U. S. and elsewhere to deal with 
the problem of chronic pain. This condition was newly defined as a disease, rather 
than a symptom, characterized by its duration and resistance to curative 
treatment.85 Hospices and palliative care units were also established during this 
period, particularly in Britain but also elsewhere, and were largely presented as 
Harvey Young, American Se(fDosage Medicines: An Historical Perspective (Lawrence, KA: 
Coronado Press, 1974). 
83 Caroline Acker, "From Ali Purpose Anodyne to Marker of Deviance: Physicians' Attitudes 
Towads Opiates in the U. S. From 1890 to 1940," in Drugs and Narcotics in History, ed. Roy 
Porter and Mikulas Teich, (Cambridge: Cambridge University Press, 1995), 114-32. 
84 For example, R. M. Marks and E. J. Sachar, "Undertreatment ofMedicallnpatients With 
Narcotic Analgesics," Annals of Internai Medicine 78, no. 2 (1973): 173-81: Margo McCaffery 
and L. L. Hart, "Undertreatment of Acute Pain With Narcotics," American Journal of Nursing 76 
(1976): 1586-91; Ronald Melzack, "The Tragedy ofNeedless Pain," Scientific American 262, no. 
27-33 (1990). 
85 Baszanger, Inventing Pain Medicine. 
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places to better relieve the pain of the dying.86 Pain and palliative care were 
redefined as specialised topics of research and practice, occupying a growing 
number of societies and journals. Isabelle Baszanger has called this 
institutionalisation the "invention of pain medicine. ,,87 
The institutions of pain medicine also served to launch broader campaigns 
to reform medical practices and attitudes towards pain. Efforts to identify and 
remove barri ers to adequate pain treatment, education campaigns to raise 
awareness of pain among healthcare professionals, lobbies for less restrictive laws 
on the prescription of opiates and for the institution of national standards for pain 
treatment are aIl part ofwhat Baszanger has called the "culture of pain," which, as 
she noted, emerged in France in the 1990s.88 My own research confirms a similar 
trend in the U. S. 
Within these movements, pain was redefined as a multi-dimensional, 
individual, subjective1y-defined experience with broad psycho-social (as weIl as 
ethical and cultural) implications. This more "social" definition of pain was 
welcomed by sorne social scientists, who saw it as an opening for collaboration 
with medical scientists in studying the causes and consequences of pain 
experiences.89 The new attention given to pain by healthcare practitioners may 
have stimulated the development of a historical and anthropologicalliterature on 
pain in the 1980s and 90s. The work of Elaine Scarry and David Morris, for 
example, seems to have been inspired by this 'revolution' in medical thinking 
about pain, while anthropologists such as Arthur Kleinman began to turn their 
attention towards chronic pain. Other researchers have instead begun to analyse 
the historical and sociological development of the se movements per se. These 
studies have attempted to identify the social and professional goals that motivated 
86 Noémi Tousignant, "Exposing Relief." 
87 Baszanger, lnventing Pain Medicine. 
88 Isabelle Baszanger, "Douleur," Dictionnaire De La Pensée Médicale. Dir. Dominique Lecourt 
(Paris: Presses Universitaires de France, 2004), 356-361. 
89 Morris, The Culture of Pain; Scarry, The Body in Pain; Mary-Jo Del Vecchio- Good, et al., Eds. 
Pain As Human Experience: An Anthropological Perspective (Berkeley: University ofCalifomia 
Press, 1992). 
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them, the processes by which they were formed, and their consequences for the 
definition and treatment of pain. 
In her history of the anaesthesia department in Oxford, Jennifer Beinart 
pointed out that the development of specialised clinical services for pain 
management created new professional opportunities for anaesthetists who were 
attracted by the prospect of "escap[ing] from the operating theatre and ... [to] use 
diagnostic and therapeutic skills" and "retuming to the general practitioner type 
role.,,9o 
Isabelle Baszanger has provided a useful sociological history of pain 
medicine, showing that the concepts both of the pain clinic and of chronic pain as a 
diagnostic and therapeutic entity were stabilised with the creation of a "world of 
pain," a group of individuals ready to adopt these concepts who became connected 
within institutional networks. However, the results of Baszanger's fieldwork suggest 
that two different types of pain clinics, and two approaches to treatment, came out of 
this "world of pain" even though pain physicians shared a common theoretical 
foundation and presented themselves as a unitary group. The first model was 
consonant with the traditional biomedical approach in that it located pain primarily 
within the body, and treated pain with therapeutic techniques aimed at "curing" it. 
The second model was focused on the person in pain, and sought to "manage" pain 
by modifying the person's behaviour.9! 
Jean Jackson also studied the operation of a pain clinic through ethnographie 
observation. The treatment approach ofthis clinic was similar to Baszanger's second 
model, in which chronic pain was defined as a set of behaviours needing to be 
modified or managed. Jackson shows that patients were often surprised and 
90 Jennifer Beinart, "Pain Relief- A New Sub-Specialty ?" Bulletin for the History of Medicine 36 
(1985): 13. See also 1. Beinart, A History of the Nuffield Department of Anaesthetics Oxford 
1937-/987 (Oxford: Oxford Medical Publications, 1987), 111-132, in which Beinart described the 
establishment of a pain c1inic in Oxford in which anaesthetists played a prominent role. She also 
remarked on the opportunity for anaesthetists to transform their professional roi es through this 
development: "This is perhaps the field, arguably a sub-specialty, in which anaesthetists have the 
best chance of retuming to the general practitioner type role, of direct interface with their own 
patients ... " 
91 Isabelle Baszanger, "Pain Physicians: Ali Alike, Ali Different," in D{fferences in Medicine: 
Unraveling Practices, Techniques, and Bodies. eds Marc Berg, and Annemarie Mol (Durham and 
London: Duke University Press, 1998), 119-43. See also Baszanger, 1nventing Pain Medicine. 
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confused by the "tough love" aspects of this therapy-the staff s discouragement of 
"pain behaviours" such as complaining, resting, or stopping an activity because of 
pain-and expressed resistance to the centre's ideology. Despite staffs daims that 
aIl pain was "real," patients felt that the interpretation of chronic pain as maladaptive 
behaviour delegitimised their own experience and interpretation of their pain. 92 
Participants in the emergence of pain medicine created a new object, chronic 
pain, as a target ofresearch and therapy. Similarly, activists for the creation of 
hospices for the dying also manipulated the meaning of pain to construct a new field 
of intervention. In Britain, Cicely Saunders and her allies represented the hospice as 
a pain-free space, in contrast with the large amounts ofunrelieved terminal pain 
found in general wards and other spaces of care, to legitimate both a new model of 
care and a new form of expertise in relieving the pain of the dying.93 David Clark 
has analysed the function of the concept of "total pain" elaborated by Cicely 
Saunders. For Saunders, "total pain" was a nexus connecting the multiple 
dimensions of the pain ofthe dying-spiritual, psychological, physical, social and 
emotional-as weIl as the multiple types of interventions offered in hospice care. 
This concept, however, had a paradoxical consequence, unintended by Saunders, in 
that it could be seen as a strategy of power that extended the medical or caring gaze 
more widely and deeply into the social and psychologicallife of the patient.94 
Together, these studies show that understandings of the nature and function 
of pain change because society changes. Reformers-humanitarian or medical-
invested pain with new meanings, representing and treating it according to their 
vision ofhow pain should be dealt with within specific social arrangements. Their 
success in transforming pain depended on their power to rally other people to their 
vision. Practices of infliction and treatment of pain were also changed by the 
formation of new ways of exercising judiciary power, changing conditions of social 
92 Jean E. Jackson, "'After a While No One Believes You': Real and Unreal Pain," in Pain As 
Human Experience. ed. Mary-Jo Del Vecchio Good, et al. (Berkeley, Los Angeles and Oxford: 
University ofCalifomia Press, 1992)138-68. See also: Jean Jackson, Camp Pain: Talking With 
Chronic Pain Patients (Philadelphia, PA: University of Pennsylvania Press, 2000). 
93 Tousignant, "Exposing Relief." 
94 David Clark, '''Total Pain,' Disciplinary Power and the Body in the Work of Cicely Saunders, 
1958-1967," Social Science and Medicine 49 (1999): 727-36. 
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organisation and interaction, new forms ofprofessional authority, and processes of 
social differentiation. 
There is more work to be done on the shifts and movements these authors 
have begun to explore and on the social history of pain more generally. 1 believe that 
the changing function of, and responses to, pain in the 20th century, before and 
beyond the late-century movements that have made pain their specific concem, 
remains particularly ignored. The role of the pharmaceutical industry, the media, and 
the evolution of systems of insurance and compensation; of employers, workers, 
soldiers, psychologists, physiotherapists, and patients' groups in addressing and 
defining pain are sorne of the many topics that have yet to be fully explored in 
different national contexts. 
By studying practices of pain measurement, rather than attempts to treat, 
theorise, compensate, represent, or inflict pain, during this this period, 1 hope to ofler 
new perspectives on the relationship between pain and social change during a 
period-the late 19th century to the post-war decades-that has largely been 
neglected by historians of pain.95 1 argue that the changing social, material, and 
technical conditions under which technologies of pain-measurement were created 
and implemented influenced how pain was defined and understood. In particular, 1 
highlight a transformation in conceptions of pain that resulted from a convergence of 
professional, military, commercial, and public health interests in the measurement of 
pain for analgesic testing in the 1940s and 1950s. 1 show that the social and material 
reorganisation of analgesic testing enabled new pain-measuring practices that 
influenced the definition of a "measurable" pain. 
1 am also arguing here for the importance of studying the history of pain as 
a history of practices. That is, to look at pain not only as a concept fashioned by 
theoretical frameworks, religious and medical discourses, or cultural mentalités, 
but also by those processes aiming to make pain more intelligible, manageable, or 
usable for specific purposes, such as evaluating the pain-relieving potency of new 
substances, providing adequate healthcare, making populations more productive, 
or allocating disability benefits. 
95 An exception is Betts and Eghigian, eds, Pain and Prosperity. 
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My initial concem in researching this dissertation, however, was not to 
explain a specific shift or trend, but rather to historicise the processes of 
communication that are used in attempts to make experiences of pain collectively 
intelligible. Many historians and social scientists have shared this concem, making it 
one of the major themes in the social study of pain. The following section ofmy 
review thus examines the way in which this theme has been raised and addressed in 
different studies. 
2.2 Themes: Communicating Pain 
How is it possible to know another's pain? Most researchers who have brought up 
this question since 1985 have referred to Elaine Scarry's landmark study titled 
The Body in Pain: the Making and Unmaking of the World. Scarry begins her 
analysis of the nature of human creation and destruction with the assertion that 
pain is inherently resistant to language, and thus to verbalisation and expression. 
One of Scarry' s often quoted statements is: "To have pain is to have certainty; to 
hear about pain is to have doubt,,96 In Scarry's analysis, the quality of 
expressibility is closely connected with the capacity to create: pain's 
inexpressibility makes it a tool of destruction: of imagination, of the self, of social 
bonds, even of the "world",,97 
Scarry does not deny the possibility of expressing pain, and applauds 
modem efforts to objectif y pain as a means of "neutralizing" it and eliminating its 
destructive potential. 98 However, she uses a definition of pain as essentially 
inexpressible and "world-destroying" to analyse the structure of torture, war, and 
creation. For example, she explains that the function of pain in modem torture is 
to render its victims voiceless; pushing them beyond common bonds of words and 
expression, and is used by unstable regimes to appropriate the voice of the people 
in consolidating their legitimacy.99 
96 Scarry, The Body in Pain, 13. 
97 Scarry, The Body in Pain, 19. 
98 Scarry, The Body in Pain, 5-1l. 
99 Scarry, The Body in Pain, 27-59. 
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It must be emphasized that Scarry's approach to pain is literary, not 
historical. lndeed, her analyses ofboth pain and torture have been criticized for 
their ahistoricism. Lisa Silverman, for example, has argued that Scarry's view of 
modern illegal torture, which is hidden and renders its victims inarticulate, is not 
applicable to pre-modern legal torture that was based on a cultural consensus 
about the value of pain in making its victims speak the truth. 100 Mitchell 
Merback' s study of medieval visual representations of pain is more specifically 
critical of Scarry' s ahistorical definition of pain as private and incommunicable. 
Merback argues that the experience of public spectacles of punishment was part 
of a web of viewing experiences, in particular of depictions of the Crucifixion, 
which gave me die val viewers shared beliefs and feelings about pain as a means of 
expiating human sins. He concludes that "medieval people did not perceive the 
pain of the body as an alienating, isolating and stigmatising power" but rather as a 
"powerful emblem of intersubjective experience ... Pain in the penitential 
spectacle is therefore not 'world-destroying' in the sense theorised in Elaine 
Scarry's brilliant essay on the structure of torture, but rather 'world-making.",IOI 
My own analysis suggests that the late 20th century tendency to define pain as 
"inherently" private and subjective is tied to historically-specific views of the 
person, and was the product of a process of "subj ectification" of pain that began 
around 1940. 
Others, without necessarily rejecting some "inherent" quality of privacy 
and incommunicability in pain, have instead focused on the historically and 
culturally specific strategies by which individuals and collectivities have tried to 
make pain publicly intelligible. Historians and anthropologists have also found 
useful, and expanded on, Scarry's focus on pain and power. They have focused on 
two interrelated problems: that those with less power tend to have less access to 
the mcans of making their pain visible or recognisable, and that their pain is more 
likely to be misrepresented by others. 102 More generally, many have accepted the 
100 Silverman, Tortured Subjects, 20-22. 
101 Merback, The Thief, the Cross and the Wheel, 20. 
102 For example, Keith Wailoo, Dying in the City of the Blues: Sickle Cell Anemia and the Politics 
of Race and Realth (Chapel Hill: University of North Carolina Press, 2001), 204 : "The crucial 
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notion that making pain expressible is a means of creating social bonds, while 
situations and responses that silence expressions of pain dissolve these bonds. 1 03 
The theme ofpain's social transmission has been explored in a wide variety of 
contexts and time periods, focusing on two general issues: the operation of artistic 
and social conventions for expressing pain, and the standards of evidence gui ding 
the judgment of pain within specifie normative processes. 
As we have already seen, Merback argued that there existed, in the 
medieval period, a religious visual culture of pain that gave representations of 
suffering collective meanings. 104 Focusing on the late medieval period, Esther 
Cohen has instead attempted to identify codes of behaviour governing the 
expression of pain. For Cohen, like Scarry, making pain intelligible is a means of 
"socialising" it. These codes, which varied depending on the situation and on 
sufferers' social position, thus facilitated the integration of expressions of pain 
into social relations. When pain was expressed outside these codes ofbehaviour, 
the contact between sufferer and audience was broken, making pain 
misunderstood (for example in labelling the sufferer insane). 105 Cohen's analysis 
raises the possibility that those who are either not familiar with, or refuse to 
follow, such codes for the expression of pain will be more liable to be excluded 
from the bonds that make pain intelligible. 
Lucy Bending, in a wide-ranging study of representations of pain in 
Victorian culture, has argued against Scarry's denial that pain has shared 
referential qualities by pointing to the existence of literary and social conventions 
for expressing suffering. Bending, however, shares Scarry's concern about the 
openness of pain, because of its subjectivity, to misrepresentation by others, 
problem of pain, of course, was that it was invisible within the culture of ciinical 
measurement. .. Thus pain continued to exist in the realm of the subjective-and because of it, 
medical professionals regarded self-reporting pain with suspicion ... Medical pracitioners' very 
inability to speak 'objectively' on the topic merely accentuated the power of cultural assumptions 
in their ciinical practices." 
103 For example: Eghigian "Pain, Entitlement and Social Citizenship in Modern Germany," 20: 
"Th us, the ability of pain to help forge and cement (or by the same merit, loosen and unravel) 
community also has a history." 
\04 Merback, The Thief, the Cross and the Wheel. 
lOS Esther Cohen, "The Animated Pain of the Body," American Historical Review 105 (2000): 36-
68. 
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especially when these others have more power than sufferers. "To be without 
power is dangerous where pain is concerned," Bending explained, because pain is 
"liable to be represented or misrepresented by powerful groups aiming to 
manipulate those with less power.,,106 Bending is particularly concerned with the 
labelling of sorne categories of people, such as the "primitive," as insensible. She 
thus suggests that we need to pay attention to the social distance between 
sufferers and those who are in a position to judge, interpret, or speak for their pain 
in studying processes of communication. 
This problem of social distance complicated the representation of the pain 
of slaves. As Marcus Wood and Elizabeth Clarke have pointed out, the perception 
of slaves' bodies as fundamentally different-by their inability to feel pain and 
their inexpressiveness-from free, white bodies, made it difficult for abolitionists 
to use representations of slaves' suffering in their cause. l07 Yet, such 
representations played a central role in abolitionist campaigns. Clarke explains 
this by showing how abolitionists used the conventions of religious revivalism as 
a model for the use of narratives of suffering in the cultivation of sympathy. \08 
The conventions of sentimental art also served as a model for reformist 
discourses, as Karen Halttunen has pointed out, while representations of suffering 
were meant to "instruct" readers and viewers on the appropriate response to 
pain. l09 N evertheless, Wood claims that the racial "othering" of experiences of 
suffering continues to pose a problem for the use of visual representations of 
torture in contemporary commemorations of slavery.llo 
lndividuals, in their roles as patients, c1aimants, subjects, or witnesses of 
various sorts, have also expressed their pain as a form of evidence to be 
examined, interpreted, and judged within specifie legal, bureaucratie, medical, or 
experimental processes. While the techniques of art history and literary theory 
have enriched our understanding of past ways of representing pain, it seems that 
106Sending, Representations of Bodily Pain, 81. 
107 Wood, Blind Memory, 231-233; Clark, "The Sacred Rights," 474. 
108 Clark, "The Sacred Rights,"473-487. 
109 Halttunen, "The Pornography of Pain," 330. 
110 Wood, Blind Memory, 281. 
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the questions that preoccupy historians and sociologists of science might be 
particularly fruitful for examining the relationship between truth, trust, evidence, 
objectivity, and pain. Surprisingly, there has been relatively little effort to 
examine pain from this angle. It has often been taken for granted that expressions 
of pain are inevitably subjective and mistrusted by experts and judges, without 
examining the origins ofthis mistrust or investigating attempts to objectif y pain. 
There are, however, a few exceptions. 
Participating in a recent surge of interest in the history of witnessing and 
the construction of truth, Silvia De Renzi has examined the function of medico-
legal testimony in the courts of counter-reformation Rome. In one of her case 
studies, she analysed attempts to prove the existence of an incapacitating 
headache. De Renzi explained that the alleged rise of faked illnesses put pressure 
onjudges to impose higher standards of evidence for pain and to reject the 
testimony of "hearsay" witnesses, demanding impossible conditions of 
"visibility" to prove its existence. Some physicians, however, argued that they 
possessed special expertise that made them capable ofverifying the existence of 
pain on the basis of patient testimonies. III 
In more detail, Greg Eghigian has analysed the construction of evidence in 
the process of adjudicating disability claims in early 20th century Germany. 
Officially, subjective experience and moral considerations were excluded from 
consideration by insurers in calculating entitlement. Insurers instead adopted a 
"thermodynamic" model of the impact of disability on work, that is, they 
envisioned the body as a machine that could only be functionally incapacitated by 
changes in structure, that is, by "objective" signs of injury or disease. However, 
claimants persisted in expressing their pain and suffering when they engaged with 
the welfare system, and, as is shown by the high number of appeals, were ready to 
dispute rejections oftheir suffering. In resolving these appeals, the Reich 
Insurance Office was more willing than insurers to take pain into account, but did 
so by integrating pain into the "thermodynamic" calculation of entitlement-as a 
III Silvia De Renzi, "Witnesses of the Body: Medico-Legal Cases in Seventeenth-Century Rome," 
Studies in the History and Philosophy of Science 33 (2002): 233-237. 
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functional impairment-rather than in the moral and subjective terms expressed 
by claimants. Eghigian concluded that claimants used their experiences of pain to 
engage with the social security system, and to the nation, an engagement that 
created a sense of entitlement and of social citizenship. "In effect," he wrote, 
"Germany's national security system transforrned somatic pain into a medium of 
national belonging." 1 12 
Deborah Stone's study of disability insurance in the u. S. suggests that 
similar "unofficial" negotiations of pain as legitimate grounds for disability 
claims took place in American courts, despite its exclusion from codified 
standards of evidence. 113 Thus, while historians will find little about pain in the 
manuals and schedules for disability rating or evaluation of the Social Security 
Administration, as well as those of the Veterans Administration, state industrial 
accident boards, or the American Medical Association, at least until the 1990s, 
Stone and Eghigian' s studies suggest that records of claims and appeals may be 
much more informative about how pain was expressed and negotiated within 
the se institutions. 
De Renzi, Eghigian, and Stone each pointed out that the evaluation of pain 
in bureaucratie and legal settings is quite different from its interpretation within 
doctor-patient relationships. Despite its obvious importance in medical 
encounters, the communication of experiences of pain between patients and their 
carers has received fairly little attention. This is partly a problem of sources. 
Records of medical consultations are often incomplete, while recent ones are 
inaccessible because oflaws protecting patient confidentiality. In addition, pain in 
these and other sources may seem to be both everywhere and nowhere. 
Discussions about pain may not have been noted in medical records. Until 
recently, it often did not receive attention as a separate category or theme in 
various types of medical textbooks and manuals, nor was it the object of a 
particular type of care, but could instead be found under many headings and in 
many types of institution. Despite these difficulties, a few studies have offered 
112 Eghigian, "Pain, Entitlement, and Social Citizenship," 21. 
113Deborah A. Stone, The Disabled State (Philadelphia: Temple University Press, 1984). 
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intriguing glimpses of how pain was communicated in medical settings, while 
others have outlined major shifts in the epistemological relation between doctors, 
patients, and disease that have had an impact on the medical judgment of pain. 
One ofthese shifts seems to have occurred in the early 19th century, with 
the constitution of the "clinical gaze," as described by Michel Foucault in The 
Birth of the Clinic. The "clinical gaze" interpreted pain as a specific symptom that 
pointed, most importantly by its location, to a pathological lesion within the 
body. 1 14 This new interpretive style, which has been called hospital or anatamo-
pathological medicine because of its associations with hospital practice and its 
focus on body tissues as revealed by autopsies, represented a shift away from a 
pre-existing style of "biographical medicine," focused instead on the patient's 
narrative. lls A good description of the function of pain in "biographical" medical 
encounters has been given by Barbara Duden in her study of the records of 
Johannes Storch, an lSth century doctor practising in the Prussian town of 
Eisenach. Storch's patients, Duden remarked, used a ri ch vocabulary to express 
their inner experience of pain, the wealth of which is, she claimed, "now lost to us 
[ modems]." 116 It was on the basis of this expression of suffering that the doctor 
worked. Pain was not considered to be a symptom-in the sense that it was not a 
message either from body to consciousness or from disease to doctor-but rather 
to be the very means by which the body, indistinguishable from the soul, 
expressed itself. 117 
In contrast, anatamo-pathological medicine sought to use pain as a means 
to locate lesions within the body. While it placed less emphasis on patient 
114 Michel Foucault, Naissance De La Clinique; Une Archéologie Du Regard Médical (Paris: 
Presses universitaires de France, 1963). 
See also: David B. Morris, "An Invisible History of Pain: Early 19th-Century Britain and 
America," The Clinical Journal of Pain 14 (1998): 192. 
115 John V. Pickstone, Ways ojKnowing: A New History of Science, Technology and Medicine 
(Chicago: University of Chicago Press, 2001); Erwin H. Ackerknecht, Medicine at the Paris 
Hospital, 1794-1848 (Baltimore: Johns Hopkins University Press, 1967); Nicholas D. Jewson, 
"The Disapppearance of the Sick-Man from Medical Cosmology, 1770-1870," Sociology 10 
(1976): 225-244. 
116 Barbara Duden, The Woman Beneath the Skin: a Doctor's Patients in Eighteenth-Century 
Germany [Geschichte under ter Haut] Trans. Thomas Dunlap (Cambridge, MA: Harvard 
University Press, 1991), 87. 
117 Duden, Woman Beneath the Skin, 88. 
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narrative, it still relied on patients' descriptions of pain. However, the information 
that was elicited was more limited and precise, and interpreted according to 
physicians' knowledge of the inner structure of tissues and organs. Historians of 
pain have pointed out that this new way of interpreting the body "demoted" pain 
from being the illness to being a symptom of disease, and constrained 
explanations of pain to the frame of reference of the physicallesion. 118 By the 
early 20th century, patients' complaints were increasingly being verified using 
laboratory tests and other diagnostic technologies, giving rise to "laboratory 
medicine" and apparently demoting the epistemological status of pain even 
further. 119 
Such a typology may give a mistaken impression that pain has 
progressively been eliminated from the doctor-patient encounter. It has been 
pointed out, however, that new ways of eliciting and evaluating information about 
illness have not replaced older styles, but that they have co-existed. 120 Thus, in 
sorne settings and situations, doctors have probably continued to listen carefully 
to their patients' detailed descriptions of pain. In addition, "biographical 
medicine" has reappeared in new forms in practices of pain evaluation. Andrew 
Hodgkiss has shown that, while pain was defined as a function oflesions-even if 
these lesions were invisible-for most of the 19th century, by the end of the 
century the inception of a psychoanalytic paradigm provided new perceptual tools 
that allowed "lesionless pain" to be interpreted in its metaphorical relations to 
biographical events. 121 Isabelle Baszanger similarly describes a return to a 
"biographical" style in deciphering chronic pain in a French pain clinic in the 1980s 
(which we can assume was similar in sorne American clinics).122 
What Baszanger does not discuss extensively is the creation of a large 
number of instruments to standardise and quantify the assessment of clinical 
118 Francis Schiller, "The History of Algology, Algotherapy and the Role of Inhibition," History 
and Philosaphy afthe Lire Sciences 12 (1990): 28-29; Andrew Hodgkiss, From Lesion ta 
Metaphar: Chronic Pain in British, French and German Medical Writings, 1800- 1914 
(Amsterdam: Rodopi, 2000). 
119 Jewson, also called analytical medicine or science by Pickstone, Ways of Knawing 
120 Pickstone, Ways ofKnawing. 
121 A. Hodgkiss, From Lesian ta Metaphar. 
122 Baszanger, Inventing Pain Medicine, 186-188. 
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pain-particularly chronic pain-in the 1970s and 80s. Though it is difficult to 
tell, from published sources, how and where these instruments were actually used, 
they seem to be associated with new concerns about, and practices for, the clinical 
judgment of pain. 
The chronological scope of my research on pain-measuring technologies 
1eaves out, for the most part, the clinical evaluation of pain. Such technologies 
were not widely used in the clinic to evaluate individual patients' pains (outside 
of experimental contexts) untillate in the century. To understand how pain was 
evaluated in clinical practice before this, it will be be necessary to adopt sorne 
other focus of analysis. Before pain became a meaningful diagnostic category in 
the 1970s, there were few explicit published discussions ofhow physicians should 
approach complex complaints of pain. It might make sense to follow a specifie set 
of diagnostic categories involving pain, such as headache or low back pain, to 
draw together the web of techniques, criteria, and considerations that have 
determined how patients in pain have been sorted out. And, of course, as patient 
records become available they will prove extremely useful for this type of study. 
There is a need to look not only for shifts in the general means of 
evaluating pain, but also at the ways in which specific types of patients' pains 
have been differentiated. The judgment of pain experiences may reflect trust or 
mistrust for certain types of individuals-potential malingerers and addicts, 
women, people qualified as sensitive, respectable or neurotic--or certain styles of 
expression-over-emotional, vague, reserved, articulate. For example, the patient 
records and correspondence of William Livingston, a medical examiner of the 
State of Oregon, indicate that he sometimes referred ta his patients' honesty as 
evidence of their genuine suffering when he communicated with insurance 
officiaIs. 123 
Two historians have drawn attention to the operation of a "politics of 
pain" in the differential evaluation of patients' pains and their need for medical 
123 William K. Livingston Papers, Manuscript Collection 136, History & Special Collections 
Division, Louise M. Darling Biomedical Library, University ofCalifornia, Los Angeles, CA. 
Adjust footnote to text. 
69 
70 
resources. Martin Pernick has shown that 19th century American doctors drew on 
cultural assumptions about social groups' vulnerability to pain in calculating the 
value and risk of anaesthesia for particular patients. 124 For example, women were 
generally seen to be more sensitive, and thus to "need" anaesthesia more than 
men, but this judgment was not usually extended to black women. Keith Wailoo's 
study of sickle cell anaemia in Memphis has drawn links between changing 
responses to pain and the politics of race and health in the 20th century. Formerly 
neglected, the distinctive pain of sickle cell disease was used to mobilize 
compassion, resources, and recognition for the plight of African-Americans in the 
1960s and 70s. However, this sympathy became suspicious as the highly visible 
pain of sickle cell came to represent a "special interest 'ethnic disease 
politics' .,,125 This scepticism grew in the increasingly conservative environment 
of the 1980s and 90s, as fears of drug addiction put the credibility of self-reports 
of pain in question and warned against "too liberal" pain management. 126 
Pernick and Wailoo's studies draw our attention to a theme that has 
recurred in many of the studies 1 have reviewed here: the interaction between 
representations and evaluations of pain and notions of hum an difference. As we 
have seen, it has been pointed out that sorne people's pains have been more 
visible that others', while representations of the "Other' s" pain can fail to draw 
attention to neglect and injustice unless they are made under favourable socio-
political conditions. 127 There are other ways in which pains have been 
differentiated. Anthropologists, for example, have noted that sorne people-
because of their powerlessness rather than their sensitivity-are more vulnerable 
to shouldering society's burden of suffering. 128 While useful for drawing attention 
to structural injustice, this statement must be seen as a specific political and 
historical explanation for differences in susceptibility to pain. The ways in which 
individual and collective responses to pain have been compared and explained can 
124 Pemick, A Calculus ofSuffering, 171-195. 
125 Wailoo, Dying in the City of Blues, 200 
126 Wailoo, Dying in the City of Blues. 
127 Clarke, "The Sacred Rights of the Weak,"463; Wood, Blind Memory, 231-233; Wailoo, Dying 
in the City of Blues. 
128 Del-Vecchio Good, et al., Pain as Human Experience. Kleinman, et al., Social Suffering, 
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also be related to historically specific notions of how bodies, psyches, practices, 
and environments interact to fashion subjective experiences that are differentiated 
along lines of race, gender, class, personality, culture, power, etc. 
Pain-measuring technologies were designed both to control for and to 
measure interpersonal variations in experiences of, responses to, and expressions 
of pain. In other words, they were meant to eliminate irrelevant sources of 
variation that could confuse the measurement of a particular aspect of pain, for 
example, the influence of personal meaning on the pain relief provided by an 
analgesic drug. However, they were also used to compare pain responses, for 
example, between groups of neurotic and normal individuals. These actions both 
presupposed and produced ideas about why and how people differ in pain. 
As l will show in Chapter 3, when the first pain-measuring instruments 
were invented in the 1ate 19th century, differences in pain were thought of as 
physi010gica1 differences in nervous sensitivity that were projected-through the 
lens of social Darwinism-onto social and evolutionary divisions of gender, race, 
deviance, and age. My findings confirm observations by Mary Gibson, Lucy 
Bending, and Martin Pernick. 129 
This understanding of differences in pain was different from previous 
ones, as is shown by Joyce Chaplin's study of English views of American native 
bodies and practices in the context of c010nization in the 1 i h century. The English 
saw "lndian" resistance to pain as the artificial product of bodily techniques, 
transmitted through upbringing and therapeutic means, rather than as a natura1 
state proving their inherent strength. Whi1e this attitude might be seen to praise 
native skill in hardening their bodies, the English saw a preoccupation with these 
bodi1y techniques as hampering the progress of other kinds oftechnical to01s and 
skills, in which they themselves surpassed the natives, and as a confirmation of 
129 Mary Gibson, "On the Insensitivity ofWomen: Science and the Woman Question in Liberal 
Italy, 1890-1910," Journal ofWomen's History 2 (1990): 11-41; Pernick, A Calculus ofSuffering; 
Bending, Representations of Bodily Pain. 
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their own conviction that they possessed the strength to populate America. 130 
More studies are needed to bridge the gap between the 1 i h and 19th centuries. 
As anthropologists and psychologists broke away from Spencerian Social 
Darwinism in the first decades of the 20th century, they began to draw on 
psychoanalytical notions to explain human differences. 131 As 1 show in chapter 4, 
the development of new techniques for measuring psychosomatic correlations 
between physical stimulation and emotional experience, and between emotional 
events and bodily experience, allowed researchers to measure pain as a 
psychological event. The cause of differences in individuals' responses to pain 
was no longer seen to be linked tovariations in physiological sensitivity but 
instead to variations in psychological responsitivity. The former was associated 
with biological categories of difference-race, age, sex-and the latter with 
psychological ones-personality, culture, and past experience. 
ln chapters 5,6, and 7, we will also see that a new method for measuring 
pain-relieving efficacy supported a model of pain that was open to multiple 
psychological influences from within and without. The analgesic clinical trial 
measured collective rather than individual pain relief, and controlled the 
phenomenon it measured from irrelevant influences though social and statistical 
means, rather than individual psychological and physiological means. This new 
mode of experimental control made it possible to conceptualise pain as a 
"disembodied" experience, modulated by personal and social factors more than by 
physical stimulation or individual bodies. 
ln the 1980s and 90s, sorne anthropologists made efforts to move away 
from an individualized and psychological framework towards a more collective, 
inter-subjective, and political perspective on the roots of differences in 
susceptibility to pain. 132 From the 1990s, however, as more funds have been 
directed towards the question of differences in pain in the U. S.-partly as a result 
\30 Joyce E. Chaplin, Subject Matter: Technology, the Body, and Science on the Anglo-American 
Frontier, 1500-1676 (Cambride, Mass. and London: Harvard University Press, 2001), 245-279. 
\3\ George W. Stocking, Race, Culture and Evolution; Essays in the History (J{ Anthropology 
(New York: Free Press, 1968). 
\32 Arthur Kleinman, Veena Das and Margaret Lock, Social Suffering (Berkeley, CA and London: 
University of Califomia Press, 1997). 
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of the integration of lobbies for pain and women's health research within the NIH, 
along with new concerns about the introduction of "diversity" regulations in 
clinical testing, as well as interests in a potentially lucrative market for 
individually tailored analgesic treatment-attention has been focused on the 
genetic, hormonal and neuronal determinants of such variation. 133 Thus, by 2003, 
the NIH had firmly put the "bio" back into research on differences in pain, calling 
for proposaIs on its "bio-behavioural" determinants. 134 
My own work seeks to explain how changing conceptions of inter-
individual differences in responses to pain were linked with new definitions of 
pain as "subjective," and the development of measurement techniques. 
Conclusion 
The concerns articulated by historians and social scientists working on pain in a 
range of periods and social contexts have encouraged me to look at pain-
measuring instruments as one set, among many different types, of strategies for 
transforming the experience of pain into collectively readable and meaningful 
133 For example, a conference on "Pain and Gender" was organised in 1998 by various institutes of 
the NIH, mainly by the NIH Pain Consortium, created in 1996, and the Office for Research on 
Women's Health (ORWH), also affiliated with the NIH and created in 1990. The majority of the 
papers presented at this conference suggested that neurological, hormonal and genetic mechanisms 
accounted for findings of differential responses to pain in men and women (or female and male 
animais). Only a few papers emphasized the psychological and psychosocial mechanisms of 
gender differences in pain thresholds, pain coping and pain behaviour. Though the research 
presented at this conference mainly addressed women's greater vulnerability to pain, it also 
expressed a new interest in gender differences in responses to analgesic therapy. Since the late 
1980s, the NIH had established a policy mandating the inclusion ofwomen and minorities as 
subjects in c1inical research, which was made into public law with the NIH Revitalization Act of 
1993. This new policy focused attention on the ways in which genderlsex and ethnicity/race might 
affect responses to analgesic therapy. This information was considered to be of importance not 
only for designing experiments, but also for designing drugs. A growing body ofresearch on the 
genetic modulation of pain in men and women was considered to be promising in guiding the 
pharmacogenetic tayloring of gender-specifïc analgesic therapy. For a summary of papers 
presented at the conference, see: http://painconsortium.nih.gov/gcndcrandpain/Default.htm. For 
information about the Pain Consortium and the OR WH, see: 
http://painconsortium.n ih.goy /indcx.hlml; http://o]'wh.od. nih. gOY /. 
134 In 2003, the NIH advertised a "biohavioral pain research program," inviting applications" to 
study individual differences in pain responses that may be due to factors such as genetic 
differences, endocrine activity, neural activity, immune function, psychological state, 
developmental stage, cognitive capacity, disability state, age, gender, social context and cultural 
background. See: http://grants.nih.gov/grants/guide/pa-files/P A-03-152.html 
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information. Pain-measuring instruments might, in this sense, be seen as 
technologies of communication, technologies to facilitate the exchange and 
interpretation of information about experiences of pain. 
This literature also suggests a number of questions to ask of these 
technologies or of other types of strategies for communicating information about 
pain. Have these strategies, by making pain more intelligible, "socialized" it and 
created new social bonds? Or have disagreements about the use and interpretation 
of pain-measuring instruments instead aggravated a lack of common 
understanding? Have these strategies, in narrowing the range of possible 
expressions of pain, silenced the voice of the sufferer and misrepresented or 
misappropriated subjects' pain? Or has this narrowing or framing of expression 
given sufferers more equitable access to an intelligible language of pain, and thus 
a fairer distribution of resources-inc1uding acknowledgment-to deal with their 
pain? Have these instruments been used to differentiate sufferers, exc1uding sorne 
from participation in the production of knowledge about pain or the use of 
available resources to fight it? Who has decided what kind of pain, and whose 
pain, can be communicated, and in what form? 
None of the se questions can be answered if strategies of pain 
communication, inc1uding pain-measuring technologies, are considered in 
abstraction from the contexts in which they were used and the concerns of those 
who designed and adopted them. 
74 
75 
3. The Emergence of Algometry, 1890s-1930s 
The first pain-measuring instruments were invented in the last decades of the 19th 
century. These algometers, despite their name, were not used to measure how 
much pain a person was feeling. What they quantified, as weIl as standardised, 
was the intensity of a pain-producing stimulus. To translate stimulus-intensity into 
a measurable dimension of the experience of pain, researchers determined the 
point at which a pers on just began to feel pain: their threshold of pain sensation, 
or sensitivity. A quantified sensitivity became a comparable sensitivity. People 
adopted algometers to compare the sensitivity of different body surfaces, the 
sensitivity of different persons, or the sensitivity of a person in different states, for 
example, under the influence of a potentially sensitivity-altering drug. 
This chapter situates the origins and early uses of algometers from the 
1890s through the first decades of the 20th century in different epistemological 
and professional contexts. The central questions that orient this chapter are the 
following: What drove the first quests for precision, consistency and 
quantification in the study of pain? For whom, and in what contexts, did it make 
sense to number, c1assify and compare sensitivities to pain? Aigometry can also 
be explained as part of a broader phenomenon, and explored by asking the more 
general question: for whom did it make sense to measure sensation? 
When they were invented, algometers did not stand alone in their c1ass of 
instruments, but joined a growing number of meters for the senses, inc1uding 
acoumeters, sonometers, photometers, ophtalmometers, olfactometers, and 
aesthesiometers. Aigometers can first be situated as part of the creation of a larger 
psychophysical toolbox and thus, as a product of a turn to sensation in 
experimental physiology in the early 19th century, and of the later articulation of 
psychophysics as a branch of experimental psychology. 
Like other psychophysical instruments, algometers were considered to be 
useful in elucidating basic, universal mechanisms of sensation. Along with other 
forms of measurement, algometry helped to define psychology as a science 
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grounded in experimental and quantitative practices. 135 More specifically, 
psychologists used evidence produced with algometric methods to contribute to a 
heated debate between the advocates of two theories of pain mechanisms that took 
place during the early decades of the 20tl1 century. 
As with other psychophysical instruments, the use of algometers was 
extended From the study of universallaws of sensation to the study of variations 
in sensitivity in general populations. While the first could be generalised from 
data obtained in a handful of good "universal" subjects, the second relied on large 
numbers of categorized subjects, which had to be organized into comparison 
groups. In the late 19t11 century, psychophysical instruments were used, along with 
anthropometric tools, by psychological, physical and criminal anthropologists in 
their exploration of hum an differences. 136 With algometry, sensitivity to pain 
joined brain size and facial angle as a measurable quantity used to classify 
humans on scales of evolution and deviance. Attempts to align differential 
sensitivity to pain with categories such as sex, criminality, intelligence, 
primitivism, and age made social and scientific sense within a conceptual 
framework that rooted mental and moral abilities in measurable biological 
characteristics. Pain sensibility, in particular, had, since at least the l8tl1 century, 
been associated in Anglo-American society with other kinds of attributes that 
were used to distinguish classes ofhumans from each other, as well as from 
135 For an argument about the value of quantitative techniques in the foundation of experimental 
psychology, see Gail A. Hornstein, "QuantifYing Psychological Phenomena: Debates, Dilemmas, 
and Implications," in The Rise of Experimentation in American Psychology, ed. J. G. Morawski 
(New Haven and London: Yale University Press, 1988), 1-34. 
136 The use of anthropometrical tools in racial and sex differentiation has received quite a bit of 
attention from historians. However, the use of psychophysical measurement as a means to root 
perceptual abilities in measurable biological differences has received some attention in recent 
histories of concepts of race in psychology: see Graham Richards, 'Race', Racism and 
Psych%~~gy: Tuwards a Reflexive Histury (London and New York: Routledge, 1997). Andrew. S. 
Winston, ed., Defining Difference: Race and Racism in the History of Psych%gy (Washington, 
DC: American Psychological Association, 2004). For a useful textbook overview of the treatment 
of race, culture and ethnicity in psychology, see Paul Voestermans and Jeroen Jansz, "Culture and 
Ethnicity," in A Social History of Psychology, ed. J. Jansz and P. van Drunen, 165-194 (Oxford: 
Blackwell Publishing, 2004). One detailed study ofpsychophysical differentiation deals with 
specifically with pain sensitivity measurements: Mary Gibson, "On the Insensitivity of Women: 
Science and the Woman Question in Liberal Italy, 1890-1910," Journal of Women 's History 2, 
nO.2 (\ 990): 11-41. 
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animaIs; these included civilisation, refinement, courage, intelligence, sympathy 
and moral sensibility. 
Two novel uses for algometry were proposed in the early decades of the 
20th century. An American clinician, Emmanuel Libman, promoted the use of a 
test of pain sensitivity as a means of improving diagnostic judgment. This project 
can be related to Libman's larger preoccupation-shared by many other 
contemporary American physicians-with the status of clinical observation in 
American medicine. Secondly, the use of algometric instruments was extended to 
the quantification of drug effects on the pain threshold. Only two experiments, by 
two different groups of researchers, were reported in the mid-191 Os. No further 
attempts were made to compare pain-relieving drugs by algometric methods in the 
U. S. until twenty years later. By the mid-1930s, a growing interest in analgesic 
drug testing stimulated an unprecedented que st for quantitative tools for the 
evaluation of pain relief, and gave a new importance to algometry. In the mid-
1910s, however, bringing quantitative precision to analgesic testing was not a 
sustainable project. 
These different uses of algometry are part of distinct narratives: the history 
of sensory physiology and psychology, the history of the differentiation of 
individual and group psychological characteristics, the history of the 
interpretation of symptoms in clinical diagnosis, and the history of drug 
evaluation. Algometers, and future pain-measuring technologies, became 
important to different people, for different reasons, and at different times, within 
each of these histories. 
Yet, despite differences in the evolution of the function, importance and 
status of pain-measuring technologies in each of these narratives, they share a 
roughly parallel chronology in the conceptualisation of pain and of its 
rneasurability. This is illustrated in the way pain-rneasuring instruments were 
often created in one context, and then transferred into another. Though psycho-
physicists, cri minaI anthropologists, clinicians and pharmacologists used 
algometers for different reasons in the late 19th and early 20th centuries, they 
adopted a similar psychophysical model of pain sensitivity as rooted in a 
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physiological sens ory apparatus, measurable by means of algometry, and as 
varying from one individual to another. Each of these notions would be 
challenged in the 1940s and 50s. 
3. 1 Algometry in the Laboratory 
The question that prompted a search for more precise methods of pain sensitivity 
in physiology was the following: was pain a specifie sensory modality, served by 
its own neural apparatus, or was it an attribute of other sensations, for example, 
the result of intense stimulation applied to pressure receptors? The first position 
has been called the intensive, summation or pattern theory of pain. It was opposed 
to the specificity theory of pain, according to which sensations were differentiated 
because nerves were specialised to respond to a precise type of stimulation. This 
latter theory has been traced back to Johannes Müller's doctrine of specific nerve 
energies, according to which the differentiation of the senses originated in a 
physiological differentiation of the nerves, and thus explained that a single type of 
stimulation, such as electricity, could generate different sensations (light, 
pressure, warmth, pain, sound) when applied to different organs. 137 To solve this 
question empirically, late-19th century physiologists in Sweden, Germany and the 
U. S. took on the ambitious project ofmapping out the sensory qualities elicited 
by stimulation on the surface of the body. This project required the elaboration of 
techniques to apply discrete stimuli to minuscule areas of skin. In the I880s, Blix 
and Goldscheider began mapping out the distribution of sensory spots using 
needles, faradic current from a single electrode, narrow jets of hot and cold water, 
cork points, and small drops of ether. 138 To pursue this work, Max von Frey, a 
German physiologist, searched for even more precise and consistent techniques of 
137 Edwin G. Boring, Sensation and Perception in the History of Psychology (New York: 
Appleton-Century Company, 1942),467. For a discussion ofhow Müller's doctrine influenced 
conceptions ofpain, see Roselyne Rey, The History of Pain, trans. Louise Elliott Wallace 
(Cambrige, MA: Harvard University Press, 1995), 192-196. On Müller's doctrine and the study of 
vision, and particuJarly the constitution of a subjective observer in the early 19th century, see 
Jonathan Crary, Techniques of the Observer: on Vision and Modernity in the Nineteenth Century 
(Cambridge, MA: MIT Press, 1990), 88-96. 
I38Boring, Sensation and Perception, 467 
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stimulation that would ensure that stimuli were of comparable magnitudes each 
time they were applied to the skin. 139 
Von Frey invented an instrument consisting of a wooden stick to which a 
hair-obtained from a man, woman, horse or hog-was attached with sealing 
wax. A hair of a specified diameter and length applied a precise amount of 
pressure when pressed perpendicularly on the skin until it was bent, but not 
broken. By varying the hair lengths and diameters, it was possible to determine 
the relative amount of pressure required to elicit sensations of pressure or pain on 
"microscopic" areas of skin. Von Frey also constructed a modified instrument, in 
which the hair protruded from a narrow hole in an adjustable sleeve, thus making 
it easier to change the length of the hair. 140 Von Frey Hairs, or the Von Frey 
aesthesiometer (that is, an instrument to measure tactile sensation, thus named 
rather than "algometer" because it was also used to measure pressure thresholds), 
has commonly been cited by 20th century pain researchers as the first precision 
• •• 141 pam-measunng mstrument. 
Von Frey's instrumentjoined a growing number ofmeters for the senses 
that equipped physiology laboratories and the new laboratories of psychology in 
the second half of the 19th Century. Why were so many sense-meters invented? 
The discovery of separate sensory and motor nerves in the spinal cord in the early 
19th century established sensation as a physiological matter. Previously the realm 
ofphilosophers, sensation had been studied as a phenomenon of the mind rather 
than of the body. Physiologists who became interested in the study of sensation in 
the earlY to mid-19th century began creating instruments and methods to measure 
sensory thresholds and discrimination. For example, E. H. Weber designed an 
aesthesiometer, an instrument that was similar to a two-point compass, to measure 
the minimum length between two points at which the subject felt two distinct 
contacts, rather than a single one. Other instruments were developed to study 
sensations included the acoumeter, sonometer, ophtalmotrope, photometer, 
139 Rey, The History of Pain, 215-216 
140 Boring, Sensation and Perception, 488-89 
141 For example: B. Berthold Wolff, "Laboratory Methods of Pain Measurement," Pain 
Measurement and Assessment. Ed. Ronald Melzack (New York: Raven Press, 1983), 7. 
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stroboscope, stereoscope, spectroscope, kinesimeter, aesthesiometer, inductorium, 
olfactometer, as well as sets of standardised stimuli such as piano keyboards, 
colour mixers and fruit flavours. 
Sorne physiologists saw in the experimental study of sensation a potential 
for articulating a distinct branch of investigation concerned with the science of the 
mind: psychophysiology. Building on Weber's work, Gustav Fechner 
systematized the principles of psychophysiology. The main assumption of 
psychophysical measurement was that sensory judgment could be correlated with 
the magnitude of a stimulus such as a ray of light of a particular brightness. 
Fechner proposed that three kinds of sensory judgments could be quantified: the 
point at which a stimulus became perceptible (the absolute limen, or sensory 
threshold), the point at which two stimuli became distinguishable (the differential 
limen, or "just noticeable differences"), and the point at which two stimuli 
appeared to be the same. 142 
The use of psychophysical instruments, and the development of principles 
of measurement, was thus greatly stimulated by the definition of psychophysics as 
a field of experimental psychology in the second half of the 19th Century. As Gail 
Hornstein has argued, quantification was central to the project of carving a space 
for the new science of psychology that was methodologically distinct from 
philosophy and pseudo-psychology, such as phrenology and palmistry, with 
which it shared its subject-matter: the phenomena of the mind. In order to make 
psychology quantitative, the early psychologists delimited their new field by 
selecting objects of study that were amenable to quantification, and rejecting 
those that were not. Because of its interest to physiologists, sensation was one of 
the research topics that seemed apt for establishing psychology as a quantitative 
and experimental science. 143 
Dcfining psychophysical measurement as the basis of psychology was 
challenged by sorne psychologists who favoured non-quantitative methods of 
142 Hornstein, "Quantifying Psychological Phenomena," 3-4; Boring, Sensation and Perception, 
34-45; Crary, Techniques of the Observer, 141-149. 
143Hornstein, "Quantifying Psychological Phenomena," 1-3,18. 
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inquiry into the mind. They charged that the mind did not make quantitative 
distinctions, and thus that sensation-as a mental phenomenon-could not be 
measured. Yet, experimental psychologists continued to practice psychophysical 
measurement without fully addressing this objection, despite its seriousness. 
Hornstein has argued that this can best be understood if the debate about 
quantification is situated within a larger battle to establish a scientific psychology: 
the alternative proposed by the critics was introspection, a method of study which 
was not seen as precise and reliable enough to give psychologists the institutional 
and professional status they sought. 144 
The success of psychophysiology is important to the history of pain, 
because it provided both the general framework and quantitative techniques for 
conceptualising pain as measurable and as a sensation. It was by defining pain as 
a topic amenable to psychophysical investigation that algometers became 
thinkable and relevant. The psychophysical concept of sensation was based on the 
assumption of a direct relationship between the type and intensity of a stimulus, 
the physiological sensory apparatus and the psychological detection of the 
presence and quality of a sensation. 145 This concept dominated thinking about 
pain throughout the first decades of the 20th century. 
The success of psychophysiology helps to explain not only the emergence, 
but also the function of algometers as instruments for building up the quantitative 
techniques of early psychology. Algometers seem to have become part of the 
standard set of psychologicallaboratory tools, which included a range of meters 
for the senses, stimulation devices, chronometrie instruments and physiological 
measuring technologies. For instance, when American psychologist E. B. 
Titchener produced a guide for equipping a psychologicallaboratory on the 
Cornell model, he included "pain aesthesiometers" as weIl as an algometer 
designed by James McKeen Cattell, one of the pioneers of American psychology, 
144 Hornstein, "QuantifYing Psychological Phenomena," 5-8. 
145 For an overview of the study of sensation in physiology and psychology, see Boring, Sensation 
and Perception. For a more detailed study of physiological pain research in the 19th century, see 
Rey, The History of Pain. For a discussion ofphysiological research on vision, see Crary, 
Techniques of the Observer. 
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in his recommended purchase list. 146 The Cattell algometer, which cost $15 in 
1900, was manufactured by Brown & Getty in Camden, New Jersey, which 
suggests not only that standardisation of the instrument was considered to be 
important, but also that it had a relatively wide distribution. 147 SeveraI early 
aIgometers can also be found in the online apparatus collection of the Archives of 
the History of American Psychology.148 
More specifically, algometric methods were given an important roIe in 
resolving fundamental questions about the mechanism of pain sensation. They 
were invented and used to produce evidence that might help resolve the enduring 
controversy between specificity and summation theories of pain. 
With the help of his hairs, which showed differential pressure and pain 
thresholds at distinct points, Von Frey had concluded in the 1890s that pain was a 
specific sensory modality. He then correlated the distribution of sensory spots-
hot, cold, pain, and pressure-with that of the different cutaneous nerve-endings 
that had recently been discovered through histological observations. This theory, 
though constantly reinterpreted, strongly influenced research and thinking on pain 
for much of the 20th century. It was, nonetheless, "passionately debated and 
criticized.,,149 Its most vocal critic was Goldscheider, who, though he had initially 
interpreted his sensory-spot findings as evidence ofpain specificity, had, after 
failing to locate any analgesic spots, concluded that the sensation of pain resulted 
from the intense stimulation of pressure receptors. 
Pain theories came to occupy American psychologists, particularly in the 
laboratory ofpsychology at Cornell University. In 1919, Cornell researchers 
found that, surprisingly, pain did show the phenomenon of adaptation, that is, that 
146 Edward B. Titchener, "The Equipment of a Psychological Laboratory," American Journal of 
Psychology Il, no.2 (1900): 251-265. 
147 Titchener "The Equipment of a Psychological Laboratory," 260; Alexander MacDonald, 
Juvenile Crime and Reformation (Washington OC: Government Printing Office, 1908), 196 
148Archives of the American History ofPsychology, "Apparatus Collection- Cutaneous," 
http://www3.uakron.edu/ahap/apparatus/category list.phtml?code id=2 (accessed January 22, 
2006). 
149Rey, The History of Pain, 217. 
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it subsided after continued, constant stimulation. ISO Adaptation became the object 
of an experimentum crucis in the specificity vs. summation debate. Both Von Frey 
and Goldscheider produced data that supported their theories; Goldscheider found 
that, before disappearing, the sensation underwent a qualitative change towards 
one of pressure or contact. Von Frey, however, showed that, given an adequate 
source of stimulation-a ray ofheat focused by a magnifying glass-pain simply 
died away, without qualitative change. At this point, another Comell researcher, 
Karl Dallenbach, undertook a series of experiments in the hopes of resolving this 
Issue. 
For Dallenbach, the Von Frey-Goldscheider controversy touched on "one 
of the fundamental problems in sensory physiology and psychology." 151 To settle 
the problem, Dallenbach would need to come up with imaginative new means of 
inflicting precise amounts of painful stimulation to his colleagues and graduate 
students. For one set of experiments, a stimulator was devised that consisted of a 
coil of resistance wire placed inside a glass tube and insulated with asbestos. 
When the coil was heated by a current of specified strength, heat radiated onto the 
forearm of the observer. Further mechanisms of precision included placing the 
observer's arm in a plaster cast to avoid movement and the timing of observations 
with a stopwatch. In another experiment, a similarly structured stimulator made 
out ofbrass was filled with dry ice, and was insulated with asbestos and cotton. 
Such elaborate instruments were necessary because it was crucial that heat 
and co Id be produced without pressure, and applied to the skin in a controlled and 
focused stream, in order to determine whether the graduaI disappearance of pain 
was preceded by qualitative changes, and, if so, whether these changes 
corresponded to the type of stimulation or the nature of the receptor. Though this 
goal did not, in fact, require the measurement of stimulation, Dallenbach's 
attention to the calibration of stimulation and the measurement of time responses 
reflect a concem for greater standardisation in the study of pain. 
150 H. H. Straus and R. F. Uhlman, "Adaptation of Superficial Pain," American Journal of 
Psychology 30, no.4 (1919): 422-424. 
151 Karl M. Oallenbach, "Pain: History and Present Status," American Journal of Psych%gy 52 
(1939): 331-347. 
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Dallenbach placed the results ofthese studies at the conclusion of an 
ambitious review of the history of the principal debates concerning the nature of 
pain in Western thought, which he published in the American Journal of 
Psychology in 1939. 152 Presenting his data on the observation of precise 
stimulations of pure heat, cold and pressure, Dallenbach showed not only that 
pain indeed underwent adaptation, but also that the qualitative changes 
experienced by observers during the disappearance of pain were derived from the 
type of stimulation used-cold, heat or pressure-and were not of a "pressury" 
nature in each case. If pain did not result from the intensive stimulation of 
pressure receptors, then Goldscheider' s theory would be disproved. 
Dallenbach rested the strength of his conclusion not only on the quality of 
his methods for producing pain, but also on the quality ofhis observers: 
Did our observers, in the two studies with temperature, miss Goldscheider's 
pressures? Were those pressures so weak that they escaped notice? We think 
not. Our Os were highly trained in cutaneous observation; it is hardI y 
possible that aIl ofthem would have failed aIl the time to report those 
qualities if they occurred, particularly as our experimental conditions 
fulfilled aIl the requirements that Goldscheider laid down and should, 
therefore, have been highly favourable for their observation. 153 
This comment raises an important point. Though psychophysical instruments 
provided carefully controlled and measurable stimuli, they did not obviate the 
need for subjects (or observers, as they were called previously) to make fine 
distinctions in observing their inner sensations. Variations in the ability of 
individuals to make such judgments accurately and consistently would come to 
preoccupy many pain-measurers. In the early psychology laboratory, however, 
this potential objection was avoided by controlling for the quality of observers' 
judgments. Psychological observers-who we now call subjects-usually 
consisted of, in algometric as well as other laboratory experiments, a smaIl 
number of graduate students, colleagues or ev en the experimenter. They were 
152 Dal1enbach, "Pain: History and Present Status," 331-347. 
153 Dal1enbach, "Pain: History and Present Status," 346. 
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familiar with the principles of experimentation, often highly trained, and could be 
trusted to maintain a scientific attitude of both attentiveness and detachment 
towards their sensations. The expertise of observers could be ascertained by the 
readers of published reports, in which their names, experience and individual 
results were often provided. 154 
To settle fundamental theoretical issues ofpsycho-physiology, results 
from a few good observers, who were considered as "universal minds" could be 
generalised into laws of normal human pain sensation. For sorne researchers, 
however, algometry mattered not because it was informative about universal 
mechanisms of pain sensation, but because it allowed a finer differentiation of 
inter-individual variations in the degree of sensitivity to pain. This was another 
early use for which algometers were developed. 
3.2 Algometry and the "Great Chain of Feeling" 
"In view of the oft-repeated statement that savages in general are less susceptible 
to pain than white men," reported William McDougall, "it seemed a matter of 
sorne interest to obtain a measure of the threshold of sensibility to pain.,,155 With 
the help of a Cattell algometer, McDougall made a quantitative comparison of 
pain sensibility of Torres Straits Islanders and English men and boys. McDougall 
had gone to the Torres Straits as a member of the Cambridge Anthropological 
Expedition, which, in 1898, set out on an ambitious scÎentific mission to study the 
Islanders, before the "civilising" efforts of traders and missionaries could erode 
their state of "primitiveness." 1 56 Among the numerous facets of the lives, bodies 
and minds of the Murray Islanders and Sea Dayaks that were scrutinised by the 
Expedition-which included language, customs and physical dimensions-was 
the acuity oftheir senses, to be measured with the instruments of the 
154 Karl Danziger, "A Question ofIdentity: Who Participated in Psychological Experiments?" in 
The Rise of Experimental Psychology, 35-52; Constructing the Subject, (New York: Cambridge 
University Press, 1990), 5. 
155 Alfred C. Haddon, ed. Reports of the Cambridge Anthropological Expedition to Torres Straits 
(Cambridge: University Press, 1901-1935) Vol. 2, Part 2, 194. 
156Richards, Race, Racism and Psych%gy, 44. 
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psychophysicallaboratory.157 Responsible for the cutaneous senses, McDougall 
measured pain sensibility thresholds on the fingernails and foreheads of a group 
of Murray Islanders, five Dayaks and, upon returning to England, performed 
similar measurements on a group of men and boys in a 'Cheadle convalescent 
home.,158 After comparing results from these two groups, McDougall concluded 
that the Murray Islanders were only half as sensitive to pain as the English. 159 
McDougall's results provided quantitative confirmation ofwidely held 
beliefs about differences in sensitivity that Martin Pernick has evocatively 
described as the "great chain offeeling.,,160 Pernick used this expression, a play 
on the words "great chain ofbeing," to describe the concept of a scale of 
differential pain sensibility that could be mapped onto a hierarchy of social and 
evolutionary development. Even before the invention of algometers, it was widely 
believed that people differed in their ability to feel pain, and that sensibility to 
pain-both to one's own pain and, in sympathetic resonance, to that of others-
was a marker of social and biological difference. 
A number ofhistorical studies have attested to the pervasiveness ofthis 
belief in various aspects of 19th century European and American thought and 
157 For a more detailed description of the Cambridge Anthropological Expedition and an analysis 
of its signiticance for the conceptualisation of race in the history of psychology and anthropology, 
see Richards, Race, Racism and Psychology, 41-64. Richards situates the expedition within the 
general framework of Scientific Racism, and sees it as implicitly reinforcing the acceptance of 
British superiority and domination of colonial subjects on the basis oftheir primitivism. Henrika 
Kuklick discusses the signiticance ofthis episode in the history of British anthropology in The 
Savage Within: The Social History of British Anthropology, 1885-1945 (Cambridge and New 
York: Cambridge University Press, 1991), 133-149. 
158Richards. Race, Racism and Psychology, 46 
159Haddon, Reports, 195.This fin ding and other findings of the expedition contirmed the 
expectation, according to Herbert Spencer's theory of Social Darwinism. that the "Iower" senses 
such as touch and vision were more highly developed in "primitive races," while "higher" senses 
such as pain were more highly developed in "civilized races." See, Voestennans and Jansz, 
"Culture and Ethnicity," J 73. 
160Martin S. Pemick, A Calculus ofSuf{ering Pain, Pr(){essionalism, and Anesthesia in Nineteenth-
Century America (New York: Columbia University Press, 1985), 157: "Thus ail living things 
might be arranged in a hierarchy of sensitivity, a great chain of feeling. Brute animaIs, savages, 
purebred nonwhites, the poor and oppressed, the inebriated, and the old, constituted the lower 
orders. The most sensitive included women: the rich, civilized, educated and sophisticated; sober 
drunkards; and mulattos. Children were usually considered feminine in sensitivity, though infants 
were sometimes believed not to feel. Occupying the virtuous middle ground were the study 
yeoman farmers." 
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practice. 161 In a wide-ranging study of the representation of bodily pain in late 
Victorian me di cal, religious, scientific, literary and humanitarian discourses, Lucy 
Bending has shown that, by selectively attributing to themselves the ability to feel 
pain, the English elite distanced themselves from supposedly insensible criminals, 
savages, and other forms of degeneration and brutality, while also defining 
themselves as civilised. Physiological sensibility to one's own pain was seen as 
being correlated with moral sensibility to the pain of others, and thus was linked 
with the ability to inflict pain. One of the major concems ofhumanitarian 
reformers was with the brutalising or dehumanising effects of both viewing 
violence and inflicting pain on others. These concems were also articulated in 
evolutionary terms that made a paraUel between sensibility and civilisation. 
Bending note d, for example, that antivivisectionist tracts qualified as savage the 
insensibility ofthose who dissected live animais. 162 
Other historians ofhumanitarian movements have also drawn attention to 
the equations made by reformers to link sensibility, civilisation and virtue. Sorne 
of these studies have, in addition, emphasized that reformers often felt they had to 
confront widely held beliefs about the insensibility of slaves, animaIs, criminals 
or the insane in order to elicit sympathy for the suffering of the abused. 163 
Analysts of literary and visual representations of slaves' suffering, for example, 
have pointed out the challenges faced by abolitionists in endowing slaves' bodies 
with the capacity to suffer, and thus humanizing them as subjects. 164 Sorne 
abolitionists, on the other hand, accepted that slaves were insensible to pain, but 
161 Pernick, A Ca/cu/us ofSuffering, 148, has remarked : "The beliefthat people varied widely in 
their ability to feel pain influenced almost every aspect of nineteenth-century social and 
professional life ... " 
162 Lucy Bending, The Representation of Bodily Pain in Late Nineteenth-Century English Culture 
(Oxford, New York: Clarendon Press. Oxford University Press, 2000), 3-4, 123-4. 
163 For example, Karen Halttunen, "Humanitarianism and the Pornography of Pain in Anglo-
American Culture," American Historical Review 100 (1995): 303-34. Elizabeth R Clark, '''The 
Sacred Rights of the Weak": Pain, Sympathy and the Origins of Humanitarian Sensibility," 
Journal of American History 82, no. 2 (1995): 463-93. James Turner, Reckoning with the Beast: 
Animais, Pain, and Humanity in the Victorian Mind. (Baltimore, MD: Johns Hopkins University 
Press, 1980). 
164 Clark, "Sacred Rights," 474. Marcus Wood, Blind Memory: Visual Representations ~rSlavery 
in England and America, 1780-1865 (New York: Routledge, 2000), 215-231. 
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argued that repeated abuse, rather than inherent racial features, had robbed them 
oftheir sensibility.165 
Admission into the world of sentience entitled individuals not only to 
sympathy and humane treatment, but also to medical relief and to the recognition 
of their intellectual achievements. Pernick' s study of professionaljudgment and 
anaesthesia has shown that beliefs about the greater sensitivity of women, the 
insensitivity of slaves and decreasing sensitivity with age entered into American 
physicians' decisions about who should receive anaesthesia. 166 Rebecca Herzig 
has also pointed out that individuals judged as insensible were also judged unable 
to freely submit to, and heroically endure, acts of noble self-sacrifice. Herzig has 
argued that an ethic of self-sacrifice was increasingly used to characterize the 
disinterested pursuit of scientific knowledge in the 19th century. However, to 
sacrifice oneself, an individual required not only courage, but also the ability to 
feel pain as well as full possession of one's self and body. These possibilities 
were not extended equally to all beings. Thus, the "Eskimo" and "Negro" 
participants of the American polar expeditions were exc1uded from the praise and 
credibility extended to the expedition leaders for their contribution of suffering 
for science. 167 
AH of these analyses show that the 19th century concept of sensibility was 
not limited to a narrow physiological meaning but also encompassed moral and 
intellectual sensibility. Stating that a person, or animal, was more or less sensitive 
to pain in 19th century Europe or America was not a neutral judgment about their 
responsiveness to bodily harrn. Judgments about sensitivity to pain were also 
judgments about a person's moral qualities ofvirtue, courage and sympathy; 
about their intellectual abilities and social rank; and about what kind of protection 
from pain was owed to them, whether this protection consisted of anaesthesia or 
freedom from slavery. 
165 Pernick, A Ca/cu/us ofSuffering, 156,158. 
166 Pernick, A Ca/cu/us ofSufJering, 171-195. 
167 Rebecca Herzig, SufJeringfor Science: Reason and Sacrifice in Modern America (New 
Brunswick, NJ and London: Rutgers University Press, 2005), 24, 65, 80-81. 
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Alongside its social and moral implications, the concept of sensibility was, 
since the 18th century, firmly anchored in the physical reactivity of nerves. 168 This 
was reinforced by the development of sensory physiology in the 19th century. By 
the end of the century, differences in sensitivity were increasingly understood 
with reference to degrees of physical evolutionary development. 169 A more highly 
developed nervous system would be quicker to transmit the feeling of pain. 
Associations of sensibility with social and moral qualities were not excluded by 
this evolutionary framework, but instead strengthened by proponents of Social 
Darwinism. 170 In its simplest formulation, this doctrine, chiefly associated with 
Herbert Spencer, superimposed the differentiation and classification of social, 
psychological and biological characteristics onto a hierarchical evolutionary scale. 
This framework provided a rationale for the production and comparison of 
algometric data that cou1d be mapped onto categories of social, biological and 
pathological identities. 
In the last decades of the 19th century, a few scientists took up algometry 
as part oflarger projects ofmeasurement and classification ofhuman difference 
and deviance. Criminal anthropologists in Italy such as Cesare Lombroso and 
Salvatore Ottolenghi, William MacDougall-British psychologist and member of 
the Cambridge Anthropological Expedition-and Arthur MacDonald-Specialist 
in the U. S. Department of Education-counted algometers as an important item 
in their arsenals of instruments of precision. A variety of other anthropometric 
and psycho-physiological tools, such as Broca callipers, craniographs, 
168G. J. Barker-Benfield, The Culture ofSensibility: Sex and Society in Eighteenth-Century Britain 
(Chicago: University of Chicago Press, 1992), 1-36, traces the anchoring of sensibility in nerves 
back to physiological theory of Newton, but shows that the notion was rapidly popularised in the 
genre of the Iiterature of sensibility, where it was given social meanings, in particular a gendered 
dimension. 
169 For description of pain and sensitivity as understood within a late 1 9th century evolutionary 
framework, see Bending, The Representations of Bodily Pain, 66, 178-194; Herzig, Sufferingfor 
Science, 34-5. 
170 On criminal anthropology as a form of Social Darwinism, see Gibson, "On the Insensitivity of 
Women," 13. On the influence of evolutionary and degeneration theory on Lombroso, see Leonard 
Savitz, "Introduction to the Reprint Edition," in Criminal Man According ta the Class{fication of 
Cesare Lombroso, ed. G. Lombroso-Ferrero, (Montclair, N. J.: Patterson Smith, 1972), vii. On the 
influence ofSpencerian thought on the Cambridge Anthropological Expedition to the Torres 
Straits, see Voestermans and Jansz, "Culture and Ethnicity," 173. 
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pelvimeters, aesthesiometers, thermaesthesiometers, and dynamometers were 
used to quantify and compare pelvic and cranial dimensions, sensibility to heat 
and pressure, and physical strength. Lombroso, Ottolenghi, MacDougall and 
MacDonald participated in a much broader movement in tum of the century 
anthropology, psychiatry, psychology and criminology to align categories of race, 
sex, age, social c1ass, mental pathology and criminality with quantifiable 
differences in physiological characteristics. 
Aigometric measurements were scientific not only because they were 
precise, and thus could be compared, c1assified and correlated with more 
qualitative characteristics, but aiso because they allowed experimenters to delve 
beyond manifest variations in responses to pain to uncover "true sensitivity." 
Indeed, the question of whether apparent responsiveness to pain was justified by 
true inner physiological sensitivity, considered to be the fundamental form of 
interpersonal variation, was preoccupying for late I9th and early 20th century 
physicians and scientists. 171 Distinguishing between superficial and deep 
manifestations of sensitivity was an important goal for those who sought to 
objectif y pain-measurement during this period. This goal was part of different 
types ofprojects. 
Cesare Lombroso, founder of the ltalian school ofpositivist criminology 
or criminal anthropology, proposed to shift the emphasis in criminology from the 
nature of crimes to the nature of criminals. 172 Through comparative measurements 
of offenders' body parts, facial features and sensibility, a "knowable, measurable 
171 Pernick, A Ca/cu/us of Suffering, 161: "Nineteenth-century commentators carefully 
distinguished between "insensitivity" -the inability to feel pain, and "endurance"- the ability to 
bear it. They insisted that the differences discussed so far were real differences in the way pain 
was perceived, not simply differences in the capacity to withstand it." See also, D. Crompton, 
"Courage or Insensibility (?) to Pain During Double Amputation of the Legs Without 
Chloroform," Guy's Hospital Report 44 (1887): 142-3, in which a surgeon describes the case ofa 
man who underwent amputation without showing any signs of pain. It is unclear whether the man 
was insensible, and th us felt no pain, or whether he had sufficient courage and will power to 
remain stoic in the face of great pain. Details of his social status are given, and seem to be the on Iy 
available clue for answering this question. However, the author does not express any conclusions. 
172Gibson, "On the Insensitivity of Women," 12-13: Positivists, led by the physician Cesare 
Lombroso, rejected this abstract equation of crime and punishment and instead recommended the 
individualised treatment of each defendant based on his or her degree of "dangerousness" to 
society." 
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and predictable" cri minai type emerged: the born criminal. 173 The classification 
and examination of actual and potential offenders promised, according to criminal 
anthropologists, to make criminal justice more effective through the 
individualization oftreatment, and even the prevention of criminality.174 For 
criminal anthropologists, the biological anomalies such as insensibility that 
characterised born criminals were signs of both physical and moral degeneration, 
that is, ofbeing less evolved than normal, morally healthy individuals. 
One of the physiological markers of inherent criminality was a sensibility 
to pain that was "much less acute" than that of normal individuals, "and 
sometimes non-existent.,,175 Not only was Lombroso able to support his statement 
with anecdotal stories about criminals who had carried on as if unbothered by 
serious injuries, or observations on criminals' predilection for tattoos, but he also 
provided his readers with a precise, quantitative range of normal sensibility.176 
These measurements were significant for Lombroso because he considered 
physical and moral insensibility to be tightly connected. l77 To measure general 
sensibility and sensibility to pain, Lombroso had adapted a common electric 
apparatus, developed by Du Bois-Raymond, for use as an algometer. 178 
173 Savitz, "Introduction to the Reprint Edition,"x-xi. 
174 This is illustrated by the introduction by Gina Lombroso-Ferrero ofa chapter on the 
examination of criminals in Criminal Man, which is a synthesis of Lombroso's work, 219: 
"Criminal anthropologists are unanimous in insisting on the importance of the results to be gained 
from a careful examination of the physical and psychic individuality of the offender, with a view 
to establishing the extent ofhis responsibility, the probabilities ofrecidivation on his part, the cure 
to be prescribed or the punishment to be meted out to him; but besides furnishing the magistrate 
with a sound basis for his decisions, the anthropological examination will prove of great assistance 
to probation officers, superintendents of orphanages and rescue homes and ail those who are 
entrusted with the destinies of actual offenders or candidates for crime." 
175 Lombroso-Ferrero, Criminal Man, 247 
176 Lombroso-Ferrero, Criminal Man, 247 and Cesare Lombroso, Nouvelles Recherches de 
Psychiatrie et d'Anthropologie Criminelle, (Paris : F. Alcan, 1892),88. It is unclear, however, in 
what units Lombroso is expressing pain sensitivity. In Criminal Man, the normal range is given as 
10-25, while Nouvelles Recherches states that the normal figure is 35. ln both cases, the same 
instrument was apparently used. 
177 For example, Lombroso-Ferrero, Criminal Man, 39: "Cruelty depends on moral and physical 
insensibility, those incapable offeeling pain being indifferent to the sufferings of others." For a 
more general description of the criminologists' views of the criminal as morally insensible, see 
Gibson, 'On the Insensitivity,"28-42. 
178 There is good evidence that Lombroso's algometric method preceded von Frey's, but does not 
seem to have become widely known to psychophysical researchers. His method is apparently 
described in L'Algométria Electrica in 1867, almost two decades before von Frey published his 
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Essentially, the apparatus delivered precisely quantified electric shocks to the 
subject. Lombroso did not de scribe its use more extensively. For Lombroso and 
his followers, then, algometers were diagnostic tools that could help identify the 
criminal and thus reform criminal science and the cri minaI justice system. 
In the 1880s and 90s, cri minaI anthropologists turned their attention to the 
study of female offenders. The interests of criminal anthropologists extended 
beyond criminality itselfto the evolutionary ranking ofhuman types and the 
identification of atavistic markers in idiots, epileptics, or primitives. When they 
studied cri minaI women, they also made claims about the relative status of 
women to men, based on data obtained from the normal subjects who served as 
their controls. In 1890, Lombroso claimed, controversially, that women were less 
sensitive to pain than men. 179 This went against the commonly stated beliefthat 
women were more sensitive than men, and the frequent pointing to hypersensitive 
white, urban, middle-class women as a warning of the pathological dangers of too 
much civilisation. 180 Lombroso, however, dismissed the hypersensitivity of 
women as an illusion, pointing instead to data obtained with his algometer. His 
work was acclaimed and pursued by fellow criminal anthropologists, most 
notably Salvatore Ottolenghi, whose book Sensitivity ofWomen was published in 
1896. On the basis of algometric evidence, Ottolenghi argued that "true 
sensitivity" could be distinguished from the superficial emotionality of women. 
Though he found that numerous women were apparently more responsive to pain 
than men, Ottolenghi labelled this response as "excitability," the result ofhaving 
imagined pain before it could actually be felt. 181 
article on his hair aesthesiometer. See n.2, p 87 of Nouvelles Recherches de Psychiatrie et 
d'Anthropologie Criminelle. For a description of Lombroso's algometer, see G. Lombroso-
Ferrero, Criminal Man, 246 and 249. 
179 Cesare Lombroso, "Tatto e Tipo Degenerativo Nelle Donne Normali," Archivio 1 1 (1890) :558, 
cited by Gibson, "On the Insensitivity," 15, 35n.1O 
180Pernick, A Calculus ofSuffering, 154. See literature on the relationship between the 
neurasthenia and hysteria and their association both with hypersensitivity and overcivilisation, for 
example, L. Briggs, "The Race of Hysteria: 'Overcivilisation and the 'Savage' Woman in Late 
19th Century Obstetrics and Gynecology," American Quarterly 52 (2000): 246-73. Francis 
Gosling, Before Freud: Neurasthenia and the American Medical Community (Urbana: University 
of Illinois Press, 1987). 
181Gibson, "On the Insensitivity ofWomen," 17-8. 
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According to Mary Gibson's analysis, the ltalian criminologists' inquiries 
into the sensibility to pain ofwomen was meant to be a contribution to debates 
about the "woman question" taking place at the time in ltaly. The measurement of 
sensibility was a central feature of the criminologists' experiments because of the 
associations between physical, moral and intellectual sensibility. For the 
criminologist, the sensitivity tests "offered an objective, scientific evaluation of 
women's nature." ltalian criminologists recommended that restrictions on 
women's public roles and political engagement-on the basis oftheir limited 
moral and intellectual sensibility-be maintained by insisting on the primacyof 
their "natural" role as mothers. 182 
Lombroso's ideas were particularly influential in the United States. 183 One 
of the manifestations ofthis interest was a series of bills presented before the U. 
S. Senate for the establishment of a "psycho-physicallaboratory" for the study of 
"the criminal, pauper and defective classes" under the federal government. 
Instrumental in promoting these bills was Arthur MacDonald, who came before 
Senate judiciary committees to give detailed descriptions of the rationale and 
methods of such a laboratory in 1902 and 1908. 184 "The most rigid and best 
method" for a scientific study of man, explained MacDonald, was that of the 
"laboratory, with instruments of precision in connection with sociological 
data.,,185 
Following French and ltalian cri minaI anthropologists, MacDonald 
believed that it was possible to understand and prevent the causes of social 
pathologies through careful correlations of quantitative anthropometrical and 
psycho-physiological data with information about behaviour, social class, 
education, intelligence, etc. The algometer was especially important in 
182Gibson, "On the lnsensitivity ofWomen," 11-12, 19-26. 
183 Savitz, "Introduction to the Reprint Edition," xix. 
184 The first bill on which MacDonald was granted a hearing was H. R. 14798 in 1902, see 
Alexander MacDonald, Hearing on the Bill (H. R. 14798) ta Establish a Labarataryfar the Study 
of the Criminal, Pauper, and Defective Classes, with a Bibliagraphy (Washington: Govemment 
Printing Office, 1902). See also, Alexander MacDonald, A Plan for the Study q{ Man with 
Rejèrence ta Bills ta Establish a Labaratary for the Study of the Criminal, Pauper and Defective 
Classes (Washington: Govemment Printing Office, 1902). 
185MacDonald, Hearing on the Bill, 8. 
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MacDonald's collection of instruments of precision, because he believed, like 
Lombroso, that physical insensibility accompanied moral insensibility.186 Indeed, 
he had designed his own algometer. It consisted of a scale that indicated pressure 
in grams, a rod and a disk, covered in flannel to avoid eliciting cold sensations, 
which was applied to the subject's temple until the subject "felt the pressure to be 
the least bit disagreeable.,,187 
The MacDonald algometer was used by him and various other American 
researchers to compare the pain sensibility of various categories of adults and to 
correlate data on sensibility with other information obtained in schoolchildren. In 
two hearings before the Senate, in 1902 and 1908, MacDonald presented 
algometric data that he and other researchers had obtained. In one table, he 
compared the sensibility to pain in the right and left temples ofwomen by age and 
by occupation. In another, he presented data he had obtained with the Cattell 
algometer in groups of individuals of different classes, sexes and nationalities. 
MacDonald also presented the results of extensive studies of schoolchildren, 
which included figures on pain sensibility. MacDonald proposed that, to study the 
roots of criminality and abnormality, one should begin with the investigation of 
children. As specialist in the U. S. Bureau of Education from 1892 to 1902, 
MacDonald had access to data obtained in large studies of schoolchildren. In 
various tables, he compared the sensibility to pain of girls and boys, public and 
private school students, and according to age, the season ofbirth, strength, and 
puberty. At least two other studies that focused on the measurement of sensibility 
in schoolchildren with MacDonald's algometer were pub1ished in the American 
Journal of Psychology. In one study of Michigan schoolchildren, sensibility to 
pain was correlated with age, sex, hair and eye colour, birth order, and 
186MacDonald, Hearing on the Bill, 41, "we shall see that from this physical insensibility cornes in 
great part moral insensibility." 
187 Descriptions of MacDonald's temple algometer are found in MacDonald, Hearing on the Bill, 
98-99; MacDonald, A Plan for the Study of Man, 26-28; and MacDonald, Juvenile Crime and 
Reformation, 190-193. In the latter MacDonald also decribes Cattell's and Chéron's algometers. 
MacDonald also emphasized in each ofthese texts the importance ofusing instruments of 
precision in the study ofhumans. See, MacDonald, A Plan, 8: "The time has come wh en it is 
important to study a child with as much exactness as we investigate the chemical elements of a 
stone or measure the mountains on the moon." 
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"brightness" or "dullness." 188 A further study of pain sensibility in schoolchildren 
attempted to verify the se findings with respect to age and mental ability. 189 
While, according to available evidence, there were probably fewer than a 
do zen algometric studies conducted in the United States at the turn of the century, 
sorne of these studies included hundreds and even thousands of children. Even 
more significant is the fact that repeated attempts were made to introduce bills for 
the establishment of a federallaboratory for the study of "abnormal classes" and 
that these received endorsements from about three do zen senators and 
congressmen, 55 "American Specialists," 20 "European Specialists" including 
Lombroso, Ottolenghi and Havelock Ellis, as well as a motion passed by the 5th 
International Congress for Criminal Anthropology.190 James B. Gilbert has shown 
that MacDonald's theories enjoyed briefpopularity in Congress, and that he was 
viewed as an eminent criminologist doing reputable work until he was dismissed 
as a "crank" in the 1930s. 191 If the bills to establish such a laboratory had not been 
defeated, it is possible to imagine that algometric measurement would have been 
practiced much more extensively. 
Aigometry thus enjoyed a brief period of popularity at the turn of century, 
especially in the U. S., as a means ofmeasuring group differences in pain 
sensibility. This way ofusing algometers resonated with broader trends in 
thinking about the significance of differences in pain sensibility; the relevance of 
correlations of social and biological data; the measurability of pain as a psycho-
physiological event determined by nervous sensibility; and the use of common 
typologies of social, biological and pathological classification. Despite 
contradictions in algometric findings, and the relatively limited scale on which it 
188 A. Carman, "Pain and Strength Measurements of 1,507 School Children in Saginaw, 
Michigan," American Journal of Psychology 10 (1899): 392-398. 
189 E. J. Swift, "Sensibility to Pain," American Journal of Psychology Il (1900): 312-317. 
190MacDonald, Hearing on the Bill, 135-7, also incJudes excerpts from texts published in scientific 
medical and legal joumals expressing support for the psycho-physicallaboratory. 
191 James B. Gilbert, "Anthropometries in the U. S. Bureau of Education: The Case of Arthur 
MacDonald's 'Laboratory, "'History of Education Quarterly 17 (1977): 169-195. Gilbert also 
argues that a major source of opposition to MacDOnald's lab was his employer in the bureau of 
education Willam T. Harris. Gilbert suggests that had MacDonald not been employed in this 
branch of govemment, his laboratory might have been established more easily. 
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was practiced, turn of the century algometry is revealing of more widely accepted 
notions about pain, individual difference and the value of quantification. 
Specifie claims about differences in pain sensibility were not universally 
accepted. Nor did everyone agree about the social and political implications of 
observed differences. For example, as we have se en, claims were made both for 
the superior and inferior sensitivity ofwomen to pain. ltalian women's rights 
activists rejected the criminologists' findings as a basis for granting civil and 
political rights, and called for a "friendly" and "objective" science to replace the 
biased and illogical methods of the criminologists. l92 In the United States, many 
feminists agreed that women were more sensitive to pain than men. While sorne 
saw this as an indicator ofwomen's moral superiority, others blamed Victorian 
medical culture for making women hypersensitive. 193 There was also sorne 
confusion about whether infants were insensible, like animaIs, or hypersensitive, 
like women; debates about whether slaves' insensitivity was "natural" or could be 
cured by freedom from brutality; 194 and different positions on whether increased 
pain sensibility was proportional, or inversely correlated with the acuity of 
"lower" senses such as touch and vision. 195 
That specific claims about the sensitivity to pain of certain groups were 
often contested reveals the importance given to the implications of differences in 
192 M. Gibson, "On the Insensitivity ofWomen," 26-31, for the response ofwomen's groups to 
Lombroso and Ortolenghi's findings. 
193Pemick A Ca/cu/us of Suffering, 160-1. 
194 Pemick, A Ca/culus ofSuffering, 153, points out that both sorne abolitionists and some 
proponents of slavery argued that slaves' insensibility was the result of brutal treatment, the first 
to criticize slavery, and the second to "improve" slavery by making it less brutal, and thus more 
defensible. 
195 Spencer believed that the "Iower" senses such as sight and tactile discrimination were more 
highly developed in primitive peoples, as they were in animaIs, leaving less nervous energy for 
rational thought, while sensibility to pain was more highly developed in English subjects, see note 
23. Similarly, Ortolenghi had explained divergences in his findings between general sensitivity 
and pain sensibility in women by arguing that the first represented only the delicacy of the skin, 
while the second was more directly linked to the level of cerebral evolution, see M. Gibson, "On 
the Insensitivity ofWomen." Others, like Galton, argued that ail sensory perceptiveness was 
Iinked to mental ability, but what counted was not the measurement of the first threshold of 
perception, but the differences in intervals that could be discriminated. Thus Galton distinguished 
between the delicacy fo sorne women's nerves, which he likened to a morbid hypersensitivity, and 
the power to discriminate between minute differences in intensity of stimulation, which was 
greatest in men. See Francis Galton, lnquiry into Human Faculty and its Deve/apment (London: J. 
M. Dent & Sons, 1911). 
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sensitivity. In addition, those who commented on the topic generally described 
sensitivity to pain as a physiological characteristic, a stable, if not fixed, attribute 
of the responsiveness of the nervous system. Criticisms of particular experiments 
or statements often confirmed the beliefthat inter-individual variations in 
sensibility were not only real, but could be measured and patterned according to a 
specific typology.196 
By the first decades of the 20th century, however, after the failure of 
MacDonald's project, interest in this type of algometric practice waned. While 
psychologists and anthropologists seem to have lost their interest in algometric 
studies of differential pain sensibility in race, sex, age and intelligence after the 
turn of the century, American clinicians drew on the techniques and concepts of 
these studies to develop methods to refine the accuracy of clinical judgment. They 
proposed to use this technique not to differentiate racial and class-based 
sensibility, but to test their individual patients' "sensitiveness" to pain. They were 
critical of categorical generalisations about pain sensibility, but did not reject the 
relevance of finer differentiations. For them, the utility of algometric principles, 
which they applied without instrumentation, was to improve the quality of their 
clinical judgment. 
3.3 The Importance of Clinical Observation 
A typical view on pain and differences was Richard J. Behan's, author of a 
popular American clinical textbook on pain, initially published in 1914 and 
several times re-edited. Behan dismissed such "general statements" about racial 
differences in sensitivity, for example, he warned that a comment made in a BMJ 
editorial-that "the Hebrew stands pain less easily than any other race"-
196 For example E. B. Titchener, "On Ethnological Tests of Sensation and Perception with Special 
Reference to Tests ofColor Vision and Tactile Discrimination described in the Reports of the 
Cambridge Anthropological Expedition to the Torres Straits," Proceedings of the American 
Philosophical Society, 55 (1916),204-36: criticised the techniques used by expedition members, 
but applauded the effort and offered constructive criticism on how to conduct psychophysical 
measurements in the field. 
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"smack[ ed] of the feuilletonist and [was] not to be taken too seriously." 197 He also 
advised his readers to take "the generalisation" made by MacDonald and 
Ottolenghi on differences in pain sensibility in different classes of women "cum 
grano salis" (with a grain of salt) 198 Behan nevertheless accepted the idea of 
differential susceptibility to pain, and suggested that temperament and 
complexion affected sensibility, while he also accepted "a certain relationship 
between the degree of mentality and susceptibility to pain. The higher the 
development and the more vivid the imagination, the greater is the 
susceptibility." 199 
Behan advised that differences in susceptibility to pain be taken into 
account when estimating the intensity of a patients' suffering. While he praised 
the value and accuracy of algometers, Behan instead proposed a simple pinching 
test to determine patients' quickness to react to pain. In this manner, it was 
possible to weigh patients' complaints against a rough measure oftheir 
physiological sensitivity. Descriptions of suffering alone were deemed not to be 
"of much practical assistance in deciding upon the severity of a pain.,,200 
Variations in "descriptive ability, powers of imagination, and vocabulary,,20 1 
made one patient more convincing than another, even while both may be 
experiencing the same degree of pain. Thus, for Behan, algometric measurement 
would theoretically be a means of putting patients on same level, despite their 
different abilities to access language Ca quality that was presumably linked to 
education level, and therefore socioeconomic status). Behan emphasised the 
importance of pain patterns as a diagnostic guide for physicians. Along with an 
examination of patients' appearance, reflexes and blood pressure, knowledge of 
their sensitivity to pain helped to provide an accurate clinical picture of their real 
symptoms. For example, more sensitive patients afflicted by the same disease 
197 Richard J. Behan, Pain, ifs Origin, Conduction, Perception and Diagnostic Significance (New 
York: D. Appleton, 1914), 112, the reference given was to the SM} (1906), 880. Pain, its Origin 
was again published in 1916, 1920, 1921 and 1926 
198 Behan, Pain, 113. 
199 Behan, Pain, 115. 
200 Behan, Pain, 128. 
201 Behan, Pain, 128. 
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might present a different pattern of symptoms from less sensitive ones. 
Differences in patients' expressiveness, however, might mask these essential 
differences.202 
Emmanuel Libman was one of the physicians who agreed with Behan that 
testing patients' sensitivity to pain could help decipher the relationship between 
the intensity of symptoms and the severity of disease, without running the chance 
ofbeing deceived by patients' inability to express, or to feel, their own pain. 
In the late 1920s, Emmanuel Libman, a distinguished American physician, 
described a test designed to determine sensitiveness to pain, which he had 
reportedly been using "for a number ofyears.,,203 It was a simple technique by 
which the physician applied strong pressure to patients' mastoid bone with his 
fingers, observed their reaction and then questioned them about whether they had 
felt pain. It was important that the patient be unaware of the test, which was one 
of the reasons why Libman felt that algometers were not appropriate for clinical 
use. By surprising the patient, it was possible to bypass their own interpretations 
of suffering and thus distinguish between the "natural sensitivity,,204 of the 
patient, the "sensitiveness to which he is born,,,205 as measured on the basis of 
their spontaneous response to the painful pressure, and their reactivity to, or 
tolerance of pain, which was expressed in their tendency to complain. A patient 
who showed little or no reaction to the test was given a score of 0 or + and 
classified as hyposensitive, while one who cried out or withdrew was called 
hypersensitive and scored as +++. The Libman test was shown to be sensitive to 
202 Behan, Pain, 120-129. This section was section titled "estimation of the intensity of pain." 
203 Emanuel Libman, "Practicallecture, New York Academy of Medicine, Dr Emanuel Libman, 
Friday afternoon, January Il, 1929," Libman Papers, Modem Manuscripts Collection (MMC) 
406, Box 18, History of Medicine Division (HMD), National Library of Medicine (NLM). See 
also Emmanuel Libman, "Observations on Sensitiveness to Pain," Transactions of the Association 
of American Physicians 41 (1926): 305-8. 
204 Emmanuel Libman, "Observations on Individual Sensitiveness to Pain With Special Reference 
to Abdominal Disorders," Journal of the American Medical Association 102 (1934): 355-41. 
Libman writes: "lt is of course necessary to distinguish between the sensitiveness to pain and the 
way in which the patient acts in response to what he feels. The increased or decreased response 
can be termed decreased or increased tolerance ( ... ) The sensitiveness that is determined by means 
of the test is regarded as the natural sensitivity." 
205 Emanuel Libman, "Practicallecture, New York Academy of Medicine, Dr Emanuel Libman, 
Friday afternoon, January Il,1929,'' Libman Papers, MMC 406, Box 18, HMD, NLM. 
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racial differences: 98% of "Pueblo lndians" had scored as hyposensitive, based on 
a study conducted by a medical student. Libman himself had found a high 
proportion ofhyposensitives among pugilists (boxers).206 
While Libman encouraged further testing of age, sex, race and even 
species-based differences in sensitiveness to pain by means ofhis test, his real 
interest was in improving physicians' ability to match clinical symptom patterns 
with cardiac and abdominal disorders.207 He was particularly interested in the 
diagnostic challenges presented by hyposensitive individuals. Libman complained 
that textbook descriptions of pain patterns in particular disorders were based on 
hypersensitive patients, while hyposensitives-who constituted 30% ofhis own 
patients and over 90% in particular groups-presented an entirely different 
constellation of symptoms.208 Knowing the hyposensitive status of a patient could 
draw a clinician's attention to what Libman called "substitution" or "covered" 
symptoms that would have been manifested as pain in more sensitive patients 
suffering from the same disorder. 209 
While it may not be possible to determine how widely the Libman test was 
used in routine clinical practice, his observations were both familiar to, and 
commended by, many physicians including eminent American physicians su ch as 
the Mayo brothers, founders of the Mayo Clinic, Walter Alvarez, and M. C. 
Winternitz, Dean of the Yale University School of Medicine.2lo Libman was often 
invited to lecture specifically on pain, or to comment on papers dealing with 
206 Libman, "Observations on Sensitiveness," 305-8. 
207 Libman, "Observations on Individual Sensitiveness," 355-41. This article was based on a paper 
read before Section of Gastroenterology and Proctology of AMA session 1933. 
208 "Classifies patients by sensitiveness to pain: Dr Libman Says Sorne People Feel None, Though 
Disease. Calls for Text-book Revision," New York Times (January 12, 1929), in Libman Papers, 
MMC 406, Box 18, HMD, NLM. 
209 Libman, "Observations on Individual Sensitiveness," 355-41; Emanuel Libman, "Practical 
lecture, New York Academy of Medicine, Dr Emanuel Libman, Friday aftemoon, January 1 l, 
1929," Libman Papers, MMC 406, Box 18, HMD, NLM. 
210 William J. Mayo to Emanuel Libman, August 24,1933, Libman Papers, MMC 406, Box 5, 
HMD, NLM; Walter Alvarez to Emanuel Libman, May 15, 1925, Libman Papers, MMC 406, Box 
3, HMD, NLM; M. C. Wintemitz to Emanuel Libman, n.d., Libman Papers, MMC 406, Box 6, 
HM D, NLM : "You recall that we talked about sensitiveness to pain when 1 saw you last, and 1 am 
particularly impressed by the clear way in which you have stated this difficult problem." 
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painful symptoms in cardiac and gastrointestinal disorders.211 In severallectures 
and at least three published articles, Libman described the use ofhis test.212 One 
ofthese lectures was reviewed in a New York Times article, in which it was 
reported that "a number of physicians present said it was of extreme practical 
importance, especially to the general practitioner.,,213 His publications, in 
particular an article in lAMA, were later qualified as "classic" contributions on 
the topic of pain symptoms.214 
The apparent appeal of Libman's method, and ofhis detailed observations 
on the relationship between sensitivity, symptoms and disease, can be linked to 
contemporary preoccupations among elite clinicians about the status of clinical 
observation. Libman' s test of pain sensitivity did not challenge traditional clinical 
judgment. It was meant as an aid, rather than a replacement, ofa physician's 
diagnostic skills and powers of observation. It thus conformed to older styles of 
celebrating physicians' uncanny ability to "read" patients' pains through the art, 
rather than science, of medicine.2ls Libman acknowledged that, to apply the test 
211Harold Brunn (Mount Zion Hospital) to Emanuel Libman, January 7, 1941, [MS C 406, 
Emanuel Libman Papers, Box Il], mentions that the members of staff of Mount Zion Hospital 
requested that Libman speak about pain at a dinner, and that Libman should also speak on the 
topic of pain to the students the following afternoon. William J. Kerr (University ofCalifornia) to 
Emanuel Libman, January 16, 1941, [MS C 406, Emanuel Libman Papers, Box Il]: "1 think it 
would be of great interest to the students and to those ofus on the Faculty who are able to attend If 
you would discuss the subject of pain in general and with particular reference to your own 
contributions. 1 always ave been tremendously impressed by your discussions and writings on this 
subject."H. L. Blockus (American Medical Association) to Emanuel Libman, January 12, 1933, 
[MS C 406, Emanuel Libman Papers, Box 12], invites Libman to participate in a session on 
abdominal pain during a meeting of the section of Gastroenterology of the AMA. 
212"Copy of notes taken by stenographer of Diagnostic Clinic given by Dr. E. Libman at the 
meeting of the Inter-State Post Graduate Assembly at Cleveland Ohio on October 18, 1926," [MS 
C 406, Emanuel Libman Papers, Box 18]; Libman, "Observations on Individual Sensitiveness," 
355-41; "Observations on Sensitiveness,"305-308; "Studies in Pain," Transactions of the 
Association of American Physicians 44 (1929): 52. 
213 "Classifies patients by sensitiveness to pain: Dr Libman Says Sorne People Feel None, Though 
Disease. CaUs for Text-book Revision," New York Times (January 12, 1929), Libman Papers, 
MMC 406, Box 18, HMD, NLM : "Though Dr. Libman disclaimed after the lecture any 
revolutionary importance for his work, a number of physicians present said it was of extreme 
practical importance, especiaUy to the general practitioner." 
214 L. PeIner, "The Determination ofSensitivity to Pain. A Simple Clinical Method," Journal of 
Laboratory and Clinical Medicine 27 (1941): 248-51; E. D. Sherman, "Sensitivity to Pain. (With 
an Analysis of 450 Cases)," Canadian Medical Association Journal 48 (1943): 437-41. 
215 A good illustration ofhow pain would ideally be read by the skilful, observant physician in the 
early 20th century is given in: "Gestures' Meaning in the Pain-Striken," New York Times (June 30, 
1907), 12, an article about Professor Thomson, a "minutely observant physician" who was able to 
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and interpret its results correctly, experience and judgment on the part of the 
physician were required.216 Applying finger pressure on the styloid process of the 
patients' mastoid bone had to be done with precision and consistency, a task that 
was not standardised by an instrument. In addition, the test enabled physicians to 
tailor their diagnostic interpretations to the individual characteristics of the 
patient. Thus, greater accuracy in diagnosis did not necessarily have to de pend on 
recourse to laboratory tests; it could also originate in a more individualised 
reading of symptoms. 
Libman's interest in pain is explicitly linked, in his lecture notes, to a 
concern about the waning prestige of clinical medicine and the authority of 
laboratory research. At the conclusion ofhis lecture to the New York Academy of 
Medicine, Libman explained: "1 did not choose this subject [pain] at random. 1 
chose this subject for specific reasons. 1 wanted to speak on something that was 
purely clinical. We aU realize that clinical medicine is faUing behind, not only in 
this country, but an over. The practitioner is ashamed that he is not doing 
laboratory work.,,217 ln another set ofundated "lecture notes on clinical 
medicine," Libman elaborated on the importance of clinical observation, and 
emphasized the dangers of not conducting a thorough examination before calling 
for laboratory tests. Quoting Robert McNair Wilson and Alexis Carrel, Libman 
presented the progress of clinical me di cine as depending on physicians' efforts to 
attain "the widest possible knowledge of human nature" and their "ability to grasp 
the characteristics which make each human being an individual.,,218 Libman's 
emphasis on the importance of clinical observation sounds similar to the 
diagnose diseases simply by reading their body language while they described their pain. 
Thomson explained this to his students, the article reported, "in an effort to teach medical students 
the value of cultivating habits of intelligent observation." 
216 Untitled, n.d., Libman Papers, MMC 406, Box 19, HMD, NLM : "1 fear that Dr. Boles has had 
Iittle experience with the test. Whatever method is employed, errors can be minimized only by 
much experience 
217 Libman, "Practicallecture," 
2lS"Lecture notes on clinical medicine," Libman Papers, MMC 406, Box 19, HMD, NLM. The 
Wilson quote, drawn from Pygmalion or the Doctor of the Future (1926), depicts the doctor ofthe 
future not as a laboratory scientist but as a humanist, having "the widest possible knowledge of 
human nature, and the deepest possible understanding ofhuman motives. He will be a cultured 
man, ripe in intellectual attainments, but not lacking in emotional sympathy ... " The Carrel quote 
is probably drawn from Alexis Carrel, Man, the Unknown (1935). 
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antireductionist stance described by Christopher Lawrence in the rhetoric of elite 
British clinicians during the Interwar period.219 This rhetoric defended the value 
of knowledge produced by bedside observation, and thus of special skills and 
gentlemanly status of elite clinicians, against the dominance of laboratory-
generated knowledge. In suggesting that patients' sensitivity should be tested, 
Libman did not promote instrumental precision or inter-observer standardisation 
in the measurement of symptoms, nor did he promise impersonal diagnostic 
accuracy. Instead, Libman, like many American and British clinicians in the late 
19th and early 20th centuries, believed that the potential power of the laboratory, 
rationalisation and instruments of objectivity should be harnessed without 
threatening their traditional claims to authority: humanism, skill and 
individualisation.22o 
While agreeing with Libman's emphasis on reading symptoms in the light 
of sensitivity, several physicians criticized his test in the late 1930s and early 
1940s for its lack of precision and calibration. They charged that the constancy of 
the degree of pressure applied by the physician' s finger might vary from one test 
or examiner to the next, and that the imprecision of the stimuli gave only a rough 
estimate of sensitivity. Laboratory methods of algometry, which had multiplied 
since the 1890s, were, unfortunately, too unwieldy and time-consuming for 
clinical use. Two new, more accurate but still clinically convenient, methods of 
sensitivity measurement were proposed. 
219 Christopher Lawrence, "Still Incommunicable: Clinical Holists and Medical Knowledge in 
Interwar Britain,"in Greater Than the Parts: Holism in Biomedicine, 1920-1950, ed. C. Lawrence 
and G. Weisz, 94-111 (New York and Oxford: Oxford University Press, 1998). 
220 There is a fairly extensive literature on medical "resistance" or "conditional acceptance" of 
diagnostic, laboratory and standardising technologies with reference to a des ire to protect 
traditional medical autonomy, authority and ski Ils. Some examples that are relevant for this period 
in the U. S. and U. K. include: Christopher Lawrence and George Weisz, eds. Greater Than the 
Parts: Holism in Biomedicine, 1920-1950. (Oxford: Oxford University Press, 1998); Joel Howell, 
Technology in the Hospital: Transforming Patient Care in the Early 20th Century (Baltimore and 
London: The Johns Hopkins University Press, 1995). Steven Sturdy and Roger Cooter, "Science, 
Scientific Management, and the Transformation of Medicine in Britain c. 1870-1950," History of 
Science 36 (1998): 421-466; Harry M. Marks, "Medical Technologies: Social Contexts and 
Consequences," in Companion Encyclopedia of the History 0.[ Medicine, ed. W.F. Bynum and R. 
Porter (London and New York: Routledge, 1993), 1592-1618. 
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The first, a "clinical gauge for sensitivity to pain," which was described in 
1938 by E. Hollander, consisted of an elliptical metal grater that was taped to the 
inner surface of a blood pressure cuff. As the cuff was inflated, the grater pressed 
into the skin without puncturing it. When patients either winced or made a "verbal 
protest," the mercury level ihdicated on the cuff was read. The instrument could 
easily be reconverted to its original function. Hollander, agreeing with Libman, 
advised that patients not be informed about the test in order to obtain a 
"spontaneous, unconditioned reaction." His concern was to obtain a reading that 
was untainted by patients' ownjudgment oftheir sensitivity.221 
The second instrument was Pelner's sensometer, which could be made by 
adapting a universally available instrument called a Geneva Lens Measure. Unlike 
HoUander's gauge, Pelner argued, the sensometer could be used in hypertensive 
patients and would not be affected by the amount of subcutaneous fat on patients' 
arms. The sensometer consisted of two fixed points, which were pressed onto the 
non-fleshy surface of the thumb "until the pain becomes unbearable," while a 
central point moved in response to the pressure exerted and could be read off a 
dial. PeIner described the calibration and recording measurements in detail, and 
noted that the instrument was "standardised the same way aU over the world." 
PeIner was thus concerned with the repli cation of measurement from one observer 
to another. 222 
While those physicians who used the HoUander gauge and sensometer 
between 1938 and 1944 explicitly placed themselves within the framework of 
Libman' s "classic" work on the relationship of sensitiveness to symptoms of pain, 
their concerns in testing sensitiveness was different from Libman's. First, as we 
have seen, they seemed much more preoccupied with standardisation and 
quantitative precision, for which instruments seemed necessary. They were also 
interested in making a new kind of comparison: between the sensitivity of 
neurotic and anxious patients who suffered from ill-defined somatic complaints, 
221 E. Hollander, "A Clinical Gauge for Sensitivity to Pain," Journal of Laboratory and Clinical 
Medicine 24 (1938-1939): 537-38. 
222 Peiner, "The Detennination of Sensitivity," 248-51. 
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and the sensitivity of apparently mentally-healthy patients who clearly suffered 
from organic disorders or did not suffer at al1.223 While there is no evidence that 
the sensometer and HOllander gauge continued to be used beyond these few 
experiments, this new interest in the relationship between psychological 
characteristics such as neuroticism and differential responsiveness to pain would 
persist during the next few decades. 
3.4 Precision in Therapeutic Evaluation 
Two articles, published in 1915 and 1916, reported the use of an algometric 
method to measure drug effects. The first was written by a team of researchers 
from the Laboratory of Physiology at Harvard Medical School, who had 
developed a quantitative method of measuring sensitivity by means of faradic 
current, which was part of a bigger project on the measurement of induction 
shocks.224 This article was part of a series of publications describing the 
calibration oftheir method and its use for measuring variations in sensitivity over 
time, as weIl as under the influence of fatigue and drugS.225 In reporting this small 
experiment, conducted on two subjects, who were medical students, they 
emphasized the validity of their method for measuring physiological sensitivity 
rather than the significance oftheir findings or the implications oftheir method 
for pharmacological testing. 
223 R. M. Wilder, Jr., "Sensitivity to Pain," Proceedings of the Staff Meetings Maya Clinic 15 
(1940): 551; Sherman, "Sensitivity to Pain," 437-41. Wilder and Sherman specifically compared 
pain sensitivity in patients with organic and those with functional complaints, including 
nervousness, anxiety, exhaustion, and vague and i\l-defined pains. See also J. O. Haman, "Pain 
Threshold in Dysmennorrhea," American Journal of Obstretics and Gynecology 47 (1944): 686-
91, the focus in this article was somewhat different. It attempted to determine whether women 
who experienced more menstrual pain received more physiological pain signaIs, or were simply 
more sensitive to pain. The implicit question may have been about whether dysmennorrheic 
women had a "psychological" susceptibility to pain. 
224 E. G. Martin, C. M. Grace and 1. H. McGuire, "The Influence of Drugs on the Human Sensory 
Threshold," Journal of Pharmacology 6 (1915): 527-32. Martin, The Measurement of Induction 
Shocks; a Manualfor the Quantitative Use ofFaradic Stimuli (New York: J Wiley & Sons, 1912). 
225 E. G. Martin, "A Quantitative Study of Faradic Stimulation. II. the Calibration of the 
Inductotherm for Break Shocks," American Journal of Physiology 22 (1908): 116. E. G. Martin, P. 
R. Withington, and 1. 1. Putnam, "Variation in the Sensory Threshold for Faradic Stimulation in 
Normal Human Subjects III. The Influence of General Fatigue," American Journal of Physiology 
34 (1914): 97. 
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The second team used a similar method of measurement, but expressed 
more concern about the need for objectivity and accuracy in therapeutic 
evaluation. Accurate information about the pain-relieving efficacy of the opiate 
drugs was lacking, the authors pointed out, because no attempt had been made to 
quantifY pain, and because of the "notorious subjectivity" of patients' reports of 
analgesia.226 They "blinded" their two subjects (kept them ignorant ofwhat they 
received), who were also medical students, and tested the effects ofboth active 
and inactive substances on their pain thresholds. That inactive substances 
produced no change in thresholds was presented as proof of the validity of the 
method. The team placed a strong emphasis on the control of the conditions in 
which measurements were made, ensuring that subjects were not distracted by 
noise or drafts, and that their expectations did not influence their reports. This 
experiment was part of a more general investigation of the pharmacological 
effects of opiate drugs that was supported by a grant from the American Medical 
Associations's Council on Pharmacy and Chemistry.227 These experiments fitted 
well with the Council's goal of ensuring that daims for therapeutic efficacy-
especially those made by the pharmaceutical industry-were evaluated expertly 
and objectively. Despite this, there was no follow-up to the se studies until the 
mid-1930s. Only then did interest in analgesic innovation and testing become 
strong enough to stimulate the development and use of more precise techniques to 
measure pain relief. 
Conclusion 
By the late 1920s, algometry had been a part of four very different kinds of 
projects. Basic psychophysiological research on pain continued to create a modest 
demand for algometers into the 1930s. The application of psycho-physiological 
226 D. 1. Macht, "Action of the Opium Alkaloids, Individually and in Combination With Each 
Other, on the Respiration," Journal of Pharmacology and Experimental Therapy 7 (1915): 339-73. 
227 See also D. 1. Macht, "Action of the Opium Alkaloids, Individually and in Combination With 
Each Other, on the Respiration," Journal of Pharmacology and Experimental Therapy 7 (1915): 
339-73. 
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instruments by psychophysical and criminal anthropologists was brief: its 
popularity doesn't seem to have endured past the first years of the 20th century. 
Afterwards, from the 1920s, algometric data on differential pain sensitivity was 
produced by clinicians, who were more interested in the diagnosis and aetiology 
of individual ills than that of social pathologies. In the late 1930s, clinicians 
proposed new, more precise and consistent methods to measure pain sensitivity in 
patients. In addition, they became interested in the sensitivity of anxious and 
neurotic patients, an interest that would continue to develop in the 1940s. In the 
mid-1910s, two research groups used algometric techniques to obtain quantitative 
measures of the efficacy of analgesic drugs by algometric means, but there was no 
foUow-up to the se attempts in the U. S. until the mid-1930s. 
How did these researchers seek to transform the evaluation of pain 
sensibility by using algometers? Because they sought to compare and classify 
human responses to pain, they valued quantitative precision. However, they did 
not aU aspire to the same level of precision. For early 20th century clinicians, 
rough comparative classifications of sensitivity were sufficient. For them, 
algometry would function as an aid to clinical judgment rather than a means to 
eliminate it. To map out the sensitivity of skin surfaces, more precise and neutral 
values were required. Because algometers were not used as part of large 
coUaborative projects, it did not matter that the type of instrument, how it was 
used, and what units it measured in, was not standardised among pain-measurers. 
These researchers also sought to move beyond what they saw as 
superficial differences in subjects' pain responses-their emotional fluctuations, 
variations in their ability to express themselves, or their willingness to show their 
suffering-to detect a stable, inner "true" physiological sensitivity. How they did 
this varied to sorne extent, and this seems to have depended both on the nature of 
the project and of the subjects. In many cases, subjects were required to make 
rather difficult judgments in identifying the precise moment at which a stimulus 
became painful. The mechanization of the stimulus, using instruments that could 
de li ver discrete, measurable, constant sources of pain, was meant to facilitate the 
precision of this judgment. In other cases, especiaUy when clinical patients were 
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used as subjects, 'algometers were used to measure automatic or spontaneous 
responses, such as movements or complaints. In both cases, there was a concern 
to make subjects' responses more automatic, to mechanize them to a certain 
extent either by training subjects to become impartial "instruments" or by keeping 
them naïve and eliciting responses that were not the product of conscious and 
deliberate judgments. 
Late 19th and early 20th century pain-measurers conceptualized differences 
in sensitivity to pain as physiological differences that mapped onto moral and 
intellectual qualities, and were aligned with a biological classification of human 
differences. Within this conceptualisation of pain, however, there was room for 
different categorisations of difference and political positions, and for the influence 
of environmental modulation. 
In 1940, the introduction of a new algometric technique promised greater 
precision and accuracy in pain-threshold measurement, and produced data that 
suggested a new way of conceptualising pain. The reception of this method, the 
Hardy-Wolff-Goodell radiant-heat or dolorimetric method, is revealing of 
changes in the purpose and value given to the quantification and standardisation 
of pain. According to its creators, the dolorimeter showed that the sens ory 
threshold for pain-that is, physiological sensitivity-was constant in all 
neurologically normal individuals, independent of gender, personality, fatigue or 
emotional state.228 
The two following chapters will examine how the potential of the 
dolorimetric method, and the implications of its findings, were embraced by 
different groups of researchers. 1 will argue that the enthusiastic reception of the 
dolorimeter was indicative ofbroader transformations in the meaning and 
importance of pain-measurement. In chapter 4, 1 will de scribe how the search for 
differenees in responses to pain shifted its foeus from biologie al to psychological 
sources of variation. This shi ft conformed with dolorimetric data suggesting that 
228 A. Schumaker, H. Goodell, 1. D. Hardy, H. G. Wolff, "Uniformity of the Pain Threshold in 
Man," Science 92, no. August 2 (1940): 110-112. See also, 1. D. Hardy, H. G. Wolff, H. Goodell, 
"Studies on Pain. A New Method for Measuring Pain Threshold: Observations on Spation 
Summation of Pain," Journal ofClinicallnvestigation 19 (1940): 649-57. 
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variations in responses to pain originated in differing psychological and emotional 
responses to pain sensation rather than in differing physiological capacities to 
perceive pain sensation. However, this shift also followed from a broader social 
conviction that culture and personality were at the root of significant differences 
in human behaviour and subjective somatic experience, and that personality could 
be "algogenic". The measurement of sens ory thresholds was replaced by the 
measurement of psychological reactivity to pain, while new tools, developed to 
measure personality characteristics and attitudes towards pain, were also applied 
in the study of differential responses to pain. 
The precision offered by the dolorimeter was also welcomed by those who 
were seeking a better means oftesting analgesics. In chapter 5, l will describe 
how a growing interest in analgesic innovation intensified the search for pain-
measuring technologies in the late 1930s. The dolorimeter was well-suited to the 
requirements formulated in this search. However, the continuing interest in 
analgesic innovation and testing eventually created new demands and possibilities 
for methods of measuring pain-relief, and the dolorimeter was displaced by the 
techniques of the analgesic clinical trial. 
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4. "AlI Brothers under the Skin": How Responses to Pain Became a 
Psychological Matter 
In 1940, a group of researchers from Cornell University Medical School 
announced before the National Academy of Sciences that everyone had the same 
capacity to perceive pain?29 Results obtained with the dolorimeter, a new pain-
measuring instrument, in 150 subjects, of different ages and sexes, and of 
different self-reported sensitivities, showed that the pain perception threshold was 
stable and uniform.230 This was an astonishing finding. Not only did it contradict 
five decades of algometric measurement, but it also went against the plainly 
obvious: that people varied widely in their responses to pain. Three implications 
of this dramatic revelation were emphasized by its authors and their audience: 
First, despite their apparent differences in responses to pain, individuals were, 
deep inside, equal in their physiological sensitivity. Second, a pain-threshold 
measuring method ofunprecedented precision and accuracy, one capable of 
detecting the true pain-perception threshold, had been discovered by the Cornell 
researchers. Finally, if the explanation for differences in responses to pain was not 
to be found at the level of sensory physiology, then it must have something to do 
with the psychological state of the experiencing subject. Though all three ofthese 
statements would be criticized and modified, the last had perhaps the greatest 
long-term impact on pain-measuring practices. 
As 1 will show in this chapter, however, the integration ofthis 
proposition-that individuals varied in their psychological reactivity rather than 
their physiological sensitivity to pain-into research practice had fairly little to do 
with the dolorimeter itself. Instead, this integration depended on the appropriation 
of techniques and conceptual models from other areas of research that could 
broadly be defined as "psychosomatic." These were techniques and models that 
229 "Brothers Under the Skin: We Ali Feel Pain in Same Way, National Academy is Told", 
Newsweek (May 6, 1940) in WolffPapers, Box l, Folder 6, Medical Center Archives of New 
York-Presbyterian/Weill Comell. 
230 A. Schumaker, H. Goodell, J. Hardy, H. G. Wolff, "Uniformity of the Pain Threshold in Man," 
Science 92 (1940): 110-112. 
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allowed researchers to define, standardise and measure the influence of 
psychological processes on bodily phenomena and experience, and conversely, of 
psychological reaction to physiological stimulation. While the dolorimeter may 
not have, on its own, brought about a dramatic shi ft in ways of thinking about 
pain, the impact of this shift on pain research is reflected in the ways in which 
sorne contemporary researchers took up this new instrument and adopted the 
theoretical distinction between the sensation of, and the reaction to, pain 
formulated by its creators Hardy, Wolff and Goodell. There were other 
dimensions of the contemporary response to the dolorimeter and its findings, 
which were adopted, modified and criticized by a new generation of researchers. 1 
will briefly describe these as a means of illustrating the significance of the 
dolorimeter, and of exploring the different meanings and uses of pain-
measurement circa 1940: Why were people interested in pain-measurement? 
What exactly did they want to measure? What was the value of data produced by 
measuring technologies? 
Popular news coverage of the discovery drew attention to the broad social 
and cultural implications of the discovery, heralding a break with old beliefs 
about sens ory inequality and proclaiming a new scientific position of sensory 
egalitarianism. "Science" had now shown that Americans were, in matters of pain 
sensitivity, "brothers under the skin," according to the title of a Newsweek 
article.231 This discovery went against everyday experiences and popular notions 
of sensitivity, which would not be "so easily shaken," according to the Victoria 
Colonist. 232 The American Weekly gave an example: "Y ou no doubt have heard an 
individual brag and say he never feels pain, while someone else cringes at the 
very thought of going to the dentist and says, 'am so sensitive' ,,,233 which was 
echoed by Newsweek "as far as physical sensitivity to pain is concerned, a 
231 "Brothers Under the Skin," in WolffPapers, Box 1, Folder 6, Medical Center Archives of New 
York-Presbyterian/Weill Cornel!. 
232 "Threshold of pain," The Victoria C%nist (September 6, 1941) in Wolff Papers, Box 1, Folder 
6, Medical Center Archives of New York-Presbyterian/Weill Cornell. 
233 "When You Begin to Say 'Ouch!'" American Weekly (July 7,1940), in WolffPapers, Box 1, 
Folder 6, Medical Center Archives of New York-Presbyterian/Weill Cornel\. 
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phlegmatic labourer and a high-strung woman are in the same boat.,,234 The 
Sunday Mirror Magazine Section offered an evocative illustration of the 
implications: "iftwo persons are subjected to the same stimulus and one yells 
'Ouch!' louder than the other, it does not mean that the louder one has greater 
sensitivity to pain but merely that he is in better voice.,,235 Other articles, 
including those published by the New York Times and Life magazine, echoed this 
tone. 236 For the general public, then, measuring pain was significant for what it 
could say about how individuals interacted with each other and about the ways 
they were, or were not, fundamentally different. 
The inventors of the dolorimeter, James Hardy, Harold G. Wolff and 
Helen Goodell, emphasized the methodological implications of the constant 
threshold: their method had succeeded where others had failed. Previous 
researchers such as Libman, explained the Cornell team, had found wide 
variations in sensitivity because their testing methods had failed to discriminate 
between subjects' perception of the painful stimulus, and their reaction to the 
experience of pain. In the dolorimetric method, a focused beam of heat was used 
as a stimulus, one which allowed subjects to differentiate sharply between the 
sensation ofwarmth and the beginning of the sensation ofpain. In other words, it 
made it easy for subjects to become detached and accurate judges of an isolated 
"pure" pain sensation. Previous algometers, on the other hand, had measured a 
mixture of sens ory and emotional responses to pain. While the sensory threshold 
for pain was the same for aIl neurologically normal individuals, explained Hardy, 
Wolff and Goodell, the psychological reaction to pain varied greatly from one 
person to another.237 
234 "Brothers Under the Skin." 
235 "Why you Holler 'Ouch' ," Sunday Mirror Magazine Section (September 7, 1941) in Wolff 
Papers, Box l, Folder 6, Medical Center Archives of New York-Presbyterian/Weill Cornel!. 
236 Harry M. Davis, "Science in the News" New York Times (August 31, 1941); "Pain: Researchers 
at New York Hospital Discover that everyone is equaliy Sensitive to it," Life (March 3, 1941),46, 
49-50, in Wolff Papers, Box l, Folder 6, Medical Center Archives of New York-
Presbyterian/Weill Comel!. 
237 Hardy, Wolff and Goodell often explained this distinction in their numerous publications. It is 
discussed at length in their book J. D. Hardy, H. G Wolff, and H. Goodell, Pain Sensations and 
Reactions (Baltimore: Williams & Wilkins, 1952). See also: Schumaker et a!., "Uniformity of the 
Pain Threshold," 110-112. J. D. Hardy, "The Nature of Pain," Journal ofChronic Diseases 4 
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The separation of pain into these two components-sensation and 
reaction-was not new. It had been articulated, for example, by American 
psychologist C. A. Strong as a means of reconciling the "quale" theory of pain, in 
which pain was defined as an emotion of displeasure, with the definition of pain 
as a sensory event that could be studied by psychophysical methods.238 Clinicians 
such as Behan and Libman had also discussed the difference between individuals' 
sensitivity to painful stimulation and their capacity to endure or tolerate the 
experience of pain. However, they, and many of their contemporaries, had defined 
sensitivity as the "true" seat of pain feeling. Libman and Behan had valued 
algometric tests because they thought it important to dig beyond differences in the 
proclivity to show or express feelings of pain, differences which were only 
superficial and of little medical interest per se, to uncover this "true 
sensitivity.,,239 What was new in 1940, then, was to claim that manifest variations 
in responses to pain were not due to differences in sensitivity, and to suppose that 
they were wholly psychological rather than physiological in nature. It was also the 
first time that results indicating universal uniformity between subjects, rather than 
findings of regular patterns of difference between groups, had been held up as 
evidence for the validity of an algometric method. 
Hardy, Wolff and Goodell suggested that the stable sens ory threshold 
produced by the dolorimeter could be useful in several contexts. Its capacity to 
detect and quantifY the effect of analgesic drugs on stable threshold made it useful 
as a means of comparing the potency of different drugS.240 As we will see in the 
following chapter, this possibility was welcomed by those who, in the context a 
(1956): 22-51. H. G. Wolff, "Corne 11 Conference on Therapy: Psychologie Aspects ofTreatment 
of Pain," New York State Medical Journal 45 (1945): 1003-9. 
238e. A. Strong, "The Psychology ofPain," The Psychological Review 2 (1895), 329-347. This 
was the published version of a paper read before the American Psychological Association at its 
Princeton meeting, and was given in response to the publication in 1894 of Pain, Pleasure and 
Aesthetics written by proponent of the quale theory of pain Henry R. Marshall. 
239 See previous chapter. See also: E. Libman, "Observations on lndividual Sensitiveness to Pain 
With Special Reference to Abdominal Oisorders," Journal of the American Medical Association 
102 (1934): 355-41; Richard Joseph Behan, Pain Its Origin, Conduction, Perception and 
Diagnostic Significance (New York, London: O. Appleton, 1914). 
240 H. G. Wolff, J.O. Hardy and H. Goodell, "Studies on Pain. Measurement of the Effect of 
Morphine, Codeine and Other Opiates on the Pain Threshold and an Analysis ofTheir Relation to 
the Pain Experience," Journal ofClinicalInvestigation 19 (1940): 659-80. 
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growing interest in analgesic innovation in the 1930s and 40s, were searching for 
a more precise and consistent test of analgesic efficacy. 
The dolorimetric capacity to isolate the sensory component of pain was 
also exploited by its creators in launching "a wholehearted attack" in the area of 
the quantitative psychophysics of pain "in a manner analogous to the 
psychophysics of vision or hearing.,,241 The Cornell team used the dolorimeter to 
apply psychophysical measurement techniques, such as the measurement of just 
noticeable differences (jnd), which had been used in other areas of sensation, but 
not to pain. On the basis of jnd measurements, Hardy, Wolff and Goodell 
elaborated a scale of pain intensity in dol units, specifying the range, magnitude 
and number of degrees of discriminable intensities of stimulation. The focus of 
this research was on universallaws of pain psychophysics. While Hardy, Wolff 
and Goodell did show that the threshold for pain perception was alterable by 
suggestion and distraction, these were transitory modifications of a threshold 
which, under conditions of attentive and detached observation, was said to be 
usually constant. That the threshold could be altered in the se ways did not imply 
stable patterns of individual difference, unless one considered that individuals 
were differentially susceptible to the effects of suggestion.242 
Although this line of investigation was commended as the first real 
attempt to develop a thorough and quantitative psychophysical investigation of 
pain,243 few researchers followed up on it. Nor were the few attempts to make the 
dolorimeter relevant in clinical pain evaluation successful in converting clinicians 
to its use.244 Apart from those who adopted the dolorimeter for analgesic 
24\ W. Edwards, "Recent Research on Pain Perception," Psychological Bulletin 47 (1950): 449-74. 
242 J. D. Hardy, H. Wolff, and H. Goodell, "Studies on Pain: Discrimination of Differences in 
Intensity ofPainful Stimuli As a Basis of a Scale of Pain Intensity," Journal o/Clinical 
Investigation 26 (1947): 1152-8; J. D. Hardy, H. Wolff, and H. Goodell, "Studies on Pain: An 
Investigation ofSome Quantitative Aspects of the DOL Scale of Pain lntensity," Journal 0/ 
Clinicallnvestigation 27 (1948): 380-6. H. G. Wolff and H. Goodell, "The Relation of Attitude 
and Suggestion ta the Perception of and Reaction to Pain," Proceedings of the Association/or 
Research on Nervous and Mental Disease 23 (1943): 434-48. 
243 Edwards, "Recent Research on Pain Perception," 449-74; Edwin G. Boring, "Introduction," in 
Hardy et al., Pain Sensations and Reactions. 
244 James Hardy and Carl T. Javert, "Studies on Pain: Measurements of Pain Intensity in 
Childbirth," Journal o/Clinicallnvestigation 28 (1949): 153-62; Frederik P. Haugen and William 
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evaluation, researchers seemed to be more interested in the reaction to pain, 
which, according to Hardy, Wolff, and Goodell, was dominated by the 
psychological characteristics of the individual (their previous experience, the 
meaning they attributed to the pain, their personality), than in its sens ory 
perception.245 
Indeed, many researchers in the 1940s, 50s and 60s were more 
preoccupied by the manifest variability of responses to the infliction of pain, than 
in the underlying uniformity in sens ory sensitivity. In searching for the patterns 
and causes of this variation, researchers after 1940 turned towards the study of 
reactivity to pain. Sorne even challenged the uniformity of the pain perception 
threshold proposed by Hardy, Wolff and Goodell in the 1940s,246 and it became 
widely accepted by the 1950s that even the sensory aspects of pain could not be 
isolated from a person's psychological disposition?47 In other words, while sorne 
researchers c1aimed that even the sensory threshold was, to sorne extent, 
modulated by psychological influences, and others c1aimed that it was stable, 
most saw the reaction threshold as wholly determined by individual's previous 
experience, personality and interpretations of the painful event, and thus as key in 
investigating these sources of modulation.248 
K. Livingston, "Experiences With the Hardy-Wolff-Goodell Dolorimeter," Anesthesi%gy 14 
(1953): 1 09-16. 
245 Hardy, et al. Pain Sensations and Reactions. See also: Schumaker et al., "Uniformity of the 
Pain Threshold," 110-112; Hardy, "The Nature of Pain," 22-51; Wolff, "Comell Conference on 
Therapy," 1003-9. 
246 L. H. Lanier, "Variability in the Pain Threshold," Science 97 (1943): 49-50. J. R. Schamp, 
R.M. Schamp, "Variability of the Pain Threshold in Man," Journal of Dental Research 25 (1946): 
101-4. There were also sorne teams who obtained high levels of variability in the data they 
obtained from the Hardy-Wolff-GoodeIl apparatus but continued to consider it valuable 
nonetheless. See chapter 3 for references. 
247 Edwards, "Recent Research on Pain Perception," 449-74. 
248 Sorne who rejected the uniformity of the pain threshold believed that there did exist a purely 
sensory threshold but that it was not necessarily invariable, for example: W. P. Chapman, C.M. 
Jones, "Variations in Cutaneous and Visceral Pain Sensitivity in Normal Subjects," Journal (){ 
Clinicallnvestigation 23 (1944): 81-9l. J. W. Clark, "Factors Affecting Human Responses to Pain 
Stimulation," (PhD Thesis, McGill University, 1955). Others, however, rejected the possibility of 
a measurable sensory threshold because, they argued, by the time the sensation ofpain enters 
consciousness, a subjects' brain had already begun to "react" to the pain, and thus sensation and 
reaction cannot be separated. For example: H. K. Beecher, "Relationship ofSignificance of 
Wound to Pain Experienced," Journal (){the American Medical Association 161 (1956): 1609. 
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My aim in this chapter is to situate this "psychological turn" in pain 
research with respect to a much broader surge of interest in the relationship 
between emotional responses, psychological makeup (personality) and somatic 
experience, which preceded and accompanied the response to the dolorimeter. 1 
will trace sorne of the connections between research on differential pain responses 
from the 40s to the 60s and the preoccupations, as well as the methods, of a 
CUITent of psychosomatic interest that touched sorne quarters of American 
medicine, psychiatry, psychology and anthropology. 1 will thus argue that Hardy, 
W 01ff and Goodell' s claim that differences in responses to pain were 
psych010gica1 in nature was convincing because it fit within the concerns and 
explanatory framework of this broader psychosomatic movement. Perhaps more 
importantly, this claim was convincing because it was possible to investigate it 
using experimental techniques and categories developed by psychologists, 
psychiatrists and physiologists that connected emotional, mental and 
psychological processes. 
4.1 The American Psychosomatic Movement and the Pain fui Personality 
ln 1940, when the first articles on the dolorimeter were published, words such as 
"personality," "stress," "neurotic" and "psychosomatic" seemed to be seeping into 
the vocabulary of a growing number of American medical scientists and 
clinicians. These words would soon enter into the writings of pain researchers. 
The increasingly prevalent use of such terms was a consequence of the growth of 
psychosomatic medicine in the U.S. in the 1930s and 40s. While psychosomatic 
ideas had existed much earlier in physiology and psychiatry, psychosomatic 
research, as an organized and funded field, began to emerge in the 1930s. 
Robert Powell has traced the roots ofthis modern American 
psychosomatic movement to three ditIerent strands: the physiological 
investigation of emotional responses, pioneered by Walter B. Cannon and 
influenced by the work of Pavlov; the psychobiological, holistic approaches to 
medicine developed by American psychiatrist Adolf Meyer, and pursued by 
Helen Flanders Dunbar; and the psychoanalytic approaches to the psychogenesis 
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of somatic symptoms proposed by European-influenced American psychiatrists 
such as Franz Alexander.249 
In the 1930s, the efforts of advocates of psychosomatic medicine such as 
Dunbar and Alexander, 250 combined with new support from American 
philanthropies, began delineating this field as an active, coherent and laboratory-
based area of research. Psychosomatic research was presented by its supporters as 
a strategy for filling the gaps left behind by rapid but selective medical progress. 
Introductions to books and conferences on psychosomatic medicine, for example, 
sometimes began with descriptions of the significant advances in medical 
diagnosis and treatment resulting from bacteriology and pathology, a narrative in 
which Virchow and Flexner often figured as champions. Soon, however, the 
authors were bemoaning the paucity of etiological and therapeutic knowledge 
about many complex chronic disorders, the lagging status of psychiatry, and the 
deplorable neglect of the patient as a whole in modern medicine.25 1 This view was 
shared by representatives of philanthropies, such as Alan Gregg of the Rockefeller 
Foundation, who also emphasized the importance of applying experimental and 
preferably quantitative methods to the study of psychical processes and their 
physiological correlates in order to make psychiatry stronger and more relevant to 
mainstream medicine.252 The Josiah Macy Jr. Foundation began funding an 
249 Robert Powell, "Healing and Wholeness: Helen Flanders Dunbar (1902-59) and the Extra-
Medical Origins of the American Psychosomatic Movement, 1906-36," (PhD Thesis, Department 
of History, Duke University, 1974). For an analysis of the emergence of the physiology of the 
emotions, see Othniel E. Dror, "The Affect of Experiment: The Tum to Emotions in Anglo-
American Physiology, 1900-1940," Isis 90 (1999): 205-37. For a description of how Cannon's 
research intluenced the later psychosomatic ideas of Franz Alexander and Hans Selye, see Alan 
Young, "Walter Cannon and the Psychophysiology of Fear," Greater than the Parts, ed. C. 
Lawrence and G. Weisz (Oxford and New York: Oxford University Press, 1998),234-256. 
250 Other key actors included Stanley Cobb, Harold G. Wolff, Stewart Wolf, John C. Whitehom, 
among others ... 
251 F. Alexander, "Introduction," and "The Role of Modem Psychiatry in the Development of 
Medicine," Psychosomatic Medicine: Its Principles and Applications (New York: Norton, 1950), 
17-23 and 24-34. 
E. Weiss and O. English, "Chapter 1: Psychosomatic Medicine," in Psychosomatic Medicine: The 
Clinical Application of Psychopathology to General Medical Problems (Philadelphia and London: 
W. B. Saunders, 1943),3-20; Franklin G. Ebaugh, "Introduction to Symposium on Military 
Neuropsychiatry," Proceedings of the Associationfor Research on Nervous and Mental Disease 
25 (1946): xiii-xv. 
252Jack D. Pressman, "Hum an Understanding: Psychosomatic Medicine and the Mission of the 
Rockefeller Foundation," in Greater Than the Parts: Holism in Biomedicine, 1920-1950, ed. C. 
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extensive review of research on "emotions and bodily changes" in the early 
1930s. The book that came out ofthis review, first published by Dunbar in 1935 
and re-edited in 1938 and 1946, also emphasized the need for physiological and 
quantitative research methods in psychosomatic medicine.253 When Dunbar's 
newly formed American Society for Research in Psychosomatic Problems (which 
would become the American Psychosomatic Society) founded the journal 
Psychosomatic Medicine in 1939, the Josiah Macy JI. Foundation contributed to 
its publication?54 The Commonwealth Fund also provided grants for 
psychosomatic research in the 1930s and 40S.255 The Rockefeller Foundation 
initiated a significant funding program for psychosomatic research in the mid-
1930s, under the direction of Alan Gregg, which notably provided support to the 
Chicago Institute ofPsychoanalysis, directed by Franz Alexander, and the 
psychiatrie service of the Massachusetts General Hospital run by Stanley Cobb.256 
Alexander's c1inic received additional funding from the Julius Rosenwald Fund, 
257 while Cobb did additional contract work for the Office for Scientific Research 
and Development (OSRD) during World War n?58 
Lawrence and G. Weisz, 189-208 (Oxford and New York: Oxford University Press, 1998).1. 
Groen, "Foreword to Symposium on Life Stress and Bodily Disease" Proceedings of the 
Associationfor Research on Nervous and Mental Disease 29 (1950): xv-xviii. 
253 Helen Flanders Dunbar, Emotions and Bodily Changes: A Survey of Literature on 
Psychosomatic Interrelationships, 1910-1933 (New York: Columbia University Press, 1935); 
Emotions and Bodily Changes: A Survey of Literature on Psychosomatic Interrelationships, /9/0-
1933, 2nd Edition (New York: Columbia University Press, 1938); Emotions and Bodily Changes: 
A Survey of Literature on Psychosomatic /nterrelationships, /9/0-1945, 3rd Edition (New York: 
Columbia University Press, 1946); Emotions and Bodily Changes: A Survey of Literature on 
Psychosomatic Interrelationships, 1910-/953 (New York: Columbia University Press, 1954); 
Emotions and Bodily Changes: A Survey of Literature on Psychosomatic /nterrelationships, /9/0-
1953, Reprinted edition (New York: Columbia University Press, 1972). 
254 Dunbar, "[ntroduction to the Second Edition," in Emotions and Bodily Changes, 2nd Edition 
(1938), xviii, n.2 and 4; R. Powell, "Healing and Wholeness." 
255 Various articles in Volume 29 of Proceedings of the Associationfor Research on Nervous and 
Mental Disease (1950) on "Life Stress and Bodily Disease" report funding from the 
Commonwealth Fund. The main sponsors also included the Rockefeller foundation, the Office of 
Naval Research and the National Institute for Mental Health. 
256 Pressman, "Human Understanding," 189-208. 
257 Powell, "Healing and Wholeness," 30. 
258 P. D. White, S. Cobb, W. P. Chapman, et al., "Observations on neurocirculatory asthenia," 
Transactions of the Association of American Physicians 58 (1944): 129-137. The work described 
in this paper and others was done under a contract, recommended by the Committee on Medical 
Research, between the OSRD and the MGH. Responsible investigators: Stanley Cobb and Paul D. 
White. 
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This instance of OSRD funding for psychosomatic research also illustrates 
the importance of military and wartime concerns about neurotic disorders in the 
development of American psychiatry and psychosomatic research. The prevalence 
of psychoneuroses among military recruits and fighters during W orld War II 
focused the attention of military authorities on the need for a well-organized 
psychiatric service, and convinced them of the value ofresearch into the aetiology 
and diagnosis of psychosomatic disorders?S9 More broadly, as Colonel Ebaugh 
put it in the introduction of the Proceedings of a symposium on Military 
Neuropsychiatry: "in the war experience every responsible medical man has seen 
the need of a medical profession better prepared to deal with emotionally 
deterrnined forms of incapacitation. ,,260 The need for diagnostic and screening 
technologies for military purposes may also have stimulated the development of 
psychometric tools to measure dimensions of personality, such as the Minnesota 
Multiphasic Personality Inventory (MMPI), first described in print in 1940, and 
the Maudsley Personality Inventory, for which research began in 1940?61 Such 
tools were soon used to determine the presence of personality disorders that were 
thought to make individuals susceptible to neurotic and psychosomatic illnesses. 
One doctor, for example, advocated the wide use of the MMPI in general practice 
as a means of differentiating between the organic and psychogenic aetiology of 
unexplained somatic symptoms.262 
259 Dunbar, "Introduction to the Third Edition," in Emotions and Bodily Changes, 3'cl Edition 
(1946); . Ebaugh, "Introduction to Symposium on Military Neuropsychiatry," xiii-xv. 
The massive epidemic of"neurotic disorders" during World War 1 had first stimulated the 
development ofpsychiatric services. 
260 Ebaugh, "Introduction to Symposium on Military Neuropsychiatry," xiii. 
261 S. R. Hathaway and J. C. McKinley, "A Multiphasic Personality Schedule (Minnesota): 
Construction of the Schedule," Journal of Psychology 10 (1940), 249-254; A. Petrie, Personality 
and the Frontal Lobes: An Investigation of the Psychological EjJects of Different Types of 
Leucotomy (Philadelphia: Blakiston, 1952). 
262 A. A. White, "Evaluation of Psychogenic Symptoms in General Medicine: U se of the 
Minnesota Multiphasic Personality Inventory," Journal of the American Medical Association 
(1951),1521-26. Others also investigated and advocated the use of the MMPI in general medicine, 
for example: D. Cohen, "Psychological Concomitants of Chronic lllness: a Study of Emotional 
Correlates of Pulmonary Tuberculosis, Peptic Ulcer, Arthritides, and Cardiac Disease," (PhD 
Thesis, University of Pittsburgh, 1949); 1. Fisher, "Some MMPI Dimensions of Physical and 
Psychological Illness," Journal ofClinical Psychology 20 (1964): 369-75; L. J. Hanvik, "MMPI 
Profiles in Patients with Low-Back Pain," Journal of Consulting Psych%gy 15 (1951): 350-351; 
D. W. Hastings, et a1., "Ear1y Objective Personality Evaluation in Medical Diagnosis," University 
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Increased funding for psychosomatic research programs was followed by 
the publication oflandmark texts on psychosomatic medicine such as Dunbar's 
Emotions and Bodily Changes (1935)263, Weiss and English's Psychosomatic 
Medicine (1943i64 , and Alexander's Psychosomatic Medicine (l950)?65 
Conferences on psychosomatic themes were also increasingly organized from the 
late 1930S266, while a specializedjoumal and research society were also founded 
at that time. These initiatives demarcated psychosomatics as a specifie area of 
medical research and practice. Though psychosomatic research and theory 
continued to encompass diverse approaches characterized by its psychoanalytic, 
physiological and psychological roots, the concretization of the field through 
funding, publications and institutional organisation provided a common heading 
for different types of research activities, as weIl as opportunities for collaboration 
and synthesis between researchers. The emphasis on quantitative and 
experimental methods also encouraged methodological cross-fertilization, 
particularly in adopting research techniques from physiologists of the emotions 
and psychologists' psychometrie instruments. An illustration of the growing 
collaboration and emphasis on exact methods of investigation can be found in the 
published proceedings of a symposium on "Life Stress and Bodily Disease" 
sponsored by the Association for Research in Nervous and Mental Disease in 
1949. Its participants included physiologists such as Hans Selye, psychoanalysts 
such as Franz Alexander and neurologists such as Harold G. Wolff, while its 
of Minnesota Medical Bulletin 28 (1957): 1-12; H. B. Hovey, "Somatization and Other Neurotic 
Reactions and MMPI Profiles," Journal ofClinical Psychology 5 (1949): 153-57. 
263 Dunbar, Emotions and Bodily Changes (1935, 1938, 1946, 1954, 1972). 
264 Weiss and English, Psychosomatic Medicine (1943, 1949), followed by Weiss, E., and O. S. 
English. Psychosomatic Medicine: a Clinical Study of Psychophysiologie Reaction (Philadelphia: 
Saunders, 1957). 
265 Alexander, Psychosomatic Medicine, (1950, 1952). 
266 See, for example: Dunbar, "Introduction to the Second Edition," xviii-xix n.5: Iists a few of the 
meetings on psychosomatic themes held in the late 1930s by the American Psychiatrie Association 
(a yearly symposium on psychosomatic problems inaugurated in 1933-34; the Tenth Medical 
Congress for Psychotherapy (a major section devoted to psychosomatic problems in 1938), and 
the Association for Research on Nervous and Mental Disease (the annual program in 1938 was 
devoted to the mind-body problem). The latter association a1so he Id meetings on the topic of Pain 
(1942, published in 1943), Military Neuropsychiatry (1944 published in 1946, the Frontal Lobes 
(published in 1948) and Life Stress and Bodily Disease (1949 published in 1950) that addressed 
psychosomatic issues. 
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papers presented results obtained from methods such as Rorschach testing of 
individuals with thalamic brain lesions, and analysis adrenal gland secretions in 
laboratory animaIs subjected to stressful situations.267 
Sorne of the researchers who became interested in the psychological 
modulation of individual responses to pain participated in such meetings, and thus 
can easily be associated with this movement for psychosomatic research.268 Many 
more, however, can be linked to psychosomatic research through their use of 
terminology and concepts of causation. The design and interpretation of 
experiments on differential pain reactions were based on the assumption that 
personality factors such as neuroticism, as well as individual and collective 
conditioning, were the main variables affecting responses to pain. Implicitly or 
explicitly, research reports conceptualized stimulation, response and pathogenesis 
in terms that made sense within the framework ofpsychosomatic thinking. For 
example, painful stimulation was often conceptualized as a form of stress, to 
which individuals responded emotionally and physiologically according to the 
"threat content" they associated with the stimulus.269 Ifthey had a neurotic or 
anxious personality, they were likely to be more reactive to painful stimulation.270 
267 Various chapters in Proceedings of the Associationfor Research on Nervous and Mental 
Disease 29 (1950). 
268 M. Furer and J. Hardy, "The Reaction to Pain as Determined by the Galvanic Response," 
Proceedings of the Associationfor Research on Nervous and Mental Disease 29 (1950), 72-89. W. 
P. Chapman, A. S. Rose, and H. C. Solomon, "Measurements of Heat Stimulus Producing Motor 
Withdrawal Reaction in Patients Following Frontal Lobotomy," Proceedings of the Association 
for Research on Nervous and Mental Disease 27 (1948): 754-768; W. P. Chapman, 
"Measurements of Pain Sensitivity in Normal Control Subjects and in Psychoneurotic Patients," 
Psychosomatic Medicine 6 (1944): 252-57. R. B. Malmo, C. Shagass, F. H. Davis, "Specificity of 
Bodily Reactions Under Stress. A Physiological Study of Somatic Symptom Mechanisms in 
Psychiatrie Patients," Proceedings of the Associationfor Research on Nervous and Mental 
Disease 29 (1950)237-268. 
269 R. B. Malmo, C. Shagass, J. F. Davis, "Pain As a Standardized Stimulus for Eliciting 
Differentiai Physiological Responses in Anxiety," American Psychologist 2 (1947): 344; R. B. 
Malmo, et al., "Standardized Pain Stimulation As Control\ed Stress in Physiological Studies of 
Psychoneurosis,"Science 1 08 (1948): 509-11; J. D. Hardy and M. Furer, "Reaction to Pain As 
Determined by Galvanic Skin Response," Federation Proceedings 9 (1950): 56. 
270 Malmo, Shagass and Davis, "Pain As a Standardized Stimulus," 344. Malmo et al., 
"Standardized Pain Stimulation," 509-11; W. P. Chapman, J. E. Finesinger, C. M. Jones, and S. 
Cobb, "Measurements of Pain Sensitivity in Patients With Psychoneurosis," Archives of 
Neurology and Psychiatry 57 (1947): 321-31. 
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Conversely, the relief of anxiety raised the reaction threshold.271 The way in 
which individuals responded to, or (mis-)adapted to stress could also put them at 
risk of developing psychosomatic disorders, which often included symptoms of 
pain such as headache, chest and low back pain.272 The level ofthreat content that 
was attributed to different kinds of stressors, including painful stimulation, was 
informed by personal and cultural conditioning, while the range of acceptable 
responses to stress was constrained by both cultural and self-imposed norms and 
values.273 This conception ofpsychological reactivity to pain was not only to be 
found in experiments of differential pain reaction, but was also reflected in new 
emphases on central (cerebral), as opposed to peripheral, mechanisms in the 
neurophysiology of pain, 274 and, among a few psychiatrists, in reflections on the 
psychodynamic processes that could cause psychogenic experiences of pain.275 
Investigations of the pain reaction can also be linked more concretely with 
contemporary developments in psychosomatic research through their 
methodoIogies. To correlate responses to pain with variables such as personality 
and past experience, researchers needed not only the means to standardise specifie 
dimensions of pain responses, but also the means to standardise and manipuIate 
psychologicaI states and processes. SeveraI different strategies were adopted by 
those who investigated differentiaI pain reactions from the 1940s to the 1960s. 
271 H. E. Hill, R. E. Belleville, and A. Wikler, "Anxiety Reduction as a Measure of the Analgesie 
Effectiveness of Drugs," Science 120 (1954): 153. 
272 For example: Thomas H. Holmes and Harold G. Wolff, "Life Situations, Emotions and 
Backache," Proceedings of the Associationfor Research on Nervous and Mental Disease 29 
(1950): 750-772. 
273 H. G. Wolff, "Life Stress and Bodily Disease-A Formulation," Proceedings of the 
Associationfor Research on Nervous and Mental Disease 29 (1950): 1059-1094; Hardy, et al., 
Pain Sensations and Reactions; Mark Zborowski, "Cultural Components in Response to Pain," 
Journal of Social Issues 8 (1952): 16-30; Ronald Melzack, "The Effects of Early Experience on 
the Emotional Responses to Pain," (Phd Thesis: McGill University, 1954) 
274 Edwards, "Recent Research on Pain Perception," 449-74; T. Barber, "Toward a Theory of Pain: 
Relief of Chronic Pain by Prefrontal Leucotomy, Opiates, Placebos, and Hypnosis," Psych%gical 
Bulletin 56 (1959): 430-460. 
275 L. Rangell, "Psychiatric Aspects of Pain," Psychosomatic Medicine 35, no. 1 (1953). 
George L. Engel, "Psychogenic Pain and the Pain-Prone Patient," American Journal of Medicine 
26 (1959): 899-918. Engel, "Psychogenic Pain," Journal ofOccupational Medicine 31 (1961): 
249-56. See also the Iiterature on low back pain, which increasingly emphasizes the emotional 
aspects of pain beginning in the 1950s: Steindler, A., Lectures on the Interpretation of Pain in 
Orthopedie Practice, (Springfield, 111.: Charles C. Thomas, 1959); Holmes and Wolff, "Life 
Situations," 750-772. 
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First, new means of measuring pain were designed to focus on more 
psychologically labile dimensions of how individuals responded to pain. 
However, in most cases, the measurement of these responses alone told 
researchers little about what they meant. To make them meaningful, data on pain 
responses had to be correlated with information about the psychological makeup 
of subjects. Drawing on a wide range of psychological categories and 
technologies that had recently been defined in psychiatry, psychology, physiology 
and even anthropology, investigators of pain reactions began to measure, model 
and even alter the personalities oftheir experimental subjects. In the remainder of 
this chapter, 1 will de scribe the techniques used to make measurements of 
responses to pain psychologically meaningful. 
4.2 New Measures of Pain 
Most researchers adopted the dolorimeter, or other algometric methods, to apply 
standardised painful stimuli. However, both who and what they measured with 
these instruments differed from previous practices of sensibility or sensitivity 
measurement. Instead of, or in addition to, measuring the introspective detection 
of pain perception, they measured the point at which subjects showed a motor 
reaction (wincing or withdrawal),276 the point at which a subject could no longer 
endure the painful stimulation (asked for it to be stopped),277 or the autonomie 
response of subjects to painful stimulation (such as sweating, finger tremor, 
increased pulse, etc.).278 These measures ofreaction, tolerance and autonomie 
indicators were understood to represent emotional responses to pain. In the latter 
276 This was the strategy employed by W. P. Chapman in his numerous experiments on pain 
reactions. Chapman also measured pain perception thresholds, by the same method as Hardy, 
Wolff and Goodell, and compared the variance in both thresholds, as weil as the differences 
between them. 
277 This method was used by Asenath Petrie in the late 1950s: A. Petrie, W. Collins, and P. 
Solomon, "Pain Sensitivity, Sens ory Deprivation, and Susceptibility to Satiation," Science 128 
(1958): 1431-33. 
278 For examp\e, Malmo, et al. "Pain As a Standardized," 344; Malmo, et al., "Standardized Pain," 
509-11; Furer and Hardy, "The Reaction to Pain," 72-89; Richard A. Stembach and Bernard 
Tursky, "Ethnic Differences Among Housewives in Psychophysical and Skin Potentia1 Responses 
to E1ectric Shock," Psychophysiofogy 1 (1965): 241-46. 
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case, the development of measurement techniques, and the association of 
autonomie indicators with emotional responses, can be traced to research on the 
physiology of emotions.279 
A few other innovations were made in developing methods to measure 
pain. One psychologist dedicated his doctoral research to the development and 
validation of a Pain Apperception Test. This was a self-rating instrument, in 
which subjects rated the emotional content of a standard set of images.280 In itself, 
this method seems to have had little impact, but it represented a new approach to 
the standardisation and quantification of subjects' own reports that was not only 
becoming increasingly common in contemporary psychometric practices, but 
which would also, two decades later, become prevalent in the design of pain 
assessment tools. Finally, in one study, qualitative ethnographic methods were 
used to investigate culture as a determinant of differential pain responses.281 This 
approach was not picked up by other anthropologists, but the results of the study 
became widely cited among pain researchers, and made ethnicity into a 
meaningful category for future quantitative studies on pain. 282 
4.2.1 Choosing Subjects, Modelling Personality 
While measures of reactions to pain such as withdrawal were labelled as 
emotional responses, data obtained on these reactions in samples of "normal" 
subjects gave ambiguous results. It was clear that they varied, but what did this 
mean? Selecting specific comparison groups of subjects was one way in which 
279 See O. Dror, "The Scientific Image of Emotion: Experience and Technologies of Inscription," 
Corifigurations 7 (1999), 335-40 l, for an analysis ofthe way in which physiological recording 
techniques were constructed as means of representing emotional processes, in particular, his 
comments on "emotion-gauging technologies," 361-368. See also the section on "the problem of 
measurement" in H. F. Dunbar, Emotions and Badily Changes, 81-1 07(discussion) and 458-474 
(bibliography) to see how technologies such as the psychogalvanometer were debated in relation 
to the question of the measurability ofpsychosomatic mechanisms. 
280 Donald V. Petrovich, "The Pain Apperception Test: Psychological Correlates of Pain 
Perception," Journal afClinical Psychology 14 (1958): 367-74. 
281 Zborowski, "Cultural Components," 16-30. 
282 Sternbach and Tursky, "Ethnie Differences," 241-46; B. Tursky and R. A. Sternbach, "Further 
Physiological Correlates of Ethnie Differences in Response to Shock," Psychophysiology 1 
(1967): 151-62. 
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investigators could produce more meaningful data. After obtaining ambiguous 
measures of pain perception and reaction thresholds in a series of "normal" 
subjects, William P. Chapman, research fellow at Harvard Medical School, turned 
to the study of "psychoneurotics." 283 For Chapman, neurotic subjects would 
potentially clarify the meaning of variations in perception and reaction 
thresholds.284 The pain reactivity ofpsychoneurotic patients was found to be 
higher than that of normal patients, which was consistent with contemporary 
beliefs, but their ability to perce ive pain was no different. Thus, it was the choice 
ofsubjects that confirmed the pain-reaction to be a psychologically modulated 
response. Another team, from the Allan Memorial Psychiatrie Institute took up 
the dolorimeter to measure more precisely the difference between psychoneurotic 
and normal responses to stress. For these researchers, standardised pain 
stimulation was seen as a means to pro duce a standard stress situation, and thus to 
obtain more exact measurements of the characteristic features ofpsychoneurotics. 
These measures consisted of physiological processes associated with stress 
reactions: lymphocyte counts, finger tremor, galvanic skin resistance and the 
EEG.285 
Once the correlation between neuroticism and increased reactivity-but 
not sensitivity-to painful stimulation was established, several groups of 
researchers explored the use of the pain-reaction test as a means to identify 
possible psychological disturbances in patients afflicted by chronic painful 
conditions.286 One such attempt linked pain reaction measurements to military 
283 Chapman and Jones, "Variations in Cutaneous," 81-91. 
284 Chapman and Jones, "Variations in Cutaneous," 81-91, the experiment reported in this article 
shows that both perception and reaction threshold vary in groups of normal subjects. While it is 
hypothesized that the reaction threshold indicates a psychological processing of the pain sensation, 
while the perception threshold indicates a purely sens ory phenomenon. ln the concluding 
comments, Chapman and Jones suggest that that the psychological reaction would dominate in 
clinically neurotic individu ais, implying that an experiment using neurotic subjects might clarify 
the psychological meaning of the reaction threshold. It was followed by such a study: Chapman, 
"Measurements of Pain," 252-57. See also: Chapman et al., "Measurements of Pain Sensitivity," 
321-31. 
285Malmo, Shagass and Davis, "Pain As a Standardized Stimulus," 344. Malmo et al., 
"Standardized Pain Stimulation," 509-11. 
286 Margaret A. Kennard, "The Responses to Painful Stimuli of Patients With Severe Chronic 
Painful Conditions," Journal of Clinical Investigation 31 (1951): 245-52. 
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sponsored research investigating the possible psychological aetiology of chronic 
disorders that were prevalent among sol di ers and recruits. One such disorder was 
neurocirculatory asthenia (N. C. A.), also called effort syndrome and sometimes 
associated with anxiety neurosis, which not only affected many military men, but 
was also often found in recruits during draft board medical examinations. A study 
ofN. C. A. was contracted by the OSRD to members ofboth medical and 
psychiatric divisions of the Massachusetts General Hospital and Harvard Medical 
School, under the supervision of Paul D. White and Stanley Cobb.287 The choice 
of investigators for this study reflects a concern to study the psychosomatic 
aspects ofN. C. A., and to differentiate between physiological and affective 
mechanisms. The aetiology ofN. C. A. was contested, and sorne doctors firmly 
maintained that disorders of the cardiovascular system were responsible for the 
condition.288 The Harvard team, however, after measuring the lactic acid content 
of muscles after training, the capillaries of the nail folds, the scores of patients on 
the Psychosomatic Experience Test and the MMPI, as weIl as their reactivity to 
painful stimulation (an experiment conducted by Chapman), concluded that, in its 
chronic form, N. C. A. was "not simply [a disorder] of disturbed circulatory 
reaction and symptoms alone, but is associated with measurable psychological 
symptoms and abnormal behaviour and difficulty in adjusting to life 
situations.,,289 Thus, in this study, Chapman's method of comparing reactivity and 
sensitivity to pain was used as a means of distinguishing between the 
physiological and psychological basis of a pathological state. 
Lobotomized individuals were another category from which pain-
measurers recruited their subjects. In the early 1940s, the American pioneers of 
psychosurgery, James W. Watts and Walter Freeman, had begun operating on 
287 White, et al. "Observations on Neurocirculatory Asthenia," 129-137; W. P. Chapman, M. E. 
Cohen, S. Cobb, "Measurements Related to Pain in Neurocirculatory Asthenia, Anxiety Neurosis, 
or Effort Syndrome: Levels of Heat Stimulus Perceived As Painful an Producing Wince and 
Withdrawal Reactions," Journal of Clinicallnvestigation 25 (1946): 890-896. 
288 I. Starr, "Studies on the Circulation of Draftees Rejected for Neurocirculatory Asthenia," 
Transactions of the Association of American Physicians. 58 (1944): 138-140, c1aimed that 
neuroticism was a result rather than a cause of the symptoms experienced by individua1s in 
neurocirculatory asthenia. 
289 P. D. White, S. Cobb, W. P. Chapman, et al. "Observations on Neurocirculatory Asthenia," 
Transactions of the Association of American Physicians, 58 (1944): 129-137. 
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patients who suffered from intractable pain after noticing that sorne of their 
patients, operated on for psychiatric reasons, no longer complained of pain after 
the operation. 290 When asked directly about their pain, however, patients 
sometimes admitted that pain was still present, and ev en that it was undiminished 
in intensity, but they no longer seemed to be bothered by it. As lobotomies were 
increasingly performed specifically for the relief of intractable pain, more 
opportunities arose to observe this phenomenon. The peculiar attitude of the 
lobotomized was made into an illustrative example of dissociation between the 
distinct sens ory and emotional components ofpain.29 \ Measuring the "before and 
after" pain thresholds of individuals who underwent lobotomy was a means of 
providing quantitative confirmation of this dissociation by showing that the pain 
reaction was significantly altered, while sensory perception remained 
unchanged.292 These measurements also confirmed the personality-dependent 
nature of the pain reaction threshold. Lobotomized patients were popular subjects 
not only for pain threshold measurements, but also for a range of psychometric 
personality assessments that were being developed from the late 1930s and 
increasingly in the 1940s such as the MMPI and items of what would become 
known as the Maudsley Personality Inventory?93 Through the se assessments, 
specific techniques oflobotomy were defined in terms oftheir personality-altering 
effects. 
These personality assessments were also applied to psychoneurotic 
patients, and in individuals with various suspected psychosomatic disorders such 
290 J. W. Watts and W. Freeman, "Frontal Lobotomy in the Treatment ofUnbearable Pain," 
Proceedings of the Associationfor Research on Nervous and Mental Disease 27 (1948): 715-722. 
291 Watts and Freeman, "Frontal Lobotomy," 715-722; Hardy, et al., Pain Sensations and 
Reactions. Barber, "Toward a Theory ofPain,"430-460. 
292 Chapman, et al., "Measurements of Heat," 754-68. W. P. Chapman, H. C. Solomon, A. S. Rose, 
"Measurements of Motor Withdrawal Reaction in Patients following frontal Lobotomy," in 
Studies in Lobotorny, ed. M. Greenblatt, R. Arnot, and H. C. Solomon, 386-392 (New York: Grune 
& Stratton, 1950); H. E. King, J. Clausen, J. E. Scarff, "Cutaneous Thresholds for Pain Before and 
After Unilateral Prefrontal Lobotomy," Journal of Nervous and Mental Disorders 112 (1950), 93-
96; Hardy, et al., Pain Sensations and Reactions. 
293 Petrie, Personality and the Frontal Lobes, 5-6; A. L. Anderson, "Personality changes following 
prefrontallobotomy," Journal of Consulting Psychology 13 (1943): 105-107; M. Vidor, 
"Personality Changes Following Prefrontal Leucotomy As Retlected by the MMPI and the Results 
of Psychometrie Testing,"Journal of Mental Science 97 (1951): 159-73. 
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as N. C. A. and hypochondria.294 Thus, the psychoneurotic and lobotomized 
subjects whose pain reactions were measured had not only been literally created 
by psychiatric techniques of diagnosis and therapy. They had also been 
constructed as subjects in states of disordered or altered personality by 
psychometric personality tests, and more generally by psychiatric theory and 
terminology. The definition of the se subjects' personality dimensions made pain 
reaction measurements meaningful as personality-dependent variables. 
2.2.2 Pain and the Measurement of Personality 
Personality tests were also used to make more direct correlations between 
personality characteristics and responses to pain. An approach that elicited a lot of 
interest in the 50s and 60s was that of Asenath Petrie, who proposed that 
individuals' pain tolerance, their personal way of experiencing pain in the world, 
was a product of the perceptual style that was associated with their personality. 
Petrie's understanding ofpersonality, and of the way in which personality could 
be broken down into measurable components, was based on the work of 
psychologist Hans J. Eysenck. In response to wartime demands for techniques to 
diagnose neurotic disorders, Eysenck, then affiliated with the Maudsley Hospital, 
a psychiatric hospital in London, had begun searching for psychometric measures 
ofpersonality. 295 He defined personality as being composed oftwo principal 
axes: neuroticism and introversion/extroversion. He then correlated these 
personality features with the results oftasks, tests or interviews.296 For example, 
an extroverted person would complete a particular task with more concern for 
294 J. C. McKinley, S. R. Hathaway, "A Multiphasic Personality Schedule (Minnesota): A 
DifferentiaI Study of Hypochondriasis," Journal of Psychology 10 (1940), 255-268. J. C. 
McKinley, S. R. Hathaway, "The identification and Measurement of the Psychoneuroses in 
Medical Practice: Minnesota Multiphasic Personality Inventory," Journal of the American 
Medical Association 122 (1943) 161-167; Asenath Petrie, "Repression and Suggestibility as 
Related to Temperament," Journal of Personality 16 (1948):449 cited in Petrie, Personality and 
the Frontal Lobes, 6, in which Petrie reports on the use of Eysenck's personality tests in a wartime 
neurosis centre. 
295 Petrie, Personality and the Frontal Lobes, 5-6. 
296 H. B. Gibson, Hans Eysenck: The Man and his Work (London: Peter Owen, 1981), 118-144, on 
Eysenck's personality theory. See also: Hans Eysenck, The Structure of Human Personality 
(London: Methuen & Co Ltd, 1953). 
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speed, while an introverted person would be more concerned with accuracy. 
Petrie had adopted these tests in studies of patients in a British wartime neurosis 
centre, and in a study of personality changes in patients who had undergone 
lobotomy.297 Her observations on the parallel changes both in personality and in 
the attitude towards pain of lobotomized patients interested her in pursuing an 
investigation ofthis correlation in normal subjects.298 
Meanwhile, Eysenck had extended and systematized his battery of 
psychometrie tests as the Maudsley Personality Inventory. Petrie adopted a test of 
susceptibility to satiation, which Eysenck showed to be sensitive to personality 
differences on the introversion/extraversion axis, as a promising correlate of pain 
tolerance. A blindfolded subject was instructed to rub a standard, and then a 
larger, block ofwood for a certain amount oftime, and then to estimate its size on 
another piece of WOOd?99 Petrie labelled subjects who systematically 
overestimated the size of the wood block "augmenters" and those who 
underestimated it "reducers." After sorting subjects out on the basis oftheir 
susceptibility to satiation, Petrie tested their tolerance to pain using the Hardy-
Wolff-Goodell dolorimeter. Tolerance was defined as the difference between the 
threshold of pain perception and the maximum time for which a subject could 
endure painful stimulation. She also tested subjects' tolerance to sensory 
deprivation by measuring the amount of time they were willing to remain in a 
specially designed tank. In the late 1950s, Petrie and her colleagues began 
announcing positive results: "augmenters" were less tolerant to painful 
stimulation, and more tolerant of sensory deprivation, "reducers" showed the 
opposite tendency.300 By the late 60s, she had extended this model ofperceptual 
style measurement to the study of delinquency, alcoholism, hypochondria, 
297 Petrie, "Repression and Suggestibility;" Petrie, Personality and the Frontal Lobes. 
298 Petrie, Personality and the Frontal Lobes (1952) Asenath Petrie, lndividuality in Pain and 
SufJering (Chicago: University of Chicago Press, 1967), 16-21. 
299 Petrie, Collins, and Solomon, "Pain Sensitivity," 143 1-33; Petrie, Collins, and Solomon, "The 
Tolerance for Pain and for Sensory Deprivation," American Journal of Psychology 73 (1960); 
Petrie, lndividuality in Pain. 
300 Petrie, Collins, and Solomon, "Pain Sensitivity," 1431-33. 
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smoking, etc. in addition to individual differences in response to painful 
stimulation such as in childbirth or in relief obtained from drugS.301 
Another psychologist, Donald Petrovich, became interested in the 1950s in 
the question of whether responses to pain were "a unique experience in the 
psychology of the individual," or associated with personality attributes such as 
neuroticism and anxiety.302 Petrovich did not measure pain thresholds. He had 
instead, as a doctoral student, developed a Pain Apperception Test, which 
consisted of a standard set of pictures depicting various situations in which pain 
was anticipated, felt, inflicted by oneself, or inflicted by another, and which 
subjects were asked to rate according to "painfulness" on numeric scales. The 
results ofthis test were correlated with data obtained with other psychometric 
questionnaires measuring self-reports of physical and psychological complaints 
associated with neuroticism (measured with the Medical Questionnaire) and of 
manifest anxiety (measured with the Taylor Manifest Anxiety Scale). The 
reliability of the correlations was conclusive, confirming the value of the Pain 
Apperception Test for studying the psychological correlates of pain, as weIl as the 
role ofpersonality factors in shaping the response to pain.303 
Personality assessment tools, in particular the MMPI, began being used 
more frequently in the 1960s in studies of both psychiatric and medical patients 
who suffered from unexplained symptoms ofpain.304 The psychiatric examination 
of patients, including an assessment with the MMPI, was also instituted in the 
1960s at the interdisciplinary pain clinic at the University of Washington founded 
by J. J. Bonica in 1960.305 Sorne clinicians recommended its widespread use in 
medical practice for differentiating between organic and psychogenic disorders, 
301 Petrie, lndividuality in Pain. 
302 Petrovich, "The Pain Apperception Test," 367-74. 
303 Petrovich, 'The Pain Apperception Test," 367-74. 
304 For example: L. J. Hanvik, "MMP! profiles," 350-3. E. L. Phillips, "Sorne Psychological 
Characteristics Associated with Orthopaedic Complaints," Current Practice in Orthopedic 
Surgery 23 (1964): 165-76; M. J. Martin, "Tension Headache, a Psychiatrie study," Hèadache 6, 
no.2 (1966): 47-54; L. F. Pilling, T. L. Brannick, W. M. Swenson, "Psychologic characteristics of 
psychiatric patients having pain as a presenting Symptom," Canadian Medical Association 
Journal 97(1967):387-94. 
305 Boniea Papers, MS C 118, Box 135, Folders 20-25, History & Special Collections Division 
(HSCD), Louise M. Darling Biomedical Library (Darling Library), UCLA. 
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many ofwhich were associated with painful symptoms ofunknown aetiology. 
The standardisation of psychological characteristics allowed researchers and 
clinicians to base their diagnostic judgment on positive findings of personality 
disturbance rather than using a process of elimination on the basis of negative 
findings of organic lesions. Both the MMPI and similar questionnaires designed 
specifically for complaints of pain became more widely used with the expansion 
of pain clinics in the 1970s. 
4.2.3 Early Experience or the Formation of Individual and Collective 
Psychologies 
Researchers in the 1950s and 60s also became interested in studying the 
relationship between early experience and differential responses to pain. The 
factor of early experience had long been thought to influence pain responses, but 
had not been tested empirically. A cluster of studies published in the 1950s and 
early 60s proposed to fill this gap. While these studies did not explicitly link early 
experience to specific personality types, they drew on a conception of factors such 
as upbringing, conditioning,and family structure as psychological forces that 
shaped patterns of individual and collective behavioural, emotional and cognitive 
responses. This conception was shared by many contemporary psychologists and 
anthropologists. In order to correlate pain responses with early experience, 
investigators faced the challenge of standardising the latter factor. 
The solution for one psychologist, Ronald Melzack, was to study reactions 
to pain in laboratory animaIs whose upbringing could be directly manipulated. 
Melzack raised sorne groups of rats and dogs isolated in "restriction cages," in 
which they were exposed to minimal sensory stimulation. The rats in the control 
group were raised in normal cages, where they could interact with each other, and 
were exposed to electric shocks at early ages. The isolated and control rats were 
then subjected to a learning test in which electric shocks were used as 
punishment, and compared on the basis of the number of trials required to learn 
the task. The control dogs had been raised in a home or in the laboratory, and 
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exposed to a normal range of stimulation. Their avoidance response to electric 
shocks, as well as lit matches, pinching, hitting on the head, and piercing of the 
skin were compared with those of the isolated dogs in a number of tasks. Based 
on both quantitative data (the number of trials required to learn an avoidance 
response) and qualitative observations, Melzack concluded that the "behaviour of 
dogs reared without opportunity for contact with noxious stimuli is grossly 
abnormal." Using psychological methods of research in laboratory animaIs, 
Melzack was able to demonstrate the effect of early experience on the emotional 
response to pain.306 
Ethnic categorization, for anthropologist Mark Zborowski, was another 
meaningful way of creating subjects whose pain responses could be compared on 
the basis oftheir early experience. In the early 1950s, Zborowski conducted a 
study on the "Cultural Components in Attitudes toward Pain," funded by the U. S. 
Public Health Service.307 Zborowski proposed to investigate the suggestion, made 
by Hardy, Wolff and Goodell, that the "conditioning influence" of "culture" 
shaped collective patterns of reaction to pain. In their understanding of culture, 
and of its potential effect on psychosomatic processes, both Zborowski and the 
Cornell researchers, particularly H. G. Wolff, were influenced by "culture and 
personality" theory that had become popular among American anthropologists 
from the 1930s.308 Zborowski shared Margaret Mead's view ofupbringing as a 
306 Melzack, "The Effects of Early Experience." 
307 Zborowski, "Cultural Components in Response," 16-30. 
308 G. W. Stocking, "Essays on Culture and Personality," G. W. Stocking, Jr. (Ed.) Malinowski. 
Rivers, Benedict and Others: Essays on Culture and Personality (Madison: The University of 
Wisconsin Press, 1986), describes how cultural psychological determinism was adopted as an 
alternative to Spencerian evolutionary racism as a means of explaining differences in mental 
characteristics between human groups as a result of the work of Frank Boas in the tirst decades of 
the 20th century, and then developed by a new generation ofanthropologists who were also 
influenced by psychoanalytic theories: Ruth Benedict, Margaret Mead, W. H. Rivers, Bronislaw 
Malinoski, and anthropologically-inclined psychiatrists such as Abram Kardiner. The shift from 
bio-racial to psycho-cultural based mechanisms to explain human differences in both psychology 
and anthropology is described more succintly in: P. Voestermans, J. Jansz, "Culture and 
Ethnicity," in J. Jansz, P. van Drunen (eds.), A Social History of Psychology (Malden, MA: 
Blackwell Publishing, 2004): 182-3. 
The interconnections between personality and culture theory in anthropology and psychosomatic 
research have yet to be explored. 
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mechanism for the transmission of cultural values and norms.309 Zborowski also 
counted among his influences the work of Lawrence Frank, another important 
player in the rise of 'culture and personality' research, 310 who had demonstrated 
the profound influence of culture on biological functions and physiological 
sensations, such as hunger and sexual desire, which were normally labelled 
"instinctive.,,3!1 In the design of his study, as in his choice of advisors-Frank and 
Wolff-Zborowski drew on definitions ofboth pain and culture that were 
informed by psychosomatic thinking. 
Zborowski conducted qualitative ethnographie research in a Veterans 
Administration Hospital in order to understand the origins of differences in 
manifest behaviours towards pain in four "ethnie" groups: Jews, ltalians, Irish and 
Old Americans. These groups were selected because they were described by the 
hospital staff as adopting strikingly different attitudes towards pain. On the basis 
of interviews conducted with patients on their present and past experiences of 
pain, Zborowski suggested that explicit child-rearing practices, combined with 
children's observation of accepted behaviours in their immediate social 
environment-which could also be drawn from the dominant culture of the host 
country-profoundly shaped attitudes and behaviours towards pain. Zborowski 
also distinguished between present and future-oriented concerns about pain to 
explore ethnie differences. Thus, the seemingly similar vocal and emotional 
responses to pain of Jews and ltalians were in fact rooted in different attitudes; 
Jews were more anxious about the possible ramifications ofpainful symptoms 
(such as disease and death), while Italians were more preoccupied with obtaining 
immediate symptomatic relief.312 
309 The connection between Zborowski and Mead can be found not only in his text, but also in his 
biography. Zborowski worked as a research assistant for M. Mead, and she wrote the introduction 
to his book People in Pain published in 1969. 
310 R. Darne Il , "Personality and Culture: The Fate of the Sapirian Alternative," and V. Yans-
McLaughlin, "Science, Democracy and Ethics: Mobilizing Culture and Personality for World War 
Il,'' in G. W. Stocking, Jr. (Ed.) Malinowski, Rivers, Benedict and Others: Essays on Culture and 
Personality (Madison: The University of Wisconsin Press, 1986), 163 and 196. 
311 Mark Zborowski, People in Pain, (San Francisco: Jossey-Bass, Inc. 1969). 
312 Zborowski, "Cultural Components in Response to Pain," 1 6-30; People in Pain. 
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While there was little interestamong anthropologists in following up on 
Zborowski' s work, psychologists and psychiatrists often quoted his studies as 
evidence for ethnic and attitudinal differences in responses to pain. One team of 
psychiatrists from Harvard explicitly drew on Zborowski's findings in designing a 
study of the influence of attitudinal differences on physiological responses to pain 
in the mid-1960s. Bernard Tursky and Richard A. Sternbach recruited 
"housewives" (so, they explained, that the process oftransmitting attitudes toward 
pain could be explored in interviews) from the same ethnic groups as studied by 
Zborowski, and studied their reactions to electrical shocks. Combining 
psychophysical methods for producing painful stimulation with methods to record 
autonomic responses (heart rate, sweating, skin temperature), Tursky and 
Sternbach found quantitative differences that were compatible with Zborowski's 
qualitative differentiation between ethnic groups.313 
Birth order, or family structure, was also identified as a potential influence 
on pain responses in the early 60s. After one psychologist incidentally found a 
relationship between reactions to electric shock and birth order that suggested that 
first-born and only children were less willing or able to withstand pain,314 a 
c1uster of experiments were designed to test this hypothesis. One study, using a 
structured interview, found a significant correlation between family size and 
persistent complaints of pain among neurological patients. 3 1 5 However, two other 
studies did not find significant correlations. One of these used an ultrasonic 
therapy unit as a heat-producing stimulus in order to measure pain tolerance in 
313 Stembach and Tursky, "Ethnie Differences," 241-46; "Further Physiological Correlates," 151-
62. In the last article, the authors declared that they were not interested in ethnie, or sub-cultural 
differences, per se. Rather, they sought to demonstrate the influence of "sets" (implicit attitudes) 
on psychophysiological activity and autonomie functioning. They presented their results as a 
warning of the "extraneous" variables that could "distort, or subtly influence or greatly increase 
the variance of the results in our experimental procedures, often without the experimenter's 
awareness." These concems echoed more general concerns expressed during the 1950s and 60s 
about the control ofinterpersonal variation in experiments dealing with aspects ofpsychological 
and subjective experience. 
314 S. Schacter, The Psychology of Affiliation (Stanford: Stanford University Press, 1959). 
315 T. A. Gonda, "The Relation Between Complaints of Persistent Pain and Family Size," Journal 
ofNeurology, Neurosurgery, and Psychiatry 25 (1962): 277-81. 
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female nurses. 316 Another study combined pain threshold measurements using 
electric current with responses on two questionnaires: items of the MMPI related 
to pain and a Pain Complaint Scale (PCS).31? Though the debate on the 
relationship between family and pain was inconc1usive, it shows that this 
correlation was identified as a potentially meaningful one, while also illustrating 
the growing use of psychometric measurement techniques to study responses to 
pam. 
Conclusion 
The measurement of psychological reactions to pain from the 1940s to the 1960s 
was not practiced on a large scale, nor was it part of a well-defined investigation 
of pain mechanisms. Rather, it was characterized by small c1usters of experiments 
on particular topics, which are remarkable in the similarity of their objective: to 
study correlations between some aspect of subjects' responses to pain and some 
aspect oftheir psychological makeup (often called personality). This way ofusing 
pain-measuring technologies was quite unlike the function they were given before 
1940 and would continue to expand in the 1970s. As often as not, the chief 
motivation for measuring pain in the 1940s, 50s and 60s was not an interest in the 
nature ofpain, but rather, an interest in the nature of the psychological modulation 
ofphysical experiences. In the 1970s, however, pain would become the central 
focus of such investigations. 
If the investigators who ran these studies were not participating in any one 
project: who were they and what were their objectives? They were graduate 
students in psychology who began, in the 1950s, wanting to study the emotional 
modulation of pain responses (Melzack, Petrovich and others), 318 psychiatrists 
316 S. Gelfand, "The Relationship of Birth Order to Pain Tolerance," Journal ofClinical 
Psychology 19 (1963): 406. 
317L. G. Collins and L. A. Stone, "Family Structure and Pain Reactivity," Journal ofClinical 
Psychology 22 (1966): 33. 
318 Several other dissertations and theses illustrate this. For example: R. D. Nemoff, "A Study of 
Pain Sensitivity and its Relationship to Certain Manifestations of Anxiety," (PhD Dissertation: 
New York University, 1954); James W. Clark, "Factors Affecting Human Response to Pain 
Stimulation," (MA Thesis: McGill University, 1955). 
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who wanted to obtain physiological measurements from psychiatric patients 
(Malmo & Shagass), anthropologists interested in the cultural determination of 
bodily experience (Zborowski), psychologists seeking to explain the roots of 
"individuality in suffering" as weIl as those of alcoholism and juvenile 
delinquency (Petrie), or psychiatrists interested in identifying attitudinal variables 
that might affect experimental responses to pain (Tursky and Sternbach). 
The important shi ft in thinking about pain took place starting in 1940, this 
was stimulated by the discovery of the d010rimeter and of the uniform pain 
threshold, and influenced by the later work of Hardy, Wolff and Goodell. 
However, it was principally enabled by important shifts not only in thinking about 
the correlation between physical experience and psychological processes, but also 
in the creation of the methods to measure it. These came as a result, in part,of 
private funding strategies that favoured psychosomatic research in the 1930s, and 
of new military as weIl as medical concerns about psychoneurotic disorders 
growing out from wartime experiences. Unfortunately, there have been only a few 
serious historical investigations of these phenomena, none of which have focused 
specifically on the development of research and measurement techniques such as 
the personality tests that would become so widely used in the post-war decades. 
My reading ofboth the primary literature on pain research and the secondary 
literature on psychosomatic research, psychiatry, psychology and anthropology 
during this period, suggests that there are important links to be made between, on 
the one hand, World War II, new funding patterns and a need for new ways of 
managing inter-individual differences and emotional stress, and, on the other 
hand, the development of new psychological measuring techniques and new ways 
of differentiating human experiences, abilities and susceptibilities. 
Pain-measuring practices during this period indicate that a process of 
"psychologisation" of pain took place after 1940. Pain had previously been seen 
as having both psychological and physiological dimensions. After 1940, however, 
psychological influences were seen to define the experience of pain, to be its chief 
causal, precipitating and modulating factor, and to act independently ofthe 
magnitude, or even absence of physiological stimulation. 
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What did this psychologisation mean for the objectification of pain? 
Generally, it implied that it was impossible, in fact that it made no sense, to 
eliminate or control for the subject's personal thoughts, feelings and 
interpretations in the measurement of pain. After 1950, it was widely accepted 
that those emotions and meanings constituted the very experience of pain that was 
being measured. This was true even for analgesic testing, where the ideal of an 
emotionally-neutral and impersonal pain had persisted in sorne quarters 
throughout the 1940s. But in later decades, human and even animal models of 
pain came to integrate variables such as fear and anxiety in order to reproduce an 
"authentic" pain, which would reveal the "true" effects ofanalgesic therapies.319 
Technologies for measuring this newly "psychologised" pain produced 
objectivity in at least two different ways. Sorne researchers began measuring 
autonomic indicators (pulse, skin resistance, blood pressure) and automatic 
behaviours (withdrawing, wincing, finger tremor) that did not require the 
conscious and cooperative participation of subjects. These measures were 
arguably more "objective" that earlier algometric measurements that required 
subjects to make introspective judgments and to express them verbally in the 
sense that they removed a layer of hum an interpretation. On the other hand, 
subjects were not trained or instructed to remain neutral and emotionally 
detached. Quite the opposite, since investigators were interested in the effects of 
emotional fluctuations. These methods were thus associated with a very different 
form of "mechanical objectivity" from that which 1 described in the previous 
chapter, in which, ideally, the subject's mind would be "mechanised." 
There was a second way of measuring "psychologised" pain from the 
1940s onwards through the use of self-rating instruments such as scales and 
questionnaires. The subjects' full, cooperative and highly personal participation 
was required to make the se too1s function. How did researchers make sense of 
subjects' idiosyncratic interpretations and responses to the questions they were 
asked? By standardising the questions and obtaining measurements from large 
319 H. E. Hill, R. E. Belleville, and A. Wikler, "Anxiety Reduction as a Measure of the Analgesie 
Effectiveness of Drugs," Science 120 (1954): 153. 
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numbers of patients, they were able to identifY large-scale trends and correlations, 
thus determining the validity and meaning oftheir measurements. The objectivity 
of the results produced by these tools thus depended on large numbers and 
procedural standardisation rather than on eliminating patients' personal 
interpretation of their pain. 
These different techniques for measuring the modulation of pain were also 
associated with different ways of thinking about why and how people varied in 
their responses to pain. In the late 19th and early 20th centuries, pain-measurers 
had been measuring the delicacy of subjects' nerves, their quickness to feel 
sensory stimulation that made them more susceptible to suffering, regardless of 
whether they suffered in silence or not. After about 1940, they began measuring 
the influence of personality-whether it was writ small in individual upbringing 
and past experience or writ large in 'culture'-on subjects' emotionalreactivity to 
pain. As we will see, particularly in chapters 6 and 7, analgesic evaluators became 
preoccupied with subjects' differential susceptibility to suggestion, but they also 
associated suggestibility with the emotional status, personality and culture of 
subjects. While nerve-based sensitivity had been associated with an evolutionary, 
biologically racialised and gendered classification of people, personality-based 
reactivity differentiated individuals according to their psychological and cultural 
experiences. The latter classification was still normative, in that it identified sorne 
levels of reactivity as pathological, but it was less hierarchical and rigid than the 
previous nerve-based model. Perhaps the most important questions that remain to 
be asked, however, are: Who was favoured and included by specific ways of 
measuring and classifying pain? And who was disadvantaged and excluded by 
them? 
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5. The ~ise and Fall of the Hardy-Wolff-Goodell Dolorimeter: 
Modelling Pain for Analgesie Testing 
In 1940, the future was bright for the Hardy-Wolff-Goodell dolorimeter. Hailed as 
"elegant,,320 and "ingenious,,,321 this new measuring device announced a 
revolution in the quantification of pain and analgesia. The method had immediate 
appeal: it seemed easy to use, efficient and inexpensive; it offered results that 
were precise and astonishingly stable. As measured by the dolorimeter, the human 
pain threshold was uniform, no matter who the subject, no matter what their 
mood. Never had human pain manifested itself in such regular patterns. 
This astonishing news was particularly welcome in the field of analgesic 
testing. For sorne years, researchers had been looking for a way to quantify the 
relief of pain, a symptom that remained stubbornly erratic, vague and 
unpredictable in humans. Over the next decade, researchers in laboratories across 
the United States took up the promise of the dolorimeter. By 1950, aIl signs 
pointed to its success: The apparatus had travelled to Britain and Canada. Over 20 
research teams had published data produced with a dolorimeter.322 Students at 
Johns Hopkins and Cornell medical schools experimented with the method in 
their physiology and neurology classes.323 It could be purchased as a two-piece 
320 G. Woolfe and A. D. Macdonald, "The Evaluation of the Analgesie Action of Pethidine 
Hydrochloride (Demerol)," Journal of Pharmacology 80 (1944): 300-307. 
321 Lyndon E. Lee, "Medication in the Control of Pain in Terminal Cancer, With Reference to the 
Study ofNewer Synthetie Analgesies," Journal of the American Medical Association 116 (194 J): 
216-20. 
322 This approximate number was calculated from my literature review and the bibliography 
provided by A. H. Kutscher and H. W. Kutscher, "Evaluation of the Hardy-Wolff-Goodell Pain 
Threshold Apparatus and Technique: Review of the Literature," International Record ({[ Medicine 
(April 1957),228-230. 
323 Harold G. Wolff and Henry S. Dunning, "The Teaching ofClinical Neurology," Journal orthe 
Association of American Medical Colleges 22 (1947), 263-273, describe the use of the dolorimeter 
at Cornell Medical School. R. A. Kuhn and R. B. Bromiley, "Human Pain Thresholds Determined 
by the Radiant Heat Technique and the Effect Upon Them of Acetylsalieylic Acid, Morphine 
Sulfate, and Sodium Phenobarbitol," Journal ({[Pharmacology 101 (1951): 47-55, this study was 
"undertaken wh en medieal students using the HWG pain threshold apparatus during their 
laboratory course in physiology were unable to reproduce phenomena that have been described 
and widely quoted." 
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apparatus from the Experimental Engineering Corporation, in Bergenfield, NJ.324 
The commercialisation of the instrument seemed, in particular, to indicate a 
stabilization of the technique and expectations that it would remain popular. 325 
By 1953, however, signs of the dolorimeter's decline were already 
apparent. Donald Williamson, president of the Co-Design Corporation, 
complained about their recently redesigned and marketed dolorimeter: "Frankly, 
the volume on this instrument has been disappointing." 326 Concerned by the low 
sales of the instrument, Williamson wrote to a selected group of researchers 
interested in pain-measurement to find out what they thought: Why did no one 
buy the dolorimeter when such a strong demand had been predicted for rnethods 
ofpain-measurement? Was there a flaw in its design, or in the company's 
marketing campaign? The disenchantment with the dolorimeter apparently ran 
deeper. In the pages of Science, that same year, the dolorimetric method's validity 
was under attack.327 In laboratories too it seemed to be falling into disuse: after 
1950, the number of articles reporting results obtained with the dolorimeter for 
analgesic evaluation had levelled off.328 
324 L. C. Miller, "A Critique of Analgesie Testing Methods," Annals of the New York Academy of 
Science 51 (1948): 34-50, provides this information. The Co-Design Corporation would also 
market the dolorimeter a few years later: Sales pamphlet for the Hardy-Wolff-Goodell 
Dolorimeter, Co-Design Corporation, Winchester, MA, n.d., WolffPapers, Box 3, Folder 12, 
Medical Center Archives ofNewYork-Presbyterian/Weill Cornell. This pamphlet can also be 
found in: Travell Papers, Box 19, Folder 30, Special Collections and University Archives, The 
George Washington University (GWU). 
325 Miller, "A Critique of Analgesie Testing," 34-50, points this out in his review of analgesic 
testing methods. 
326 Donald E. Williamson to Janet Travel\, June 16, 1953, Travell Papers, Box 19, Folder 30, 
Special Collections and University Archives, GWU. 
327 Henry K. Beecher, "Experimental Pharmacology and the Measurement of Subjective 
Response," Science 116 (1952): 157-62; James D. Hardy, Harold G. Wolff and Helen Goodell, 
"Pain - Controlled and Uncontrolled," Science 117 (1953): 164-67; Beecher, "Pain- Controlled 
and Uncontrolled. Rejoinderto Dr. Hardy, Dr. Wolff and Miss Goodell," Science 117 (1953): 164-
67. 
328 This trend is suggested in the number of publications reporting results using the dolorimeter in 
my own literature review and confirmed by the references enumerated in the bibliography 
provided by Kutscher and Kutscher, "Evaluation of the Hardy-Wolff-Goodell," 228-230. It is of 
course possible that the dolorimeter was still in use after 1950 but that results were rarely 
published. For example, in 1953, one group reported that they still used the dolorimeter, but only 
as a test preliminary to clinical studies. See S. C. Cul\en and E. G. Gross, "Analgesie Testing 
Methods," Bulletin of the Committee on Drug Addiction and Narcotics (1953), 626. Nevertheless, 
it seems unlikely that the method was widely used. 
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After little over a decade of acclaim, the validity of the dolorimeter was 
disputed and its utility largely rejected in the field of analgesic evaluation. What, 
apparently so unexpectedly, had changed? The most obvious sign of change was 
the emergence of a new technology for testing analgesic efficacy: the analgesic 
clinical trial. By the early 1950s, sponsorship for analgesic testing was mainly 
directed towards the use ofthis new technology. Not surprisingly, the strongest 
advocates of the analgesic clinical trial-of whom the most vocal was Henry K. 
Beecher-were the harshest critics of the dolorimeter. 
Advocates of the clinical trial objected to the dolorimeter on both 
technical and theoretical grounds. Its results were not replicable, Beecher claimed, 
while those of the clinical trial were more robust. The dolorimetric method did not 
fulfil essential conditions to safeguard against sources of bias, conditions that 
were at the core ofthe clinical trial design. The dolorimeter evaluated analgesics 
on an "artificial" pain that was induced in the laboratory, while the clinical trial 
measured analgesic effects on the more realistic "natural" pain that occurred in 
the clinic.329 But why did this criticism become persuasive in the early 1950s? 
Why had the dolorimeter been so appealing as an analgesic test only a few years 
earlier? 
In this chapter, 1 will argue that the displacement of the dolorimeter can 
only be understood by paying close attention to transformations in the social and 
material conditions under which analgesics were evaluated from the late 1930s to 
the early 1950s. Who used analgesic testing technologies? What resources were 
made available to them? What kinds of investments, collaborations and 
compromises did it take to make these technologies work? What was expected of 
these technologies? These, 1 will argue, are key questions for explaining how the 
validity and value of analgesic testing technologies were defined and appreciated. 
329 Beecher attacked the dolorimeter in many ofhis writings. The earliest seems to have been in 
Beecher, "Experimental Pharmacology," 157-62, while the most detailed formulation ofhis 
arguments can be found in Beecher, Measurement of Subjective Responses: Quantitative Effects (~f 
Drugs (New York: Oxford University Press, 1959). Beecher and his colleagues also wrote often 
about the value of clinical, pathological or naturally occurring pain. See particularly: Arthur S. 
Keats, Henry K. Beecher, and Frederic C. Mosteller, "Measurement of Pathological Pain in 
Distinction to Experimental Pain," Journal of Experimental Physiology 3, no. 1 (1950): 35. 
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My intention is not to write off the importance of either technical or theoretical 
considerations in comparing the value attributed to the se two methods. 1 do, 
however, suggest that we need to look beyond the technical and theoretical 
arguments that were used to compare these methods explicitly, and pay attention 
to the ways in which the technical capacities ofthese instruments interacted with 
the social and material conditions under which they were operated. 
In the late 1930s and 1940s, the demand for information about analgesic 
efficacy and the resources that were made available for analgesic testing created 
conditions under which the dolorimeter made sense. Running successful clinical 
trials required hum an and material resources that had not been made available for 
analgesic evaluation before the later 1940s. At that time, however, new 
investments-monetary, but also professional and institutional-made it possible 
to create, promote and support the analgesic clinical trial as a valid and valuable 
technology. The dolorimeter's displacement appears to be tightly bound to the 
emergence of the clinical trial as an effective strategy for analgesic assessment. 
My approach has allowed me to link debates about the validity and utility 
of analgesic testing methods to the broader dynamics of American analgesic 
innovation and therapeutic evaluation during this period. In particular, 1 will 
examine the role of key actors who contributed funding, time and expertise to 
analgesic evaluation: various professional groups of experimenters 
(pharmacologists, physiologists, anaesthesiologists, clinical pharmacologists); 
different types of observers (nurses, technicians, physicians, nurse-observers), of 
subjects (laboratory animaIs, hospital patients, medical students, self-
experimenters, prisoners), as weIl as sponsors (pharmaceutical firms, public 
institutions, philanthropies). The differences between methods of analgesic 
evaluation were not just theoretical. These different tools required different kinds 
of resources to work, and were implemented under conditions that were dictated 
by fluctuating commercial, medical and regulatory interests in analgesics, as weIl 
as by the larger professional and institutional organization of medical research 
and oftherapeutic evaluation. 
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1 will begin this chapter by comparing the two methods, describing how 
the dolorimeter and the analgesic clinical trial offered very different strategies for 
managing variability and imprecision in order to create a measurable pain. Each 
ofthese models thus proposed a different form of control, and suggested different 
ideas ofwhat needed to be controlled, in order to measure analgesic efficacy. 
Paying attention to pain-measurers' own arguments about the advantages and 
drawbacks of each method, 1 will point out how each model of measurement 
relied on a specific collection of expertise, instruments, authority, material, 
subjects, practices and other financial, spatial and organisational resources. 
Which resources were available to experimenters was contingent on the 
broader professional, political and institutional framework of analgesic 
evaluation. To explain the initial appeal of the dolorimeter, and its later 
displacement, 1 will then fit the trajectory of the dolorimeter into the history of 
American interests in analgesic research. Who showed an interest in the 
dolorimeter? What kinds of problems was it called in to solve? An expansion in 
American analgesic innovation, which began in the 1930s, created a gap in 
analgesic testing methods that the dolorimeter proposed to occupy. 
In a third section, 1 will clarify the nature of this gap, which was not only a 
conceptual, but also a material, professional and financial one. 1 will then visit the 
dolorimeter at work. Focusing on the controversial issue of subject-training, 1 will 
examine debates about the proper use of the dolorimeter. Several researchers in 
the 1940s were willing to make certain concessions and adaptations to make the 
dolorimeter work. Others, most notably Beecher, rejected the se conditions as 
inappropriate. 
Beecher instead proposed a different way of making subjects, and their 
statements about pain, that were suitable for measuring analgesic effect. In the 
fourth part of this chapter, 1 will describe the shifts in the organisation and 
funding of analgesic evaluation that made Beecher's clinical trial feasible in the 
late 1940s and his arguments more convincing by the early 1950s. 
In conclusion, 1 will discuss how each model of analgesic evaluation 
enabled a different conception of pain: what it was, how subjects experienced and 
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interacted with it, how it travelled through minds, bodies and environments and 
what influenced its trajectory. l will argue that beyond the surface of a debate 
about pain's authentic nature and intelligibility was a contest between different 
practices for the experimental management ofits variability. 
5.1 Two Sources of Precision, Two Models of Control: High Volume versus 
High Resolution. 
What exactly was the dolorimeter? In 1940, two articles by neurologist Harold G. 
Wolff, physiologist James Hardy and a research assistant, Helen Goodell, of 
Cornell Medical School appeared back to back in the Journal of Clinical 
Investigation. 33o The first offered a general description of an experimental set-up 
for measuring pain thresholds in human subjects. Essentially, it consisted of a 
strong beam of light from 1000 watt bulb that was focused through a fixed 
aperture onto a smaIl area of a person's forehead that had been blackened with 
China ink. This light, of variable intensity, was delivered in exposures timed to 
exactly 3 secondsby an automatic shutter. The subjects' task was simple, a task it 
seemed almost anyone could perform: To identify the exposure that produced in 
them a sensation described as: "heat finally 'swelling' to a distinct, sharp stab of 
pain at the end. ,,331 What was remarkable about this sensation is that it was 
"easily recognizable, ev en by untrained subjects,,332 and that it was consistently 
identified at the same level of intensity by all subjects, at aIl times. This sensation 
was the subject's pain perception threshold. Through a correlation of the moment 
330 Marcia L. Meldrum, "'Departures From the Design': The Randomized Clinical Trial in 
Historical Context, 1946-1970," (PhD dissertation, State University of New York, Department of 
History, 1994), 282-283, n.236, writes : "James Hardy received his PhD at Johns Hopkins in 1930 
in physics, but began working shortly after on physiological problems at the Russell Sage 
Institute; he joined the Comell faculty in 1941. His research interests turned to aviation medicine 
in the 1950s. Harold G. Wolffwas professor ofneurology at Cornel!. Helen Goodell was a 
research associate in the department of medicine; as happens too frequently with women scientists, 
1 have been unable to learn much more about her." It might be added, however, that Goodell 
worked c\osely with Wolff on a variety ofprojects and that they published fairly extensively 
together. For example : Harold G. Wolff, Stewart Wolf, and Helen Goodell, Stress and Disease 
(Springfield, 1l1: Thomas, 1968). ' 
33lHardy, Wolff, and Goodell, "Studies on Pain. A New Method for Measuring Pain Threshold: 
Observations on Spatial Summation of Pain," Journal of Clin ical Investigation 19 (1940):649-657. 
332 Hardy, Wolff and Goodell, "Studies on Pain. A New Method," 650. 
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of sensation to the intensity of the exposure at which it had appeared, the 
thresho1d was a quantifiable entity. The job of the experimenter was to keep the 
machine calibrated, to vary the intensity of each exposure by means of a rheostat 
and, when the threshold leve1 had been confidently identified by the subject, to 
read off the measurement indicated by the dial of a radiometer. 
The second ofthese articles proposed the dolorimeter as a solution to the 
problems that had been plaguing attempts to evaluate ana1gesics in humans: 
vagueness, subjectivity, variabi1ity.333 As 1 have described in chapter 3, sorne 
attempts were made in the 1910s to replace clinicians' observations of patients' 
responses to painkillers with a1gometric measurements of changes in the pain 
threshold. 334 At that time, however, there was little real interest in making 
analgesic drug evaluation more objective. By 1940, ana1gesic testing had taken on 
new significance as a result of a large investment in analgesic innovation. New 
attempts were made to adapt a1gometric methods for pharmacological purposes. A 
most difficult prob1em remained, however. The data produced by these methods 
was high1y variable, both between and within individua1 subjects. Analgesie drugs 
were just one source of influence on pain that had to be isolated from other factors 
that were known to make its intensity vary: personality, sensitivity, attention, 
mood, emotion, and so on?35 The problem was to distinguish therapeutic effect 
from the se other causes of variation. The baseline pain thresho1d produced by the 
Hardy-Wolff-GoodeU do10rimeter was reported to be remarkably constant, 
impervious to changes in mood or personality, but sensitive to drug effects. It was 
the perfect medium for human drug assays: standardised, purified, stable and 
amenable to quantitative measurement. 
333 Wolff: Hardy and Goodell, "Studies on Pain. Measurement ofthe Etfect of Morphine, Codeine 
and Other Opiates on the Pain Threshold and an Analysis ofTheir Relation to the Pain 
Experience," Journal ofClinical Investigation 19 (1940): 659-80. 
334 For example, D. l. Macht, N. B. Herman and C. S. Levy, "A Quantitative Study of the 
Analgesia Produced by Opium Alkaloids, Individually and in Combination With Each Other, in 
Normal Man," Journal ofPharmacology 8 (1916): 1-37. 
335 In the few discussions of attempts to evaluate analgesics before 1940, variation between 
measurements was usually cited as the main obstacle to the objective evaluation ofthis class of 
drugs. 
145 
146 
While Hardy, Wolff and Goodell were fiddling with radiometers, rheostats and 
potentiometers, the Harvard anaesthesiologist Henry K. Beecher apparently 
contented himself with pencils and a notebook for the measurement of analgesic 
potency. In 1953, Beecher wrote ofhis analgesic clinical trial design, while not 
too subtly attacking the dolorimeter: 
We are concerned incidentally, of course, with simplicity. A method that 
can function with no apparatus other than a note book and a pencil is 
manifestly more desirable and more broadly useful, other things being 
equal, than one that requires complex and delicate apparatus which needs 
calibration by a well-trained physicist.336 . 
In addition, Beecher chose as his experimental medium the more "natural" 
pathological pain of real hospital patients, while he portrayed Hardy, Wolff and 
Goodell's stimulated pain as highly contrived. Hardy, Wolff and Goodell 
measured each individual's pain threshold as the intensity of radiation specified in 
hundreds of millicalories per square centimetre per second, and the effect of 
analgesics was calculated as percentage changes between normal and drug-
induced readings. Beecher's experimental subjects, on the other hand, were asked 
to estimate their relief as "none, slight, moderate or complete.,,337 Later this 
question was refined, and patients could choose between only two options: Was 
their pain significantly relieved, more than 50%? Or was it not? 
In the basic model of the analgesic clinical trial, as designed by Beecher 
and various colleagues, subjects were recruited from the surgical wards of a major 
teaching hospital. They were given, for their post-operative pain, a randomly 
chosen analgesic drug, which could be a standard drug (usually morphine), a test 
drug, or a placebo (usually saline). After his initial trials in the late 1940s, 
Beecher introduced a new experimental device. Instead of alternating doses in 
different patients, the different drugs -standard, test and placebo- would be 
administered in a sequence in the same patient. Therefore, test substances could 
be compared on the basis of how they affected each patient, using, in Marcia 
336 Beeeher, "Experimental Pharmaeology," 160. 
337 Jane E. Denton and Henry K. Beeeher, "New Analgesies. 1. Methods in the Clinieal Evaluation 
of New Analgesies," Journal of the American Medical Association 141 (1949): 1051-57. 
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Meldrum's words, each patient as their "own control.,,338 At regular intervals after 
each dose was administered, a technician or observer came by to interrogate 
subjects, using standard questions, about how much pain they had, or how weIl 
their pain had been relieved. Neither subjects nor observers were informed of the 
nature of the drug that was administered. Data collected by observers was then 
compiled and analysed. 
We should not be fooled by the appearance of simplicity that Beecher 
gave his method. Beecher's method, no less than Hardy, Wolff and Goodell's, 
intervened to manage sources of variability and to create a measurable pain for 
the evaluation of analgesic efficacy. The complexity, control and precision of the 
analgesic clinical triallay elsewhere: in the creation of the optimal conditions for 
the collection of data, and in the coordination of the work of numerous 
collaborators; observers, consultants and subjects. 
How did each method manage the variability of experiences and 
expressions of pain? 339 The dolorimeter eliminated it. Dolorimetric subjects were 
"aIl brothers under the skin," as Newsweek had announced. "Tom, Dick and 
Harry, aIl ages, all races, if they are alert and attentive, exhibit the same pain 
threshold, i.e., the intensity of stimulation at which pain is first felt under fixed 
circumstances is uniform," explained Harold Wolff at a session on "the 
Psychologie Aspects of the Treatment of Pain" of the Cornell Conferences on 
Therapy.34o As we saw in chapters 3 and 4, differences in pain thresholds had 
previously been explained in terms of differences in nervous sensitivity. 
According to Hardy, Wolff and Goodell, the dolorimetric method was successful 
in producing a uniform threshold because it split the perceptive and reactive 
elements of pain. In the isolated perception of pain, those factors that made 
33R Marcia Meldrum, "Each Patient His Own Control: James Hardy and Henry Beecher on the 
Problem of Pain Measurement," American Pain Society Bulletin 9, n. 1 (1999): 
http://www.ampainsoc.org/pub/bulletin/jan99/history.htm (accessed 9/29/2003). 
339 An insightful comparison of the dolorimeter and Beecher's analgesic clinical trial design can be 
found in Meldrum, "Each Patient His Own Control." The comparison 1 offer in this chapter 
elaborates on Meldrum's work, in particular through an examination of the social and material 
conditions ofthe practice of analgesic testing. 
340 Harold G. Wolff, "Cornell Conference on Therapy: Psychologie Aspects of Treatment of Pain," 
New York State Medical Journal 45 (1945): 1003-9. 
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responses to pain vary-that is, the confusing and inconvenient aspects of 
individuals' interpretations oftheir experience, and oftheir personalities, moods, 
memories and expectations-were eliminated. The dolorimetric experience 
allowed subjects to maintain a neutral attitude towards the beam that was heating 
their foreheads; it produced a pain that was precise, unthreatening, and temporary. 
This pain was "free of suffering," a sens ory experience in which "the implications 
of pain is not a major factor.,,341 
Hardy, Wolff and Goodell recognised that this pain was only a fragment 
of the "whole pain experience" and that its responsiveness to analgesic drugs 
represented only a part of the whole experience of analgesia. This is precisely 
what made it valuable. This pain could be isolated, manipulated, and quantified. 
In response to Beecher' s criticism, Hardy, Wolff and Goodell pointed out: "it is 
obvious that pain sensation itself is only a part of this constellation [the 
components of pain] and bears somewhat the same relation to it that vision does 
to graphie art. It would be only the extreme aesthete who would insist upon 
limiting the study of vision to the art gallery. ,,342 
The dolorimeter thus standardised the painful stimulation, but also, by 
extension, the experience ofpain, and even the experiencing subject. By ensuring 
the accurate quantification and calibration of the stimulus, and by maximising the 
distinctiveness of the sensation to be identified, the dolorimeter provided each 
subject with optimal conditions for making an exact, reproducible judgment. In 
theory, the quality ofthe sensation itself ensured this standardisation. In practice, 
users of the dolorimeter found that subjects had to acquire the capacity to 
discriminate the endpoint consistently and with emotional detachment through a 
period of "familiarisation" or "training." Hence, the dolorimeter itself 
standardised the stimulus and the conditions of stimulation, but it was through its 
"propcr use" that subjects' ability to perceive it was standardised. In any case, the 
control exercised by the dolorimetric method targeted the individual experience of 
paIn. 
341 Hardy, Wolff and Goodell, "Pain-Controlled and Uncontrolled," 165. 
342 Hardy, Wolff and Goodell, "Pain-Controlled and Uncontrolled," 165. 
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By contrast, Beecher's method of the clinical trial exercised little control 
at the level of individual subjects or their pains. The source of pain was a surgi cal 
wound. Similar wounds, Beecher insisted, did not necessarily give similar 
pains.343 Protocols for the trials did not specify any means of standardising 
subjects themselves, beyond selecting postoperative patients for intelligence and 
cooperativeness. We do know that, in practice, further efforts were made to make 
patient samples more uniform. For example, Beecher reportedly favoured male 
subjects because "the menstrual cycle requires troublesome controls.,,344 Two 
other techniques of standardisation were described explicitly in research reports. 
For sorne years Beecher maintained that "placebo-reactors" should be screened 
out because they "diluted" the data.345 In addition, Beecher's novel technique of 
using each subject "as their own control" allowed sorne variability to be 
eliminated. If patients were matched against themselves, their idiosyncratic 
judgments about pain intensity could be cancelled out. However, both these 
techniques-eliminating placebo responders and using subjects as their own 
controls-were measures of economy rather than devices essential to the 
functioning of the method. They were useful, but, it was recognised, if sufficiently 
large series of subjects were employed, they were unnecessary. 
Abundance, rather than a capacity to make certain types of judgments, was 
the main virtue of Beecher's experimental subjects. "The concept of group effect 
will perhaps always be necessary in dealing with general problems of pain and 
other subjective ailments," wrote Beecher in 1953.346 Beecher's method 
measured this group effect, and not the pain relief of individuals. While individual 
343 Keats, Beecher, and Mosteller, "Measurement ofPathological," 35. 
Beecher had formulated this idea earlier, but it was only in the later article that he discussed its 
implications for analgesic testing. See: "Pain in Men Wounded in Battle," Bulletin of United 
States Army Medical Department 5 (1946): 445-54. 
344 Beecher, "Experimental Pharmacology and Measurement of the Subjective Response," 157-
162. 
345 Louis Lasagna, Frederic Mosteller, John M. von Felsinger, and Henry K. Beecher, "A Study of 
the Placebo Response," American Journal of Medicine 16 (1954): 770-779, determining a 
technique to screen out placebo responders from analgesic c1inical trials was cited as one of the 
rationales for this study. However, later results showed that it was very difficult, if not impossible, 
to identify those who would respond to placebos consistently. 
346 Henry K. Beecher, "A Method for Quantifying the Intensity of Pain," Science 118 (1953): 322-
24. 
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testimonies of pain and relief could be expressed in number form, they were 
qualitative judgments rather than quantitative ones. The calculation of the efficacy 
of a test drug was made on the basis of how many patients it relieved. Large 
numbers also flattened out variability: "When the series is large ... one can control 
suggestion, inherent or implied, the presence of the investigator, practice effect, 
learning, motivation, interest, the subject's anticipation of an unknown 
medication, his drug history ... ," adding that "sufficient numbers" would also 
"cancel out normal mood swings, above and below par.,,347 
The validity of pain-measurements for analgesic evaluation thus depended 
on their quantity, but it also depended on the conditions under which 
measurements were made. Observers had to be consistent and neutral. They used 
pre-determined questions to interrogate subjects. The expectations ofboth 
subjects and observers concerning fluctuations in pain had to be avoided and 
eliminated through "blinding," that is, ignorance of the nature of the dose 
administered to the patient. Finally, the validity ofthese numbers was ensured 
through statistical verifications and interventions. Implementing the se conditions 
and controls required coordinated collective action. 
Hardy, Wolff and Goodell had not paid much attention to the role of the 
observer who measured out pain thresholds-the real observer was understood to 
be the subject herself-nor did they emphasize details oftheir relatively 
uncomplicated statistical analyses. Instead, they calibrated both the pain and its 
perceiver through the instrumental production of pain and, by extension, of 
sensory judgment. Beecher used simple interrogation, "fairly primitive questions" 
as one ofhis colleagues would later say, to obtain data about relief, and did not 
attempt to standardise the source of pain.348 He relied, however, on a whole team 
of observers, subjects and consultants to collect and manipulate information under 
appropriate conditions, and on a sufficiently large scale. 
347 8eecher, "Experimental Pharmacology," 160. 
348 Marcia Meldrum, "Oral History Interview with Louis Lasagna," 8 September 1995, MS C 
127.19, John C. Liebeskind History of Pain Colfection, HSCD, Darling Library, UCLA, 6. 
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Each method offered a different model for pain-measurement and 
analgesic evaluation that depended on a different scale and target of control. 
Indeed, control was a central issue in the debate between the Harvard and Cornell 
teams, a debate in which each team accused the other of inadequately controlling 
the experimental evaluation of analgesic effect. Part ofthis debate was published 
as two open letters in the "comments and communications" section of the journal 
Science, which were aptly titled "Pain-Controlled and Uncontrolled." Hardy, 
Wolff and Goodell claimed that pain had previously eluded precise measurement 
because clinicians and researchers had failed to recognise the difference between 
the sensation of pain and a reaction to it. Only by isolating the sens ory aspects of 
pain could its measurement be objective. This could only be done under specifie 
conditions, as Hardy, Wolff and Goodell insisted: "pain sensation is far more 
difficult to investigate when an individual is extremely frightened, inattentive, 
obtunded, prostrated, "sick" or exhausted.,,349 
Beecher, on the other hand, saw the experienced subject as the one who 
was, experimentally speaking, out of control: "1 doubt ifthey can achieve [the 
double-blind experiment] with their highly trained, drug-wise subjects ... Subjects 
who know how to recognize the subjective sensations of analgesics and who have 
an interest in the outcome cannot be considered as unbiased. ,,350 Beecher admitted 
the utility of distinguishing between pain sensations from reactions, but he denied 
that the dolorimeter had succeeded in doing so, and furthermore, doubted that this 
experimental separation was possible. His later writings affirmed more 
confidently that pain experience was indivisible, and that the concepts of 
sensation and reaction were only theoretical. The inconsistencies in data obtained 
with the dolorimeter by different investigators showed that sorne "reaction" 
leaked into the experience. No human experience of pain was immune from the 
experiencing subject. By failing to acknowledge this, dolorimetric experimenters 
were, according to Beecher, turning a blind eye to the necessary controls and 
precautions. 
349 Hardy, Wolff and Goodell, "Pain-Controlled and UncontroIled," 165 .. 
350 Beecher, "Pain- Controlled and Uncontrolled," 167. 
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Thus, each team pointed to how the other allowed their measurements to 
be contaminated by "bad" subjectivity: bias, suggestion, emotion, expectations. 
The Cornell and Harvard teams also accused each other of sacrificing elements of 
a useful kind of subjectivity. For Beecher, a pain worth measuring was an 
authentic, whole experience of pain. For the Cornell team, the subject's sensory 
judgment could be honed and guided to be made more precise, neutral and 
accurate with the dolorimetric method, but this was impossible if subjects were 
not in a condition to exercise their judgment properly. 
Why did Beecher's model of control become so widely persuasive in the 
early 1950s? There are several possible explanations. It might be suggested that 
Beecher's model was self-evidently superior in that it produced more stable 
results without resorting to the "tricks" employed by users of the dolorimeter, 
such as using trained, un-blinded and drug-wise subjects. Just a few years earlier, 
however, the dolorimeter had been recognised to work quite well under 
appropriate conditions, and to present many advantages over clinical trials. In 
addition, Beecher's clinical trial was expensive, slow and also required work and 
specific conditions to produce good results. 
It might also be suggested that Hardy, Wolff and Goodell' s "pure" pain 
perception was anachronistic, while Beecher's indivisible, emotional and 
idiosyncratic pain was more persuasive and authentic given the process of 
"psychologisation" of pain 1 described in chapter 4. To a certain extent, this is a 
useful explanation. However, 1 would argue that, because analgesic testing 
methods were in demand, a new way of controlling pain had to emerge before the 
old one no longer made sense. The distinction between "clinical" and 
"experimental" pain had preceded the Beecher versus Hardy, Wolff and Goodell 
debate.351 However, only experimental pain had been seen as appropriate for 
providing objective and precise information about analgesic efficacy. Beecher 
was able to argue for the superiority of clinical pain as a medium for analgesic 
351 For example: Robert C. Batterman, "The Clinical Aspects of Evaluating Analgesie Agents," 
Yale Journal of Biology and Medicine 18 (1946): 595-607. 
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testing when he was also able to argue that it could be brought under experimental 
control. 
l suggest that a crucial distinction between these two methods needs to be 
made on the basis of what kinds of resources and conditions were required to 
make each of them work, and what type of information each of these methods 
offered. It will then be possible to explain how transformations in the demand, 
and resources made available, for analgesic testing in the late 1940s underlay the 
shift from the dolorimeter to the analgesic clinical trial, and thus to re-evaluate the 
terms of the debate between Beecher and Hardy, Wolff and Goodell. 
What did it take to make each method work? The method of Hardy, Wolff 
and Goodell depended on a precise and mechanical source of stimulation, which 
produced a stimulus that was quantifiable and easily discriminated. This source 
was an instrument that was relatively cheap, but which needed to be constructed 
and used identically by each team that hoped to obtain comparable results. The 
best way of using this instrument seemed to be through the recruitment of a small 
number ofreliable subjects who could be trained, and thus were available for 
repeated trials over a period oftime. The instrument could be used in a fairly 
small, quiet space, ideaUy sorne sort oflaboratory. It could be used by anyone 
who had the technical expertise to set it up and calibrate it, access to the right type 
of subjects, and who could afford to buy the instrument. 
For aU Beecher's talk of simplicity, the analgesic clinical trial was more 
expensive, time-consuming and difficult to coordinate. It required full-time 
observers, assistants and statistical experts who had to be paid salaries and 
consultant fees. It depended on a steady, plentiful supply of patient "material." 
The investigator needed access to a clinical facility and had to have sufficient 
clinical authority to recruit patient-subjects, oversee their care, and coordinate the 
clinical activities that entered into the operation of the clinical trial. 
What did these different requirements mean in terms of choosing an 
analgesic testing method? l will answer this question by reviewing the history of 
analgesic innovation and evaluation over the course of almost two decades using 
the following question: Who wanted analgesic efficacy to be measured, and for 
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what? Bywhom, and with what, were analgesic-testing technologies operated? 
On the basis of these questions, 1 have divided the early history of American 
analgesic evaluation into three waves. From the mid-1930s to about 1940, a 
search for new, more precise means of measuring analgesic efficacy emerged 
from a systematic research program to develop a non-addictive analgesic. The 
initial appeal of the dolorimeter, when it was introduced in 1940, was defined in 
terms of the requirements formulated within this search. A second wave came 
with the introduction into the U. S. of German synthetic analgesics in the early 
1940s. Pharmaceutical firms were very interested in these new compounds. The 
dolorimeter was usefu1 for laboratory scientists who tested these analgesics using 
mode st grants from industry. By the late 1940s, the evaluation of the new 
synthetics began to attract larger investments, first through the army and then 
through a consolidation of industry funding. This represented a third wave of 
analgesic evaluation, which was characterised by more concentrated sponsorship 
of analgesic testing, as well as by the new involvement of clinicians in operating 
analgesic-testing technologies. 
5.2 The Appeal of the Dolorimeter and the Quest for a Non-narcotic 
Analgesie 
The precision and consistency of dolorimetric data took on value within 
the context of an American expansion in analgesic research that had begun in the 
early 1930s. The search for better methods of analgesic evaluation emerged out of 
another quest: to find an analgesic capable of relieving pain without causing 
addiction. Such a pro gram had been launched by the Committee on Drug 
Addiction, under the auspices of the National Research Council, in 1929. 352 By 
352 The history ofthis program has been analysed by Caroline Acker. See Caroline J. Acker, 
"Addiction and the Laboratory: The Work of the National Research Council's Committee on Drug 
Addiction, 1928-1939," Isis 86 (1995): 167-93. And the chapter titled "The Technological Fix: 
The Search for a Nonaddicting Analgesic," in Caroline J. Acker, Creating the American Junkie: 
Addiction Research in the Classic Era ofNarcotic Control (Baltimore: Johns Hopkins University 
Press, 2002), 62-97. Useful details about areas ofresearch, funding and participants in the program 
can also be found in Nathan B. Eddy, The National Research Councillnvolvement in the Opiate 
Problem. 1928-1971 (Washington, D. C. National Academies of Science, 1973). 
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the early 1930s, the program had begun generating new substances that needed to 
be evaluated and a demand for methods to assess pain relief in humans and 
animaIs. The program also created a framework-a set of objectives, a social 
network, specific financial and human resources-that determined what kind of 
testing was required, and what kind of testing would be feasible. When the 
dolorimeter was introduced in 1939-1940, it was exactly what members of the 
Committee on Drug Addiction had been looking for. 
The origins of this quest for a non-addictive painkiller can be traced to a 
growing conviction, in the 1920s, that pharmacological innovation was a 
promising solution to the American "drug problem." As Caroline Acker has 
shown, a network of influential groups subscribed to this idea, and rallied around 
the goal of constructing an American opiate research program. The que st for a 
non-addictive analgesic became a "boundary object" for the se various groups, a 
common objective towards which they each invested, with the expectation of 
different retums.353 Elite American pharmacologists, for example, aspired to the 
expansion of drug research along the lines of the German model. They were 
instrumental in persuading the Committee on Drug Addiction (CDA) to create a 
program of analgesic innovation. For representatives of the American Medical 
Association (AMA), and many of its members, a safe analgesic would relieve the 
medical profession of its responsibility for the high rate of iatrogenic addiction, 
which had been reported to be alarmingly high.354 If successful, such a project 
would also offer greater control over drug supply and distribution, and fit in with 
the increasing support for the criminalisation of drug addiction in public health 
and drug enforcement circles. Through their continuing links with Committee, 
each interest group contributed resources to the accomplishment of the project: 
academic links, publications, confiscated drugs, research facilities, manufacturing 
353 Acker, Creating the American Junkie, 65. Acker borrows the term "boundary object" from 
sociologists Susan Leigh Star and James Griesemer. 
354 Acker argues that efforts by physicians to control opiate use were part of a broader effort to 
reform American medicine through self-regulation. See Acker, "From Ali Purpose Anodyne to 
Marker of Deviance: Physicians' Attitudes Towads Opiates in the U. S. From 1890 to 1940," in 
Drugs and Narcotics in History, eds. Roy Porter and MikulasTeich, 114-32 (Cambridge: 
Cambridge University Press, 1995). 
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of substances, etc. Funding was provided by the Rockefeller Foundation, while 
the National Research Council provided the Committee with an institutional home 
and the coordination of its research activities. 
The objectives and resources contributed by the constituents who had a 
stake in opiate research shaped the early development of analgesic testing 
methods. The general objective of the pro gram was to design a drug that targeted 
pain selectively, and thus was driven by the expectation that the desirable 
therapeutic properties of opiates could be chemically dissociated from their 
unwanted side effects, mainly addictiveness. To achieve this chemical 
dissociation, it would also be necessary to differentiate, and measure, the various 
pharmacological effects of opiate substances in living organisms, particularly pain 
and addictiveness. In other words, the success of the pro gram depended on 
finding a means to isolate pain as an experimental variable. 
The evaluation of analgesic potency also had to fit within the organisation 
ofthe Committee's activities. The Committee's analgesic program was conceived 
to coordinate and harmonize chemical and pharmacological work so that both 
areas of activity would inform each other and guide the process of innovation. 
Two sites were initially selected. In the chemistry laboratory of the University of 
Virginia, under the direction of Lyndon F. Small, morphine-like structures would 
be manipulated and modified into new substances. The generation of these 
substances required new ways of defining and quantifying aspects of animal and 
human experience such as pain, tolerance, dependence, euphoria, respiratory 
depression, nausea, and cough. Initial screening and testing was carried out in 
laboratory animaIs at the University of Michigan by Nathan B. Eddy, under the 
supervision of Charles W. Edmunds. In the early years, there were frequent 
ex change visits of staff between the two laboratories, and the collaboration 
between them gave rise to new knowledge about the structure-action relationships 
of opiate substances.355 
355 Eddy, The National Research Council, 20. 
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Eddy set to work on developing a method of testing analgesic potency in 
cats.356 Initially, Eddy's animal tests provided sufficient information to estimate 
the analgesic potential of the substances synthesized by Small. Indeed, because of 
the high volume of tests substances that needed to be screened-in first two and a 
half years, 66 substances had been prepared and sent to Michigan-the 
convenience and rapidity of animal tests was probably considered to be crucia1.357 
On the basis of Eddy' s findings, two substances were eventually 
recommended for further testing in humans. At first, the priority of human testing 
was to obtain more conclusive evidence on addictive liability. The first facility to 
be made available for this purpose was the federal Prison Annex at Fort 
Leavenworth, Kansas, where narcotic addicts were incarcerated and treated. A 
quantitative scale was devised to determine the presence of abstinence-as an 
indicator of addiction-· -in the prisoner subjects recruited at Fort Leavenworth, 
and th~n at the Public Health Service's Narcotics Hospital in Lexington, 
Kentucky when it opened in 1935?58 For the abstinence test, subjects were given 
the test substance for a certain period of time, which was then withdrawn. An 
observer then determined the intensity oftheir symptoms of abstinence, or 
withdrawal, such as nausea, sweating and running eyes. 
Members of the committee disagreed about the validity of the abstinence 
test in these subjects, who had previous experience of narcotic addiction, and it 
was resolved that the crucial test would be an evaluation in subjects who had 
never been addicted.359 In the mid-30s, arrangements were made by the 
Committee, with the help of the Surgeon General, to obtain access to clinical 
356 A description ofthis method can be found in: Nathan B. Eddy, "Studies on Morphine, Codeine 
and Their Derivatives," Journal of Pharmacology 45 (1932): 339-59. 
357 Eddy, The National Research Council, 19. 
358 Walter Treadway (Office of the Surgeon General) to Charles White, April 30, J 935, Projects: 
Development ofNonaddictive Analgesies: Clinieal studies: PHS Hospital: Lexington General, 
Committee on Drug Addiction (CDA), National Academy of Sciences Archives (NASA). 
359 Walter Treadway to Charles White, July 23,1934, and Nathan B. Eddy to Charles White, June 
29, 1934, Projects: Development ofNonaddictive Analgesies: Clinical Studies: Pondville 
Hospital, CDA, NASA. 
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facilities of the Massachusetts Department of Health.36o Chronic cancer and 
tuberculosis patients were selected as populations to whom promising, but 
potentially addictive substances could be administered over prolonged periods for 
the relief of pain and cough. Clifton Himmelsbach, a young PHS officer who had 
worked on the development of abstinence tests in animaIs and the Leavenworth 
prisoners, was given the responsibility to oversee these studies. While the 
emphasis in this trial was on the determination of addictive liability, impressions 
oftherapeutic efficacy were also recorded.361 
Another disagreement between committee members put tests of analgesic 
efficacy higher on the agenda. When Himmelsbach showed that one of the 
promising drugs, called desomorphine, produced withdrawal symptoms in cancer 
patients, Eddy expressed concern about the excessive dosages they had been 
administered. He suggested that the calculation of effective dosages on the basis 
of animal tests was not reliable, and that the drug might still be salvageable. On 
account of its high potency, Eddy pointed out, in April of 1935, desomorphine 
might still be found to be "a very valuable drug.,,362 To determine its true value, 
its propensity to bring about addiction would have to be carefully weighed against 
its power to relieve pain. The search for a less addictive rather than a non-
addictive painkiller demanded a finer calculus of analgesic efficacy, leading to a 
stronger emphasis on pain-measurement in humans. 
This emphasis may also have been stimulated by the opening of the 
Lexington narcotics hospital, which was made available to the Committee for 
human experimentation in 1935. The implementation of clinical trials of metopon, 
360 H. S. Cumming (Surgeon General) to Henry D. Chadwick (Commissioner of Public Health), 
June 23, 1934, Projects: Development ofNonaddictive Analgesics: Clinical Studies: Pondville 
Hospital, CDA, NASA. 
36\ Clifton Himmelsbach to Office of the Surgeon General, January 12, 1935, cc- White, 
Chadwick, Pope, Parker, Daland, Blake, Barrows, Gregg, Lambert, Projects: Development of 
Nonaddictive Analgesics: Clinical Studies: Pondville Hospital, CDA, NASA. 
362N. B. Eddy to C. White, April 24, 1935, Projects: Development ofNonaddictive Analgesics: 
Clinical Studies: Pondville Hospital, CDA, NASA: "It seems to me there is still a possibility that 
this may be a very valuable drug in sorne fields on account of the intensity of its action. We need 
to know primarily the minimal effective clinical dose of the substance, information which Doctor 
Seevers has volunteered to obtain for us. With that as a basis trial of the substance by several 
experienced men in different fields under the most rigid and close control of our organization 
could determine its therapeutic advantages or otherwise." 
158 
159 
another promising but somewhat addictive drug, in a network of five sites in 
1937-39 provided further impetus for developing a method to collect data about 
pain relief. In any case, from 1935, committee members embarked on a more 
concerted search for hum an measures of pain and its relief. 363 
What was the Committee looking for in human tests of analgesic efficacy? 
The nature of Committee members' inquiries and attempts in this area gives us an 
idea of their criteria. Their efforts were directed towards two types of potential 
measures of pain: thresholds of pain perception and physiological correlates of the 
pain experience. The latter physiological avenue represented a desire for more 
objective measurement, where 'objective' meant bypassing the conscious 
deliberate statement of the subject by drawing information directly from their 
bodies' autonomic (and automatic) responses. Nathan B. Eddy, the Michigan 
pharmacologist who also began to take over the coordination of the CDA's 
activities, contacted Drs Cobb364 and Whitehorn365 in 1935 to ask them what they 
though ofusing a device referred to as a cardiotachometer for purposes of pain-
measurement or detection.366 Inquiries were also made of Walter Cannon, a 
Harvard physiologist well-known for his studies of the effects of emotions on 
involuntary body processes,367 "in regard to sorne possible objective 
measurements of pain, and if Dr. Cannon can give us no suggestions along that 
line to see whether he feels observations on blood pressure, pulse rate, and 
possibly skin temperatures, could be used as measurements ofpain.,,368 
These inquiries represent an attempt to draw on what Othniel Dror has 
called 'emotion-gauging technologies,' methods used to locate and represent 
363 This is partieularly notieeable in the eorrespondenee eontained in: Projeets: Development of 
Nonaddictive Analgesies: Clinieal studies: PHS Hospital: Lexington General, CDA, NASA. 
364 Though his full name is not speeified in Eddy's letter, he is presumably referring to Stanley 
Cobb, a Professor of Neuropathology at Harvard Medical Sehool and previous member of the 
Committee on Drug Addiction. 
365 Presumably John C. Whitehom, who was also involved in psyehosomatic researeh. 
366 Eddy to Himmelsbaeh, July 15, 1935, Projeets: Development ofNonaddietive Analgesies: 
Clinieal studies: PHS Hospital: Lexington General, CDA, NASA. 
367 See for example Walter B. Cannon, Bodily Changes in Pain, Hunger, Fear and Rage: an 
Account of Recent Researches into the Function of Emotional Excitement (New York and London: 
D. Appleton and Company, 1915). 
368 Pope to White, Mareh 23, 1937, Projeets: Development ofNonaddictive Analgesies: Clinieal 
Studies: Pondville Hospital, CDA, NASA. 
159 
160 
emotional traces in physiological and autonomie bodily processes. Cannon, Cobb 
and Whitehom were aU active participants in the "emotional tum" of research in 
American physiology, psychiatry and neurology in the 1930s. According to 
Dror's analysis, the power ofthese technologies was seen to lie in their ability to 
investigate "emotion" without relying on language, will, and personal interaction. 
Reading directly from the interior body, they could expose a preconscious, pre-
linguistic truth about emotional fluctuations both in adult subjects, who could not 
be relied on to express their emotions objectively, and mute ones, like animaIs 
and young infants, who could not express them at al1.369 The appeal to these 
"emotionologists" for he1p with the problem of pain-measurement may indicate 
that the se values were considered to be relevant by members of the committee. 
For reasons that were not specified in this correspondence, Whitehom and 
Cannon were, unfortunately, not enthusiastic about the extension ofthese 
"emotion-gauging" technologies for the purpose of analgesic evaluation. 
The other hopeful route to precision in analgesic measurement was 
through threshold-based techniques. When Eddy suggested that it might be 
possible to salvage desomorphine on the basis of more precise data about 
efficacy, it occurred to him immediately that Maurice Seevers might be able to 
help.37o Seevers was a pharmacologist whose field of expertise was drug 
addiction, and whose main contribution to opiate research would later be the 
development of a test of addiction potentiality in the monkey. Around 1935, 
Seevers was working on modifying a technique developed in the late 19th century 
by von Frey, which 1 described in chapter 3, and to adapt it to the measurement of 
changes in sensitivity produced by analgesics.371 This basic principle of 
measurement was first applied to the evaluation of analgesics around 1915. 372 
369 Othniel E. Dror, "The Scientific Image of Emotion: Experience and Technologies of 
Inscription," Configurations 7 (1999): 366-7. 
370 Eddy to White, April 24, 1935, Projects: Development ofNonaddictive Analgesies: Clinical 
Studies: Pondville Hospital, CDA, NASA. 
371 Maurice H. Seevers and Carl C. Pfeiffer, "A Study of the Analgesia, Subjective Depression, 
and Euphoria Produced by Morphine, Heroin, Dilaudid and Codeine in the Normal Human 
Subject," Journal ofPharmacology 56 (1936): 166-87. 
372 D. 1. Macht, N. B. Herman, C. S. Levy, "A Quantitative Study of the Analgesia Produced by 
Opium Alkaloids, Individually and in Combination With Each Other, in Normal Man," Journal of 
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But no further reports seem to have appeared until 1936, when Seevers and his 
colleague Carl Pfeiffer pub li shed the results of their studies. They contrasted their 
algometric measurements of analgesia with the testimony of the "average clinical 
patient" for whom it was difficult to "critically analyze and report his 
sensations.,,373 
CDA researchers, however, were unable to eliminate variations by using 
threshold-measuring instruments to evaluate analgesics. It had been hoped that 
Seevers' method would be useful for adding precision and objectivity to the 
clinical observations to be carried out at Pondville Cancer Hospital, as long as use 
of the device was not too time-consuming.374 The principal problem, it turned out, 
was the high variability in his readings.375 Attempts to find more reliable 
measures of analgesia based on threshold measurement at Lexington were 
similarly unsuccessful. U sing the inductorium, a device that delivered electric 
shocks, Lexington researchers obtained such high fluctuations over time, even 
within the same subject, that the Director of Laboratories was forced to conclude 
that: "judgemental and interpretive factors were of more significance in producing 
pain than any particular degree of stimulation." Another approach was devised, 
which at first seemed to give reproducible results, but "further work with the 
method ... revealed the fact that here too, other factors were at work which were 
uncontrollable and, to sorne extent, little understood." Intensive work along these 
lines was abandoned. 376 
Pharmacology 8 (1916): 1-37, this research team seems to have been mainly interested in opiate 
pharmacology. E. G. Martin, C. M. Grace, and J. H. McGuire, "The Influence of Drugs on the 
Human Sensory Threshold," Journal of Pharmacology 6 (1915): 527-32, the aim ofthis study, 
conducted in the Laboratory ofPhysiology of Harvard Medical School was to develop a 
quantitative method to determine sensitivity. It was part of a series of studies examining the 
influence of various factors, in this case drugs, on the sensory threshold. 
373 Seevers and Pfeiffer, "A Study of the Analgesia," 166-87. 
374 "Memorandum Number 2, June 18, 1936," Projects: Development ofNonaddictive Analgesies: 
Clinieal Stùdies: Pondville Hospital: outlines the protocol for the Pondville clinical study, CDA, 
NASA. 
375 L. E. Lee, Jr., "Studies of Morphine, Codeine and Their Derivatives," Journal of 
Pharmacology 75 (1942): 161-73. 
376 E. Williams, "A Quantitative Measure of Analgesia (Summary ofWork Done at Lexington in 
Past Year, November 12, 1938" in L. Kolb to White, November 12, 1938, Projects: Development 
ofNonaddietive Analgesies: Clinical studies: PHS Hospital: Lexington General, CDA, NASA. 
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The Committee was therefore left without an objective means of 
measuring analgesia. Clinical studies of metopon were nevertheless initiated at 
the University of Michigan Hospital, Pondville Cancer Hospital, Walter Reed 
Army Hospital, Marine Hospital and eventually the Massachusetts General 
Hospital. Determinations of pain relief were made on the basis of impressions 
obtained by nurses, patients and attending physicians but, as noted in one report, 
"not, unfortunately, upon any quantitative measure of analgesic effect.,,377 Unable 
to distinguish between degrees of relief, researchers produced relatively imprecise 
data. To improve consistency, attempts were made to control rigidly the 
conditions of observation: patients and observers were to be blinded, nurses were 
to fill in standardised protocol forms to be sent to the Committee for tabulation, 
and comparison groups were to be created by pairing patients who experienced 
pains of similar origin and intensity.378 It was difficult to enforce these controls. 
Committee researchers complained about the shortage of patient "material," 
which made it difficult to form control groups; about the failure of nurses to 
completely fill out protocol forms; about the difficulty of obtaining the 
cooperation of attending staff; about the unreliability of certain patients.379 They 
had little clinical authority in the sites where studies were carried out, and little 
means of coordinating the production of data in different sites. These difficulties 
help us to understand the appeal of the precision and standardisation offered by 
the dolorimeter when it was introduced to the chairman of the Committee in 1939, 
377 "Report on Work on Analgesia at the University of Michigan, October 6, 1937," Projects: 
Development ofNonaddietive Analgesies: Clinical Studies: University of Michigan Hospital, 
CDA, NASA. 
378 "Memorandum Number 2, June 18, 1936," Projeets: Development ofNonaddietive Analgesies: 
Clinieal Studies: Pondville Hospital, CDA, NASA; Eddy to Metealfe, November 18, 1938, 
Projects: Development ofNonaddietive Analgesies: Clinieal Studies: Walter Reed General 
Hospital, CDA, NASA; Lyndon Lee to Eddy, November 21, 1938, Projeets: Development of 
Nonaddietive Analgesies: Clinieal Studies: Pondville Hospital, CDA, NASA. 
379 Lee to White, Deeember 8, 1938, Projeets: Development ofNonaddietive Analgesies: Clinieal 
Studies: Pondville Hospital, CDA, NASA: "Admissions to Pond ville Hospital are at a low ebb at 
present, eonsequently suitable study cases appear very infrequently." 
Denney to Eddy, November 13, 1939, Projeets: Development ofNonaddietive Analgesies: 
Clinieal Studies: Marine Hospital, 1938-1939, CDA, NASA: Descriptions of individual patients 
and the problems in using them for analgesie studies ean be found in the Committee's 
eorrespondenee. For example, in this letter, Denney deseribes one patient as being: "a highly 
emotional, unstable person." 
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after these few years of intensive and futile search for such a method. It is also 
evident from these comments that clinical trials of analgesic drugs were not 
precision-measuring technologies at this time. 
William Charles White, chairman of the CDA, was approached by Wolff 
at a meeting of the Division of Medical Sciences in 1939. Wolff demonstrated the 
apparatus to White and offered to make it available to the Committee.38o White 
had been impressed by the quality of Wolff s results, noted that the method was 
inexpensive and, at his recommendation, Nathan Eddy, H. L. Andrews, a 
Lexington physiologist and Lee, who oversaw the Pondville Hospital studies, 
were sent to visit the Cornelllaboratory.38\ 
The Committee had high hopes for the dolorimeter. It was estimated that 
the equipment could be duplicatedfor about $300.382 The consistency of its 
results was met with much approva1.383 And, while the development of a portable 
apparatus to use in clinical studies was discussed, the main hope was to use this 
method with "normal" subjects by Andrews at Lexington.384 Since recruiting non-
addict subjects was expected to be difficult, it was hoped that the post-addict 
prisoners at Lexington-the subjects to which CDA researchers had the quickest 
380 White to Treadway, May 8, 1939, Projeets: Development ofNonaddietive Analgesies: Clinieal 
studies: PHS Hospital: Lexington General, CDA, NASA. 
381 White to Harold G. Wolff, ee Lee, Andrews and Kolb, June 30, 1939, Projeets: Development of 
Nonaddietive Analgesies: Clinieal studies: PHS Hospital: Lexington General, CDA, NASA. 
382 Eddy to Howard L. Andrews, June 30, 1939, Projeets: Development ofNonaddietive 
Analgesies: Clinieal studies: PHS Hospital: Lexington General, CDA, NASA: reports that the 
apparatus eould be replieated for 300$. However, in Andrews' "Report to the Surgeon General on 
his visit to Wolff's laboratory by H. L. Andrews, July 28,1939," Projeets: Development of 
Nonaddietive Analgesies: Clinieal studies: PHS Hospital: Lexington General, CDA, NASA: he 
states that sinee the Lexington laboratory already had a potentiometer, the rest of the apparatus 
would eost only 50$. 
383 Lee to White, July 24, 1939, Projeets: Development of Nonaddietive Analgesies: Clinical 
studies: PHS Hospital: Lexington General, CDA, NASA: "the uniformity of Dr. Wolffs results 
with a small group of subjeets is remarkable"; "Report to the Surgeon General on his visit to 
Wolff's laboratory by H. L. Andrews, July 28,1939," Projeets: Development ofNonaddietive 
Analgesies: Clinieal studies: PHS Hospital: Lexington General, CDA, NASA: "The fact that the 
threshold has praetieally the same value for ail 'normal' individuals is another feature in favor of 
the method." 
384 Lee to White, July 24, 1939, Projeets: Development ofNonaddietive Analgesies: Clinical 
studies: PHS Hospital: Lexington General, CDA, NASA. 
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and easiest access-couid function as "normals.,,385 These subjects couid aiso be 
more easiIy manipulated and studied in a controlled environment. Human data 
that couid be obtained quickIy, without waiting the years it took to organise and 
run even mode st clinicai studies, was clearly desirable. After his visit to the 
Cornelllab, Andrews reported: "1 feel that this technique fills a long-felt need in 
our substitute drug program,,,386 and that he was eager to begin work immediately 
"because of the fact that the complete evaluation of the addiction liability of a 
drug requires a knowledge of its analgetic power.,,387 
Though Andrews did take up the dolorimeter in his laboratory, the 
Committee disbanded soon afterwards. The termination of Rockefeller funding, 
and then the war, interrupted the Committee's testing activities in 1939.388 Eddy 
and Small were transferred to the National Institutes of Health, where they would 
be active in wartime research on malaria drugs.389 However, H. L. Andrews 
would continue to study the potential of the dolorimeter in his laboratory at the 
Lexington narcotics hospital. 
5.3 Synthetie Analgesies and the Bright Future of the Dolorimeter 
While the Committee's relationship with the dolorimeter was short-lived, 
the demand for anaigesic testing did not dry up. The arrivaI of two new 
substances from Germany sparked the interest of American pharmaceuticai 
researchers and manufacturers: Demerol in the early 40s and Methadone at the 
end of the war. A small testing industry grew up around these two drugs and their 
hopeful derivatives, while general research in opiate pharmacology was also 
given a boost. Their arrivaI was marked by clusters of scientific articles in major 
385 "Report to the Surgeon General on his visit to Wolffs laboratory by H. L. Andrews, July 
28,1939," Projects: Development of Nonaddictive Analgesies: Clinical studies: PHS Hospital: 
Lexington General, CDA, NASA. 
386 Andrews to White, July 28, 1939, Projects: Development ofNonaddictive Analgesies: Clinical 
studies: PHS Hospital: Lexington General, CDA, NASA. 
387 "Report to the Surgeon General on his visit to Wolffs laboratory by H. L. Andrews, July 
28,1939," Projects: Development ofNonaddictive Analgesies: Clinical studies: PHS Hospital: 
Lexington General, CDA, NASA. 
388 Eddy, The National Research Council, 42-51. 
389 Leo Slater, personal communication, 2005. 
164 
165 
journals reporting on their pharmacological assessment.390 Pharmaceutical firms, 
particularly Hoffmann-LaRoche, were also interested in determining the value of 
anticholinesterase drugs as potentiating agents that would heighten the 
effectiveness of morphine, and thus allow smaller doses to be used.39 \ The Hardy-
Wolff-Goodell dolorimeter proved to be very popular during this expansion of 
analgesic testing.392 
Demerol (also called meperidine in the U. S.) was first synthesized in 
Germany in 1939 by Eisleb and Schaumann?93 Testing in the United States seems 
to have begun in 1941, and the drug was approved by the Food and Drug 
Administration in 1942.394 The compound represented a departure from previous 
attempts to create new analgesics, which had focused on tinkering with the 
morphine molecule. As a piperidine compound, Demerol represented a new 
avenue for analgesic pharmacological innovation. Demerol began to be tested 
clinicallyat Bellevue, a teaching hospital of New York University, in 1941, by R. 
C. Batterman.395 But, perhaps dissatisfied with the lack of objectivity of the se 
clinical data, Batterman and Himmelsbach published results obtained with the 
dolorimeter in 1943.396 While they concluded that side effects made Demerol a 
poor substitute for morphine, they pointed out the advantages of fully synthetic 
390 A systematie review of publications on analgesics and opiates in the Federation Proceedings, 
particularly in the abstracts of the Society for Pharmacology and Experimental Therapeutics, 
during the 1940s, indicates first that analgesics became a more popular topic during this decade, 
and that more numerous abstracts appeared in 1942, wh en Demerol was being tested, and then 
again beginning in 1946 with the arrivaI of methadone. 
391 Donald Slaughter and D. W. Munsell, "Sorne New Aspects of Morphine Action. Effects on 
Pain," Journal of Pharmacology 68 (1940): 104-12. This study was funded by Hoffmann-Laroche, 
which also provided the test drug. Hoffmann-Laroche would also fund these researchers to 
examine the value of the dolorimeter for evaluating its efficacy, see: Siaughter and F. T. Wright, 
"A Modification of the Hardy-Wolff-Goodell Pain-Threshold Apparatus," Current Research in 
Anesthesia and Analgesia 23 (1944): 115-19. 
392 This can also be ascertained from a review ofthe abstracts of the Society for Pharmacology and 
Experimental Therapeutics published in Federation Proceedings for 1940-1950. 
393 1-methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester, also known in various countries as 
dolantin (the name it was first given by the German researchers), isonipecaine, dolantol, dolasol, 
pethidine (often used by British researchers), mefedine and lido!. 
394 Robert C. Batterman and Clifton K. Himmelsbach, "Demerol - A New Synthetic Analgesie," 
Journal of the American Medical Association 122 (1943): 222. 
395 Robert C. Batterman, "Clinical Effectiveness and Safety of a New Synthetic Analgesic Drug, 
Demerol," Archives of InternaI Medicine 71 (1943): 345-56. 
396 Batterman and Himmelsbach," Demerol," 222-26. 
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narcotics. Demerol was soon presented as a potential solution to increased 
wartime needs for pain-relief and possible threats to American opium supplies.397 
News of more compounds synthesized by German chemists was disclosed 
by the U. S. Department of Commerce in a report based on information gathered 
by a team headed by Dr. Kleiderer of the Technical Industrial Intelligence 
Committee,·under the Foreign Economic Administration. 398 Ofthese 
compounds, the one with the seriaI number 10820 appeared particularly 
promising: it was called amidone by the Germans, but in 1947 the Council on 
Pharmacy and Chemistry of the American Medical Association announced that its 
generic name would be methadone.399 
Methadone was approved by the FDA soon after the initial American 
report under the trade name of Dolophine, which was already manufactured by 
the pharmaceutical firm Eli Lilly and Company. Indeed, Eli Lilly had been quick 
to act. By March of 1946, two of its researchers, C. C. Scott and K. K. Chen, were 
already announcing the results of analgesic tests of compound 10820 to the 
American Society for Pharmacology and Experimental Therapeutics. They had 
conducted tests in albino rats, 7 trained dogs and 3 human subjects. For the last, 
they had used the Wolff-Hardy-Goodell apparatus. The Lilly Research 
Laboratories continued to keep busy testing the analgesic activity of other 
compounds in the German series, and determining the relative potency of the two 
different isomer forms of methadone, for which they also used the dolorimeter. 400 
397 Batterman and Himmelsbach," Demerol," 222. 
398 C. C. Scott and K. K. Chen, "The Action of 1, I-diphenyl-I-( dimethylaminoisopropyl) 
butanone-2, a Potent Analgesie Agent," Journal of Pharmacology and Experimental Therapy 87 
(1946), 63-71. . 
399 Methadone is now popularly known as a heroin substitute that is used for the therapeutic 
maintenance or controlled withdrawal ofheroin addition. However, it tirst attracted interest as a 
fully-synthetic potent analgesic. Other names given to the compound l, I-Diphenyl-l-
(Dimethylaminoisopropyl)-butanone-2 included: amidon, methadon, "10,820", miadone, "AN-
148", butalgin and dolophine. 
400C. C. Scott, E. B. Robbins and K. K. Chen, "Pharmacologie Comparison of the Opticallsomers 
of Methadon," Journal of Pharmacology and Experimental Therapy 93 (1948) 282-6: compared 
the two forms ofmethadone and obtained different results with each organism: Rats with Haffner 
tail-pinching technique found the l-isomer to be 7.5 times more potent in its analgesic action th an 
the d-form. In dogs the l-isomer was 25 times more potent an in humans, 50 times. Scott and 
Chen, "The Action of l, I-Diphenyl. .. " 63-71, note that details of pharmacological work not 
available trom the report ofthe Department of Commerce. 
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Hoffman-LaRoche had also taken an active interest in analgesic testing 
following the arrivaI of the new synthetics. Scientists employed by its research 
department organized a collaborative study of analgesic testing methods in which 
academic and industry researchers compared five compounds, including Demerol 
and methadone. The firm did not only test the German substances, but also began 
modifying molecular structures to obtain novel and hopefully profitable 
substances. In 1947, its pharmacology department screened a series of piperidine 
derivatives (like Demerol) in rats, using a modified Hardy-Wolff-Goodell set-
up.401 Three ofthese showed an interesting level ofpotency, and were handed 
over, along with a research grant, to a research team at the University of Iowa. 
The team, headed by E. G. Gross assessed these compounds in medical students 
using the original Hardy-Wolff-Goodell dolorimeter.402 
This was a time of expanding analgesic research, but the 1940s was also a 
time when academic researchers-particularly pharmacologists-could 
increasingly hope to obtain research funding from the pharmaceutical industry.403 
Most of the hum an testing of analgesics was carried out in academic settings, 
though one group used it in an industriallaboratory. In commercial settings, the 
use of modified Hardy-Wolff-Goodell designs adapted for animal subjects was 
popular.404 But pharmaceutical firms obviously thought that human data on 
analgesic efficacy was important enough to justify providing grants to academic 
pharmacologists for drug evaluation. Eli Lilly,405 Hoffman-LaRoche406 and 
WhitehaIl Pharmacal407 aIl provided grants for specifie studies using the 
dolorimeter, while Smith, Kline & French funded a fellow who worked 
401 R. H. K. Foster and A. 1. Carman, "Studies in Analgesia: Piperidine Derivatives With 
Morphine-Like Activity," Journal of Pharmacology 91 (1947): 195-209. 
402 E. G. Gross, H. L. Holland and F. W. Schueler, "Human Studies on Analgesie Piperidine 
Derivatives," Journal of Applied Physiology 1 (1948): 298-303. 
403 John P. Swann, Academic Scientists and the Pharmaceuticallndustry: Cooperative Research in 
20th-Century America (Baltimore: Johns Hopkins University Press, 1988), 25. 
404 Pfeiffer, et al., "Experimental Methods for Studying Analgesia," Annals of the New York 
Academy of Science 51, nO.l (1948): 21-33. 
405 Scott, Robbins and Chen, "Pharmacologie Comparison," 282-6. 
406 Slaughter and Wright, "A Modification of the Hardy-Wolff-Goodell,"115-19; E. G. Gross, H. 
L. Holland, and F. W. Schueler, "Human Studies," 298-303. 
407 F. B. Flinn and A. S. Chaikelis, "An Improved Instrument for the Determination of Changes in 
the Pain Threshold Caused by Drugs," AmericanJournal ofPsychiatry 103 (1946-1947): 349-50. 
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intensively with other academic researchers on evaluating the dolorimetric 
method.408 
During the years from 1948 to 1950, the Hardy-Wolff-Goodell 
dolorimeter appears to have been at the peak of its career. The recent spurt of 
activity in synthesis and testing of analgesics was in full swing. In the 
introduction to a volume on the "newer synthetic analgesics" published by the 
Annals of the New York Academy of Science, E. L. Tainter, of the Sterling-
Winthrop Research Institute commented on the intimate relationship between the 
modern history of analgesic drugs and the development of methods in quantitative 
pharmacology. While the first three periods of analgesic history had been 
characterized by the discovery of substances and of new chemical methods of 
isolation and synthesis, the fourth, or "modern" period was "characterised by the 
development of quantitative pharmacological methods oftesting" which guided 
the design ofnew molecules based on knowledge of the relationship between 
structure and effect.409 Reviews of analgesic testing methods by industry 
researchers sang the praises of the dolorimeter: "Of the methods proposed and 
used in the last decade, it is safe to say that the Hardy-Wolff-Goodell procedure 
has gained the widest acceptance," 41 0 commented Miller of the Sterling-Winthrop 
Research Institute, a statement echoed by Chen of the Eli Lilly Research 
Laboratories who declared it to be "the best. ,,411 Both noted that the apparatus had 
recently been made available commercially: someone clearly had had the 
impression that, given the surge of interest in analgesic innovation, there would be 
a growing market for this type of equipment. 
Even at the height of its popularity, few denied that using the Hardy-
Wolff-Goodell method required adjustments and compromises. Nor did anyone 
dispute the need for clinical confirmations oftherapeutic efficacy. In addition, 
408 R. R. Sonnenschein and A. C. Ivy, "Failure of Oral Antipyretic Drugs to Alter Nonnal Human 
Pain Thresholds," Journal ofPharmacology 97 (1949): 308-13. R. Sonnenschein was a fellow of 
Smith, Kline and French. 
409 E. L. Tainter, "Pain," Annals of the New York Academy of Science 51, nO.1 (1948): 3-11. The 
publication ofthis volume on the new synthetic analgesics was funded by pharmaceutical firms. 
410 Miller, "A Critique of Analgesie Testing," 34-50. 
411 K. K. Chen, "Physiological and Pharmacological Background Inc\uding Methods of Evaluation 
of Analgesie Agents," Journal of the American Pharmaceutical Association 38 (1949): 51-55. 
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obtaining consistent results turned out to be more difficult than initially 
anticipated. As we will see, sources of variation in the data were not always easy 
to identify, manage and interpret. Of particular concern to the pharmaceutical 
industry was the apparent lack of sensitivity of the dolorimetric method to weak 
analgesics, particularly antipyretics such as aspirin.412 However, the dolorimeter 
served an important purpose: rapidly estimating the analgesic potency-accurate 
in humans-of new, exciting compounds. Neither animal tests nor clinical studies 
seemed to be able to yield this kind of data at that particular time. The dolorimeter 
situated itself within this gap. 
5.3.1. Filling a Gap: between Animal "Pain" and the "Total" Pain 
Experience 
From the outset, Hardy, Wolff and Goodell carved a space for the dolorimeter, a 
gap in objectivity between the "animal experimentation" and "clinical 
impression" that had previously informed researchers about analgesic action.413 
As l have aIready suggested, this gap had started being defined through the 
CDA's activities in the late 1930s. Animal tests, such as Eddy's technique of 
squeezing cats' tails, were useful for initial, high-volume screening, but were 
sometimes found to give inaccurate values for human dosages and potency. 
However, animal tests presented various advantages, both practical and 
epistemological. Clinical studies, on the other hand, were judged to be extremely 
difficult to control. "Clinical pain" was undoubtedly seen as more authentic, but 
its measurement lacked precision, standardisation and objectivity. The level of 
control obtained in the clinical studies organised by the CDA, or the handful of 
other clinical studies run during the 1940s, did not greatly contribute to bridging 
412 Miller, "A Critique of Analgesic Testing," 34-50. The lucrative market for weaker over-the-
counter analgesics may have made this a big disadvantage from the perspective of the 
pharmaceutical firms. 
413 Wolff, Hardy and Goodell, "Studies on Pain. Measurement of the Effect of Morphine,"659-
680: Introduce this report by stating that ail previous studies had either relied on animal tests or 
"clinical impression" but that: "since the prime purpose of an analgesic drug concerns its action in 
man, it is desirable to measure accurately its effect on man's pain threshold. For such 
measurement a suitable method has now been developed." 
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the gap between laboratory "animal pain" and clinical impression. This gap was 
an epistemological one, but was also, significantly, a financial, logistical and 
professional one. It only began to narrow in the late 1940s. 
For data on analgesic efficacy to be useful, it had to be both meaningful 
and comprehensible. But to what extent could the phenomenon of pain be made 
more intelligible through experimental manipulation before it lost its original 
meaning? This question was present, at least implicitly, in most discussions about 
the merits of testing methods. The different possible qualities that data could take 
on-precision, authenticity, clarity, uniformity, exactitude, consistency-had to 
be weighed against each other. These qualities came at a cost. The standardisation 
of experimental practice often entailed a loss of accuracy and precision. There 
were other, more banal costs for these qualities: the price of equipment, the 
difficulty of obtaining subjects, the time needed to produce data, the volume of 
data that had to be produced, the authority required to control practices of data 
collection, the staff needed to collect data, the facilities required for 
experimentation, and so on. 
These issues were certainly not peculiar to analgesia as an experimental 
object.414 Working with animaIs rather than humans presented similar advantages 
for analgesic testing as it did for other kinds of laboratory work; animaIs offered 
more possibilities for standardisation, they were easy to recruit or to purchase, and 
their whole lives could be dedicated to therapeutic testing. Animal models for 
measurement were very useful for industriallaboratories, where modified animal 
versions of the Hardy-Wolff-Goodell proved to be very popular.415 There, 
animaIs could be kept readily available, and the methods could be operated by 
pharmacologists and physiologists on company payrolls. Results could be 
produced fast enough to affect decisions about manufacturing. 
414 For example, see : Thomas Schlich, Surgery, Science and Industry (Houndmills and New 
York: Palgrave Macmillan,2002), 86-109, for an analysis of the debates about the relevance of 
laboratory-produced knowledge for clinical practice on humans in fracture surgery. 
415 H. E. Hill, R. E. Belleville, and A. Wikler, "Anxiety Reduction as a Measure of the Analgesic 
Effectiveness of Drugs," Science 120 (1954): 153. 
170 
171 
The trade-offs, however, were in sorne ways specifie to the way in which 
experimenters perceived pain as an experimental variable, as well as to the 
context in which analgesic research was funded and organized. As one reviewer 
put it: "Because pain is a subjective phenomenon, more difficulty arises on this 
point with animaIs than with human subjects, a situation which is the reverse of 
that usually encountered in pharmacological studies.,,416 One of the most 
significant merits of animal measures of analgesia was also their principal fault: 
the subjects did not speak. Animal responses to painful stimulation could only be 
read directly in their bodies, which made animal tests more objective but also less 
informative, as well as potentially less accurate.417 
Animal researchers accepted, implicitly or explicitly, that what they 
studied bore an uncertain, possibly distant relationship to human experiences of 
pain. Animal "pain" was sometimes deliberately framed in quotation marks, 418 
while other researchers refused to use the term altogether, preferring, for example, 
to write about an "avoiding reflex" instead of a "pain threshold." 419 In the 1930s, 
there was still hope of objectifying human pain on the same "pre-linguistic, 
preconscious" level as in animal tests. During the 1940s, however, as such hopes 
416 Miller, "A Critique of Analgesic Testing," 34-50. 
417 There are other instances in which scientists were willing to make trade-offs between accuracy 
or information and objectivity, see for example: Lorraine Daston and Peter Galison, "The Image of 
Objectivity," Representations 40 (1992): 8 1 -128. 
Molitor and H. Robinson, "The Quantitative Determination of a Weak Local Anesthetic Action," 
Current Research in Anesthesia and Analgesia 17 (1938): 188-94, explain how animal reactions 
were less informative than human ones: "In experiments on man it is possible to depend to a 
certain degree on his statements provided he is intelligent and cooperative, but in animais we must 
rely entirely on reactions which accompany the sensation ofpain, such as cry, flight reflex, 
changes in respiration, blood pressure, pupillar diameter or nerve and brain action currents." Frank 
R. Goetz\, D. Y. Burrill and A. C. Ivy, "A Critical Analysis of Aigesimetric Methods With 
Suggestions for a Useful Procedure," Quarterly Bulletin of the Northwestern University Medical 
School 17 (1943): 280-291, explain how these reactions might be seen as more objective: " ... an 
avoiding reflex, an objective phenomenon ... should be more reliable for the determination ofpain 
threshold than the subjective report of a human subject. This should obtain particularly wh en 
drugs are used which effect the subjective feeling tone or the mental attitude ... " 
418 For example: G. C. Knowlton and E. G. Gross, "A Method for Studying the Analgetic Effect of 
Drugs in Animais," Journal of Pharmacology 78 (1943): 99, conclude that their method is suitable 
for determining "pain"thresholds in animais (quotation marks in original, though not used 
consistently throughout article). 
419 F. R. Goetzl, D. Y. Burrill, and A. C. Ivy, "Observations on the Analgesic Effect of Morphine 
During Continued Daily Administration ofSmall and Uniform Doses to Dogs," Journal of 
Pharmacology 82 (1944): 110-119. 
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were abandoned; the gap between human and animal measures of pain seemed 
only to grow wider. 
If animal tests did not measure pain, what did they measure? The basic 
princip le was the same in nearly aU the experimental setups: an animal, when 
subjected to a strong, presumably unpleasant stimulus, would, at some point, 
exhibit some responsive behaviour that could be measured.420 By choosing a 
suitable animal, an appropriate stimulus and a recognisable and reliable response, 
a researcher could produce a measurable endpoint that would be sensitive to drug 
effects. An astonishing variety of contraptions were designed to do this from the 
1930s onwards in the U. S., which shows just how valuable such tests were 
considered, but also how difficult it was for researchers to agree on the precise 
merits of each one. Whether they subjected cats, dogs, rats or mice to the violence 
oftail-pinching, tooth shocking or being made to stand on hot-plates, researchers 
competed in producing endpoints-if possible cheaply and easily-that were 
definite, observable, quantifiable, consistent, and discriminative.42 \ Examples of 
such endpoints were: lifting ofhind legs, skin twitch, tail twitch, widening of 
420 This type of set-up is fairly typical for behaviourist experiments in psychology, though in this 
case what is being measured is the impact of drug effect rather than the impact of leaming or 
conditioning on responses. 
421 Woolfe and Macdonald, "The Evaluation of the Analgesic," 300-307: state that, in their 
method, the 
lifting ofhind legs was chosen as "criterion ofacute discomfort" because the first response to the 
heat was to lift the front paws to cool them, a response that could easily be confused with normal 
grooming behaviours. The lifting ofhind legs was therefore more definite. 
D. Slaugther and D. W. MunseIl, "Sorne New Aspects of Morphine Action. Effects on Pain," 
Journal of Pharmacology 68 (1940): 104-12: state that the recording ofresponses was done by 
two different observers to "obviate any personal error," the lack of changes in results made this 
"work more acceptable." 
R. E. Lee, H. L. Williams and C. C. Pfeiffer, "A Warm Wire Aigesimeter," Federation 
Proceedings 8 (1949): 314: this device was said to obtain "more quantitative results" in mice than 
the "usual tail-pinching method. 
Fred E. D'Amour and Donn L. Smith, "A Method for Determining Loss of Pain Sensation," 
Journal of Clinicallnvestigation 72 (1941): 74-80: previous methods for testing analgesic in 
animais were said to "suffer from two main defects: doubt exists as to the stimulus, i.e., whether it 
is pain or merely touch, and there are great individual variations in test animais." This method was 
valuable because the individual variation was found to be small. See also: Knowlton and Gross, 
"A Method for Studying," 93-99: the opening or widening of eyelids was chosen as an endpoint 
even though "the only sure sign ofpain in an animal is a typical cry or howl" because the 
sequence ofresponses was so uniform, and it could be elicited consistently with little variation in 
stimulation 
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eyelids, and squeaks. Even devoid of its cortex, it was observed, an animal would 
display such reactions to strong stimulation.422 
As pre-cortical reactions, animal expressions of "pain" were protected 
from the interference of the conscious will. But, stripped of its meaning and 
experiential qualities, how could this reflex animal behaviour be translated back 
into information about the relief of clinical suffering? On the other hand, clinical 
studies were faced with the problem of differentiating the effect of analgesics 
from a tangle of other possible influences on pain: expectations of relief, fear, 
mental processes, mood, psychological disposition, variations in personality and 
sensitivity.423 Animal subjects were presumably less prone than human ones to 
infuse meaning into their experiences and to ponder the implications of their 
sensations, while they offered numerous practical advantages. Thus, as is made 
evident by the large number of animal analgesia tests that were created and put 
into use during the 1930s and 1940s, their advantages made certain compromises 
in "authenticity" and accuracy worthwhile. 
At the other end of the spectrum was the hum an patient, living a "total" 
experience of pain. Information about this pain could be collected in hospitals, 
usually in post-operative, obstetric and cancer wards. Unquestionably more 
authentic, clinical pain was subject to complex influences and fluctuations; it was 
confusing, unwieldy, difficult to control and to standardise. To be useful, 
information about the relief of clinical pain had to be obtained in large volumes. 
Rare reports of analgesic clinical studies in the 1940s were published only when 
they had evaluated analgesics in hundreds of patients (as many as 1200 and no 
fewer than 47), sometimes over more than a year. The "psychological make-up" 
of the patient was considered to be "of prime importance" in clinical evaluations 
422 H. Molitor and H. Robinson, "The Quantitative Determination," 188-94. 
423 For example: Batterman, "The Clinical Aspects," 596. Though Batterman called for the 
evaluation of analgesics in clinical patients, he cautioned: "consider the difficulties, however, of 
evaluating the complaints of a patient who is supposedly in distress on the basis of organic 
disease. In addition to the perception of the pain fuI stimulus, every patient varies to an astounding 
degree in the development of associated ideas or introspective analyses of the responsible factor 
for the discomfort." 
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of pain relief.424 This was a difficult factor to control, and was probably do ne in 
large part through the informaI selection of subjects. In addition, control groups 
were usually matched up with test groups on the basis of the severity of their pain. 
It was essential, then, that clinical analgesic evaluators have access not only to 
"clinical material" but a lot of it. Physiologists and pharmacologists, the ones 
usually entrusted with the testing of analgesics, did not commonly have this kind 
of access. When they did, they may have lacked authority over the recruitment 
and care of experimental subjects that made it possible to select proper groups, 
and implement controls. Despite several appeals to the importance of using 
placebos in any study oftherapeutic effect where pain was involved,425 it may 
have been difficult to convince regular hospital staff to administer placebos for 
pain relief. For whatever reason, placebos were rarely used. 
The results offered in thefew available reports of clinical studies of 
analgesics were approximate compilations of qualitative judgments, for example, 
the number of patients reporting "satisfactory relief,,,426 or, "complete, moderate, 
slight or none.,,427 In addition, these judgments were often based on patients' own 
statements. In the early 1940s, no claims were made about the desirability of 
relying on the subjects' impression of pain relief. This was seen as an unfortunate 
necessity, to be supplemented when possible by adding physicians' and nurses' 
objective observations of patients' behaviours-restlessness, moaning, 
appearance of comfort-as well as their evaluations of the trustworthiness of 
patients' complaints.428 These observations and evaluation were rarely 
standardised, thus making it difficult to compare them. 
424 Batterman, "Clinical Effectiveness," 345-56. 
425 Harry Gold, N. T. Kwit and H. Otto, "The Xanthines (Theobromine and Aminophyl1ine) in the 
Treatment of Cardiac Pain," Journal of the American Medical Association 108 (1937): 2173-
2179.; E. M. Jellinek, "Clinical Tests on Comparative Effectiveness of Analgesie Drugs," 
Biometries Bulletin 2 (1946): 87-91.; Batterman, "The Clinical Aspects of Evaluating," 595-607. 
426 C. C. Scott, K. G. Kohlstaedt, and K. K. Chen, "Comparison of the Pharmacologie Properties 
of Some New Analgesie Substances," Anesthesia and Analgesia (1947): 12-17. 
427 Batterman, "Clinieal Effeetiveness," 345-356; Elizabeth B. Troxil, "Clinieal Evaluation of the 
Analgesie Methadon," Journal of the American Medical Association 136 (1948): 920-923. 
428 For example: Batterman, "Clinieal Effeetiveness,"345-356; Lyndon E. Lee Jr., "Studies of 
Morphine, Codeine and Their Derivatives," Journal ofPharmacology 75 (1942): 161-73. 
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Given these difficulties, it is not surprising that few clinical studies of 
analgesics were conducted during the 1940s. These would later be dismissed as 
po orly controUed. Such studies were not only long and complex, but also 
expensive. Pharmaceutical companies, who funded most of the analgesic testing 
during this decade, may not have been willing to invest that kind of money for 
data. In this context, rare caUs for more and better controUed clinical evaluation 
were theoretica1.429 ControUing clinical pain, its relief and evaluation required 
resources that had not yet been made widely available for analgesic testing. In the 
1940s, the clinical trial was not seen as a specific technology, much less a 
precision-measurement instrument, for gathering data about pain relief. 
Between the high cost in authenticity and certainty of animal "pain" and 
clinical studies' high cost in time, subjects, money, staffing and clinical authority, 
the dolorimeter was apparently a good option. These were human data that 
pharmaceutical companies could afford: the dolorimeter cost $850.00 in 1953 
from the Co-Design Corporation, it could be operated by pharmacologists or 
physiologists with presumably fairly modest grants, given the amount of time (a 
matter of days) and subjects (as few as 3) required to complete a tria1.430 The 
apparatus was even used in pharmaceutical company laboratories. The 
dolorimeter did not require patients as subjects. A handful of coUeagues, medical 
students, or prisoners, in the case of the studies at Lexington, were presumably 
easy to recruit and to see over several days in order to multiply observations. 
Thus, the use of the dolorimeter required the kinds of resources and the type of 
professional expertise which pharmaceutical companies and their academic 
contacts were able and willing to make available for analgesic evaluation in the 
1940s. In addition, it combined the objectivity and practicality of animaIs tests 
with the epistemological advantages of data obtained from human subjects. 
5.3.2 At Work with the Dolorimeter 
429 For example, Batterman, "The Clinical Aspects of Evaluating," 595-607. 
430 The priee of the dolorimeter is in: Sales pamphlet for the Hardy-Wolff-Goodell Dolorimeter, 
Co-Design Corporation, Winchester, MA, n.d., WolffPapers, Box 3, Folder 12, Medical Center 
Archives ofNewYork-Presbyterian/Weili Comell, New York, NY. 
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A dolorimeter, a modest grant, sorne laboratory space, a handful of subjects and a 
physiologist or pharmacologist ... it took more than this to make the dolorimeter 
work. In this section, 1 will examine the practice of dolorimetric experimentation. 
First, 1 will de scribe one research group's experience with the dolorimeter. 
Janet Travell was one of the investigators who, in the 1940s, identified the 
dolorimeter as a potentially useful therapeutic test. Having developed a 
therapeutic procedure of spraying ethyl chloride, a vapo-coolant substance, to 
relieve cardiac pain, she was exploring different ways of determining its analgesic 
efficacy. Recently promoted to Assistant Professor in clinical pharmacology at 
Cornell University, and soon to become Associate Professor, Travell was weil 
indoctrinated in the principles of the new clinical pharmacology advocated by her 
colleagues McKeen Cattell and Harry Gold, pioneers in the promotion of placebo 
controlling and double-blinding. Travell was thus familiar with the dangers of 
hast y therapeutic judgments and sought to establish the value ofher new 
procedure on a firm basis.431 ln 1949-50, trials with the dolorimeter took place in 
her laboratory. Among her notes, 1 found the following record ofher colleague's 
experiences as a dolorimetric subject: 
Kropowska- forehead 
12/22/49 
170- warmer than 
180- prick? Warmer than bef 
190-about the same as bef 
200- beginning to burn sensation- burns afterwards 
210-sharp sudden "burning" prick? 
220- more like a prick, momentary 
230- burning pain 
195- no distinct prick 
200-202 a prick maybe- not sure 
205- a prick 
235-240 burning-intense heat 
250 a little like needles 
260- burning pain 
43\ Janet Travell, Office Hours: Day and Night (New York and Cleveland: The World Publishing 
Company, 1968): 245. 
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250 "pricks" 432 
The procedure, according to other laboratory notes, was to begin with an exposure 
below 200 so "as not to frighten" the subject, and then to vary intensities until the 
point "at which just feel "pin-prick"-not pain, not heat,,433 had been bracketed 
by exposures over and under the threshold. Question marks frequently dotted this 
brief set of notes. After subjects had hesitated about whether or not they had 
encountered the "prick," experimenters had to decide how to interpret results and 
figure out how to fix procedural problems: 
Pain thresholds lower than before! Valid or not? 
II cause lowered temp 
Pain threshold determinations cause temp incr 
On both these exp skin irritation, erythema ... 
Maybe explains pain thresholds being lower than previously 
Determinations should not be made as soon as one minute apart. 
1) start below 
2) work up but don't go backwards! 
3) Let 2 min interval between tests 434 
These notes suggest that making judgments about the validity of dolorimetric data 
wasn't always clear-cut. While it was, unfortunately, impossible to locate more of 
these kinds of laboratory notes, ev en the pub li shed reports of dolorimetric trials 
provide sorne clues about the kinds of efforts and adjustments that were necessary 
for making the dolorimeter work. Decisions had to be made about what kinds of 
modifications to make; about whether these practices were legitimate uses of the 
apparatus; and about whether results had reached an acceptable level of 
consistency, certainty and precision. 
Historical and sociological studies of experiment have shown that 
replicating results has not always come easily in scientific practice. Based on his 
432 "Pain threshold experiments 1949-50," Travell Papers, Box 25, Folder 21, Special Collections 
and University Archives, GWU: The numbers in the left column correspond to the intensity of the 
radiation in millicalories per second to which Irene Kropowska's forehead was exposed, and the 
comments in the right column are presumably the subject's own. 
433 "Pain threshold experiments 1949-50," Travell Papers, Box 25, Folder 21, Special Collections 
and University Archives, GWU. 
434 "Pain threshold experiments 1949-50," Travell Papers, Box 25, Folder 21, Special Collections 
and University Archives, GWU. 
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study of laser-building, Harry Collins has proposed that achieving replication in 
practice requires "experimental ability," a form oftacit knowledge, or skill, which 
is not easily acquired. It travels capriciously, and depends on practice and often 
on personal contacts between investigators. Thus, according to Collins, 
replicability is not an "inherent" quality of the experimental result, nor a direct 
indication of the validity of the experimental method, but is a property that is also 
defined by the social context in which experiments are performed and debated.43 ) 
Because of this, it is often not a straightforward matter to determine 
whether a specific instance of experimentation constitutes "replication." Collins 
has described a vicious epistemological cycle in which experimental competence 
and the "right tools" are defined by the achievement of appropriate results, and 
results can only be judged on the basis of whether an experiment has been 
performed competently and with the right tools. Simon Schaeffer has given an 
example ofthis "experimenter's regress" in Newton's refusaI to accept evidence 
that contradicted his experiments with the glass prism. Those who had failed to 
obtain the same results were accused of having used bad prisms. Thus, the 
decisive criterion of a good experiment, as defined by Newton, was that it 
produced the right results. In this type of situation, Collins pointed out, 
"scientific" criteria are insufficient for reaching closure. The cycle can only be 
broken by negotiating the meaning of "good experiment" and "right results" in the 
social are na. In Newton's case, he acquired sufficient clout in contemporary 
scientific society to achieve authority over the identification of proper 
instruments, and thus of decisive experiments.436 
Dolorimetric experimenters seemed to accept that replication would not 
necessarily be immediate. When they failed to obtain the same results as Hardy, 
Wolff and Goodell, many were willing to figure out how use the dolorimeter 
properly before it wouLd give the "right resuLts," and/or to tolerate sorne amount 
435 Harry M. Collins, Changing Order: Replication and Induction in Scient[fic Practice (Chicago: 
University of Chicago Press, 1992), 128-157. 
436 Simon Schaffer, "Glass Works: Newton's Prisms and the Uses of Experiment," in The Uses ()l 
Experiment: Studies in the Natural Sciences, ed. David Gooding, Trevor Pinch, and Simon 
Schaffer (Cambridge and New York: Cambridge University Press, 1989), 67-104. 
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of discrepancy in their data. Others, like Janet Travell, gave up on the 
dolorimeter, and determined it was not useful for their particular purpose. Beecher 
was the first, nearly a decade after the introduction of the dolorimeter, to make a 
big deal out of the se discrepancies and to formulate an attack on the validity of 
the dolorimeter on this basis. To his criticism, Hardy, Wolff and Goodell 
responded: "The se disagreements show the importance of care and experience in 
planning studies on pain and in the operation of pain threshold measuring 
equipment.,,437 Thus, issues ofvalidity and replicability were debated alongside 
questions of proper use and of "good experiment." 
Beyond the immediate question ofwhether the dolorimeter produced valid 
results, experimenters also asked themselves: Under what conditions can we make 
the dolorimeter work? Are these legitimate conditions under which to measure 
pain and analgesia? l will explore debates about the replicability of dolorimetric 
results by focusing on a specific issue: the training of subjects. The question was 
seen as an important and sensitive one; it was discussed throughout the 1940s and 
taken up by Beecher as a key point in his criticism. 
We will recall that, in their original article, Hardy, Wolff and Goodell 
claimed that the pain threshold was "easily recognized, even by untrained 
subjects ... ,,438 But it was not long before other investigators reported that only 
subjects who were familiar with the apparatus gave consistent results. Sorne 
seemed to accept this as an unexceptional measure required to standardise the 
operation of the apparatus, a technical requirement akin to calibrating the intensity 
of radiation or using a skilled technician. 
Indeed, the training of subjects was not always viewed with suspicion in 
psychophysical experimentation. On the contrary, in late 19th and early 20th 
century European and American psychology, sophisticated subjects were not only 
tolerated but valued as highly capable and standardised 'tools' of introspection. 
The function of training in late 19th century Leipzig, according to Ruth Benschop 
and Douwe Draaisma, was to "calibrate" the minds of experimental subjects to 
437 Hardy, Wolff and Goodell, "Pain-Controlled and Uncontrolled," 165. 
438 Hardy, Wolff and Goodell, "Studies on Pain: A New Method," 650. 
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transform them into "a point of access to what has been called the "generalized 
mind," that is, being representative of the "universal features ofadult mentallife." 
In this context, training subjects was part of a quest for precision that was 
associated with a broader program to transform psychology into an experimental 
and 'natural' science. 439 In American psychology at the turn of the 20th century, 
according to Deborah Coon, training was meant both to turn the subject into a 
kind of machine, and to give the subject the skills of a technician for operating his 
own self-machine. According to Coon's analysis, the objective was to mechanise 
psychological practice in order to make it conform to the ideals of an 
industrializing society. 440 
Training was a technique for reducing the variability of outcomes, but 
'expert' subjects also acquired credentials that guaranteed the validity and 
reliability oftheir observations.441 According to Kurt Danziger, such subjects 
were part of the social arrangements of early psychology in which experimenters 
and subjects (called observers) usually knew each other personally and were on a 
similar social footing, either as colleagues or professors and graduate students. In 
fact, the se roles were often interchangeable. Subjects were often identified by 
name or initiaIs in published research reports. Over the course of the first half of 
the 20th century, the trend in American psychology was to replace the se highly 
qualified, identified "observers"-who fulfilled the role of a trained technician-
with anonymous "subjects", whose "function is that of an object of experimental 
manipulation and scrutiny. In other words, there is a shift away from the expert 
observer, toward the manipulated object of observation.,,442 This new model, 
which usually implied the use of large numbers of undergraduate students as 
439 Ruth Benschop and Douwe Draaisma, "In Pursuit of Precision: the Calibration of Minds and 
Machines in Late Nineteenth Century Psychology," Annals a/Science 57 (2000), 18-19 
440 Deborah J. Coon, "Standardizing the Subject: Experimental Psychologists, Introspection, and 
the Quest for a Technoscientific Ideal," Technalagy and Culture 34 (1993): 775. 
441 Benschop and Draaisma, "In Pursuit of Precision," 18-19. 
442 Kurt Danziger, "A Question of Identity: Who Participated in Psychological Experiments?" in 
The Rise a/Experimental Psychalogy, ed. J. G. Morawski (New Haven and London: Yale 
University Press, 1988),43. See also: Danzinger, Constructing the Subject (New York: Cambridge 
University Press, 1990). 
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experimental subjects, was more in line with the asymmetrical power relations of 
medical experimentation. 
Hardy, Wolff and Goodell could have appealed to the qualities of the 
expert observer to establish the validity oftheir initial dolorimetric data. This data 
had been obtained using themselves as subjects. After much practice, they were 
surely highly skilled in making observations and could have presented themselves 
as competent and reliable subjects. Perhaps worried that their self-
experimentation might be held against them, they appealed instead to the value of 
anonymous, interchangeable subjects by stating that the threshold could be easily 
and consistently identified by the untrained. This kind of subject could be found 
anywhere, recruited indiscriminately, employed briefly, and in large volumes. The 
usability of these subjects entailed practical benefits-easy and rapid 
implementation of the method-but it also underscored the epistemological 
qualities of the method: an 'endpoint' that could be achieved consistently without 
particular training was immune to individual variations in skill, personality and 
expectation. A method that could be used successfully with little skill was 
presented as more trustworthy. 
As Hardy, Wolff and Goodell may have anticipated, their self-
experimentation was indeed accused as the secret of their success. Their first 
critics were researchers from Northwestern University who had designed a 
method of measuring pain thresholds that delivered electric shocks to the teeth of 
subjects. The tooth pulp, they argued, was an ideal target for stimulation because 
.it was innervated solely by pain receptors, making the threshold impossible to 
confuse with irrelevant sensations ofwarmth or pressure. Such confusion could 
lead to variation, which had to be eliminated by training, as they explained in a 
thinly veiled attack on the dolorimeter: 
If an unsuitable stimuli, or an unsuitable receptive field, or both, are 
selected, the subjects are unable to discriminate sharply between the 
sensation of pain and the sensation which follows the simultaneous, 
quantitatively and qualitatively, inconstant stimulation of other afferent 
systems. To obtain more accurate results it was necessary, therefore, to use 
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only 'trained subjects', and in many instances investigators could conduct 
their algesimetric studies only on themselves.443 
In contrast, their own method eliminated the necessity of using specially 'trained 
subjects",444 During the 1940s, it was this research team-not the proponents of 
clinical trials-that challenged the superiority of the dolorimeter as an analgesic 
testing method. That the competition was another, essentially similar method 
using 'normal' subjects and 'experimental pain,' is proof of the perceived 
desirability of such methods during this decade. It also meant that the dolorimeter 
was criticised on its own terms: the validity and precision of a pain threshold 
measuring method was enhanced by using a stimulus that was easily, distinctly 
perceived by the subject. It was on these grounds that the Northwestern team 
made subject-training seem like a serious flaw. 
Meanwhile, however, other investigators were training their dolorimetric 
subjects without making a fuss about it, seemingly accepting this as a reasonable 
condition for making the apparatus function optimally. Already by 1943, H. L. 
Andrews, a physiologist at the Lexington Public Health Service Hospital, reported 
that his subjects, who were "post-addicts" (narcotic drug users who had been 
clean for 6 months or more), were given a preliminary period of training to 
familiarise themselves with the use of the apparatus. A few subjects were also 
excluded from the trial because of their "inability to distinguish the various 
stimulus intensities.,,445 E. G. Gross at the University ofIowa used medical 
students, who were "found to be particularly reliable in the se studies because of 
their great interest in the drug effects." He trained these subjects for about 10 
days, "until they could consistently recognise the normal end point ... Provided 
the end point is well defined in the mind of each volunteer the results obtained are 
443 Goetzl, Burrill and Ivy, "A Critical Analysis of Algesimetric," 280-291. 
444 Goetzl, Burrill and Ivy, "A Critical Analysis of Algesimetric," 280-291. 
445 H. L. Andrews, "The Effects of Opiates on the Pain Threshold of Post-Addicts," Journal of 
Clinical Investigation 22 (1943): 511-16. See also: Andrews, "Skin Resistance Changes and 
Measurements of Pain Threshold," Journal ofClinical Investigation 22 (1943): 517-20: the 
subjects were probab1y kept for this following experiment in which the subjects were reported to 
have "had considerable experience with the experimental procedure before being used in the 
present study." 
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remarkably consistent." 446 Scott and his colleagues reported, adding no further 
comment, that "with both dogs and men considerable preliminary training was 
needed in order to obtain consistent and reliable data.,,447 
For Andrews and Gross, training subjects did not present great difficulties. 
Their subjects were available for multiple sessions; they were generally healthy 
and lucid enough to follow instructions closely. Training did pose problems, 
however, when use of the apparatus was transferred to clinical settings. Having 
attempted to use the technique to obtain more objective data on pain relief in 
cancer patients, a team of pharmacologists at Memorial Hospital in New York 
reported that: "It was exceedingly difficult to train the se patients, since most of 
them were desperately ill. .. In the few that we were able to train, the results were 
so frequently inconsistent that it was impractical to continue the procedure. ,,448 
Training was thus seen by sorne as a reasonable-if not always practical-means 
ofreducing the range of variation ofsubjects' 'normal' responses before 
submitting them to experimental trials. 
Other investigators instead saw variability in normal thresholds, rather 
than training, as the reasonable concession they had to make in using the 
dolorimeter. Having found a discrepancy between the consistency of their data 
and the Cornell team's, Slaughter and Wright concluded: "This difference, we 
feel, is what one might reasonably expect. It is certain that, clinically, humans 
differ considerably in their reaction to pain-it is therefore quite likely that 
'normal' pain-threshold responses differ in different individuals." 449 Indeed, not 
aU had accepted Hardy, Wolff and GoodeU's assertion that the pain threshold was 
446 E. G. Gross, H. L. Holland and F. W. Schueler, "Human Studies on Analgesie Piperidine 
Derivatives," Journal of Applied Physiology 1 (1948): 298-303. 
447 Scott, Kohlstaedt, and Chen, "Comparison of the Pharmacologie," 12-17. 
448 R. W. Houde, L. H. Rasmussen and J. S. LaDue, "Preliminary Experience in the Use of Sorne 
of the Newer Analgesies in the Relief of Pain Due to Cancer," Annals ~!the New York Academy q! 
Science 51 (1948): 161-74. See also: J. Clausen, H. E. King, "Determination ofPain Threshold in 
Untrained Subjects," Journal of Psychology 30 (1950): 299-306. 
449 Slaughter and Wright, "A Modification of the Hardy-Wolff-Goodell,"115-19 
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in fact constant. They attributed variability in results to the reality of the threshold 
itselfrather than to the failure of the method ofmeasurement. 450 
Hardy, Wolff and Goodell themselves had eventually conceded that 
trained subjects were more reliable in establishing the "occurrence" of pain, and 
that untrained subjects "even ofhigh intelligence" were unsuited for analgesic 
studies with the apparatus.451 Thus, they salvaged an older model of the ideal 
subject as an expert and neutral observer. They had long maintained that a good 
subject was one who was able to focus and to maintain an objective attitude 
towards their sensations. Over-reaction, anxiety, suggestibility and prejudice 
towards the experimental situation made a subject's judgment unreliable: these 
were the causes of erratic fluctuations in pain thresholds and of errors in the 
measurement of analgesic effect. 452 In later publications, they described the 
process of instruction, which consisted in telling the subject what the endpoint 
should feellike, and of encouraging emotional detachment from the experimental 
situation by telling them not to consider this a test of endurance, nor to try to 
please or displease the operator. In addition, subjects were made to practice until 
their "estimates of pain threshold are consistent under various circumstances," at 
which point they were considered to be "trained in the analysis of the 
sensation.,,453 This training was compared to acquiring the proficiency of a 
technician in reading their own interior sensations: "The instruction given is in the 
same category as that given to a student to enable him to read an endpoint in a 
titration, or on a colorimeter, or to read a Vernier Scale.,,454 Such a subject 
produced higher quality data. Training "provide[ d] a more uniform index for 
observing the changes brought about by experimental procedures" and thus 
450 J. R. Schamp and R. M. Schamp, "Variability of the Pain Threshold in Man," Journal of Dental 
Research 25 (1946): 101-4; L. H. Lanier, "Variability in the Pain Threshold," Science 97 (1943): 
49-50. 
45\ J. D. Hardy and M. Cattell, "Measurement of Pain Threshold-Raising Action of Aspirin, 
Codein, and Meperidine (Demerol)," Federation Proceedings 9 (1950): 282; Hardy, Pain 
Sensations and Reactions. 
452 Wolff and Hardy, "On the Nature of Pain," Physiological Review 27 (1947): 167-99. 
453 Hardy, "The Nature of Pain," Journal ofChronic Diseases 4 (1956): 22-51. 
454 James D. Hardy, Pain Sensations and Reactions (Baltimore: Williams & Wilkins, 1952). 
184 
185 
lowered the threshold of significance of data: 5-10 % changes in pain intensity for 
trained subjects, in comparison with 20% or more in untrained subjects.455 
By the end of the decade, the training of subjects seems to have been fairly 
widely accepted as a feature of the standardisation of the use of the Hardy-Wolff-
Goodell method. Though striving for the highest level of automaticity and 
impersonality in their method, the designers of an improved version of the radiant 
heat apparatus admitted that they did "not feel that one can take a pers on off the 
street and make accurate observations for the comparison of one drug with 
another." Because of the subjectivity of the pain sensation, a period of 
'familiarization' with the apparatus was necessary.456 A review of analgesic 
testing methods suggested that sorne researchers' lack of success in using the 
apparatus might have been caused by a failure to train subjects. In support ofthis 
conclusion, Miller reported Gross' comments that "with training, each subject 
cornes to recognise the intensity of heat stimulus marking his threshold and that 
the threshold is very nearly the same for aIl subjects." Even rats, Miller remarked, 
had to be trained to use the procedure.457 Training provided higher accuracy, 
making it possible to economise on the number of subjects and the volume of data 
produced, while also making subjects more neutral, more precise and less 
susceptible to the influence of irrelevant information. 
Beecher, however, attacked subject-training as dangerous: "The failure to 
eliminate [trained subjects'] bias can have devastating results," wrote Beecher, 
and, though learning had to be watched for in any subject, "the hazard is far 
greater with the experienced group.,,458 A trained subject could not be properly 
blinded to the identity ofthe drug under study, and was therefore more susceptible 
to placebo effects. In the course of training, subjects came to have a vested 
interest in the outcome of the study, whether scientific, monetary or personal. 
Training, for Beecher, was the source of many biases. Only "green" and ignorant 
subjects were trustworthy. But how could the judgment of such naive subjects be 
455 Hardy, Pain Sensation, 82-83. 
456 Flinn and Chaikelis, "An Improved Instrument," 349-50. 
457 Miller, "A Critique of Analgesie Testing," 34-50 
458 Beecher, "Pain -Controlled and Uneontrolled," 167. 
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made to yield useful and accurate information about analgesic efficacy? Beecher's 
naïve subject was not, in himself, a source of precise information about pain and 
analgesia.459 Nor was he immune to suggestion and expectation. In addition, his 
experience could not be considered to be representative of the efficacy of a 
painkiller. No single individual had the authority, whether derived from training 
or the use of a particular instrument, to serve as spokesperson for the general pain 
experience, or for average analgesic efficacy. A new type of subject had to be 
created, a composite subject whose "collective pain" could be measured through 
the coordinated and controlled collection of data in a clinical setting.460 This 
happened in the late 1940s. 
5.4 Displacing the Dolorimeter: The Emergence of the Analgesie Clinical 
Trial 
Surprisingly, an increase in funding and resources for analgesic evaluation 
seems to have initiated the demise of the dolorimeter. While the synthetic 
analgesics initially attracted the interest of individual pharmaceutical firms, they 
eventually stimulated larger-scale investments of time and money into analgesic 
testing. The emergence of new interests in analgesic testing, and the re-
organisation of old ones, resulted in larger grants, given over longer periods to 
clinical researchers, thus creating conditions in which "clinical pain" could be 
made to yield reliable and consistent information about analgesic efficacy. 
Support for clinical analgesic testing was also provided by therapeutic reformers 
during a crucial period in the promotion of new methods of therapeutic 
evaluation. Though l will de scribe the emergence of the analgesic clinical trial in 
greater detail in chapter 6, l will briefly described the new forms of support for 
clinical analgesic testing that appeared in the late 1940s and which help to explain 
the displacement of the dolorimeter. 
459 The masculine is used deliberately here since 8eecher generally excluded women from his 
analgesic trials, see: 8eecher, "Experimental Pharmacology," 1 57. 
460 Keats, 8eecher and Mosteller, "Measurement ofPathological Pain," 35. 
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The potential usefulness of methadone as a substitute for opiate-based 
drugs had not gone unnoticed by the U. S. Army. World War II had raised the 
spectre of a possible "national emergency" due to the cutting off opium supplies, 
a fear that rernained present in the first years of the co Id war.46 ! During the years 
after the war, the Army and Navy Munitions Board sought definitive advice on 
the necessity of stockpiling opium, and the possibility of replacing standard 
analgesics with the new synthetics such as methadone. While the Bureau of 
Narcotics had given them advice on this point, the Surgeon General of the Army, 
R. W. Bliss stated that "professional rnilitary personnel [were] reluctant to accept 
the statements expressed by the Bureau ofNarcotics at this tirne due to the fact 
that extensive clinical and practical experience has not been obtained ... ,,462 It is 
not immediately obvious why the military insisted on obtaining clinical evidence. 
A likely reason was that they were more concerned with the general therapeutic 
value of these drugs and their acceptance by physicians and patients than with 
precise calculations of ratios of analgesic potency to addictive liability that had 
been useful in process of designing a safer analgesic. 463 
In order to obtain this "badly needed information about analgesics,,,464 the 
Medical Research and Developrnent Board (MRDB) of the U. S. Army provided 
Henry K. Beecher with funding to run his first large-scale clinical trial of the 
isorners of methadone at the Massachusetts General Hospital (MGH). This 
funding carne as part of a larger grant for the Study of Sedatives that also included 
other rnatters ofrnilitary interest such as the use ofbarbiturates for sleep and 
narcoanalysis. Further military support was given to Beecher when he expressed 
461 Minutes of the meetings of the Committee on Drug Addiction and Narcotics, successor of the 
CDA, are filled with requests from the Army for advice on its opium stockpiling policies. Military 
leaders wanted to know whether synthetic analgesics were adequate in replacing the opium-based 
standard remedies. 
462 "R. W. Bliss, Surgeon General to Dr Weed (NRC), August 5, 1947," in Bulletin of the 
Committee on Drug Addiction and Narcotics (1947): 12. 
463 This letter (R. W. Bliss, Surgeon General to Dr Weed (NRC), August 5, 1947) specifically 
asked for the opinion of the Bureau ofNarcotics on the general acceptance of the synthetic 
analgesics by the medical profession, in addition to whether this class of drugs could satisfy 
military and civilian needs in case of emergency, as weil as whether the Office should consider 
reducing its stockpile ofnatural opiates. 
464 William S. Stone to Henry K. Beecher, January 5, 1950, Beecher Papers, MS C 64, Box 22, 
Folder 15, Countway Library of Medicine. 
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an interest in conducting a field trial of these substances on the battlefields of the 
Korean War in 1950.465 
Beecher's methodological work, developed in collaboration with Jane 
Denton, subsequently received additional sources of support. Their results were 
given wide exposure and a stamp of approval by the Therapeutic Trials 
Committee of the AMA's Council on Pharmacy and Chemistry. Two articles were 
published in the Journal of the American Medical Association (JAMA) at the 
invitation of the Committee's secretary, and were prefaced with a statement 
approved by the Council that underlined the importance of their achievement. 
Denton and Beecher' s work had represented "a distinct advance in the methods 
available for quantitative evaluation of the therapeutic efficacy of [analgesic and 
narcotic drugs]." These advances were aIl the more significant since they dealt 
with a class of drugs that presented "difficulties not encountered ordinarily in the 
appraisal of other therapeutic agents.,,466 The Council's support associated 
Beecher's work to a movement oftherapeutic reform to instil specific values, and 
techniques-particularly those of the randomised clinical trial-in American drug 
testing. This movement has been described as a CUITent of elite activism for the 
promotion of a "rational therapeutics" that would be dictated by the norms of 
scientific evidence and medical professionalism, and protected against the 
excessive commercial aspirations of the pharmaceutical industry.467 Unlike the 
Army, the AMA's was interested in Beecher's methodological innovations rather 
than in the precise potency of these new analgesics. When Beecher submitted a 
report of the results ofhis field trial ofmethadone in Korea, JAMA rejected the 
article on the basis of its "limited appeal to readers" when morphine was readily 
available.468 
465 Beecher to Stone, August 15, 1950, Beecher Papers, MS C 64, Box 22, Folder 15, Countway 
Library of Medicine; Beecher to Stone, January 27, 1951, Beecher Papers, MS C 64, Box 22, 
Folder 16, Countway Library of Medicine. 
466 Walton Van Winkle Jr., "Report to the Council," Journal orthe American Medical Association 
141 (1949): 1051. 
467 Harry M. Marks, The Progress of Experiment: Science and Therapeutic Reform in the United 
States, 1900-1990 (Cambridge and New York: Cambridge University Press, 1997). 
468 Journal of the American Medical Association to Beecher, April 2, 1951, Beecher Papers, MS C 
64, Box 26, Folder 54, Countway Library of Medicine. 
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Though Beecher designed and first ran analgesic clinical trials thanks to 
military funding, this technology was further refined and diffused under 
sponsorship from the Committee on Drug Addiction and Narcotics (CDAN), the 
successor of the CDA. As l will argue in the next chapter, it was under the 
conditions provided by the Committee and its allies that the clinical trial became 
an effective and valuable analgesic testing technology. The Committee had been 
brought back to life as a response to the military, commercial and regulatory 
interests in the new synthetic analgesics. CDAN was no longer involved in 
creating new substances. It now aimed to "provide impartial advice to 
government," such as advice to the military about analgesic drug stockpiling 
policies, as weIl as to the Public Health Service (PHS) and Federal Drug 
Administration (FDA) on the addictive liability of new drugs. To fulfil this role, 
Committee members emphasised the need to sponsor the creation and use of 
analgesic testing methods, both for therapeutic efficacy and addictive liability, 
which would be used to evaluate the analgesics generated by the pharmaceutical 
industry. 
Beecher's method appeared particularly promising to the members of the 
new committee, but they knew they would have to create new alliances to fund its 
further development and sought the support of pharmaceutical firms. Indeed, at a 
meeting with key committee members, pharmaceutical industry representatives 
expressed particular interest in the development of a more reliable test of pain-
relieving efficacy in humans. However, as one representative stated, no single 
company was willing to underwrite the substantial, long-term funding it would 
take to do this.469 By pooling together the contributions from major U. S.-based 
drug companies, CDAN was able to continue funding Beecher's and others' work 
on analgesic clinical trials until the mid-1960s. 
As a clinician, and particularly as an anaesthesiologist, Beecher had also 
provided new resources for analgesic testing. As Chief of the Anesthesia Service 
469 "Minutes of Conference with Representatives of Drug Manufacturers, July l, 1949," Box 1: 
Minutes, July 1949 Conference with Representatives of Drug Manufacturers, Committee on Drug 
Addiction and Narcotics (CDAN), NASA. 
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at Massachusetts General Hospital, Beecher was responsible for its operative 
patients. This gave him ready access to a plentiful supply of subjects. Beecher 
also had the necessary authority over patient care and his staff, which included 
both a clinical and research staff, to ensure that the correct experimental drugs 
were administered according to a specific protocol. An essential means of 
controlling for suggestion and expectancy was to include placebos in the series, 
and to ensure that each drug was unknown to nurses, observers and patients. For 
this to be done properly, it was essential to obtain the cooperation ofthe staff, 
including the hospital pharmacy which prepared and labelled the doses with secret 
codes. 
Clinical trials also required the collaboration of consultants and observers. 
While previous clinical studies had relied on busy clinicians, whether nurses or 
physicians, to carry out this task, Beecher hired full-time observers. This was an 
important means of eliminating additional variation. Special observers were more 
apt to follow instructions, to accept being "blinded," to question patients 
consistently and neutrally, to follow strict schedules and to assure continuity 
between interviews. But full-time observers, whether they were technicians or 
specially-hired nurses, were not cheap. Over the years, Beecher and subsequent 
clinical experimenters would spend a large proportion of their research grants on 
the salary of their observers. 
Once large amounts of data had been collected under comparative and 
controlled conditions, it would not be intelligible until it had been statistically 
analysed. Variability in patients' experiences of pain and reliefneeded to be 
managed by a professional statistician. For this, Beecher sought the guidance of 
Frederick Mosteller, a Harvard colleague, thus helping to launch his career as one 
of the prominent pioneers of American biostatistics. Beecher also paid Mosteller 
consultant fees from his grants. Statistical expertise was required 110t only for 
manipulating results, but also for designing the method so as to pro duce data that 
would be optimal for statistical analysis. In the end, Beecher was able to attain a 
high level of quantitative precision: reporting relief in percentages and plotting 
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dose-effect curves that gave clear distinctions between the efficacy of test and 
standard analgesics. 
Beecher's clinical authority as well as his use of paid full-time staff and 
consultants allowed him to standardise clinical testing conditions to a greater 
extent than the CDA clinical studies of the late 1930s. In addition, Beecher began 
his studies in a single site, and the diffusion ofhis technology to multiple sites 
was slower and more tightly controlled than either the CDA clinical studies or the 
use of the dolorimeter. Thus, as these new resources became available for clinical 
analgesic evaluation in the late 1940s, new techniques for controlling pain and its 
measurement became possible. Beecher was able to show that the clinic and its 
supplies of suffering could be brought under experimental control. The gap 
between animal experimentation and clinical studies, into which the Hardy-Wolff-
Goodell dolorimeter had fit so well, began to narrow. 
Conclusion 
The faults Beecher imputed to the dolorimeter must be situated in the context of 
this story about how various groups demanded, supported and operated methods 
to measure pain and evaluate analgesics from the mid-1930s to the early 1950s. 
Not only did the dolorimeter correspond to requirements and values of earlier 
sponsors, but it is clear that the resources that were necessary to develop and 
implement a method such as Beecher' s were not made available before the late 
1940s. Beecher benefited from new sources of support for analgesic testing-the 
Army and the AMA' s Council on Pharmacy and Chemistry-who expected 
different things from pain-measuring methods than had previous sponsors. While 
the CDA and pharmaceutical companies in the 1930s and1940s needed rapid and 
precise information to guide pharmacological innovation and addictive liability 
testing, the Army wanted to know whether methadone would be accepted as a 
morphine substitute by those who would use it to relieve pain, and the AMA 
wished to ensure that analgesic drug evaluation would be controlled by rational 
principles and by clinical researchers. 
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When the CDAN was reconvened in the late 1940s, its focus was no 
longer on pharmacological innovation but rather on methodological innovation in 
drug testing. The Committee also had to develop a new funding mechanism, and 
sought the support of those who were then willing to invest in better methods of 
analgesic testing: pharmaceutical firms. Through the Committee, contributions 
from industry were combined into larger chunks and channelled towards 
promising, if expensive and time-consuming projects such as Beecher's. Beecher 
himself also made new resources available for analgesic evaluation: an 
anaesthesia research laboratory, access to an abundant source ofpost-operative 
patients, and a team of cooperative staff and consultants. 
In the early to late 1940s, and then in the late 1940s to 1950s, two 
different configurations of money, research settings, experimenters, subjects, 
expertise, and demands for specifie types of information, favoured two different 
types of analgesic-testing technologies. The Hardy-Wolff-Goodell dolorimeter 
was weIl suited to the production of relatively cheap but low-volume data using 
few subjects. The method offered results that were highly precise at the level of 
the individual through the exercise of a focused type of psycho-sensory control on 
the evaluation of pain through instrumental means. By contrast, Beecher's 
analgesic clinical trial produced high volumes of relatively expensive data. It 
exercised collective control through procedural and statistical means that 
depended on money and rules, as weIl as the authority to enforce them, targeted 
towards the coordination of labour. 
By controlling the evaluation of pain relief in different ways, each method 
was designed and operated with a different notion of what pain was, and 
especially of how the experience of pain was susceptible to experimental 
variables and experimental interventions. 470 lndeed, an important issue in the 
470 Davis Baird, Thing Knowledge: A Philosophy ofScienttfic ~nstruments (Berkeley: University of 
California Press, 2004), 67-88; W. D. Hackmann "Scientific Instruments: Models of Brass and 
Aids to Discovery," in The Uses of Experiment, 31-65, makes a distinction between passive and 
active instruments, the former being instruments that measure naturally occurring phenomena, 
while active ones produced nove1 ones; J. A. Bennett, "A Viol ofWater or a Wedge of Glass," in 
The Uses of Experiment, 105-114, criticizes this distinction by pointing out, using the barometer as 
an example, that many "passive" instruments interact with theory. He concludes that such a 
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debate between the Comell and Harvard teams concemed the "true" nature of 
pain. As we have seen, Hardy, Wolff and Goodell maintained that the experience 
of pain could be divided, in theory but a/sa in practice, into sensation and 
reaction. While the reaction of pain was modulated by the idiosyncratic 
characteristics of the experiencing subject-personality, past, emotional status, 
interpretations-the sensation of pain was stable. Pain sensation was 
conceptualised as a straightforward trajectory of impulses travelling from the 
stimulus through the sensory apparatus to the perceiving subject. In this model, 
the intensity of stimulation bore a stable relationship to perceived intensity. That 
is, as long as "reactive" elements were eliminated though the use of an 
appropriate stimulus as well experienced, self-disciplined subjects, and given a 
normal sensory apparatus, equally sensitive to any other set of normal nerves.471 
Beecher, however, argued that pain was indivisible at the level of 
experience. The "reaction" to painful stimulation began as soon as the organism 
was processing sensory information, and thus preceded conscious awareness of an 
experience of pain. Thus, the essential sameness of pain sensation in different 
subjects was theoretical, while the inevitable reaction was, for Beecher, "never 
alike for any two individuals and, indeed, with the passing oftime and 
accumulation of life experience, is never exactly the same for the same individual 
from one time to another.,,472 This idiosyncratic reaction was thus an unavoidable 
and ev en crucial component of any experience worth calling "pain." The 
dolorimetric pain threshold, as Beecher saw it, was in reality a mixture of 
sensation and reaction that paraded itself as pure sensation, and thus was both 
distorted and misleading. To find true pain, one had to look for it in its natural 
habitat: the patient who was suffering from an injury or disease. Dolorimetric pain 
was neither a representative model of this pain nor a discrete component of it, and 
thus there was no justification for its use in analgesic testing. Especially since, as 
distinction isn't useful, and that the taxonomies in use during the historical period being studied 
should be preserved by the historian. 
471 The implications of the Comell team's method for their model ofpain can be best discemed 
from: Hardy, Pain Sensations and Reactions. 
472 Beecher, "Limiting Factors in Experimental Pain," Journal ofChronic Diseases 4 (1956): 11-
21. 
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Hardy, Wolff and Goodell themselves had argued, analgesics seemed to act 
largely on the reaction rather than the sensation of pain.473 
Hardy, Wolff and Goodell's method intervened in the subject's experience 
of pain through the manipulation of the stimulus, but Beecher argued that there 
was no direct or predictable correlation between intervention and experience. 
There were simply too many factors that could influence the experience of pain, 
least of which was the intensity of stimulation. Indeed, Beecher firmly rejected 
the princip le of proportionality between the severity of injury or the intensity of 
stimulation and the intensity of the pain experience.474 
It has been suggested that Beecher adopted this position as a response to 
his observations during World War II.475 In the course ofhis military service, 
Beecher had noticed that many badly wounded soldiers refused morphine and 
denied experiencing pain. He concluded that strong emotion, rather than any 
modification of sensitivity, accounted for the disproportionality between the 
intensity of pain and the severity of the wound.476 There are other reasons why 
ideas about pain might have been changing in analgesic evaluation. The shift fr~m 
the psycho-physiological notion of pain advocated by Hardy, Wolff and Goodell 
to Beecher's more emotional, holistic and idiosyncratic 'clinical pain' seems to 
have announced a broader theoretical shi ft in the conceptualization of pain from 
mechanistic schemas to more cognitive, integrative and individualised ones. The 
roots of the se new models of pain have been linked back, for example, to the 
clinical work of William K. Livingston and John J. Bonica with chronic pain and 
nerve-injured patients during and after World War II, Bonica's model of the 
interdisciplinary pain clinic that he described in the 1950s and implemented in the 
473 Wolff, Hardy and Goodell, "Studies on Pain: Measurement ofthe Effect of Morphine," 659-
680. 
474 Keats, Beecher, and Mosteller, "Measurement of Pathological Pain," 35. See also: note 25 of 
this chapter. 
475 Meldrum, "Each Patient His Own Control,"; "'Departures from the Design' ,"287-288. 
476 Though the specifie explanation given by Beecher was later replaced by reference to the action 
of endogenous opiates (such as endorphins), this study would often be cited by researchers who 
sought to reform conceptions of pain by pointing out that sensory-physiological events were only 
a small, sometimes insignificant part of the total subjective pain experience. 
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1960s, and the publication by Ronald Melzack and Patrick Wall of the gate-
control theory of pain in 1965.477 
The way in which pain was defined for and by the analgesic clinical trial 
participated in these broader shifts, drawing on, but also actively contributing to 
new models of pain.478 Beecher did not simply argue that his was a more realistic 
definition of pain than Hardy, Wolff and Goodell's; he also made it manageable 
for analgesic experimentation and thus made the more mechanistic definition no 
longer useful in this context.479 The idea that pain was subjective, emotional and 
idiosyncratic was news to no one, especially not to the Cornell team researchers, 
who were active in psychosomatic research on stress, emotion, pain and disease in 
the 1940s and 1950s. This idea predated the analgesic clinical trial, and even the 
wartime observations ofBeecher, Bonica and Livingston. But the idea that such 
an experience could be measured reliably and objectively without being reduced 
to something simpler, without being transformed into a more predictable and less 
personal phenomenon, was indeed new. It was a product of the successful use of 
477 A good description ofchanging conceptions ofpain in theory and therapy is given by Isabelle 
Baszanger, Inventing Pain Medicine From the Laboratory to the Clinic (New Brunswick, N.J: 
Rutgers University Press, 1998). See also original works by these key clinicians and scientists: 
William K. Livingston, "What Is Pain?" Scientific American 196 (1953): 59-66; Livingston, Pain 
Mechanisms: A Physiologie Interpretation ofCausalgia and ifs Related States (New York: 
MacMillan, 1944); John J. Bonica, The Management of Pain With Special Emphasis on the Use (){ 
Analgesie Black in Diagnosis, Prognosis, and Therapy (Philadelphia: Lea & Febiger, 1953): 
Bonica defined a new clinical entity, chronic pain, which was characterised not only by its 
duration but by its psychological components, which developed over time ev en if the pain had a 
physical origin. This type ofpain affected the whole person and thus required a multidisciplinary 
clinicat approach in a team including psychologists and psychiatrists; Ronald Melzack and Patrick 
Wall, "Pain Mechanisms: A New Theory" Science 150, no. 699 (1965): 971-979, this theory of 
pain drew on a more dynamic and integrative model of the nervous system, in which pain signaIs 
could be modulated at various levels before they reached consciousness. Thus, factors such as past 
experience, meaning, interpretation, emotion, etc. could act on the transmission of impulses in the 
nervous system and thus determine what information reached the brain to be perceived as ' 
478 1 made a similar argument in the preceding chapter, arguing that new techniques for measuring 
psychosomatic relations made it possible to measure new kinds of responses to pain, and thus to 
redefine pain. The analgesic clinical trial also redefined what counted as measurable pain in a 
similar way, giving emotions, psychosomatic processes, as weil as individual pasts and 
psychological make-up greater importance in the pain response. However, while the techniques 1 
described in the previous chapter attempted to isolate and correlate these variables, in the 
analgesic clinical trial they were controlled without being specified in order to make the 
measurement of analgesic effect more valid. 
479 Keats, Beecher,and Mosteller, "Measurement of Pathological Pain,"35. 
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specific technologies of data collection and analysis, of practices that depended on 
certain kinds of authority, as well as material and human resources. 
Beecher' s ri ch conception of pain not only justified the analgesic clinical 
trial but was also justified by it. To Beecher, the factors that made every 
experience of pain different-emotion, interpretation, memory, attention-were 
too numerous, too constitutive of the very experience of pain, and of its relief, to 
be eliminated at the level of the individual. Yet, this variability proved itselfto be 
regular in the bird's eye view. When data was carefully collected, under 
comparative conditions, from large numbers of ignorant patients, by meticulous 
and constant observers, and then expertly analysed, it revealed regular patterns.480 
The distribution of clinical data on analgesic efficacy was normal. It clearly 
distinguished between placebos and active drugs. And, as it turned out, it was 
reproducible. 
The persisting search for cheaper laboratory-based analgesic testing 
methods would seem to confirm a link between operational definitions of pain and 
the costs of testing practices. Controlling the evaluation of clinical pain relief was 
expensive and time-consuming, and researchers, including sorne who had strongly 
advocated analgesic clinical trials, did not abandon hope of developing effective 
laboratory-based pain-measuring techniques. Even Beecher, who had declared 
experimental pain to be incommensurable with clinical pain in the early 1950s, 
sought, in the 1960s, to recover a form of experimental pain that could be more 
easily controlled and manipulated for analgesic testing. The method he developed 
was a tourniquet pain test, in which the "normal" subject was required to perform 
a certain amount ofwork with muscles to which the blood supply was cut off. 
This induced an experience of pain which, because it was sustained and included 
an element of anxiety, more successfully mimicked clinical pain. But it was not 
clinical pain: It could be produced and manipulated predictably under laboratory 
conditions, at an individuallevel, in normal subjects. 
Such as test was important, Beecher explained in 1966, because: 
"practically, there is great need for a method of appraising in man, conveniently 
480 Louis Lasagna, "The Lawfulness ofClinical Pain," Federation Proceedings 20 (1961): 309. 
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and accurately, the effectiveness of new pain-relieving agents. There is great need 
for a method which will not require the tedious use of pathological pain. Thus, the 
present findings appear to have wide usefulness to the pharmaceutical 
industry.,,481 Conscious ofthe realities of the social and material conditions of 
analgesic testing, and of the demand for quicker, cheaper methods, Beecher had 
been willing to attempt to redefine what counted as an acceptable and measurable 
pam. 
48l Beecher, "Pain: One Mystery Solved," Science 151 (1966): 840-841. 
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6. Working with Clinical Trials: the Committee on Drug Addiction 
and Narcotics and the Measurement of Analgesie Effect, 1947-1965. 
By the late 1940s, the possibilities offered by fully synthetic analgesics, such as 
Demerol and methadone, had awakened new hopes, and new worries. 
Pharmaceutical manufacturers were attracted by the possibility of lucrative new 
products. The dream of a more effective, less addictive analgesic continued to 
animate medical, public health and drug enforcement circ1es. Hoping to eliminate 
the need to stockpile opium in the eventuality of national emergencies, the 
Surgeon GeneraIs of the Army and Navy began pressing the Bureau ofNarcotics 
and the National Research Council for reliable information on the efficacy of 
synthetics.482 Sorne groups responded to this enthusiasm with caution: Elite 
physicians, public health officiaIs and regulatory agencies were concerned that the 
market might be flooded with badly tested drugs of dubious efficacy and 
unknown addictive liability.483 
Under pressure to respond to these concerns, the National Research 
Council (NRC) decided to re-establish a committee to deal with narcotics 
research. The former Committee on Drug Addiction (1929-1940), which had been 
maintained as a relatively inactive advisory committee during the war, was 
revived in 1947 as the Committee on Drug Addiction and Narcotics (CDAN). Its 
initial membership was composed of a core group of elite research 
482 "R. W. Bliss (Office of the Surgeon General) to Dr. Weed (NRC), August 5, 1947," Bulletin of 
the Committee on Drug Addiction and Narcotics (1947), 12; "Dr. Swanson (Office of the Surgeon 
General of the Navy) to Dr. Weed (NRC), August Il,1947,'' Bulletin of the Committee on Drug 
A ddiction and N arcotics (1947), 15. 
483 "Minutes of Conference with Representatives ofDrug Manufacturers, July l, 1949," Minutes, 
CDAN, NASA: ln his introduction to the meeting, Isaac Starr described the function of the 
Committee as giving impartial advice to govemment. Recently, however, the activities of the 
committee had expanded because, as Starr explained: "For example, the govemment is confronted 
with the problem ofaddictive drugs. The market is likely to be flooded with a large number of 
addiction-producing derivatives. The Bureau ofNarcotics consulted the Committee and as a 
results a program for the testing of the narcotic liability of drugs was initiated. This has proved to 
be a service, the Chairman pointed out, both to industry and government. It is in connection with 
this extension of interest that this meeting was called." 
See also, "Minutes of the 1 st Meeting," Bulletin of the Committee on Drug Addiction and 
Narcotics (1947),6. 
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pharmacologists.484 Among these were the Committee's new Chairman, Isaac 
Starr, Professor of Therapeutic Research at the University of Pennsylvania 
Medical School, and its secretary Nathan Eddy, now Principal Pharmacologist at 
the NIH. The Committee was completed by the Chief of the Laboratory of 
Chemistry of the NIH, the Assistant Chief of the PHS Division of Mental 
Hygiene, the Director of the Public Health Research Institute of the City of New 
York and the U. S. Commissioner ofNarcotics. 
In 1947, the members of CDAN met for the first time, in the company of 
representatives of the U. S. Army and Navy, the NRC, the FDA, the American 
Drug Manufacturers' Association and the AMA's Therapeutic Trials Committee, 
to discuss the future of narcotics research and the function of the new Committee. 
One of the principal topics of discussion at this meeting, and subsequent ones, 
was the evaluation of drug safety and efficacy. How could the Committee keep 
tabs on the industry's activities and provide the necessary guidance to ensure 
objective and accurate testing of new narcotics? Manufacturers, it was agreed, 
should be requested to provide information about new narcotics to the Committee. 
It also seemed important to advise manufacturers on where, and by whom, 
narcotics testing could be done competently. 
At the following meeting, however, discussion shifted from the selection 
of competent investigators to the lack of reliable methods for testing narcotic 
drugs. It became c1ear that, in order to fulfil its function as an advisory committee, 
CDAN would have to lead a quest for new drug testing methodologies. While 
addiction-liability testing was still an important concern, the evaluation of pain-
relieving efficacy stood out as a particularly thorny problem. CDAN members 
agreed that the Hardy-Wolff-Goodell dolorimeter was inapplicable to large 
groups of subjects. A more promising option for analgesic testing was Henry K. 
Beecher's work on the analgesic clinical trial, begun under army funding at the 
484 These included: Isaac Starr, Raymond N. Bieter, Nathan B. Eddy, and Maurice H. Seevers. 
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Massachusetts General Hospital (MGH).485 Beecher's funding, however, was 
about to run out. 
After considering various potential sources of funding this quest, CDAN 
turned towards the pharmaceutical industry.486 Eddy invited industry 
collaboration in an article published in Drug and Allied Industries, in which he 
emphasised that pharmaceutical firms should be interested in sponsoring narcotics 
research for their own benefit.487 The mutual interest of industry and CDAN in 
analgesic testing methodologies was confirmed: In a letter to Eddy, Edward 
Henderson, of the Schering Corporation, expressed his interest and suggested that 
a common fund be established with the collaboration of other pharmaceutical 
firms. 488 Months later, a meeting was held between key members of CDAN and 
twenty representatives of the pharmaceutical industry.489 Industry representatives 
saw analgesic measurement as a crucial issue but also as an expensive 
proposition. According to the meeting's minutes, Dr. Spoor of Bristol-Myers 
Laboratories stated that: "there is no adequate test ... for analgesic action of a drug 
485 See previous chapter for more information about Beecher, and how he first developed his 
clinical trial methodology under army funding. 
486 Among other possible sponsors considered by committee members were the National Institutes 
of Health (NIH), the Bureau ofNarcotics, the Research Grants Division of the NRC, the American 
Society of Anesthetists, and a new "Analgesic Foundation.,,486 They managed to get sorne 
temporary NIH funding, but apparently could not get it renewed. See: "Minutes of the 2"d 
Meeting," Bulletin of the Committee on Drug Addiction and Narcotics, 25. 
487 Nathan B. Eddy, "Cooperation in Narcotics," Drug and Allied Industries (1949), in which he 
explained the nature ofCDAN and asked pharmaceutical firms to seek advice from, as weil as 
provide data to, CDAN, and also proposed the constitution of a research fund for projects on 
analgesia. 
488 "Minutes of Conference with Representatives ofDrug Manufacturers, July l, 1949, Appendix 
A: Edward Henderson to Eddy, April 6 1949," Minutes, CDAN, NASA: Henderson, of the 
Schering Corporation, shared with Eddy the difficulties faced by the pharmaceutical industry in 
doing research on analgesics, ofwhich "one of the most remarkable difficulties in this field is the 
absence of a reliable measure of pain response in man." Henderson also added that: "the budget 
proposed for the study of analgesics through the NRC does not appear large. It is possible that the 
only way in which basic studies (such as determining the laboratory measure most closely 
corresponding to clinical analgesia) could be supported is by contributions to such a common 
fund." 
489 "Minutes of Conference with Representatives of Drug Manufacturers, July l, 1949," Minutes, 
CDAN, NASA: in attendance were representatives from the American Drug Manufacturer's 
Association, Winthrop-Stearns, E.R. Squibb and Sons, Sharpe and Dohme, Schering Corporation, 
Shenley Laboratories, Parke Davis and Co,. New York Quinine & Chemical Works, Merck 
Research Institute, Maltbie Chemical Co., Lilly Research Laboratories, Ciba Pharmaceutical Co" 
Burroughs-Wellcome & Co., J. T. Baker Chemical Company, and Bristol Laboratories. From 
CDAN, were present its chair, Isaac Starr, its secretary, Nathan B. Eddy and one of its members, 
Lyndon Small, chemist 
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in man ... but his company alone cannot afford the basic research necessary to 
develop such a test which he estimated would require the expenditure of perhaps 
$50,000 per year over a ten year period." 490 This statement was echoed by other 
meeting participants who, while they recognised the importance of improving 
addiction-liability testing, gave analgesia assessment a higher priority. And they 
clearly identified analgesic research in humans to be more meaningful, even if 
potentially more expensive, than tests in animaIs: a vote came out 7-3 in favour of 
human studies. Wasn't it possible to get the Public Health Service to fund these 
studies, enquired the representatives of Shenly Laboratories and of Sharpe and 
Dohme? The PHS had turned down the projects recommended by the Committee, 
said Eddy, and the Committee didn't have sufficient funds to support potentially 
promising research programs. If the pharmaceutical industry wanted to bene fit 
from these studies, they would have to take matters into their own hands. 
So, at a time when public institutions refused to fund the se projects, the 
Committee was able to tap into industry interests in order to fund analgesic drug 
evaluation. And, while individual companies were unwilling to fork out sums 
sufficient to make these projects viable, CDAN channelled their contributions into 
a combined pool to be administered as research grants. Pharmaceutical companies 
would bene fit by obtaining new methodological tools, but also by associating 
themselves with the neutrality and prestige of the National Research Council. 
From 1950 to 1960, pharmaceutical firms provided the entirety of CDAN's 
research budget, and continued to contribute a significant amount-ranging from 
$73,125 to $ 198,225-until 1970.491 From 13 contributing firms in 1950, the 
number grew to 51 in 1970. Contributions from the Office for Civil Defense 
(OCD) and the Veterans Administration (VA), motivated by the specific interests 
of these organisations in analgesic drug development, would later be added to 
CDAN's grant fund. At least eight principal investigators and their teams were 
provided with grants from these funds to work on analgesic testing methodology. 
490 "Minutes of Conference with Representatives ofDrug Manufacturers, July 1, 1949," Minutes, 
CDAN, NASA. 
49\ Nathan B. Eddy, The National Research Council lnvolvement in the Opiate Problem, /928-
/97/ (Washington, D. C. : National Academies of Science, 1973), 164, Appendix 3, Table 3. 
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Beecher's experimental model-a variant of the randomised clinical trial (RCT) 
design-was adopted, adapted and standardised for the evaluation of new 
analgesic drugs. The alliance forged between the Committee, its sponsors and its 
grantees would shape the future of American analgesic evaluation. 
ln this chapter, 1 will examine how analgesic clinical trials were designed 
and implemented under CDAN sponsorship and discuss the implications ofthis 
case for the history of pain-measuring technologies. 1 suggest that the networks 
created by CDAN's alliances and activities, through which funding and 
information were mobilised and distributed, were crucial for making the clinical 
trial into an effective technology of analgesic evaluation. 1 will show this by 
identifying ways in which various types of resources were obtained, exchanged, 
combined and manipulated by committee members and their allies (sponsors, 
grantees, and their research teams) in order to make the analgesic clinical trial 
produce better-more valuable, accurate and trustworthy-results. The focus of 
my analysis is on the interaction between the social and material organization of 
experimental practice, and the epistemological validation of the analgesic clinical 
trial. 
This analysis operates on three levels: First, 1 look at the relationships of 
mate rial exchange, communication, trust and authority among the different 
actors-sponsors, members, and grantees, their research subjects and 
collaborators-who participated in CDAN's quest for better analgesic-testing 
technology. Each ofthese actors contributed something towards this goal: time, 
money, skills, labour, ideas, ambitions ... What motivated them to make such 
investments? How were these resources valued, combined and translated into 
practice? My second focus is on the experimental practices by which analgesic 
testing technologies were implemented and improved. In particular, 1 have tried to 
identify ways in which material conditions and social interactions shaped the 
experimental practice of analgesic clinical trials. Finally, 1 point out the ways in 
which experimental practice contributed to the validity of clinical trial results. 
Why is this case study interesting? First, the CDAN-sponsored analgesic 
clinical trial was an early-and rare-success story in the history of pain-
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measurement and analgesic evaluation. As we saw in the previous chapter, the 
success of the Hardy-Wolff-Goodell dolorimeter was short-lived. And, as the next 
chapter will show, it proved extremely difficult in other contexts for people to 
agree on how pain-relief should be measured and what counted as a valid 
experiment of pain-relieving therapeutic efficacy. How, then, were CDAN 
grantees able to make the analgesic clinical trial work? l suggest that the key in 
answering this question is to pay attention to the collective nature of the effort that 
went into making this technology work, and to examine how the interaction 
between various actors shaped its practices and results. Analysing the social 
relations of the analgesic clinical trial is thus relevant to one of my central 
concems in this thesis: Under what conditions can-and has-pain become 
measurable? In addition, CDAN-sponsorship of analgesic evaluation represented 
an unprecedented, even if relatively modest, financial investment in research on 
pain and its relief.492 To improve the efficacy oftheir methods, CDAN grantees 
investigated how experiences and expressions of pain were influenced by 
different.variables, such as anxiety, conditioning and suggestion. They thus 
produced new kinds of knowledge that reinforced, and added precision to, a 
model of pain as an emotional experience that was person-and context-
specific. Somewhat paradoxically, the n, efforts to make the analgesic clinical trial 
more objective seemed to depend on defining experimental subjects as thinking 
and feeling beings who participated in the production of experimental data. 
CDAN sponsorship of analgesic clinical trials is also an important episode 
in the history of clinical trials in the U. S. Indeed, it was one of the earliest, 
though certainly not the largest-when compared to the large, publicly funded 
trials of antibiotics and cancer chemotherapy_493investments into the 
492It has been said that the first substantial grants for pain research were not al\ocated until the 
1970s. See: Isabelle Baszanger, lnventing Pain Medicine: Fram the Labaratary ta the Clinic. New 
Brunswick, N.J: Rutgers University Press, 1998,63. Pain researchers have continued to complain 
that this area is underfunded. While CDAN grants were not large or specifically earmarked for 
research on pain, they nevertheless show that pain research was indirectly funded before the 
1970s. 
4930n the NRC's study ofpenicillin and the Veteran's Administration's study ofstreptomycin, see: 
Harry M. Marks, The Pragress of Experiment: Science and Therapeutic Reform in the United 
States, 1900-/990 (Cambridge and New York: Cambridge University Press, 1997), 98-128. On 
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implementation ofrandomised controlled clinical trials (ReTs). This case study 
can thus help us understand how and why the ReT became a widely used 
technology in the U. S. during the post-war decades. Historians have already 
explored sorne of the reasons for this. In particular, Harry Marks' study of clinical 
experimentation in the U. S. has emphasised the role of "therapeutic reformers" in 
pushing for more rigorous methods of therapeutic evaluation. What united these 
reformers was a shared belief in the value of experimentation, and a mistrust of 
commercial motivations, as a guide for medical practice. In the second half of the 
20th century, the ideal source of scientific authority promoted by these reformers 
shifted from the judgment of experts to the impersonal methods embodied by the 
ReT. 
Marks' detailed study of one of the first major ReTs in the U. S.-the 
VA's evaluation of streptomycin-is useful for understanding how it became 
possible to implement this technology during the post-war years. This case, Marks 
points out, emphasises the opportunity created by the wartime reorganization of 
scientific research for elite researchers to put their vision of methodological 
reform in action. This reorganisation centralised the coordination and funding of 
research activities, thus making it possible to control them on a large scale. Once 
completed, this large cooperative trial was used as a model by reformers for future 
drug evaluation. While this trial may indeed have been influential in the early 
development of ReTs, as Marcia Meldrum has shown, early trials varied widely 
in their sponsorship, designs, and rationales, as well as in the types of resistance 
they encountered, depending on the nature of the therapy being tested and on the 
social setting in which the therapy was developed and tested. This suggests the 
importance of obtaining knowledge about a variety of conditions under which the 
ReT emerged, to which 1 propose to contribute. In addition, as Marks and 
Meldrum have pointed out, ReTs were expensive, time-consuming, required the 
early chemotherapy trials sponsored by the Cancer Chemotherapy National Service Center of the 
National Cancer Institute, see Ilana Lowy, Between Bench and Bedside (Cambridge, MA and 
London: Harvard University Press, 1996),43-68. 
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cooperation of its numerous participants and authority over their activities.494 It 
seems important, then, to pay attention to the different social and material 
arrangements underlying the practice of these early clinical trials. 
Finally, in this case, RCT methodology was developed and promoted for a 
very particular purpose: to measure subjective drug effects. As we will see, this 
goal gave RCT methodology a distinctive rationale and value, while its 
implementation required different kinds of efforts and adjustments than it did 
when it was used to evaluate therapies that had outcomes that could be measured 
"objectively" with machines (blood pressure, for example) or were much more 
definitive (such as death). Beecher and his colleagues were able to show that it 
was possible to measure subjective drug effects in an objective manner without 
transforming what they were measuring-in this case pain-into something less 
subjective. They also argued that it was possible to render drug evaluation 
, objective in the absence of mechanical instrumental technologies for controHing 
variables or collecting data (though data analysis was mechanised usirig computer 
programs in the 1960s). The objectivity of their technology depended almost 
, entirely on procedural rules to mediate the interaction between experimenters and 
experimental phenomena. This makes the analgesic clinical trial an especially 
interesting case for the study of the collective nature ofknowledge-production, 
and particularly of how the social relations of experimental practice were 
managed to pro duce objective experimental knowledge, or, as Steven Shapin has 
put it, how "social theory [is] made manifest as epistemology.,,495 The socio-
epistemic model ofthe'analgesic clinical trial would become a model for the 
evaluation cif the effects of psychotropic drugs, a class of drugs that would 
mushroom in the 1950s and 1960s, while it also set a precedent for future clinical 
pain assessment. 
494 Marks, The Progress of Experiment; Marcia L Meldrum '''Departures From the Design': The 
Randomized Clinical Trial in Historical Context, 1946-1970," (PhD Dissertation, Department of 
History, State University of New York at Stony Brook, 1994). See also the previous chapter. 
495 Steven Shapin, A SocialHistory ofTruth: Civility and Science in Seventeenth-Century England 
(Chicago: University of Chicago, 1994),359. . 
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This chapter centres on four sets of relationships. First, 1 will de scribe how 
the Committee created alliances, on which the success of its research pro gram 
depended, with investigators whose professional status and ambitions made them 
willing and able to work on analgesic testing methodology. Who were these 
investigators? What ambitions, expertise and work did they bring to analgesic 
evaluation? Focusing on the careers of sorne of the principal CDAN grantees, 1 
will show that the Committee was able to support, and tap into, contemporary 
professional resources and aspirations in making the analgesic clinical trial a 
successful technology. 
Principal investigators did not work alone. T 0 operate and improve the 
analgesic clinical trial, investigators were assisted by a team of assistants, 
consultants and observers, while they also relied on the cooperation of hospital 
staff and patients. As Steven Shapin has shown, in order to fully understand the 
collective nature of experimental knowledge-production, historians (and 
sociologists) must uncover the "epistemic role support personnel" which is often 
written out of, or at least undervalued in, public records of experimental practice. 
For example, Shapin has shown that Robert Boyle's 1 i h century experimental 
observations were presented, publicly, as the testimony of a "free and independent 
gentleman" ofhis direct unmediated experience of "nature." It was on the basis of 
these qualities that Boyle claimed the trustworthiness of his knowledge. In 
practice, however, Shapin argues that it was often Boyle's paid assistants who 
mediated this access to experience, and it was Boyle's trust in them that ensured 
the reliability of experimental results. The "trust relationship" between 
experimenter and assistant that was necessary for this collective production of 
knowledge was then erased from public presentations of experiments.496 
Likewise, the design of the analgesic clinical trial was presented as the bearer of 
objective data, but the reliability ofthis data, in practice, also depended on the 
labour, skills, judgment and knowledge of the people who produced il. 1 have 
tried, in this section, to make the "epistemic role" and work of each group of 
clinical trial participant as visible as possible. 1 will examine the tasks assigned by 
496 Shapin, A Social History, 355-407. 
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investigators to their collaborators, the strategies they developed to ensure that 
collaborators performed their tasks correctly, and the ways in which each group's 
work was seen to contribute' to the results of analgesic evaluation. 
As we,ve already seen, committee members created an alliance with 
various sponsors, particularly pharmaceutica1 firms, in order to obtain funding for 
the deve10pment of analgesic testing methodology. In my third section, I will 
examine how CDAN members mediated the relationship between sponsors and 
grantees through the attribution of research funding. These groups had different 
ideas of what constituted worthwhile research for improving analgesic evaluation. 
Their negotiations shaped a research pro gram that was open to methodological 
explorations and innovations that did not necessarily have immediate practical 
applications. As a result, the analgesic clinical trial was not just worked with, but 
a1so extensively worked on. 
In the last section ofthis chapter, I will describe how CDAN mediated the 
relationship between different research teams who operated analgesic clinical 
trials. Initially provided only to Beecher's team, CDAN grants for analgesia 
research were extended to two other research teams in 1955, and two more in 
1958. By 1962, a multi-site cooperative study of analgesics was established in 
hospitals of the Veteran's Administration. CDAN facilitated the diffusion of 
information and expertise between research teams, and encouraged the 
development oftools to help make practices of analgesic evaluation more uniform 
and their results comparable. The successfu1 diffusion of methodological models 
to new research sites helped to va1idate this technology, whi1e also making it more 
productive in providing larger volumes of data to sponsors and regulators. 
6.1 A New Kind of Pharmacology: CDAN and its Grantees 
Who were CDAN's grantees? Several, such as Henry K. Beecher, Louis Lasagna 
and Raymond Houde, were pioneers in their specialties-anaesthesia and clinicat 
pharmacology-as well as in clinica1 therapeutic experimentation. Within their 
biographies, research sponsored by CDAN converged with campaigns to promote 
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new approaches to therapeutic evaluation, aspirations to expand the breadth of 
professional opportunities, and agendas to establish new programs of research and 
training. Through its contracts with its grantees, the Committee subsidised, and 
also tapped into, these professional ambitions. CDAN grantees obtained funding 
to expand their research activities and pro duce persuasive results, which they used 
to campaign for new kinds of researchand training. They also helped to recruit 
and train competent investigators who would contribute their expertise to 
CDAN's program. They had access to research facilities and abundant sources of 
experimental subje,cts, and were able to combine CDAN grants with other sources 
of public and private funding. 
The man initially chosen for the job of making analgesia measurable was 
Henry K. Beecher. The men who assigned him this job saw it as a difficult, 
important, but also as a fairly tedious one. Would Beecher have what it took, they 
wondered? Why would Beecher, or any assistant who had any "spark," be 
interested in taking up such a "dull job," asked Isaac Starr? 497 Philip Owen, 
executive officer of the NRC, agreed that the "touch of genius ( ... ) required to 
solve the problem of assessing the effect of analgesics in man [was] not likely be 
found in the routine operations of a Department of Anesthesia. ,,498 Indeed, in 
1949, anaesthesia was not likely to be perceived as a thriving field of cutting-edge 
medical research. Yet, perhaps what made Beecher the right man for the job were 
his ambitions for the future of this field. While Beecher agreed that analgesic 
testing was "painstaking and tedious work," he was willing-and encouraged 
others-to invest in what he insisted was "a costly field, but one that promises to 
yield on cultivation an astonishingly rich harvest. ,,499 
By examining Beether's career and his campaign to promote both 
anaesthesia research and clinical therapeutic experimentation, it is possible to 
understand how his involvement with CDAN fit with his professional aspirations. 
497 Starr to Eddy, July 13, 1949, Box 2: General, 1947-June 1959, CDAN, NASA, 
498 Philip Owen (NRC) to Starr, July 20, 1949, Box 2: General, 1947-June 1959, CDAN, NASA. 
For Eddy's agreement, see: Eddy to Starr, July 22,1949, Box 2: General, 1947-June 1959, CDAN, 
NASA. 
499 Henry K. Beecher, "Experimental Pharmacology and Measurement of the Subjective 
Response," Science 116 ([952):162. 
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A good question, asked by his former colleagues and collaborators in a memorial 
article, is: Why, "in the days when anesthesia afforded little professional 
prestige," had Beecher accepted the position of Chief of Anaesthesia Service at 
the Massachusetts General Hospital? Beecher had been headed for a career in 
surgery when his mentor, the Chief of Surgery, Edward Churchill, suggested he 
take up the post in 1936. The memorializing authors offered: "perhaps his far-
sighted unconventional mind recognised the potential for a bright future when 
others did not.,,500 In another biographical piece, a former colleague suggested 
that: "Beecher was receptive to the idea, seeing anesthesiology as an untapped 
laboratory for physiologie and pharmacologie researeh."sol 
lndeed, upon taking up his post, Beecher began searching for ways to 
develop an anaesthesia research program. One of the first things he did was to 
create the Anaesthesia Laboratory of the Harvard Medical School at the 
Massachusetts General Hospital. This "laboratory" enabled Beecher and his 
collaborators to mark their published papers with the stamp of anaesthesia 
research instead of affiliating themselves with the Department of Surgery, of 
which they were dependent. 502 Having studied physiology for a year with Nobel 
Prize winner August Krogh in Copenhagen in 1935, Beecher was equipped 
scientifically to launch a pro gram of physiological research on anaesthetic 
procedures. He also proved to be talented at creating research opportunities and 
finding funds. It was rumoured that he charged outrageous fees from his private 
patients, keeping only a limited allowable amount for his own salary and putting 
the rest into the department. 503 In 1941, he also befriended Edward Mallinckrodt, 
500 O. Cope, et al. "Henry Knowles Beecher: Pioneer in Anaesthesiology and Medical Ethics. 
Faculty of Medicine-Memorial Minutes," reprinted from The Harvard Gazette (January 13, 
1978) in, 'This is No Hum bug! , Reminiscences of the Department of Anesthesia at the 
Massachusetts General Hospital: A History, ed. R. Kitz, et al. (Ashland, OH: Atlas Books, 2003), 
104. 
501 G. E. Battit, "Henry K. Beecher and the Early Years of the Anesthesia Service," in This is No 
Humbug!, 108 
502 B. McPeek, "Pain" in This is No Humbug!, 225. 
503 Battit, "Henry K. Beecher," Ill. See also: "Report of the NRC Committee, Dr Isaac Starr, 
. chairman, to visit Dr. Henry K. Beecher's laboratory in Boston, Staturday, February 241h" in "Starr 
to Wintemitz, March8, 1951," Boxl: Grantees: Beecher, H. K., 1950-1966, CDAN, NASA: "Dr. 
Beecher runs a large "show" and his budget approximates $250,000 a year, about half of which 
cornes From patients' Fees for anesthesia." 
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owner of the company that manufactured ether, from whom he obtained private 
research grants.504 
The war also turned into a research opportunity for Beecher. He became a 
medical consultant for the United States Army and was appointed to two sub-
committees on shock and anaesthesia. In 1943, he was called into active service in 
North Africa, where he served as a consultant for twenty-five months. This was 
an extremely productive time for him. Beecher recorded his observations the 
effect of anaesthetic and analgesic practices on wounded soldiers and, with the 
help ofhis associates back in Boston, published 30 papers during this period. In 
particular, Beecher developed a greater interest for pharmacology and pain. 505 
Beecher's research not only benefited the fledgling field ofanaesthesia, 
but was also ofinterest to the army. After the war, Beecher's laboratory was given 
a grant from the army's Medical Research and Development Board (MRDB) to 
study sedatives. The grant supported research on topics of military importance: 
the effect of sedatives on the restoring value of sleep, narcoanalysis (the potential 
use of "truth serums") and comparisons of the effectiveness of synthetic and 
standard analgesics. It was for this latter project that Beecher began developing 
his method of placebo-controlled, double-blind studies of analgesia. Eager to 
continue developing this work, he appealed to CDAN in 1948. CDAN members 
assisted Beecher in obtaining NIH funding for 1949, and, in 1950, began 
providing him with grants "from funds contributed by a group of interested 
pharmaceutical manufacturers," as it said on the standard.disc1aimer inc1uded in 
publications. 
Beecher kept his eyes open for opportunities to refine and publicise his 
methodological innovations. In August of 1950, Beecher wrote to Colonel Stone, 
chairman of the MRD B, asking for a chance to conduct field trials of analgesics in 
Korea: "1 should like to emphasize, if 1 may, what an extraordinarily good 
opportunity the fighting iJ:? Korea offer to make a definitive field appraisal of the 
new narcotic agents ... " If these trials confirmed that either of the methadones was 
504 Battit, "Henry K. Beecher," 111. 
505 McPeek, "Pain," 226. 
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"suitable for military use ... the Surgeon General will be free from any necessity 
for stock piling morphine."S06 By the following January, Beecher reported back to 
Stone: "It seems to me that on the whole the expedition to Korea was a very 
profitable one. The Army has had sorne good publicity out of it, and l have 
toO.,,507 
The combined funding from CDANand the Army allowed Beecher and 
his colleagues to amass material, which they transformed into over 50 scientific 
articles between 1948 and 1960, numerous public addresses and a book, published 
in 1959, under the title The Measurement of Subjective Respan~es: Quantitative 
EjJects of Drugs. With these publications, Beecher promoted his model of 
analgesia evaluation as a prototype for a new kind of pharmacological 
measurement. As he wrote, in 1951, in an application to renew his army contract: 
"Clearly what is emerging here is a new approach, or at least a heretofore un-
crystallised approach, to pharmacology, what might be called the pharmacology 
of the subjective response."S08 What followed was a decade-long campaign to 
persuade a larger audience of the power of double-blinded, placebo-controlled 
clinical trials for the measurement of drug effects on subjective experience. 
Beecher emphasised the special relevance of these methodological devices for the 
study of psychoactive drug effects, making no claims, at least initially, for their 
general necessity in therapeutic evaluation. When it came to measuring effects 
such as pain-relief, drowsiness, itching, or even "warm glow," "sensation of 
drunkenness", or "fullness in the head," these controls cou Id, in a sense, act as 
substitutes for the mechanical quantification of physiological phenomena. When 
the proper precautions were taken to eliminate bias, both conscious and 
unconscious, it was possible to transform subjective reports into hard data. For 
Beecher, experimental controls such as placebos, blinding, rigorous statistical 
analysis and the hi ring of technicians did not constrain what would be counted as 
506 h 1 Beee erto Co. Stone, August 15,1950, Beeeher Papers, MS C 64, Box 22, Folder 16, 
Countway Library. 
507 Beecher to Stone, January 27, 1951, Beeeher Papers, MS C 64, Box 22, Folder 16, Countway 
Library. 
508 "Application for Renewal of the Contract on Sedatives (Dept of the Army), May 25, 195\ ," 
Box 1: Grantees, Beecher, H. K., 1950-1966, CDAN, NASA. 
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valid evidence, but were instead keys for opening a whole new area of legitimate 
clinical research.509 
The use of these controls was not common in the early 1950s, and Beecher 
evidentlyfelt the.need to demonstrate that this new kind of pharmacology, though 
expensive and time-consuming, was a worthwhile investment. Using data he 
collected through CDAN-sponsored experiments on analgesic evaluation, Beecher 
promoted his methodology extensively. For example, during the 1950s, he 
continued to build on his distinction between experimental and clinical pain, as 1 
have described in the previous chapter, and to argue that only clinical pain was 
relevant to the evaluation of analgesics. In one article, he compared the data he 
had accumulated during the war on the pain experience of wounded soldiers with 
new data, from a recent study, on the experience of civilians who had undergone 
surgery. The data showed that the two groups' experiences of pain differed 
significantly: the civilians experienced far more pain from lesser wounds than had 
the soldiers. To Beecher, these results suggested that anxiety, fear and the 
meaning of the wound had more impact on the intensity of the pain experience 
than the severity of the injury.510 Beecher and his colleagues also conducted 
extensive research on placebos. Beecher was initially searching for a means of 
filtering out data from "placebo-responders" in order to sharpen his testing results. 
Though this search was unsuccessful, Beecher was able to transform data on the 
placebo effect into a powerful argument for the need to employ placebos and the 
"unknowns technique" in analgesic evaluation.511 
The articles on placebos published by Beecher's research team have, more 
recently, been identified as watersheds in the history of clinical research. In 1997, 
509 Key publications that outline Beecher's "pro gram" inc\ude: Beecher, "Experimental 
Pharmacology and the Measurement of Subjective Response," Science 116 (1952): 157-62; 
"Limiting Factors in Experimental Pain," Journal ofChronic Diseases 4 (1956): 11-21; "The 
Measurement of Pain. Prototype for the Quantitative Study of Subjective Responses," 
Pharmacological Review 9 (1957): 59-209; Measurement of Subjective Responses : Quantitative 
Effects ofDrugs (New York: Oxford University Press, 1959). 
SIO Beecher, "Relationship ofSignificance ofWound to Pain Experienced," Journal of the 
American Medical Association 161 (1956): 1609. 
511 Henry K. Beecher, "The Powerful Placebo" Journal of the American Medical Association 159 
(1955): 1602-1606; Ted J. Kraptchuk, "Powerful Placebo: The Dark Side of the Randomised 
Controlled Trial," The Lancet 351 (1998): 1722-1725. 
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a manifesto for making a "canon" part of medical education listed "A Study of the 
Placebo Response," published in 1954 in the American Journal of Medicine, as 
one oftwenty-seven "historically decisive works" that future doctors should read. 
The article, co-authored by Beecher and his collaborators, was cited as a "fine 
example" of a "genre" that marked the flourishing of clinical science in the "Age 
of Experiment."s 12 Ted Kraptchuk has credited another, similar article, "The 
Powerful Placebo," published by Beecher in JAMA, with the introduction of the 
modern conception of the placebo, a new conception that was associated with the 
ri se of controlled clinical trials. Kraptchuk argues that the transformation of the 
placebo from "insipid decoy to a mischievous genie that could trick the most 
discerning clinician" was the product of efforts, on the part of elite physicians, to 
promote placebo-controlling and double-blinding as new sources of authority in 
therapeutic evaluation. 5\3 The goal was to shi ft the responsibility for judging 
therapeutic efficacy away from "recognised leaders of the medical profession" 
and place it on the methods themselves, from the per~onal authority of experts to 
the impersonal authority of procedures. To persuade reticent physicians to adopt 
clinical trial methods, these reformers depicted the placebo-effect as powerful, 
deceptive, and in need of careful control. 5 14 Such was, according to Kraptchuk, 
the "entire point of Beecher's exercise" in the lAMA article, from which he cited: 
'''Clinical impression' is hardly a dependable source of information without the 
essential safeguards of the double unknown technique, the use of placebos also as 
unknowns, randomisation of administration ... ,,515 
Thus, Beecher used CDAN-sponsoréd research to promote a new kind of 
clinical pharmacology. Beecher's ambitions also benefited CDAN and its 
sponsors. At a generallevel, Beecher's efforts probably helped obtain more 
widespread acceptance of the value and validity of the clinical trial, and 
particularly for the evaluation of analgesics. More specifically, Beecher also 
512 R. Hilton, "A Manifesto for Reading Medicine," The Lancet 349 (1997): 872-874. 
513 Kraptchuk, "Powerful Placebo," 1723. 
514 Kraptchuk, "Powerful Placebo," 1724, suggests: "An enhanced 'placebo-effect' came to serve a 
valuable scientific and rhetorical function ofpersuading colleagues of the necessity of the ReT." 
515 Beecher, "The Powerful Placebo," cited in Kraptchuk, "Powerful Placebo," 1724. 
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helped to create the knowledge and expertis~ that were necessary to run analgesic 
clinical trials successfully. Because clinical trials were uncommon in the 
early1950s, there were few researchers who had the relevant knowledge and 
expertise to run them. Beecher's research helped to produce such knowledge, as 
well as to recruit-both directly and indirectly-new investigators among a new 
generation of anaesthesiologists and clinical pharmacologists. A small group of 
experts in analgesic clinical trials was created, who were available to CDAN 
when it expanded its granting program. Later, these researchers were sought after 
to do research or provide advice by pharmaceutical companies, the FDA and even 
Senate Committees. 516 
Beecher's appeal to young researchers from the growing medical specialty 
of anaesthesiology was timely. During the 1940s and early 50s, the authors of 
several articles and editorials in Anesthesia/ogy urged their readers to help elevate 
the subordinate status of anaesthesia, the "handmaiden of surgery," in one of two 
ways. Either they could put an emphasis on the clinical skill required for good 
anaesthetic care, and thus help to create distance, in the surgeon's, patient's and 
'public's' minds, between medically trained anaesthesiologists and nurse or 
technician anaesthetists. 517 Or, they could engage in research as a means to show 
anaesthesiologists' ability to contribute to the advancement of medical science.518 
516 National Research Council, Drug Efficacy Study: Fina/ Report to the Commissioner of Food 
and Drugs, Food and Drug Administration (Washington: National Academy of Sciences, 1969); 
Hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, 
United States Senate, Second Session on the Present Status of Competition in the Pharmaceutical 
Industry, Part 19, (U. S. Government Printing Office, Washington: 1970), in which two 
pharmacologists with CDAN connections, W. T. Beaver and R. Houde, as weil as an 
anaesthesiologist, J. Adriani, presented evidence. 
517 H. W. Haggard, "The Anesthetist in American Medicine" Anesthesiology 1 (1940): 1-12: this 
editorial, which introduces the first volume of the journal, called aU anaesthesiologists to help 
"shape public opinion" to "raise the prestige of anesthesia" by emphasizing the skill required to 
practice it. Editorial, "Postoperative pain" Anesthesi%gy 9 (1948): 311-312, emphasized the need 
for the anaesthesiologist to extend care into the postoperative period. H. Boyd Stewart "Editorial: 
Anesthesiology in the Practice of Medicine" Anesthesi%gy 10 (1949): 223-228, recounts the 
history of anesthesia: As more doctors became interested in the field, anesthesia became more 
respectable. However, to give the field a better image, the anesthetist was encouraged to take an 
active part in public life, in the hospital, county medical societies, civic clubs, chambers of 
commerce,etc. : "We must exercise our ingenuity to keep out of the shadow which c10uded the 
specialty when we took over from the technicians." ln the same volume, Editorial: "The 
Anesthesiologist and the Public" Anesthesi%gy 1 0 (1949): 634-635, calTied a similar message: 
"We have opportunities daily to convince patients of the significance of good anesthesiological 
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Analgesie testing, as Beeeher envisioned it, provided one kind of 
opportunity for anaesthesiologists to engage in clinical research. Beeeher's 
general research pro gram had shown that experimental research in physiology and 
pharmacology was an appropriate activity for anaesthesiologists.5l9 More directly, 
Beecher actively recruited young intems to work in his laboratory, and delivered 
public addresses, thus inviting fellow anaesthesiologists to take up research 
activities among which was analgesic evaluation. At the Annual Meeting of the 
American Society of Anesthesiologists in 1950, whieh was published in 
Anesthesiology, Beecher detailed his methodology, emphasizing to his audience 
that "in awareness of pain we have a factor that ean be measured," and second 
that "there is an abundanee ofmaterial ready at hand for study.,,520 Beeeher's 
method relied on the use of post-operative patients as experimental subjects, 
making anaesthesiologists-who had aecess to these subjects and the 
responsibility to care for their pain-the ideal investigators to carry out analgesic 
evaluation.52l 
Over the following decade, anaesthesiologists became increasingly 
involved in pharmacological research, and particularly in clinical trials of 
analgesics. Themajority ofCDAN's grantees and their collaborators were 
anaesthesiologists. When CDAN began awarding more grants, several new 
investigators were anaesthesiologists: Arthur Keats worked on the clinical 
service," by visiting patients pre- and post- operatively. It was also good to use the press and 
personal contact to ensure that anaesthesiologists would one day get their due as medical 
specialists. 
518 R. Charles Adams "Clinical Research in Anesthesiology," Anesthesia/ogy II (1950): 178-184, 
argued that research was not only of scientific interest, but was also good for the status of 
anaesthsiology. Research was "bound to stimulate the interest of surgeons and other specialists in 
the importance of a well-organised anesthesia department." "Editorial: Clinical investigation," 
Anesthesia/ogy 12 (1951): 114-118, stated: "Clinical investigation can be a respectable and 
tremendously potent contributor to the science of medicine ... " 
519 N. M. Greene, Anesthesiology and the University (Philadelphia and Toronto: J. R. Lippincott 
Company, 1975): 45-48, identified Beecher as the pioneer of an "approach to professionalism in 
anesthesiology," which emphasized the scientific rather than clinical potential of the profession. 
E. M. Papper, R. Dripps, and S. C. Cullen later joined Beecher in that approach. The pioneers of 
the clinical emphasis in the promotion ofprofessionalism in anesthesia were R. Waters, J. S. 
Lundy and E. A. Rovenstine. 
520 H. K. Beecher, "Pain and sorne of the factors that modify it" Anesthesia/ogy 12 (1951): 633-
64 \. 
521 Editorial "Postoperative pain," 3 11-12 
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evaluation of analgesics for CDAN from 1958 to 1970, Thomas DeKornfeld from 
1965 to 1972. Both previously worked with CDAN funding in collaboration with 
other investigators: Keats with Beecher and DeKornfeld with Louis Lasagna, who 
himself had worked with Beecher. Raymond Houde, a clinical pharmacologist at 
Sloan-Kettering Memorial Cancer Centre, worked with anaesthesiologist Weldon 
BeUville on CDAN-funded studies. When BeUville moved on to Stanford Medical 
Center and the V A hospital in Palo, he established his own program of research. 
He then became one of the seven Chiefs of Anesthesia in various V A hospitals to 
coordinate trials for the VA Cooperative Analgesie Study. 
In the 1950s and 1960s, anaesthesiologists became analgesic evaluators 
outside the committee granting program as weIl. John Adriani, for example, 
conducted trials of analgesics on his postoperative patients for various 
pharmaceutical companies in the 1960s, and was appointed as member of the 
FDA's Panel for the Review of Topical Analgesies, a section ofits ambitious 
evaluation of Over-the-Counter drugs in the early 1970s.522 As anaesthesiologists 
became increasingly involved in the treatment ofchronic pain, they obtained 
access to another population of potential subjects for analgesic testing. John 
Bonica, who ran a pain clinic at the University of Washington, was also in 
demand by pharmaceutical companies to run trials of analgesic drugs. 523 
There was also, among CDAN grantees, a clinical pharmacologist who 
. was influenced by Beecher's work and took up clinical analgesic evaluation: 
Louis Lasagna. In addition, Raymond Houde, originaUy an internist, was trained 
to work as a clinical pharmacologist, while William T. Beaver, who worked 
bdefly with Houde, became an expert in the clinical pharmacology of 
analgesics.524 Beecher's model had appealed to these researchers who, like him, 
believed that "the properly controUed, quantitative approach holds the only real 
522 "FDA Advisory Work: OTC Panel 1971-74" Adriani Papers, MMC 453, Box 35, HMD, NLM; 
"Squibb Institute for Medical Research, Evaluation of Bandol," Adriani Papers, MMC 453, Box 
23, HM D, NLM; "Endo Laboratories NumorphaniMorphine/Meperidine 1959-65," Adriani 
Papers, MMC 453, Box 22, HM D, NLM. 
523 "Drug Companies Correspondence, 1955-1958," Bonica Papers, MS C 118, Box 67, Folder 13, 
Darling Library, UCLA; "Drug Companies Correspondence, 1959-1963," Bonica Papers, MS C 
118, Box 67, Folder 14, Darling Library, UCLA. 
524 Meldrum, "Departures from the Design,"342. 
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hope for dealing with the oncoming flood ofnew drugs" of the post-war 
decades.525 
In addition, Beecher had drawn attention to the fact that a great deal of the 
products of this "pharmaceutical revolution" targeted subjective symptom relief 
rather than the cure of objective disease processes, thus emphasizing the 
importance of the measurement of subjective drug effects.526 The lack of attention 
given to this kind of measurement had, Beecher pointed out, hampered the 
progress of psychiatry.527 There was, he declared, an urgent need to develop a 
"systematic neuropharmacology or psychopharmacology.,,528 
The professional trajectory of Louis Lasagna connects Beecher's 
laboratory, CDAN, and analgesic testing to the emergence of clinical 
pharmacology and psychopharmacology as distinct branches of medical science, 
as weIl as to regulatory reform during the era of the "pharmaceutical revolution." 
According to his oral history interview, Lasagna had already developed an interest 
indrug testing methodology while he was a medical student. 529 Because ofhis 
interests, he was advised to do his post-doctorate at Johns Hopkins, where a new 
program linking medicine and pharmacology was being started by Gordon 
Zubrod. He did this from 1950 to 1952. He then heard about Beecher's work from 
his friend Arthur Keats, who was a resident in anaesthesia at MGH: "he told me 
about this exciting stuff they were doing, which was trying to quantify subjective 
525 Beecher, Measurement afSubjective Respanses, viii. 
526 Beecher, "Limiting Factors in Experimental Pain," Journal ofChronic Diseases 4 (1956): 11, 
citing MacDonald, Beecher notes that, though chemotherapy has captured much of the limelight in 
therapy in recent years, most medications remain concerned with the treatment of symptoms, 
among which the most important is pain. 
527 Beecher, "Experimental Pharmacology," 157, notes that the "general growth ofmedicine in 
recent years ... has served indirectly ta emphasize areas where development has lagged. Notable, 
for example, is the slowness of enduring growth in experimental psychiatry ... it is possible that 
growth in this field has becn retardcd because phannacology as it deals with the subjective 
response has not been given the attention it deserves." 
528 Beecher, Measurement of Subjective Responses: Quantitative EfJects of Drugs (New York and 
Oxford: Oxford University Press, 1959), vii-viii. 
529 Marcia Meldrum, "Oral History Interview with Louis Lasagna," 8 September 1995, MS C 
127.19, John C. Liebeskind History ofPain Collection, HSCD, Darling Library, UCLA, 8, 
Lasagna says that he read the Comell Conferences on Therapy, edited by HarrY Gold, in which the 
importance ofblinding and placebo-controlling were eIpphasized long before they became 
commonly practiced. 
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measurements, and the more l heard about it, the more excited 1 became. ,,530 
Always eager to expand his research program, Beecher managed to get Lasagna 
assigned to his Army-funded project. 531 While he worked with Beecher, Lasagna 
also participated in CDAN funded studies, and "began to learn how to conduct 
analgesic trials, studied the interaction between psychological variables and 
response to placebos and CNS drugs, performed the first modern clinical trial of 
hypnotics, and became convinced that clinical pharmacology would be a 
satisfying and exciting career. ,,532 
Thus, in Lasagna's autobiographical version of events, it was Beecher's 
laboratory that inspired him to become the researcher who would eventually be 
credited as having "invented the discipline" of Clinical pharmacology.533 After 
leaving MGH, Lasagna realised Zubrod's unfinished project by setting up the first 
Division ofClinical Pharmacology in the U. S. at Johns Hopkins. 534 There he 
began teaching people "to study drugs rationally and to train people to study 
drugs we11.,,535 Lasagna also published extensively on drug regulation and, from 
1960 to 1962, was one of the key witnesses to the Kefauver committee. Along 
with Walter Modell, Lasagna pushed for, in his words, "randomized controlled 
trials as being a necessity if you're going to approve a drug. ,,536 They were 
successful in making the Kefauver-Harris amendments to the Food and Drug Act 
of 1962 into what has been seen as one ofthe major victories in the historical 
530 "Oral History Interview with Louis Lasagna," 2 . 
. 531 "Oral History interview with Louis Lasagna," 2, Lasagna was hired on Beecher's army grant as 
a form of public service he owed for having gone to medical school on a Navy program. 
532 Louis Lasagna, "Clinical Pharmacology in the United States: A Personal Reminiscence," 
533 D. 1. Greenblatt, "The Maturation fo Clinical Pharrnacology: Recognizing the Contributions of 
Dr. Louis Lasagna," Journal ofClinical Pharmacology 38 (1998), 572. See also S. Erill, (ed.), 
Clinical Pharmacology Through the Pen of Louis Lasagna Vol.l (Barcelona and Philadelphia: 
Prous Science, 1997). This series, which aimed to explore "basic or seminal articles" in the history 
of pharrnacotherapy, began with a volume on clinical pharrnacology because of its "outstanding 
role in the shaping of modem therapeutics." To represent such an important history, the articles of 
a single author were chosen by the editor. Though the editor does notjustify this choice, and 
indeed states that "any attempt at justifying the choice may be preposterous," that he made it 
seems to indicate that Lasagna was viewed highly as a pioneer of the discipline. 
534 "Oral History Interview with Louis Lasagna," 16. 
535 "Oral History Interview with Louis Lasagna," 16. 
536 "Oral History Interview with Louis Lasagna," 8. 
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process of making clinical trials methods into the "gold standard" of American 
therapeutic evaluation. 
While he established his pro gram and lobbied for regulatory reform, 
Lasagna continued to conduct analgesic studies funded by CDAN grants, from 
1958 to 1964, and was appointed as a member of CDAN from 1969 to 1971. 
Lasagna also chaired the Committee on Analgesics for the National Research 
Council-National Academies of Science Drug Efficacy Study, commissioned by 
the FDA to evaluate drugs approved prior to 1962.537 
Lasagna has also been counted as a key figure in the emergence of 
psychopharmacology in the 1950s and 60s.538 Not only did he conduct studies of 
psychoactive drugs such as hypnotics and antipsychotics, but also pushed for the 
establishment, and then presided, the American College of 
Neuropsychopharmacology. In addition, Lasagna and Beecher's analgesic trials 
came to be seen as models for the study of psychotropic drugs. According to 
David Healy, when federal funds were made available for the evaluation of 
psychiatric drugs in the 1950s, researchers were still divided on the question of 
whether adequate tools were available for measuring the effects ofthese drugs. At 
the inaugural conference of the Psychopharmacology Service Center in 1956, a 
key topic of discussion was methodology. Healy described the discussion: 
There was a general beliefthat it was not possible to measure subjective 
change of the kind that seemed to be involved in psychiatric illness. The 
studies of Beecher, Gold, and Lasagna on analgesia, however, were 
probably critical in helping physicians and researchers realise that what had 
previously seemed impossible might after aIl be feasible. Pain, after aU, was 
just as subjective as depression. Stemming from this, one of the key issues 
at the conference was the use of rating scales for the mapping of clinical 
change.539 
5~7 National Research Council, Drug Efficacy Study. 
5,8 Lasagna was interviewed for David Healy, The Psychopharmacologists: Interviews (London 
and New York: Altman, 1996), and was invited to contribute to: David Healy, The Creation of 
Psychopharmacology (Cambridge, MA: Harvard University Press, 2002). 
539 David Healy, The Antidepressant Era (Cambridge, MA: Harvard University Press, 1997), 95-
96. 
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For both Beecher and Lasagna, working for CDAN on the improvement of 
analgesic testing was clearly only a small part of their broader ambitions. These 
included the creation of new professional opportunities in clinical pharmacology, 
psychopharmacology and anaesthesiology and the reform oftherapeutic 
evaluation in the U. S .. Beecher's success in promoting the clinical trial and in 
recruiting clinical analgesic evaluators was helped by CDAN sponsorship, but 
also facilitated by broader trends in these emerging specialties and in the reform 
oftherapeutic evaluation. The participation of Keats and Lasagna in CDAN's 
research program, first as Beecher's assistants, and then as principal investigators, 
are proof of Beecher's direct success in broadening the pool of expertise in 
analgesic testing in a way that benefited the Committee directly. 
Raymond Houde's trajectory was different from Beecher, Lasagna and 
Keats', but seems to have also been guided by Beecher's work and the hand of 
Committee members. Originally trained as aninternist, Houde was, according to 
his own recollections, recruited to launch a program of analgesic evaluation at 
Memorial Sloan-Kettering Cancer Hospital. Having dabbled in studies on 
analgesics in animaIs, he was invited to attend a meeting attended by "aU 
important people from the pharmaceutical industry but also from government, like 
l, Dr. Eddy 1 think was there, Nathan B. Eddy" who were interested in the 
development of synthe tic analgesics.54o Houde was given a sabbatical year-
probably in 1949-to study pharmacology, analgesics and study designs with 
Maurice Seevers at the University of Michigan and Abraham Wikler at Lexington 
Hospital, both membersofCDAN. 541 Through them, he was introduced to 
Beecher's work and to theCommittee, and soon met Beecher at a Committee 
meeting. 542 On the basis of the scattered information provided in his oral history, 
it seems likely that Houde-a young clinician, who held a position in a large 
clinical facility filled with patients who required analgesic therapy, and who had 
sorne knowledge of pharmacology and of the statistical requirements of study 
540 Marcia Meldrum, "Oral History Interview with Raymond W. Houde, II September 1995," MS 
C 127.16, History of Pain Collection, Darling Library, UCLA, 37. 
541 "Oral History Interview with Raymond W. Houde," 38 and 50. 
542 "Oral History Interview with Raymond W. Houde," 41 and 50 
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designs-. was handpicked by Committee members, and groomed to become a 
clinical pharmacologist specialised in analgesic studies. 
The points of personal contact and lines of influence that linked CDAN 
members and grantees created analgesic-testing careers for anaesthesiologists and 
clinical pharmacologists, and new expertise for the Committee' s pro gram. As we 
will see in the last section ofthis chapter, these connections also probably 
facilitated the replication of clinical trials conducted in different sites. 
6.2 The Women and Men who Counted: Investigators and their 
Collaborators 
Refining and implementing clinical experimental designs required the 
collaboration and compliance of a wide variety of actors, from the hospital 
pharmacist who coded drug doses to the patients themselves who rated their 
feelings of pain using pre-selected terms. As Starr reportedly pointed out, in a 
discussion of Beecher's first CDAN grant application: "No equipment was 
required: the whole financial outlay was concerned with the gathering of data."S43 
Consultant fees and salaries often made up more than three quarters of the 
budgets presented in applications for support from CDAN for analgesic clinical 
trials. The precision and reliability ofthis technology depended on the quality of 
the labour furnished for these salaries, as well as the coordination of additional 
unpaid collaboration provided by ward staff and patients. 
In this section, 1 will examine how this labour was distributed, valued and 
coordinated in the practice of analgesic clinical trials. 1 will focus mainly on the 
ways in which investigators perceived the roie oftheir various collaborators, and 
the means they devised ta ensure they performed their raIe "properly." When 
possible, 1 have included descriptions ofhow these collaborators perceived their 
own work. 
543 "Minutes of the 6th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1950), 114. 
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1 suggest that these collaborators' conscientious work, including the active 
contribution of experimental subjects, was crucially important in ensuring the 
reliability ofthis technology. To a certain extent, the work performed by these 
collaborators was invisible in published descriptions of experimental 
methodology and results.544 The design of the clinical trial itself, and not the 
people who put it in practice, was supposed to ensure the objectivity of its results. 
Various assistants were mentioned in print only when their identity was an 
element of the method itself, for example, when Beecher described the 
replacement of regular ward nurses with full-time observers for the collection of 
data. In CDAN meetings and reports, however, investigators exchanged more 
details about the role of particular assistants, particularly when discussing how to 
avoid potential obstacles to the implementation or replication of experimental 
methods. The importance they accorded to particular types of work and expertise 
for ensuring the reliability of trial results is also made evident by the attention 
they gave to the selection and training of both assistants and subjects for 
participation in trials. Budget records provide additional information about job 
descriptions, salaries and consultant fees. The oral testimony of a prominent 
analgesic nurse observed, Ada Rogers, pro vides a fascinating glimpse of the kinds 
of skills and experience she contributed to the running of clinical trials. 
While these sources make the labour and skills of analgesic trial workers 
only partly visible, they do suggest, as opposed to what some published reports 
seemed to imply, that investigators did not see clinical trial participants as 
interchangeable parts in the operation ofthis technology. Objectivity did not 
emerge directly out of experimental protocols, but through the abilities and 
attitudes of the people who made it work. 545 
544 The "triple invisibility" of 17th century laboratory technicians has been described by Shapin, 
who pointed out that they were invisible tirst to historians and sociologists, second in the fonnal 
record of experimental practice, and third, as relevant actors in the production of scientitic 
knowledge. See: A Social History, 360. Clinical trial personnel and consultants did appear in 
published descriptions of experiments, and their work was of sorne concern because of 
preoccupations about the standardisation of methodological procedures, but l suggest that their 
contribution was more extensive than acknowledged in published records. 
545 Whereas Shapin suggests that l7th century experimenters such as Boyle based t~e credibility of 
their experiments on their own authoritative testimony, in this case methodology, rather than 
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6.2.1 Hospital Staff 
Previous clinical studies of analgesics, such as those carried out by the Committee 
on Drug Addiction in the late 1930s, had relied on ward staff-nurses and 
physicians-to administer drugs and record their impressions of efficacy. 546 
Studies were coordinated either by a senior member of staff, or by an outsider-a 
member of the Committee or 'a pharmacologist-who did not hold a hospital 
appointment. Army and CDAN grants made it possible for 8eecher and future 
CDAN grantees to hire special research staff-usually an associate and one or 
more observers, sometimes a secretary-to assist the principal investigator. 
Hospital staffmembers were therefore given less active roles in CDAN-funded 
studies. Nevertheless, their cooperation was considered to be essential to running 
clinical trials and experimenting with it, especially with respect to the 
administration of placebos or unknown substances. For example, when 
Committee members discussed 8eecher' s proposaI to study the effect of positi ve 
and negative suggestion on drug effects, one member commented: "If the 
attendant offered medication to the patient but said, "1 don't think this will do you 
much good," difficulty might be encountered not only wit the patient but with the 
staff." ln response, Eddy "said that Dr. 8eecher hadfull control over the wards 
where the work was carried out so that no difficulty with the staff was to be 
expected. ,,54 7 
,~ Other types .of resistance might be encountered, particularly in hospitals 
that were not affiliated with a university or a federal institution. In a report on the 
establishment of a new clinical facility for analgesic testing, Lyndon Lee drew 
attention to strategies for promoting staff acceptance of experimental practices. 
To administrators, who might respond with "righteous indignation against 
personal authority, was presented as trustworthy. See: A Social History, 383. However, in both 
cases, trust in "support personnel," in this case including experimental subjects, was necessary for 
producing knowledge that would be considered to be reliable. 
546 For descriptions ofthese studies, see chapter 4 ofthis thesis. 
547 "Minutes of 6th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics (1950), 
115, emphasis mine. 
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'experimenting' with patients entrusted with our care," it was best to emphasise 
the reputability of the sponsors, the 'educational and patient care benefits," as 
well as the safety of the drugs being tested. "Semantics" were also important: it 
was best not to label the activity as "research" but to speak of a "clinical study." 
Professional and ancillary staff were more difficult to persuade, and should be 
approached with tact. Private patients-a delicate subject for staff-should be 
categorically excluded from studies, and it was best not to overly emphasise (or 
mention) the use ofunknowns. Indeed, the use ofunknown substances was best 
facilitated by "the introduction of the study technique of a special observer" since 
it was no longer necessary "to enlist nursing office and staff acceptance of the 
need for drugs to be administered and study observations to be recorded by 
regular ward personnel.,,548 Education might also be persuasive: Investigators 
were encouraged to accept "impromptu opportunities as well as formaI lecture 
and seminar engagements" in order to "create a certain dissatisfaction with 
standard analgesics." 
Lee's comments were relevant, remarked Starr, because of "how very 
recent this kind of clinical investigation is," even in elite research institutions. 549 
To carry out successful clinical trials in the 1950s, it was necessary to be 
innovative not only in designing studies, but also in finding ways-by command, 
omission or education-to overcome resistance to certain practices. Introducing 
special research assistants, who were paid and educated to accept the need for 
blinding and regular recording of data, was part of the solution. However, hospital 
staff still had to be persuaded to accept the presence of researchers in their 
workspace and to collaborate, or at very least not to interfere, with practices that 
might seem intrusive of their space and harmful to patients. 
6.2.2 Observers 
548 L. Lee Jr., "Progress Report on Establishment of a New Clinieal Faeility for Testing 
Analgesies," Bulletin of the Committee on Drug Addiction and Narcotics (1956), 1404-1408. 
549 Isaac Starr, eomments on: L. Lee Jr., "Progress Report on Establishment of a New Clinieal 
Faeility for Testing Analgesies," Bulletin of the Committee on Drug Addiction and Narcotics 
(1956): 1408. 
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Full-time observers were introduced to analgesic testing by Beecher as a means of 
eliminating prejudice, suggestion and personal quirks from the practice of 
collecting data. 8eecher spoke of these technicians almost as if they were a 
component of the method itself: they were listed alongside placebos and 
randomization as one of the essential controls in tests of subjective drug effects.5,50 
He valued the technician for her lack of investment in research or patient care: not 
knowing, and not caring, about the patient's treatment kept her neutral. Naïve 
observers with a high turnover rate were the best: 8eecher used "college girlS.,,55 1 
Later CDAN grantees, however, preferred observers to have nursing training and 
increasingly counted them as full members of analgesic research teams. They 
valued the observer for the expertise she brought to data collection, and began to 
pay more attention to training and understanding of experimental rationale as a 
means to instil in new observers the necessary skills and motivation to perform 
their task-questioning patients in a consistent and objective manner-
adequately. From the late 1950s, observers began to be referred to by name in 
publications and CDAN reports, either in the discussion, acknowledgments or 
authors.552 
Whether they had skilled research nurses or interchangeable technicians in 
mind, CDAN members and grantees gave observers a central role iri analgesic 
evaluation. They criticised the use of ward nurses to collect impressions of 
550 For example, Beecher, "Experimental Pharmacology,"160, describes the importance ofusing a 
constant investigating team under a subsection titled "design of the experiment." 
551 Henry K. Beecher, "Studies on Narcotics: Annual Report," Bulletin of the Committee on Drug 
Addiction and Narcotics (1955): 1073. 
552 Stanley L. Wallenstein, Ada Rogers and Raymond W. Houde, "Reiative Analgesic Potency of 
Phenazocine and Morphine," Pharmacologist. 1 (1959): 78, this is the first article 1 have foul)d in 
which A. Rogers, the nurse-observer, is listed as one of the authors in reports of the Sioan-
Kettering Memorial Cancer Hospital team. See also: Richard B. Paddock, "Report of the VA 
Cooperative Analgesic study" Bulletin of the Committee on Drug Addiction and Narcotics (1964), 
3900, in which he thanks the V A nurse observers in the acknowledgments. Their names were Mrs 
Margaret Armour, Mrs Mary Lou Garvey, Mrs Sharon Sellers, Mrs Shirley Schmelzer, Miss Mary 
Boyle, Mrs Betty Davis, Mrs Virginia Snyder. Thomas G. Kantor, "Application for Grants," 
Bulletin orthe Committee on Drug Addiction and Narcotics (1966): 4457-4466, in a list of 
previous studies performed, Kantor gives basic information about the study (date, substances 
teste d, number ofsubjects) including the name of the nurse who performed the study. In the 
discussion ofthese studies, the observers are also named. 
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analgesic efficacy in trials.553 An impartial observer made aU the difference 
between "clinical impression" and "clinical experimentation." As Beecher wrote 
in 1948: "the responsibility of testing falls on full-time observers such that 
objective, quantitative data, rather than clinical impressions, are obtained.,,554 This 
statement echoes similar comments made by CDAN members and grantees in 
their reports and meeting discussions. 
Despite the modesty of these salaries, observers added significantly to the 
cost of running clinical studies, and were usually paid from CDAN grants. CDAN 
members and grantees thus showed the valued they placed on these workers by 
their wiUingness to invest limited research funding towards their salaries. The 
creation of the full-time observer was a direct result ofthe increase in size of 
grants for analgesic testing. Beecher had introduced this practice whén he was a 
beneficiary ofhis Army grant, and was able to continue it with CDAN funding. 
On the basis of scattered evidence of grantees' finances, we can see that a 
significant proportion of research budgets was allocated to observer salaries. In 
1952, Beecher asked for $5,980 to pay technicians out of a total $16,679 budget 
(part of this budget was for a separate study of side-effects, so the salary' s 
proportion of the co st of clinical trial work was even higher).555 When Lyndon 
Lee applied to CDAN for funding to carry out analgesic research in 1955, he 
requested the amount to coyer the salary of an observer: $3,564 for a lay observer 
or $4,070 for a nurse at base pay. Raymond Houde's budget for 1963-64 included 
four salaries for his two research associates, a secretary, and his "clinical research 
technician.,,556 When a V A study was envisaged in the early 1960s, Richard 
553 "Minutes of the Ith Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1953): 643-644, when a team ofresearchers not funded by CDAN presented its results at one ofa 
1953 committee meeting, Beecher and Lasagna criticized the study design by pointing out the 
disadvantages ofusing ward nurses as observers. 
554 "Minutes of the 4th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1948): 61, where Beecher presented a preliminary report of his investigation of sedatives at MGH 
under army contract. 
555 Beecher, "Annual Report and Application for Renewal of Support to the Committee on 
Narcotics and Drug Addiction of the National Research Council, 21 January 1952," Bulletin of the 
Committee on Drug Addiction and Narcotics (1952): 225. 
556 Houde, "Application for Grant," Bulletin of the Committee on Drug Addiction and Narcotics 
(1963),3707. 
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Paddock, chief of anaesthesiology in the San Francisco V A hospital, wrote to 
Eddy saying that his team was "anxious to participate in the study" but, he 
implied, this would be impossible without sufficient resources to hire an observer 
and a clerical assistant. 557 Thus, observers were not an optional expense that 
might improve the analgesic clinical trial but one of the conditions that made it 
possible. 558 
Though multiple observers made trials more expensive, collecting data 
over a period of several shifts could speed up studies significantly. This was seen 
as particularly important when studies used postoperative patients, whosepain 
diminished rapidly over a period of days, and who received fewer doses of 
medication. Lee had proposed to begin with a single observer, but once the value 
of the study had been established, he hoped to increase his budget to $12,000 in 
order to carry out full-time observation. 559 In 1956, he began to apply pressure to 
obtain a second observer. Recognising the need for this, Nathan Eddy, secretary 
ofCDAN, arranged to obtain funding from Merck to paya second observer.56o 
CDAN's principal financial contribution to the V A study in the mid-1960s was 
the salary of secondobservers.56 \ 
At Sloan-Kettering, however, where analgesic studies were conducted on 
chronic cancer patients, a single observer did all the work. Houde and his team 
often insisted that this was the only way to ensure constancy in "the relationship 
between the observer and the patients." This relationship was a "variable" that 
557 Richard Paddock to Eddy, August 7,1961, Box 1: Grantees: Lee, Lyndon E. Jr, CDAN, 
NASA. 
558 CDAN members were, nevertheless, ready to find ways tocut the costs ofhiring observers. 
They probably hired women, and lay observers, because they could pay them less. For examp\e, 
Eddy suggested to Paddock that he hire lay observers, such as medical students' wives, to save 
sorne rnoney, though nursing training was valuable: "while the observers will be rated as 
technicians, it would be desirable ifthese individuals have nursing training to such an extent that 
the hospital can authorize them to administer the medications,"in: Eddy to Lee, December 20, 
1961, Box 1: Grantees Lee, Lyndon E. Jr., CDAN, NASA. 
559 Lyndon Lee Jr., "Protocol: Clinical Investigation of Analgesie Drugs, Wayne County General 
Hospital and Infirmary, Eloise, Michigan, n.d.," Box 1: Grantees: Lee, Lyndon E. Jr., 1954-1969, 
CDAN, NASA. 
560 Eddy to Starr, May 18, 1956, Box 1: Grantees: Lee, Lyndon E. Jr., 1954-1969, CDAN, NASA. 
56\ Eddy, The National Research Council, 107. 
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could not be controlled otherwise.562 Throughout their involvement with the 
CDAN research pro gram, the Sloan-Kettering team included the same observer: 
Ada Rogers. Over the 42 years she worked on analgesic studies at Sloan-
Kettering Memorial hospital, the whole time on a "lousy" salary paid out from 
grants, Rogers developed considerable expertise in running analgesic clinical 
trials.563 
Apart from being responsible for the collection of data, Rogers was 
consulted in designing analgesic study methods. Eventually, she also became 
involved in the training of new observers, the selection of subjects, and was 
included as a co-author in published reports from Sloan-Kettering starting in 
1959. As Rogers herself put it: "the first couple of papers" published by Houde 
and Wallenstein, "my name was never put on it and 1 complained about it because 
1 did the work.,,564 
Her oral history, collected for the John C. Liebeskind History of Pain 
Collection, provides a sense of how she viewed her own expertise, what made her 
a good analgesic trial observer, and the skills she identified as necessary in other 
observers. Though Rogers' lengthy experience was probably not representative of 
other observers', particularly not of the lay technicians employed by Beecher, 
about whom litt1e information was recorded, her views were influential: not 'only 
did Rogers herself conduct many CDAN-funded and other trials over the years, 
but she was also involved in selecting and training new observers at Sloan-
Kettering and elsewhere. In particular, she trained some of the observers who 
would work on the VA cooperative study. In addition, the model she 
represented-of the trained research-nurse rather than the naïve technician-
would endure: By the mid-60s, "especially trained observers" seem to have 
562 Houde and Wallenstein, "A Method for Evaluating Analgesics in Patients with Chronic Pain," 
Bulletin of the Committee on Drug Addiction and Narcotics (1953),661. 
563Marc ia Meldrum, Oral History Interview with Ada Rogers, 12 September 1995, MS C 127.31, 
History of Pain Collection, Darling Library, UCLA, 7-8. 
564 "Oral History Interview with Ada Rogers," 26. 
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become the norm in the design of studies reported in CDAN.565 In 1991, an edited 
volume on analgesic clinical trials included a section describing the training and 
skills of nurse-observers, to which Rogers contributed. The principal article of the 
section concluded: "The nurse-observer, or analgesic study nurse, is the central 
figure in an analgesic study. She provides day-to-day standardisation for the 
system of measurement. Appropriate selection, training, and monitoring of the 
nurse-observer increases the probability ofbeing able to repeatedly conduct 
sensitive analgesic assays." 566 
Rogers developed a new type of expertise as both a researcher and a nurse. 
On one hand, after years of experience, she tells that: " ... l didn't consider myself 
a nurse per se any more. l considered myself a clinical pharmacologist, really, 
basically.,,567 She wore a lab coat, was respected by patients and doctors, and 
envied by other nurses. She was the first nurse at Sloan-Kettering Hospital to 
become a researcher in 1951, and, when she was promoted to research associate 
in 1980, wasthe first to occupy a professional position. 568 On the other hand, she 
had the bedside contact that distinguished her from physician investigators. Her 
knowledge was different from theirs because they were "not at the bedside doing 
studies and seeing these people, and knowing how they respond to things.,,569 
Rogers listed bedside experience among her criteria for recruiting new 
observers.570 Good bedside manners, however, did not involve becoming 
personally involved with patients, or assuming that one knew them well enough to 
judge their level of pain. When it came to collecting data, Rogers didn't praise 
observers' skills in makingjudgments but their ability to suspend them. One of 
the main lessons she taught new observers was how to question patients 
objectively, refraining from asking leading questions, making assumptions about 
565 T. G. Kantor, "Application for Grants," Bulletin of the Committee on Drug Addiction and 
Narcotics (1966),4458. J. Parkhouse, "Observers, Patients and Drugs in the Study ofMild 
Analgesies," Bulletin of the Committee on Drug Addiction and Narcotics (1966),4769-4778. 
566 J. A. Forbes, "The Nurse-Observer: Observation Methods and Training," in The Design of 
Analgesie Clinical Trials, Advances in Pain Research and Therapy Vol. 18, ed. M. Max, R. 
Portenoy and E. Laska (New York, Raven Press: 1991), 619. 
567 "0 1 H' 1 . . h d ra IstOry ntervlew Wlt A a Rogers," 16. 
568 "Oral History Interview with Ada Rogers," 7. 
569 "Oral History Interview with Ada Rogers," 21. 
570 "Oral History Interview with Ada Rogers," 67. 
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a patients' pain, or trying to guess which drug they got: "This is what you try to 
teach people, you know, how to question people, and especially ifyou're doing a 
study and you're saying, 'Y ou're not having much pain now.' That would be 
leading the patient ... So you really need to train people to think before they 
speak, before you let it OUt."S71 Itwas important not to interfere with information 
given by the patient, to obtain "their" answer which was "the" answer: "when 
you're doing double-blind study, it's really a double blind. At least, l was very-I 
didn't care what they got. And l think that made me a good researcher. l had-. 
maybe it was just that l understood what we were doing-... And it doesn't matter 
what they got. They gave me their answer, they gave me the answer. S72 
A good observer should also, according to Rogers, be 'able to recognise 
how emotion might hamper her ability to collect data impartially. For example, 
Rogers recounted how, when she leamed that John Kennedy had been 
assassinated, she was glad that she had already completed the collection of data. If 
she hadn't, she says, she would have had to "g'o back and redo it." "It was just 
such an emotional event," she explains, "that l'm sure that would have entered 
into the questioning [of] the patients." A good observer was one who, because she 
understood "the whole princip le" of the studies would have been able to recognise 
"that that would have been a tirne to redo aU those drugs." She added: "1 often 
wonder when people do studies if the y really are aware of aIl the things that enter 
into being objective."S73 
To be good, according to Rogers, an observer had to "understand what 
you're doing and the who le principle"s74 of clinical therapeutic evaluation. This 
understanding was the product of experience, training and, to sorne extent, 
personal ability: "observers have to be trained by sorneone who's done studies. 
And you can't assume because she's a nurse that she's going to know how to do 
these things, and they don't, unless you train thern. And sorne nurses are very 
57\ "Oral History Interview with Ada Rogers," 62-3. 
572 "Oral History Interview with Ada Rogers," 61. 
573 "Oral History Interview with Ada Rogers," 63. 
574 "Oral History Interview with Ada Rogers," 61. 
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goodand sorne are not. It's like everything else, you know. Sorne people seem to 
grasp the meaning of the study ... and others, forget it.,,575 
Training observers became an important aspect of the implementation of 
cooperative analgesia trials in V A hospitals in the 1960s. When the protocol for 
the study was being discussed in 1962, Weldon BeUville reportedly "emphasized 
that training of observers has been, in his opinion, the most important phase of a 
pain study. A weU trained observer who understands the purposes of the studyïs 
enthusiastic. Enthusiasm and interest in the study were felt to provide motivation 
for the observer to work inteUigently within the framework of the experimental 
protocol rather than performing the job in a routine manner.,,576 The observer for 
an initial pilot study was sent to Ada Rogers at Memorial Sloan Kettering for a 
week, before beginning at the Palo Alto V A Hospital. When the study was 
extended, new observers were sent to Palo Alto or Memorial. "Observer training 
has thus been standardised," it was noted in a report of the cooperative program. It 
is likely that the V A trainees were instilled with the knowledge and skills Rogers 
described, in her oral history, as being important to the success of analgesic 
clinical trials. The importance of the job they performed was also recognised. In a 
later report of the V A Cooperative Analgesie Study, Richard Paddock included in 
his aCknowledgments "the following nurse observers without whose careful and 
thoughtful work the data from this study could ~ot have been collected.,,577 
Even in such recognition, however, observers were usually portrayed as 
workers rather than thinkers, technicians rather than scientists. The observers who 
worked on CDAN-funded projects were, without exception, women and relatively 
poorly paid. The gendered hierarchy of clinical trial work relegated them to a 
secondary "epistemic role": Their work was good because it was "careful and 
thoughtful" rather than expert and knowledgeable, while the objectivity of the 
575 "Oral History Interview with Ada Rogers," 79. 
576 Bellville in "Minutes of the Committee Meeting, VA Study Group in Anesthesia and 
Analgesia, October 21, 1962," Box 2: VA Cooperative Project, CDAN, NASA. 
577R. B. Paddock, "Report of the V A Cooperative Analgesic study" Bulletin of the Committee on 
Drug Addiction and Narcotics (1964): 3900, in which he thanks the VA nurse observers in the 
acknowledgments. Their names were Mrs Margaret Armour, Mrs Mary Lou Garvey, Mrs Sharon 
Sellers, Mrs Shirley Schmelzer, Miss Mary Boyle, Mrs Betty Davis, and Mrs Virginia Snyder. 
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data was protected by their restraint rather than by active decisions based on an 
understanding of the multiple factors that could affect data collection and the 
rationale of study design. However, Rogers' recollections, and the emphasis put 
on observer-training in the V A studies, provide a glimpse of just how important 
observers' knowledge, experience and sensitivity was in actively producing the 
consistency and reliability of analgesic data. 
6.2.3 Statisticians and Psychologists 
From the outset, Beecher was determined to set his method of analgesic 
evaluation on a sound statistical footing. In 1947, as he was developing the design 
of his clinical trial, Beecher formed a longstanding alliance with Frederick 
Mosteller. Mosteller had only recently complet.ed his PhD and had been hired as a 
lecturer and research associate in Harvard' s Department of Social Relations. He 
went on to become Professor of Mathematics in 1951 and led the effort to found a 
Department of Statistics at Harvard, of which he was the chairman from its 
inception in 1957 to 1969.578 
Consulting the young Mosteller had not been an obvious thing for Beecher 
to do. As Harry Marks has pointed out, collaborations between statisticians and 
medical researchers had been almost inexistent before World War II and were still 
rare by 1950. In some ways, statisticians threatened medical authority by 
"creating doubt about the basis for physicians' belief' in the cause-effect 
~elationship between drugs and changes in their patients, and by substituting the 
statistical management of subjects and data for physicians' ability to identify 
fluctuations and variations in disease processes. Despite this, Marks argues, 
statisticians became allies for reformers who sought to shi ft the responsibility for 
therapeutic judgment from personal sources of authority-experts and 
institutions-to impersonal devices-methodological designs and ca1culations.579 
578 Stephen E. Fienberg, "Statisticians in History: Frederick Mosteller, 1916-" American Statistical 
Association, https:!/www .3mstat.ondabout/statisticians/index.cfm ?fuseaction=biosin fi)&B io r De 1 0 
(accessed April 29, 2006). 
579 Marks, The Progress of Experiment, 129-163. 
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Beecher presented statistical expertise as a crucial condition for the 
objective clinical assessment of subjective drug effects. As he wrote in 1952: 
"There is a great field for study here, but it is a field where there are many 
obstacles ... chance or coincidence to be forced into the open by intricate and 
laborious statistical methods."S80 
Beecher consulted his statistician not only to analyse data more 
objectively, but also to introduce modifications in study designs, investigate the 
influence of various factors on data distribution, and determine possible ways of 
improving or simplifying the collection of data. Though Beecher's original 
methodological model seemed to give reliable data, it was repeatedly described as 
slow and expensive.S81 In order to make his method more sensitive to analgesic 
effects and more economical in time and in "subject material," Beecher embarked 
on a series ofmethodological investigations (which were funded by CDAN 
grants). 
One of Beecher' s great concems was the question of how responses to 
placebos might affect analgesic study results. To investigate this question, 
Beecher explained to the Committee, new experimental tools were necessary. For 
this, Beecher argued in his grant proposaI "the aid of a top level statistician is 
essentia1. Professor Mosteller has become interested in this problem and if an 
application is approved will be available for this aspect of the work."S82 When the 
Committee visited Beecher' s laboratory in 1951, they noted, in their report, that 
"The alliance with Dr. Mosteller, the Professor of Statistics at Harvard, in the 
design of the experiments and the work-up of the data impressed the committee as 
580 Beecher, "Experimental pharmacology," 162. 
581 Beecher himselfacknowledged that his method demanded conditions that were "complex and 
exasperatingly time-consuming," as weil as "costly," see: "Experimental Pharmacology," 161. See 
also: "Report of the NRC committee, DrIsaac Starr, chairman, to visit Dr. Henry K. Beecher's 
Iaboratory in Boston, Staturday, February 24th" Box 1 : Grantees: Beecher, H. K., 1950-1966, 
CDAN, NASA: in which Beecher's analgesic clinical trial was described as "extraordinarily time-
consuming, not very accurate, and extremely expensive." 
582 Beecher, "Annual Report and Application for Renewal of Support to the Committee on 
Narcotics and Drug Addiction of the National Research Council, January 21, 1952," Bulletin of 
the Committee on Drug Addiction and Narcotics (1952): 222-3. 
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very valuable."s83 In his landmark study on the placebo, Beecher also enlisted the 
help of psychologist John von Felsinger. 
Louis Lasagna also emphasised the importance of statistical consultation 
for clinical research. Lasagna explained that expert statisticians were the "most 
attuned to the need for safeguards against bias" and could also "frequently 
increase the efficiency of a trial." Lasagna warned that "failure to utilize the aid of 
such specialists can be disastrous." It was not enough to caU in the statistician at 
the end, to "chant a few mathematical formulas or Greek symbols over the corpse 
of an ill-planned experiment" in the hope of resuscitating it. Statisticians were 
most useful ifthey were involved from the planning stages.S84 
Raymond Houde developed a close and long-standing collaboration with 
psychologist Stanley Wallenstein, who was his research associate for over twenty 
years. According to Houde' s research application budgets, Wallenstein was 
"responsible for the design and analysis of studies, statistical evaluation and 
psychological investigations. ,,585 It is not clear what, exactly, these "psychological 
. investigations" consisted of. However, the evolution of Houde' s research 
practices over the years show that numerous innovations in the statistical analysis 
of data were one of the principle means by which study designs were improved 
and simplified. Statistical manipulations often enabled more information to be 
squeezed out from fewer data. For example, Houde and Wallenstein sometimes 
used a "factorially designed experiment" in order to obtain "much more 
information with the same amount of data."S86 
Statistical means were also used to make results from different trials more 
comparable. Houde and his team used a statistical technique, the "ridit 
transformation," to convert scores obtained from individual studies into "a 
583 "Report of the NRC committee, Dr Isaac Starf, ehainnan, to visit Dr. Henry K. Beeeher's 
laboratory in Boston, Staturday, February 24th" Box 1 : Grantees: Beecher, H. K., 1950-1966, 
CDAN, NASA. 
584 Louis Lasagna, "Controlled Clincal Trial: Theory and Practice," Journal ofChronic Diseases 
1 (1955): 355-356. . 
585 Houde, "Application for Grant," Bulletin of the Committee on Drug Addiction and Narcotics 
(1962),3707. 
586 Houde and Wallenstein, "A Method for Evaluating Analgesies in Patients with Chronic Pain," 
Bulletin of the Committee on Drug Addiction and Narcotics (1953), 665. 
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probability unit relative to an identified distribution."S87 ln other words, this 
technique could make data from various trials comparable, despite variations in 
results obtained from different patient samples, in order to amass a greater amount 
of relevant data. It proved to be particularly use fuI for the VA Cooperative 
Analgesia Study, since, it was explained, it "tend[ed] to normalize the distribution 
and compensate for so called 'slippage' in the data."S88 The V A Study also relied 
on the statistical assistance of William Brown.589 Working with statisticians, and 
sometimes psychologists, was an important means by which investigators sought 
to manage variability in data about analgesic effects. 
6.2.4 Subjects 
The patients who served as study subjects were also important participants in the 
project of making analgesia measurable. Though they provided their services 
ephemerally, and, before 1962, usually unknpwingly (that is, they were not 
informed about the study or asked for consent), the analgesic clinical trial would 
have been impossible without subjects' active, and conscientious, participation. 
Their own judgments about their feelings of pain made up the raw data that would 
be transformed into information about analgesic efficacy. The varying ability of 
subjects to make such judgments was a central and difficult preoccupation for 
CDAN researchers. They knew that better subjects made better data. But what 
made a subject "good"? How could they select such subjects? How far could they 
go in excluding certain types of subjects before their samples became biased? 
Research reports rarely detailed the criteria for selecting subjects, beyond 
specifying that these should be "willing, cooperative, undistracted (sic)," 590 
587 Houde and Wallenstein, "Studies ofNareoties at memorial Cancer Center. L Clinieal Analgesie 
Studies," Bulletin of the Committee on Drug Addiction and Narcotics (1958), 1794-1811 
588 Paddock, et al. "A Cooperative Program for the Evaluation of Analgesies in Five Veterans 
Administration Hospitals," Bulletin of the Committee on Drug Addiction and NarcotÎcs (1963), 
3532. 
589 Brown was affiliated with the Department of Statistics of Stanford University. 
590 Beecher, "Experimental Pharmaeology," 160. 
235 
236 
"capable of communicating their subjective experience,,,S91 or able "to 
communicate weIl with the observer."S92 In addition, they usuaIly mentioned that 
patients should have pain severe enough to require a narcotic, and that they should 
not have any adverse reactions to narcotics. Such minimal qualifications seemed 
to imply that subject groups were representative of "ordinary people" whose 
idiosyncrasies and unreliable judgment could be cancelled out by proper study 
designs. In practice, however, investigators gave a lot of attention to the quality of 
their subject samples. When Eddy remarked in a CDAN meeting that "results 
from analgesic studies slow to be made available," Beecher "replied that the type 
of work he was doing requires very careful selection of patients and that it was 
difficult to find enough suitable cases even among the large number of patients in 
the Massachusetts General Hospital.,,593 Investigators' reluctance to provide 
details about how patients were selected suggests either that the procedure was 
difficult to explain or to codify, or, perhaps, that it was deemed somehow 
indelicate to draw attention to the handpicking of subjects. Such information 
might threaten the perceived representativity of samples and the image of 
"naturalism" with which clinical experiments were associated. 
It is difficult, in most cases, to even determine whose task it was to carry 
out the task of selection. In an oral history, Louis Lasagna remarked that he 
selected patients for Beecher's studies in the early 1950s: he went to see them pre-
operatively, and then wrote orders for them. He selected among non-private 
hospital patients, and did not explain the study to them, nor did he ask them 
whether they wanted to participate. 594 These subjects were also men. According 
to Lasagna, women were excluded because of Beecher's "stereotype that women, 
5911Ioude and Wallenstein, "Studies on Analgetics at Memorial Hospital. The Evaluation of 
Analgetics in Incurable Cancer Patients," Bulletin of the Committee on Drug Addiction and 
Narcotics (1953),417. 
592 paddock, "Report of the Veterans Administration Cooperative Analgesie Study: Analgesia, 
Relative Potency and Side Effects with Pentazocine (Win 20,228)," Bulletin of the Committee on 
Drug Addiction and Narcotics (1964): 3883. 
593 "Minutes of the 8th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1951), 192-3. 
594 "Oral History Interview with Louis Lasagna," 4-5 
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because of the menstrual cycles, have more ups and downs than men dO.,,595 In 
Lasagna and DeKornfeld's studies in the late 1950s, "patients were selected by a 
singlephysician," but they do not give further details in their report. A budget 
record indicates that, when William Beaver joined Houde's team,his job was to 
"assist in the screening and selècting of patients. ,,596 
At sorne point, however, it became Rogers' job to select patients in the 
Memorial trials.597 Her oral history provides more details on the criteria she used. 
It wasn't deslrable, for example, for a patient to die on the study, in case the death 
was imputed to the effect of an experimental drug, and Rogers became skilled at 
guessing when her terminal cancer subjects were nearing the end of their lives. 598 
In screening for subjects, she had to determine whethe'r they would be able to 
answer questions quickly and decisively. She even claimed to be able to tell a lot 
from their occupation. Doctors would usually refuse to participate in studies, 
while "engineers or statisticians ... were going to be very fussy and be very exact." 
Rogers "found that the patients with the least amount of education probably were 
better patients because they, it was a gut feeling on their part."S99 There were also 
"sorne patients who can't. They cannot tell you how much pain they have. T 0 
them, it's aU one pain and it's ail the same ... So that type of patient doesn't make a 
good study patient at aIl. But you do run into problems like that, you know. And 
the thing is that, if 1 thought the patient was not a good subject, 1 would drop 
them.600 
Investigators also attempted to increase the reliability and precision of 
their data by devising means of interrogating subjects that were adapted to their 
subjects' ability to disctiminate between levels of pain intensity or quantities of 
595 "Oral History Interview with Louis Lasagna," 35. Beecher also mentioned this criteria in 
"Experimental Pharmacology," 160. 
596 Houde, "Budget for 1963-4," Bul/etin of the Committee on Drug Addiction and Narcotics 
(1963): 3707. 
597 T. G. Kantor, "Application for Grants," Bulletin of the Committee on Drug Addiction and 
Narcotics (1966),4457-4466: in the Kantor's studies at Bellevue Hospital it was also the role of 
"especially trained nurses" to "select, medicate, and monitor patients." It seems to have become 
relatively common, by the 1960s, to give the job of subject selection to observers. 
598 "Oral History Interview with Ada Rogers," 15: "1 could tell within 24 hours, you know." 
599 "Oral History Interview with Ada Rogers," 14. 
600 "Oral History Interview with Ada Rogers," 14. 
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relief. They did this by experimenting with different rating scales and assessing 
subjects' responses to them. Beecher's team, for example, started out with the 
series of pain relief categories "none" "slight" "moderate" and "complete" but, 
after finding that they were unable to make them "meaningful in terms of 
analgesic potency" they searched for other options.601 Another set ofterms: "one 
dollar pain", "seventy-five cent pain", etc. gave distinctions that were "not sharp 
enough.,,602 Finally, Beecher's team settled on two categories only: relief and no 
relief, the first being defined as "the disappearance of 'most' or 'more than half 
of the pain," while anything less was counted as "no relief.,,603 
Houde's team also tried different strategies. They preferred to measure 
pain intensity, rather than relief, because they felt that judging relief depended on 
unreliable memories. They tried the responses "bearable" and "unbearable" but 
found that "bearable to the stoic is quite different from bearable to the 
hypersensitive individual.,,604 Pain charts didn't work because patients failed to 
fill them out regularly, and attempted to use them to get attention, and «what little 
data was presented was too highly loaded with emotional and other factors to be 
valuable for our purposes." In the end, "no pain", slight, moderate and severe 
pain, and "agony" seemed, for Houde's team, "to represent the smallest degree of 
pain both meaningful to, and easily measurable by, aU our patients.,,605 Though 
they recognised the categories to be arbitrary, they worked empirically.606 
601 Beecher, "A Method for Measuring Pain in Man," Bulletin of the Committee on Drug Addiction 
and Narcotics (1953): 649. 
602 Beecher, "A Method for Measuring Pain in Man," Bulletin of the Committee on Drug Addiction 
and Narcotics (1953): 658. 
603 Beecher, "A Method for Measuring Pain in Man," Bulletin of the Committee on Drug Addiction 
and Narcotics (1953): 649. 
604 "Minutes of the 9th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1952): 205 
605 Houde and Wallenstein, "Studies on Analgetics at Memorial Hospital: The Evaluation of 
Analgetics in Incurable Cancer Patients" Bulletin of the Committee on Drug Addiction and 
Narcotics (1953): 417. 
606 Houde and his colleagues recognised these categories to be arbitrary, and to mean "different 
things to different patients,"see: Houde and Wallenstein, "A Method for Evaluating Analgesics in 
Patients with Chronic Pain," Bulletin of the Committee on Drug Addiction and Narcotics (1953), 
661. However, they were widely considered to "work empirically in distinguishing between active 
and inactive drugs." See: Lasagna and De Komfeld, "Annual Report on Analgesic Testing," 
Bulletin of the Committee on Drug Addiction and Narcotics (1959): 1981. 
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Other investigators, such as Lasagna and his associate Thomas 
DeKornfeld, nevertheless continued spending time attempting to identify other 
factors that might influence how patients rated relief.607 Thus, investigators did 
not simply trust subjects to provide reliable assessments oftheir pain, but instead 
put a lot of emphasis on searching for means of interrogation that would make 
patients' judgments easier to make and thus more likely to be accurate. 
Subjects' abilities to disériminate between test drugs also came under 
investigators' scrutiny. Beecher's studies on the placebo effect originated with the 
concern that a large number of "placebo-reactors" in their patient samples might 
"submerge" the data from "non-reactors," the latter being responsible for showing 
a significant drug efféct.608 Therefore, with various collaborators, Beecher 
attempted to determine whether sorne subjects responded to placebos consistently, 
and whether they could be identified by psychological tests-a standard 
interview, an IQ test, a thematic apperception test and a Rorschach test-and by 
the observations of ward nurses. Beecher also designed experiments to 
investigate the effects of conditioning and suggestion on relief, for example by 
giving subjects three doses of morphine and then a dose of placebo, or vice versa, 
to determine whether immediate previous experience influenced the placebo 
response.609 In the end, there appeared to be no "tags" that investigators could 
"put on these people" in order to make more uniform and discerning subject 
607 Louis Lasagna and his assistant Thomas DeKomfeld conducted a study in which they asked 
subjects to place different levels of pain intensity on a "pain thermometer" ranging from 0 to 100 
degrees, and to judge which drop in pain intensity they would be "most grateful for." They found 
that subjects varied widely in how they spaced out pain intensities, and what kind of relief they 
would des ire most. See: Lasagna and De Komfeld, "Annual Report on Analgesic Testing," 
Bulletin of the Committee on Drug Addiction and Narcotics (1959), 1978-1986. In their previous 
study, the same researchers decided to replace direct questioning with a peg board in order to 
determine whether their results would match more cJosely with the results obtained by this method 
by another team, see: "Minutes of the 1 9th Meeting," Bulletin of the Committee on Drug 
Addiction and Narcotics (1958). 
608 8eecher, "Annual Report and Application for Renewal of Support to the CDAN of the NRC, 
January 21, 1952" Bulletin of the Committee on Drug Addiction and Narcotics (1952): 222, a 
high proportion of placebo responders might also lead results to underestimate effective drug 
dosage. 
609 Beecher, "Progress Report, June 1-31 December 1950," Bulletin of the Committe.e on Drug 
Addiction and Narcotics (1951): 140. See also: Beecher, "Suggestion Study," Bulletin of the 
Committee on Drug Addiction and Narcotics (1952): 245, in which patients were given saline and 
told they were "going to receive a wonderful new drug" or morphine, described as "a new drug 
that probably would not relieve his pain to study the effects of suggestion on relief. 
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samples, but the types of experiments that were carried out clearly show that 
investigators hoped that greater knowledge about their subjects' psychologies 
would help them to produce more reliable experimental samples.610 
Investigators' concems about subjects' varying ability to perform their 
experimental role were again manifested as a response to the introduction of 
informed consent legislation by the FDA in 1962. This provision had provoked 
"considerable discussion" among committee members, who worried that the 
"requirements of a double-blind study might preclude the obtaining of 
consent. .. ,,611 Even Beecher, now famous for blowing the whistle on a series of 
"unethical" experiments in 1966, wrote, in 1965, to Commissioner Larrick of the 
FDA to wam that, if the consent provisions were to be followed strictly, it would 
be "difficult, if not impossible" to continue doing this type of study. Beecher 
proposed that, in some cases, consent was not only unnecessary but even harmful: 
"It has seemed to me that no violation of ethics occurs when no discemible risk is 
involved and when discussion with the subject would jeopardize, if not destroy, 
the possibility of getting valid data. This applies as much of the work on the 
effects of drugs on the subjective responses.,,612 
To solve the problem ofmaintaining the double-blind while still obtaining 
consent, Houde's teamdeveloped their own consent form as "a more reasonable 
substitute" to the one that had been imposed by the New York City Department of 
610 Beecher, "A Study of the Placebo Response," Bulletin of the Committee on Drug Addiction and 
Narcotics (1953): 377. Houde's team did not feeljustified in eliminating "placebo responders" 
From their samples because of the risk of introducing a selection bias. However, they were also 
concemed with the fact that the sensitivity oftheir method was limited by the "discriminative 
ability" oftheir groups. Their opinion might have been different, they suggested, ifthere existed a 
means ofpredicting subjects' responses before they entered the study.However, Houde later 
pointed out that sorne "placebo-reactors" were also "discriminators," that is, they could "tell the 
difference" between active and inactive drugs, and therefore it was not wise to exclude the 
valuable data they contributed to positive results.See: "Minutes of the II th Meeting," Bulletin of 
the Committee on Drug Addiction and Narcotics (1953): 366; Houde and Wallenstein, "Studies 
on Analgetics at Memorial Hospital: The Evaluation of Analgetics in Incurable Cancer Patients," 
Bulletin of the Committee on Drug Addiction and Narcotics (1953): 421; Houde and Wallenstein, 
"A Method for Evaluating Analgesics in Patients with Chronic Pain," Bulletin of the Commitlee on 
Drug Addiction and Narcotics (1953): 670. 
611 "Minutes of the 25th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1963):3115 
612 8eecher to Eddy, November 4, 1965, Box 1: Grantees: Beecher, H. K., 1950-1966, CDAN, 
NASA. 
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Hospitals. The new form provided no drug names, nor did it mention the use of 
placebos.613 The self-selection of patients who accepted to participate in studies 
was still considered as a possible source of bias, and the question became the 
hypothesis of an experiment by Thomas DeKornfeld in 1966, who attempted to 
determine whether consenters were more or less susceptible to analgesia than 
non-consenters.614 At the same time,. Lasagna and his collaborator John Pearson 
were also conducting studies on consent issues. They found a very high refusaI 
rate in· postpartum patients, raising questions about wasted time and "the scientific 
value of data from such a special minority.,,615 
CDAN investigators evidently remained uneasy about leaving the task of 
judging analgesic effects to imperfect and idiosyncratic subjects. They made 
various types of attempts to increase the accuracy and uniformity of data by 
improving subjects' responses through more rigorous selection or better methods 
of interrogation. To do this, they tested their subjects: their personalities, their 
susceptibility to suggestion and conditioning, their ability to manipulate different 
types of measurement instruments and their reaction to being asked for consent. 
Even though many of these studies did not lead to concrete methodological 
changes, they testify to the hope held by researchers that the se would be fruitful 
avenues of investigation: that by obtaining more information about the patterns of 
subjects' responses to the experimental situation, they cou Id tighten their 
experimental control. These investigations treated subjects as thinking and feeling 
individuals, who were likely to be influenced by their emotions, their prior 
experience and their environments. In other words, in order to increase the 
objectivity oftheir methods, investigators found it necessary to enrich their 
understanding of the subjectivity of patients' judgments of pain. 
613 R. W. Houde, S. L. Wallenstein and W. T. Beaver, "Analgesie Studies at Memorial Sloan-
Kettering Cancer Center," Bulletin of the Committee on Drug Addiction and Narcotics (1965): 
415-7-4158. 
614 T. J. DeKornfeld, "Annual Report on Analgesie Studies," Bulletin of the Committee on Drug 
Addictlon and Narcotics (1966): 4717-4725, in this study, one group of patients was asked for 
consent, another was not. Both were given morphine sulfate, the standard drug. Both groups 
seemed to respond similarly, but it was possible that the consenters received more reliefthan the 
non-consent group. DeKornfeld recommended"much additional work" on this problem. . 
615 J. W. Pearson and L. Lasagna, "Recent Experience in Clinical Analgesie Evaluation," Bulletin 
of the Committee on Drug Addiction and Narcotics (1967), 5155-5158. 
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6.3 CDAN in the Middle: the Politics of Sponsoring 
It is somewhat surprising that the pharmaceutical industry paid for the 
development of analgesic clinical trial methodology. As Harry Marks has shown, 
the RCT was promoted by many reformers who believed this technology could 
protect the autonomy and neutrality oftherapeutic judgment against the 
commercial motivations of drug manufacturers. In addition, pharmaceutical firms 
were not required before 1962 to prove the efficacy of new drugs in order to 
obtain FDA approval. However, as we've seen, pharmaceutical firms seemed 
primarily interested in testing the efficacy of analgesics for purposes of 
innovation rather than regulation, though information about efficacy also entered 
into calculations of toxicity, and th us served a regulatory purpose. Industry 
interests in analgesic innovation thus motivated pharmaceutical firms to 
collaborate with CDAN and contribute to a common pool, and they also 
demanded that such tests should bedone in humans. But how did this money 
come to be invested in clinical trial methodology, and to pay for sorne research 
that brought no clear immediate benefits to industry? 
In this section, 1 will discuss how CDAN funds were distributed, and 
whose interests shaped the content ofCDAN-funded research. To a large extent, 
the latter was determined by researchers themselves, who were free to propose 
projects on the basis of work they wanted to do, or thought should be done. 
However, pharmaceutical representatives sometimes expressed impatience when 
researchers embarked on seemingly tangentiallines of inquiry or failed to give 
results rapidly enough. CDAN members thought it important to satisfy their 
sponsors and secure continuing support, but mainly seemed to be concerned about 
their grantees' scientific autonomy. They were adamant that the research pro gram 
should not, as Starr put it, "degenerate into a simple matter of clinical testing," 
and insisted on approving "fundarnental research" bearing on methodological 
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issues and a broader understanding of analgesia.616 The freedom afforded to 
CDAN grantees, which may not have been as great under direct industry funding, 
made it possible to engage in methodological explorations and perhaps, 
ultimately, to make the analgesic clinical trial work.better. 
The reactions of industry sponsors to CDAN-funded research, particularly 
8eecher's, provoked discussions among committee members about CDAN's 
duties towards "science" -that is, towards the concept of "fundamental 
research," the NRC's reputation and their grantees' research interests-in running 
a research program mostly funded by, and ultimately aimed to bene fit, the 
pharmaceutical industry. In the early 1950s, 8eecher began to turn away from the 
immediate practical details of how to run analgesic clinical trials, and to ask 
questions about how suffering subjects responded to drugs in experimental 
situations. He began to investigate phenomena such as conditioning, suggestion 
and placebo effects, looking for possible sources of error in analgesic testing. 
These studies, however, became less directly concerned with testing 
methodology, and increasingly oriented towards broader elucidation of 
mechanisms of pain relief, and even of the nature of pain itself. 
Was such work relevant to the Committee's granting pro gram? For over a 
decade, Committee members answered affirmatively, but not without discussing 
the nature of the granting program and particularly the weight to be given to 
perceived opposition from their indus trial sponsors. Members often described the 
purpose of the granting program as the support of "fundamental research." What 
did this mean? It seems to have been the opposite of "our program [degenerating] 
into a simple matter of clinical testing," a program that would "get plenty of 
support from various drug houses.,,617 Thus, "fundamental" qualified research that 
did not have immediate, practical and, particularly, commercial benefits. 
Committee members often expressed the need to see beyond such benefits-
616 "Minutes of the Il th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1953),388. 
617 "Minutes of the Ii th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1953),388. 
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which they assumed pharmaceutical manufacturers were interested in-and thus 
to exclude their sponsors from "scientific" decision-making. 
At the same time, the Committee portrayed itself as a protector of 
industry's long-term interests. Starr concluded his comment: "We are interested 
in fundamental research in a way that the drug houses ought to be interested in the 
long run, what they make money on is dependent on it." "If the program 
degenerates into simply drug testing," he added, "the good people aren't going to 
want to do it and the Research Council won't want to give time and effort to 
it. ,,618 
Committee members were also concerned about keeping their sponsors 
happy, and occasionally interposed themselves between sponsors and grantees' 
work in an effort to maintain good relations. For example, they attempted to 
reassure their sponsors of the quality ofCommittee-funded research. Along with 
the minutes of a 1952 meeting, a letter was sent to the pharmaceutical companies 
that funded CDAN. The letter not only emphasised the relevance of Beecher's 
work, but also underlined the importance of the Committee's opinion: "While [his 
method] is tedious and expensive, Dr Beècher has been doing an outstanding job 
on the controlled study of analgesics in man and has had the courage to tackle the 
study of sorne of the disturbing and modifying factors in clinical testing of new 
drugs. The Committee considers it most important to continue the study of these 
factors.,,619 
Committee members were also interested in what their sponsors had to say 
about their program. In 1953, a letter seeking written comments was sent to 
CDAN's sponsors. This action was taken in response to a verbal comment 
reported by Eddy to the effect that "the direction of sorne of the work was taking 
was too non-objective." To Eddy, this implied that sorne pharmaceutical 
representatives thought that "Dr. Beecher's work appeared to be going off on a 
tangent instead of producing concrete results in clinical evaluation of 
618 "Minutes of the Il th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1953),388. 
619 Untitled (Letter to Pharrnaceutical Manufacturers), March 3, 1952, Box 2: General, 1947-June 
1959, CDAN, NASA" ,', 
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analgesics.,,620 The comments, however, ended up being more positive than Eddy 
had expected.621 Though Lederle had wamed that, as "diversifications tum up the 
main goal shoulcLnot be lost sight of because of possible primary interest in the 
interesting side problems,,,622 Mallinckrodt was full of praise for the Committee, 
which was "rendering a very definite service to the drug industry" by encouraging 
the study of "basic problems of mutual interest. .. which no one organization 
could afford to support alone." This was "especially true ofthose problems 
having little, or no, immediate practical application." Beecher's work, in 
particular, was described as "a very important contribution." 623 Two companies, 
Abbott and Upjohn, tentatively suggested a re-exploration of laboratory tests of 
analgesia, which would be more economic than clinical trials.624 
Committee members disagreed about how much consideration should be 
given to industry opinions. In 1955, the Committee was discussing Beecher's 
departure from work on that bore directly on drug testing methods towards "more 
theoretical aspects" of analgesia. Cameron explained that Beecher "had been 
asking, 'When a drug is effective, why is it effective?'" To Cameron, this was "a 
most important question. " The committee should support work in the testing of 
analgesic drugs and on the manner oftheir action." Seevers, however, was not 
sure that such work should be supported with Committee funds which: "come 
from industry and industry has not been satisfied with Dr. Beecher's work. If 
long-term support is to be considered, the work must be of sorne recognized 
benefit to industry." Despite these reservations, continued funding for Beecher's 
work was unanimously approved.625 
The following year, CDAN again asked industry representatives for their 
opinion on whether they approved continuation of support for five sponsored 
620 "Minutes of the Il th Meeting," Bulletin of the Committ~e on Drug Addiction and Narcotics 
(1953),387. 
62\ Eddyto Starr, May Il,1953, Box2: General, 1947-June 1959, CDAN, NASA. 
622 Eddy to Starr, May Il, 1953, Box 2: General, 1947-June 1959, CDAN, NASA. 
623 dd E Y to Starr, May Il, 1953, Box 2: General, 1947-June 1959,CDAN, NASA. 
624 A couple of studies on experimentallaboratory analgesic testing methods were funded by the 
Committee, but the Committee did not appear to be particularly interested in these projects and 
withdrew its support. 
625 "Minutes of the 15th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1955): 1023. 
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projects, and.to assign a priority to each. This evoked strong opposition from 
Louis Lasagna, who described the "sounding out" of drug companies as a 
"pemicious practice." Financial support, according to Lasagna, should be 
attributed "on scientific merit and not to fit with the desires of drug houses.,,626 
This was also the position of the NRC and, generally, ofCommittee members.627 
Eddy, who claimed responsibility forthe "questionnaire," defended himself. 
Lasagna has misinterpreted his intentions. It was useful to know the feelings of 
representatives, who were in a position to make positive recommendations to their 
companies, "in framing our annual appeal for continued support." In particular, 
Eddy had wanted to verify whether "the feeling of criticism toward Beecher" 
which had been hinted at by comments from the industry, if it was real, was still 
existent. 628 
Such discussions, however, became less frequent. As the Committee's 
research program began producing more concrete results on relative drug 
potencies from 1958, industry support seems to have become more secure. At the 
same time, however, industry influence also became more present in the granting 
program. lndividual drug companies began occasionally exerting their influence 
over research by earmarking funds for specifie studies, usually when their own 
drugs were being tested. For example, in 1958, Leo J. Cass conducted a study of 
various substances classified as mi Id analgesics, sorne of which were already sold 
commercially. The Committee generally refused to fund the evaluation of mi Id 
analgesics because itsfocus was on narcotics. For drug companies, however, 
over-the-counter pain relievers represented a lucrative market. For Cass' study, 
Eddy recalled, "the producers of the respective active agents not only supplied 
their products generously, but also allocated to the Committee special funds to 
support the project.,,629 The budget for that year shows that Endo Laboratories, 
626 Lasagna to Cannan, February 2, 1956, Box 2: Administration-General, Drug Addiction, 
CDAN, NASA" 
627 Cannan to Lasagna, February 6, 1956, Box 2: Administration-General, Drug Addiction, 
CDAN, NASA. 
628 Eddy to Cannan, February 10, 1956, Box 2: Administration-General, Drug Addiction, CDAN, 
NASA. 
629Eddy, The National Research Council, 76. 
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Burroughs Wellcome, Wyeth Laboratories and Eli Lilly and Company provided 
funds that were specifically marked out for Cass' studies.630 The same year, 
Merck and Hoffmann-LaRoche destined their grants for Arthur Keats, who was 
evaluating the analgesic effectiveness of opiate antagonists, that is, drugs that 
countered the effects of opiates (these drugs are used to treat narcotic 
overdoses).631 There was hope that this class of drugs might hold the key to 
developing a non-addictive analgesic, which, again, was very interesting for drug 
manufacturers. Such direct earmarking of funds was not common within the 
Committee's program. However, as clinical testing methods became better 
established and more teams were equipped to carry out these studies, 
pharmaceutical companies-as weIl as the NIH-increasingly provided grants 
directl y to researchers.632 
From the early 1960s, committee members also began soliciting support 
from public sources. They were able, by persuading potential sponsors that their 
interests in analgesic testing were mutual, to obtain additional funds for the V A 
Cooperative Analgesie Study from the V A Committee on Medical Affairs and the 
Office of Civil Defense (OCD). The V A put in from $5000 to $10 000 yearly for 
the VA Study from 1961 to 1970.633 When the Office of Civil Defense (OCO) 
became concemed with the choice of analgesic to stock in medical kits in public 
fallout shelters, Eddy engaged in negotiations with the OCO concerning the 
possibility of obtaining financial support. The OCD put in nearly $45,000 for 
630 "Minutes of the 1 9th Meeting: Budget,"Bulletin of the Committee on Drug Addiction and 
Narcotics (1958): 2090 
631 "Minutes of the 1 9th Meeting: Budget,"Bulietin of the Committee on Drug Addiction and 
Narcotics (1958): 2090 
632 w. H. Forrest, "Report of the Veterans Administration Coopertive Ananlgesic Study," Bulletin 
of the Committee on Drug Addiction and Narcotics (1966): 4673-4691. Supported by V A, NIH 
as weil as Eli Lilly & Co. and E. R. Squibb and Sons. T. G. Kantor, "Application for Grants," 
Bulletin of the Committee on Drug Addiction and Narcotics (1966),4466, reported receiving 
grants from Bristol-Myers Co., Squibb Institute, and Miles-Ames Co. in amounts ranging from 
7,500$ to 25,000$ for the construction of new offices and the salary of the investigator. He had 
also made an application to NIH for funds for another nurse observer, a programmer, a statistician 
and other researchers' salaires. 
633 Eddy, The National Research Council, 164, table 3 of Appendix 3. 
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three years. "It was," said Eddy, "this added resource that allowed the Committee 
to assist the V A Cooperative Analgesie Study.,,634 
CDAN's research program was shaped by a complex mix ofinterests, and 
it is difficult to evaluate how each influenced its final content. It seems, however, 
that CDAN members were fairly successful in obtaining funds-by emphasising 
how their interests converged with potential sponsors'-that could be deployed on 
their own terms. Concemed about the perceived narrowness of sponsors' interests, 
CDAN members emphasised the dangers of compromising the scientific integrity 
of the program, and, to a great extent, allowed grantees to pursue their own 
researeh interests. The result was the creation of a space in which testing 
methodology could be not only worked with, but also worked on, and included 
methodological explorations of which the relevance was questioned by sponsors. 
This work was ultimately aimed at improving testing practices. While this was not 
always the case, this work did contribute to the creation of new kinds of 
knowledge about the nature of pain, analgesia, and clinical experimental 
conditions 
6.4 Points of Contact: Diffusing the Analgesie Clinical Trial 
Analgesic testing technologies would be of little use to the Committee, or their 
sponsors, it they could not produce comparable results in multiple testing sites. As 
funding for analgesic testing continued to increase, through both CDAN's budget 
and other public and private grants, Beecher's methodological model was adapted 
and adopted by a growing number ofresearchers. In the context ofCDAN's 
research pro gram, the diffusion of the analgesic clinical trial can be divided into 
two phases. Before the organisation of the VA Cooperative Study, the clinical 
trial was implemented in new sites, but there was little explicit discussion about 
how to standardise its use. Nevertheless, it is possible to trace links of contact and 
communication that probably facilitated the replication of experimental 
procedures. As plans started being made for the VA study, however, CDAN 
634 Eddy, The National Research Council, 108. 
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members and grantees turned their attention towards more explicit means of 
standardising the procedures of analgesic testing. 
One of Beecher's earliest stated objectives with regards to analgesic 
testing was to provide a means of standardising clinical studies. From his first 
published papers on the topic, he drew attention to his innovative methodological 
devices, and provided reasons why other researchers should adopt them. His 
persuasiveness, assisted by broader trends that made clinical trial methodology 
appealing to anaesthesiologists and clinical pharmacologists, probably facilitated 
the initial diffusion of his method among the rese~rchers who would become 
CDAN grantees. 
Information about how to run analgesic clinical trials traveUed through 
both direct and indirect contacts. Several researchers had the chance to leam the 
ropes of analgesic testing with an experienced investigator before setting up their 
own experiments in a new site. Arthur Keats and Louis Lasagna worked as 
Beecher's assistants, Thomas DeKomfeld worked with Lasagna, while Weldon 
BeUville worked with Houde. They would have become familiar with certain 
procedures-such as selecting patients and instructing observers-which were 
probably importantto the smooth operation of clinical trials, but were not 
described in detail in early publications. In addition, new teams often, if not 
always, ran pilot studies to work out the kinks in their procedures. Usually they 
tested doses of morphine against each other-5mg against lOmg, or 10mg against 
10mg-to make sure their method was capable to giving the expected results. 
Other researchers did not receive this training in running trials, but they 
patterned their methods on Beecher's model. These researchers-Raymond 
Houde, Leo Cass and Lyndon Lee-were also in contact with CDAN before they 
began developing their clinical methods. Early on, CDAN meetings became 
conferences on narcotics research at which grantees, and sometimes outside 
guests, presented their methods and results. Houde and Lee had been invited to 
sorne of these meetings. Cass and Lee consulted with Committee members while 
they were working out the protocols for their studies. Though their designs were 
not exact reproductions of Beecher' s, they adopted its basic elements and 
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modified others. Houde's team, for example, asked subjects about the intensity of 
their pain instead of their degree of relief. However, initially, they also asked the 
same question as Beecher because they thought it important to pro duce 
comparable data.635 Houde's modified design also become an influential model 
for future analgesic studies, despite the fact that Houde did not publish on these 
studies outside the Committee until the latter half of the decade 636 
It is difficult to evaluate the extent or importance of the contacts and 
influences mediated by CDAN in ensuring the successful reproduction of methods 
of analgesic evaluation. However, it is clear that many clinical studies conducted 
in the 1950swithout CDAN sponsorship did not adopt similar techniques for 
evaluating pain, placebo-controlling or employing full-time observers.637 It would 
seem likely that the combination of CDAN funding-which made reproducing 
designs, particularly in the matter ofhiring observers, financially feasible-and of 
the contacts provided by its activities and conferences, favoured a certain amount 
of conformity in the adoption of analgesic testing methods. 
In the VA Cooperative Analgesic Study, however, CDAN's role in 
standardising practices and expertise for the diffusion of clinical trial 
methodology is more obvious. In preparing for the study, Committee members 
and VA investigators explicitly discussed questions ofmulti-site standardisation. 
The idea of running a cooperative study of analgesics in V A hospitals was 
reportedly inspired by the success of previous cooperative studies run by the V A, 
and by the capacity ofthis hospital system to provide the necessary resources, 
particularly patients, for analgesic evaluation.638 In the late 1950s, Lyndon Lee, 
who had recently been hired by a V A hospital, developed an experimental 
protocol with Eddy's help.639 The VA Committee on Veterans Medical Problems 
approved the protocol in principle, and an Ad Hoc Group to Consider Proposed 
635 "Oral History Interview with Ada Rogers," 5. 
636 "Oral History Interview with Louis Lasagna," 42. 
637 Kraptchuk, "The Powerful Placebo." 
638 Paddock, et al. "A Cooperative Program fo the Evaluation of Analgesies in Five V A 
Hospitals," Bulletin of the Committee on Drug Addiction and Narcotics (1963): 3530. 
639 Gilbert W. Beebe (Committee on Veterans Medical Problems) ta Starr, Nov~mber 19, 1957," 
Box 1: Grantees: Lee, Lyndon E. Jr., 1954-1969, CDAN, NASA. 
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Clinical Investigation of Analgesic Drugs in V A Hospitals was formed, and met 
in 1958. 640 It was the consensus within this group, which was composed of 
CDAN members, representatives of the NRC and of the Committee on Veterans 
Medical Problems, that "leadership" should be provided CDAN in matters of 
experimental design, as weil as the selection of test drugs and data analysis. 
CDAN's methodologicalleadership was essential because, as the group agreed 
though "thespecific protocols seem well-conceived ... any research in the area is 
beset with pitfalls for the unwary.,,64 1 
Those who planned the V A trials seemed to agree that written direction, 
such as these protocols, did not provide aU the information necessary required to 
run clinical trials successfully. Members'of the Ad Hoc Committee were 
concemed that it might be difficult to find "interested, suitably trained 
professional and technical personneL ,,642 T 0 help standardise experimental 
procedures in multiple sites, under the supervision of "green" investigators, the 
Ad Hoc Committee recommended several actions. In 1958, "the group felt that 
potential new investigators should be given an opportunity to visit centres where 
successful workof this kind is already being done. Dr. Eddy offered to assist in 
making such arrangements." Houde and Keats' work were chosen as models for 
the VA protocoL It was also recommended that a pilot study needed to be run 
before any large-scale evaluation began.643 
In addition to providing advice on the design of experiments, CDAN acted 
as a point of contact between new investigators, observers and "old hands" in 
analgesic testing. As a result of an initial pilot study, which was put off until 1961 
640 B b ee eto Starr, November 19,1957, Box 1: Grantees: Lee, Lyndon E. Jr., 1954-1969, CDAN, 
NASA. 
641 "Report of Ad Hoc Group to Consider Proposed Clinical Investigation of Analgesie Drugs in 
VA Hospitals," Bulletin a/the Committee on Drug Addiction and Narcotics (1958): 1897. 
642 "Report of Ad Hoc Group to Consider Proposed Clinical Investigation of Analgesie Drugs in 
VA Hospitals," Bulletin of the Committee on Drug Addiction and Narcotics (1958): 1897. 
Also After visiting Eddy, Houde and Keats in 1961, Richard Paddock, who was to be put in 
charge of the V A Analgesia Cooperative Study, reported that he had found that "what these 
investigators were going was extremely interesting and it was apparent that careful preparation 
and training would be necessary before 1 could embark on an analgesic testing program." 
643 "Report of Ad Hoc Group to Consider Proposed Clinical Investigation of Analgesie Drugs in 
V A Hospitals," Bulletin of the Committee on Drug Addiction and Narcotics (1958): 1896-1898. 
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because of lack of funding, additional measures of standardisation were 
recommended. Bellville suggested that the training of observers was crucial for 
preparing successful analgesic testing. A "well-trained observer" would "work 
intelligently within the framework of the experimental protocol." Forrest spoke in 
favour of computerizing data processing and analysis. The Committee agreed that 
observers would be trained in New York or Palo Alto, that each V A hospital 
would carry out a "standardisation study"---()omparing 5 and 1 Omg of morphine 
against 10mg of morphine-and that plans would be made for the centralised 
collection and processing of data.644 
Those who had already built up expertise in running clinical trials with the 
help of CDAN funding provided guidance to V A researchers in visits, meetings 
and the design of the protocol. "The discussions," with experienced investigators 
was described by Paddock as, "friendly, interesting, and at times, outright 
frank. ,,645 Investigators were also available to work out problems as they arose. In 
1963, BeUville wrote to Lee complaining that "The Yes-No scoring system 
doesn't seem to work for us as well as it does for Dr. Keats. It might be well to 
get him to stop by for a visit soon to make sure we are scoring 50% responses 
exactly as he does. ,,646 
CDAN also encouraged the development of tools to standardise the 
collection of data and centralise its analysis. Encouraged by Eddy and Lee, 
CDAN and VA investigators, along with John C. Seed, got together to collaborate 
in the development of a standardised data collection form that would be tested, 
and then implemented in VA studies.647 Such a card would have two purposes: to 
render data collection practices more uniform between multiple sites and 
observers, and to fit data into the form required for computer processing. CDAN 
put its weight, and the authority of the NRC, behind the final version of the form 
644 "Minutes of the Committee Meeting, VA Study Group in Anesthesia and Analgesia, October 
21, 1962," Box 2: VA Cooperative Project, CDAN, NASA. 
645 R. B. Paddock, et al. "A Cooperative Pro gram fo the Evaluation of Analgesies in Five V A 
Hospitals," Bulletin of the Committee on Drug Addiction and Narcotics (1963): 3531. 
646 Bellville to Lee, August 7, 1963, Box 2:VA Cooperative Project, CDAN, NASA. 
647 W. H. Forrest, et al., "A Uniforrn Method for Collecting and Processing Analgesic Data," 
Bulletin of the Committee on Drug Addiction and Narcotics (1963): 3547-62. Seed had pioneered 
the use of such data fonns at Cal vary Hospital in New York. 
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by approving it officially. Jonathan Cole, a member ofCDAN and editor of 
Psychopharmacology Bulletin agreed to publish the form, along with an 
explanation of its history, objectives, and the desirability of its widespread use in 
analgesic testing across the country.648 The form was also reproduced in the 
minutes of the CDAN meetings.649 Enquiries were also made about the possibility 
ofpublishing the form in Science.650 The objective of the Committee was to 
"urge" that the form, called the National Amilgesic Study Form, be used "as 
widely as possible for greater uniformity and comparability of data in this field." 
Bellville, one ofthe authors ofthe form, was told that "[the Committee's] 
approval and urging can be quoted.,,65 1 Though developed for the purpose of 
standardising the VA Study, it was hoped that the form might help standardise 
analgesic testing on nothing less than a national scale. 
CDAN also took the initiative to encourage the development of a 
computer program to analyse analgesic data. A grant of $4,500 was made to 
Eugene Laska in 1963.652 Such a program was said to have several advantages: it 
saved labour in processing and analysing data; it made it possible to rapidly try 
out different ways of analysing data, and helped to understand and manage any 
discrepancies in data that might arise between testing sites.653 Using computer-
analyses, the V A team were able to modify study design in ways that allowed 
them to collect more data in less time. For example, new methods of analysis 
made it possible to include "incompleters"-subjects who had not taken an entire 
round of medication-intothe calculation of results, thus saving time in 
completing studies. 654 
648 Forrest, Jr., et al., "A Unifonn Method," 1-10. 
649 Eddy to Bellville, March 21 1963, Box 1: Grantees: Bellville, J. W., 1961-1963, CDAN, 
NASA. 
650 "Minutes of the 2S th Meeting," Bulletin of the Committee on Drug Addiction and Narcotics 
(1963): 3 116 
651 Eddy to Bellville, Mareh 21 1963," Box 1: Grantees: Bellville, 1. W.: 1961-1963, CDAN, 
NASA. 
652 "Minutes of the 26th Meeting," Bulletin of the Committee onDrug Addiction and Narcotics 
(1964). 
653 Forrest, Jr., et al. "A Unifonn Method," 1-1 O. 
654 W. H. Forrest, "RepOli of the Veterans Administration Cooperative Analgesie Study," Bulletin 
of the Committee on Drug Addiction and Narcotics (1966) 4673-4691. 
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By 1964, Paddock could declare that the V A sites had evolved into 
"pharmacological clinicallaboratories"; "It has taken our group about a year and a 
halfto organise and standardise our method of study. 1 believe we now have, after 
sorne eightèen months of intensive work involving many interested and competent 
people, developed a method of drug study which is reliable. Further, we have 
access to a computation center and the keen minds associated with such a place. 
We submit that the members and consultants of the VA Study Group ... are in an 
enviable position to provide sound objective and well documented clinical 
pharmacological research to the benefit of medicine and the pharmaceutical 
industry.,,655 
The work that went into successfully standardising, diffusing and 
replicating clinical trial methodology is difficult to calculate because it shows 
itself negatively in the absence of debates, disputes and discrepancies. Other 
attempts to resolve questions about analgesic efficacy with clinical studies in 
different contexts do not seem to have been as successful as CDAN-funded 
studies. As Marcia Meldrum has shown, clinical trials of the analgesic Darvon 
varied in their methodology and results, and, because of these discrepancies, and 
disagreements about how to interpret them, the trials carried little weight in 
swaying therapeutic or regulatory decisions about its efficacy.656 As we-will see in 
the following chapter, clinical trials of acupuncture's pain-relieving efficacy 
failed to be conclusive because of disagreements about how they should be run, 
and a lack of mechanisms and aut~ority for coordinating the implementation of 
enough trials to produce sufficient volumes of data that would be seen as valid. In 
contrast, these cases underscore the considerable achievement in a relatively 
smooth process ofmethodological diffusion in the VA study and other CDAN-
funded studies, and emphasise the importance of the contacts and coordination, as 
weB as the money, provided by CDAN that seem to have made this possible. 
Those who made methodological decisions within CDAN's program were 
in contact with each other, and they shared tools and information. They had 
655 Paddock to Bird, Mareh 2, 1964, Box 2: Winthrop Laboratories (Riee), CDAN, NASA. 
656 Meldrum, "Departures from the Design," 310-372. 
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access to the means to replicate certain key conditions, in particular the hiring of 
special staff. In addition, their interests were similar, and they were unlikely to 
disagree on major theoretical or methodological points. This made it possible to 
pro duce fairly consistent data about pain relieving efficacy, which was considered 
to be reliable and objective, despite the variability of individual experiences and 
expressions of pain. As the next chapter will show, it would be much more 
difficult to achieve these conditions when analgesic testing technologies were 
designed, run and evaluated by a larger number of people with heterogeneous 
interests. 
Conclusion 
Making the analgesic clinical trial into a trusted technology of pain-measurement 
took time, effort and resources. The formation of alliances between various 
sponsors interested in analgesic evaluation and innovation provided the funds 
necessary for the introduction of key aspects of experimental design, such as the 
hiring of full-time observers. The exclusion of the se sponsors from decisions 
about the distribution of grants made it possible for researchers to explore a 
variety ofmethodological issues, such ashow to best manage the active 
participation of their experimental subjects. Investigators engaged in this 
methodological work for their own reasons, as we have seen from how it fit into 
their career trajectories, which made them committed to making the analgesic 
clinical triaitrustworthy. They were not able to do this alone, however. They 
required the assistance of various collaborators, who provided labour and 
expertise, particularly observers who played a crucial role in ensuring the "day to 
day standardisation" of the method and the production of consistent and reliable 
data. The cooperation of subjects was also necessary, but investigators seemed 
somewhat uneasy with this, and sought to obtain information about their subjects' 
abilities and susceptibilities. Finally, the smooth replication of clinical trial 
methodology required the formation of points of contact for the diffusion of 
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information, both tacit and explicit, and was assisted by the creation of 
technologies of standardisation. 
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7. Acupuncture, Pain and the Proof of Efficacy 
When acupuncture hit the American news in the early 1970s, new actors joined in 
public discussions about the value ofpain-measuring technologies. Journalists, 
chronic pain sufferers, legislators, congressmen, acupuncturists, clinicians, and 
various types of medical researchers expressed their views on the question: By 
what means could persuasive evidence for the pain-relieving efficacy of 
acupuncture be produced? Their various, and often divergent answers reflected a 
debate over the definition of appropriate conditions and practices for making valid 
judgments about experiences of pain and therapeutic efficacy. More importantly, 
they disputed to whom such judgments could be entrusted. In this chapter, 1 will 
examine representations of pain-measuring technologies, particularly the clinical 
trial, in the American debate on the efficacy of acupuncture anaesthesia and 
analgesia from late 1971 into 1974. 
The discovery of acupuncture anaesthesia by Americans signalled a new 
era in Sino-American relations. After decades oftight restrictions on travel and 
communication, the "bamboo curtain" became permeable to the gaze of American 
eyes, lifting to reveal glimpses of a new China fashioned by the Cultural 
Revolution. One of its most astonishing features was acupuncture anaesthesia, a 
technique born from the hybridisation of ancient tradition and modern medicine 
that rendered surgery painless using just a handful of vibrating needles, without 
knocking the patient out. The American fascination with acupuncture soon 
generated a traffic of images and people between the two countries. Dramatic 
eyewitness narratives of surgical anaesthesia obtained by acupuncture became a 
feature ofjournalists' and travelling scientists' reports oftheir journeys to the 
People' s Republic of China (PRC). These graphie descriptions of patients lying 
calmly and awake, even "cheerfully conscious,,657 as they were cut open and 
relieved of tumours and organs, were given wide circulation in daily newspapers 
and the medical press. 
657 "U. S. Doctor Hails China's Medicine: Rosen Praises Acupuncture and Mass-Care Plan." New 
York Times (31 October, 1971), 20. 
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These reports were met by some members of the American medical 
research community with scepticism: Could the apparent pain-relieving efficacy 
of acupuncture be an illusion? This question continued to animate debates as the 
evaluation of acupuncture's efficacy moved to American soil. While 
acupuncture' s use as a surgical anaesthetic had first made headlines, it was as a 
treatment for chronically painful conditions that acupuncture seemed to offer the 
most promise to Americans.658 Widely circulated descriptions of acupuncture in 
the news and medical media brought to many Americans the hope of relief from 
intractable pain, and they demanded information about, and access to, the 
therapy.659 As the demand for acupuncture rose, and acupuncturists' offices 
fanned out in certain states and cities, medical authorities pressed for the 
establishment of mechanisms to ensure a rigorous evaluation of acupuncture' s 
efficacy. 
It turned out, however, that it was not so easy to agree on how to properly 
evaluate acupuncture's efficacy. No other debate about the value of a pain-
relieving therapy had drawn such a wide range of participants. The acupuncture 
question spread from the news media into legislative assemblies, medical 
societies, and research institutions, making the evaluation of pain relief into a 
public issue on an unprecedented scale. New groups of actors vied for authority 
over the evaluation of acupuncture and proposed competing methods for judging 
its pain-relieving efficacy. Letters were sent to the editors of the New York Times, 
the Journal of the American Medical Association, Science and other medical 
journals. Articles, editorials, responses and debates were published. Biomedical 
institutions set up committees. Thematic conferences were organised, and annual 
658Soth can be tenned acupuncture analgesia, since "acupuncture anaesthesia" did not, strictly 
speaking, obliterate sensations ofpain and pressure, or consciousness. My focus in this chapter is 
on the evaluation of acupuncture for the relief of chronic pain, but 1 also consider arguments in the 
debate about the evaluation of acupuncture's effects on surgical pain. 
6591. A. Kotarba, "American Acupuncturists: the New Entrepreneurs of Hope," Urban Life 4 
(1975): 149-177. lndeed, Kotarba argues that the demand for acupuncture revealed the magnitude 
of the American chronic pain epidemic. My own analysis ofthe debate suggests that researchers 
played an important part in focusing attention on chronic pain in their public discussions of 
acupuncture. 
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conferences set up acupuncture panels.66o There were lecture tours and televised 
debates.66 ! 
While medical researchers called for a large-scale, long-term and 
rigorously controlled pro gram of evaluation, many chronic sufferers presented 
their own bodies-in oral and written testimonies-as evidence that acupuncture 
worked. These sufferers, backedby acupuncturists and their allies, family 
members and often by the popular press, challenged researchers' authority over 
evaluation, affirmed the legitimacy of individual experience, and protested the 
withholding of a safe and effective source of relief for lengthy and inconclusive 
experimentation. Medical researchers, however, often depicted these sufferers as 
poor judges of efficacy because oftheir susceptibility to suggestion, their 
desperation for relief, and their enthusiasm for acupuncture. Meanwhile, these 
researchers argued among themselves over the methodological details of 
acupuncture experiments and complained about the lack of resources for research. 
Why was it so difficult to resolve the question of acupuncture's efficacy? 
Various aspects of the nature of the therapy and its effects-the subjectivity of 
pain, the incompatibility of acupuncture with biomedicine, the inapplicability to 
acupuncture of models of evaluation developed for drug therapy-impeded a 
quick and decisive judgment of acupuncture's efficacy. l suggest, however, that 
the controversial nature of the debate on acupuncture can best be understood as a 
conflict of interests among the various actors who were involved in it. Various 
tensions, as well as insufficient resources-including money, authority, 
agreement, and legitimacy-made it difficult for any one group to impose its 
views on how acupuncture should be evaluated, and thus impeded a resolution of 
the debate. 
660"Acupuncture May FindUse in Rehabilitation Medicine," Journal of the American Medical 
Association 227, no. 8 (1974): 879-82, reports that the American Congress of Rehabilitation 
Medicine inc\uded panel discussions on acupuncture; "AMA Grams," Journal of the American 
Medical Association 224, no. 5 (1973): 565, announces that a general session of Annual 
Convention on June 27 would be dedicated to potential role of acupuncture in practice of medicine 
in western world. These are only two examples out ofmany. 
661 For example: "U. S. Acupuncture: Status Report, 1973," Bonica Papers, MS C 118, Box 21, 
Folder 35, Darling Library, UCLA. 
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The ways in.which elite researchers portrayed, discussed and attempted to 
implement technologies of evaluation reveal many ofthese tensions and the 
obstacles they faced in following their own agenda for acupuncture testing. The 
question of acupuncture's efficacy had different implications for the various 
actors involved in the debate, and control over its evaluation was seen as a means 
of controlling its practice, as well as a me ans to claim expertise in the treatment of 
chronic pain. In this climate, the development and implementation of pain-
measuring technologies came up against new challenges. 
This chapter examines how the idea of technologies of pain-measurement 
was mobilised and contested in the debate on how to evaluate acupuncture. In this 
debate, the technology ofthe well-controlled clinical trial functioned as a 
rhetorical device: as a means for medical researchers to express their ideas about 
pain; how pain relief could be measured, and who could, or could not,be trusted 
to judge pain-relieving efficacy and to control its evaluation. In addition, sorne 
researchers-most notably John J. Bonica-made claims about who should have 
authority over the treatment of chronic pain. l will examine who called for the 
implementation ofthese technologies and why, and then de scribe how they were 
challenged, and by whom. l will also provide an explanation for why, in the end, 
these technologies were not successfully implemented. Remaining aware that 
measuring technologies are not just ideas, but concrete practices requiring 
funding, central authority, and mechanisms of coordination and agreement for 
their implementation, l point to reasons why these resources were lacking in this 
case. First, however, Iwill provide a chronology of the American acupuncture 
debate and explain why the evaluation of acupuncture became such an important 
Issue. 
7.1 Evaluating Acupuncture: What For? 
The earliest American witnesses of acupuncture anaesthesia entered China 
through doors that began opening in the early 1970s. Strict restrictions on 
movement between the two countries had been imposed since the inception of the 
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PRC in 1949. Then in the second half of the 1960s, the Cultural Revolution 
(1966-1969) brought the trickle of travellers to a haIt. In April of 1971, the 
Chinese government unexpectedly invited the American ping-pong team to 
compete on its soil. Seizing thisopportunity, two American biologists, Ethan 
Singer and Arthur W. Galston, took advantage of a scientific visit to Vietnam to 
seek entry into China. Invited for a two-week tour, they were granted an 
interview with Premier Chou En-Lai and shown three universities, two factories, a 
commune, an opera, a ballet... and four operations performed under acupuncture 
anaesthesia.662 New York Times journalists, allowed entry to the PRC to coyer the 
first steps of a Sino-American détente, or "ping-pong diplomacy," were also 
among the first to peer upon spectacular scenes of patients eating fruit while 
tumours and organs were removed from their bodies.663 American doc tors were 
soon able to witness the phenomenon for themselves. Paul Dudley White, Victor 
Sidel, George Rosen and E. Grey Dimond, selected and invited by the AU-China 
Medical Association for a tour of the Chinese healthcare system in the fail of 
1971, were reportedly the first American doctors to have penetrated the Chinese 
border in twenty-five years.664 These doctors were foUowed by others who came 
as members of the presidential party during Nixon's historie diplomatie visit to 
Peking in 1972.665 
In 1971 and 1972, descriptions of operations performed under acupuncture 
anaesthesia were given wide circulation in the American news and medical press. 
Acupuncture anaesthesia was initially portrayed as a curious-ifimpress~ve-
662Ethan Singer and Arthus W. Galston, "Education and Science in China," Science 175 (1972): 
15-23; Us. Relations with the People 's Republic of China, CIS-NO: 72-S38 1-8, Committee on 
Foreign Relations. Senate, Hearing, June 24-25-28-29, July 20, 1971, llO-Ill, Galston testimony. 
663 Audrey Topping, "Chinese Use Acupuncture Anesthetic in Heart Surgery," New York Times, 24 
May 1971, 10; James Reston, "Now, About My Operation in Peking," New York Times, 26 July 
1971, l, Reston had come to China to cover Kissinger's visit in Peking in the summer of 1971, 
and to write about various aspects ofChinese politics and society, whcn he was operated for acute 
appendicitis and received acupuncture for the relief of post-operative pain. He was later invited to 
witness acupuncture anaesthesia, which he reported in: Reston, "A View From Shanghai," New 
York Times, 22 August 1971, sec. E 13. 
664 "Inside look at Chinese me di cine" American Medical News (Oct II, 1971 )in Bonica Papers, 
MS C 118, Box 41, Folder 17, Darling Library, UCLA. 
665William Tkach, author of"I Have Seen Acupuncture Work," Today's Health (1972): 50-6, and 
William Lukash, presenter featured in Acupuncture observations in the People 's Republic of 
China [Videorecording] (Ritter Dental Co., 1973) were members ofNixon's party. 
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feature of a strange and fascinating society. Early reports were apparently met by 
the American medical community with disbelief and disinterest.666 
By 1972, however, acupuncture had already begun drawing attention as a 
therapy meriting serious evaluation, especially for the relief of chronically painful 
conditions. For the next three years, the American media was filled with calls-
from individual researchers and various biomedical institutions-for a rigorous 
and attentive evaluation of acupuncture's efficacy, suggestions on how to do so, 
and assurances that it would be done. 
The institutional response to acupuncture was swift. In 1972, the National 
Institutes of Health (NIH) appointed an advisory Ad Hoc Committee on 
Acupuncture to look into the question. The committee advised that serious 
scientific research should be undertaken, provided sorne guidelines and priorities 
for further research and organised a conference on acupuncture research in 1973. 
In June of 1972, the American Society of Anesthesiologists issued a press release 
on acupuncture warning that "the safety of American medicine has been built on 
the scientific evaluation of each technique before it becomes a widely accepted 
concept in medical practice.,,667 In September of 1972, the Food and Drug 
Administration (FDA) held a meeting to discuss the regulatory status of 
acupuncture instruments; legalising needles and stimulators as investigational 
devices.668 Several state medical and dental boards, as well as individual 
physicians, issued position statements and testified that acupuncture should be 
666 u.s. Relations with the People 's Republic of China, CIS-NO: 72-S38 1-8, Committee on Foreign 
Relations. Senate, Hearing, June 24-25-28-29, July 20, 1971, 118, "Dr. Galston: "1 have spoken 
with sevèral people who have expressed to me skepticism, who have implied that the patients were 
hypnotized, that drugs wére secretly administered ... " 
The Chairman: "You me an they seriously suggest that the Chinese put this show onjust to impress 
you as a visitor. .. " 
Dr Galston: Sorne people have suggested exactly that..."" 
Tkach, "[ Have Scen," 50-6 and E. Grey Oimond, "Acupuncture Anesthesia: Western Medicine 
and Chinese Traditional Medicine," Journal of the American Medical Association 218 (1971): 
1558-63, confirm the existence ofthese doubts, which they daim their observations disproved. 
667 Committee on Science and Technology, United States-China Science Cooperation Hearings 
before the Subcommittee on Science, Research and Technology U. S. House of Representatives, 
May 7,8,10; June 22, 1979 (U. S. Government Printing Office Washington: 1979),226: testimony 
of M. T. Jenkins. 
668"Report on Acupuncture: NIH/FDA Meeting, September 22, 1972, Bonica Papers, MS C 118, 
Box 66, Folder 12, Darling Library, UCLA. 
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legalised only as an experimental procedure, to be practiced only within a 
coordinated research initiative. In February of 1974, the American Medical 
Association (AMA) appointed an Ad HocCommittee on Acupuncture and issued 
a position statement calling for more and better studies of acupuncture.669 The 
Committee on Scholarly Communication with the PRC, formed by the National 
Academies of Science as a result of Kissinger' s negotiations in Peking, sponsored 
a delegation for the study of acupuncture anaesthesia in 1974.670 
Why was the evaluation of acupuncture apparently taken so seriously? 1 
suggest there were four reasons motivating the different actors who took part in 
this response: the pressure of popular demand for acupuncture; the opportunity to 
build Chinese-American relations through its study; the ambition to constitute a 
specialised field of pain research and treatment; and the fear that acupuncture 
would spread extensively beyond medical control. 
Americans who saw in acupuncture the pro~ise of relief for their chronic 
pain demanded information about, and access to, this new therapy. According to 
DeWitt Stetten Jr., director of the National Institute of General Medical Science 
(NIGMS): "The patient population with pain that did not respond to ordinary 
treatments, created pressure to do something, demànded that something be done 
on acupuncture. They made their pressure felt on the White House and the various 
medial societies ... ,,671 This "population" had learned about acupuncture in articles 
that appeared nearly daily in American newspapers.672 Pressured by Congress, the 
NIH had appointed the Ad Hoc Committee on Acupuncture. Congressional 
669 "AMA Grams," Journal of the American Medical Association 227, no. 12 (1974): 1393, during 
its January meeting the AMA board oftrustees authorised the establishment of a 5 member 
committee to study and report on the state of acupuncture. 
"Ad Hoc Committee on Acupuncture, the Brown Palace Hotel, Deriver, September 12-13, 1974," 
Bonica Papers, MS C 118, Box 66, Folder 22, Darling Library, UCLA. 
670 American Acupuncture Anesthesia Study Group (AAASG), Acupuncture Anesthesia in the 
People's Republic of China a Trip Report of the American Acupuncture Anesthesia Study Group. 
Submitted to the Committee on Scholarly Communication With the People's Republic of China 
(Washington: National Academy of Sciences, 1976). 
67 1 Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations FY 1974, House of Representatives, Part 4- NIH, (US 
Govemment printing office, Washington OC: 1973), 794. 
672Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations FY 1974, House of Representatives, Part 4- NIH, (US 
Govemment printing office, Washington OC: 1973), 794. 
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representatives, apparently concemed to show their constituents that their interest 
in acupuncture was being taken seriously, continued to badger NIH officiaIs: "AlI 
we want to know today," wamed Congressman Flood during a hearing on the 
appropriation of funds to the NIH, "is that you are not fooling about this." 673 
Congressman Magnuson's interrogation of Stetten was direct: "What are you 
doing about the acupuncture? Any research on it? .. The American people want to 
know, and they want your people to give us advice, otherwise, somebody's going 
to get hurt in this process." 674 The tone of this exchange explains the rapidity of 
the NIH response, and their concem to get quick answers, but also, as we will see, 
a reluctance to fund large-scale and long-term research on acupuncture and the 
treatment of chronic pain. 
The organisation of delegations to visit China and study acupuncture was 
a means of establishing scholarly exchange and communication between the U. S. 
and the PRe. Acupuncture was only one of several topics investigated by the 
delegations sponsored by the Committee on Scholarly Communications or 
organised by American medical societies, which also included pharmacology and 
public health. To obtain permission to enter the PRC, these groups had to be 
officially sponsored by an American and Chinese organisation. The American 
interest and Chinese pride in acupuncture seemed to make it a natural topic to 
include in these exchanges. As the chair of the Committee on Scholarly Exchange 
with the PRC-a committee created following Kissinger's negotiations in 
Peking-the study of acupuncture would allow American researchers to "interact 
with their Chinesecolleagues at the research level. This is one of the few fields in 
which a kind of mutual study and leaming is possible.,,675 
But why did researchers want to participate in the se ex changes? How do 
we explain that a researcher like John J. Bonica, who apparently had no prior 
673Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations FY 1974, House of Representatives, Part 4- NIH, (US 
Govemment printing office, Washington OC: 1973), 794. 
674Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations FY 1974, House of Representatives, Part 2, (US Govemment 
printing office, Washington OC: 1973),2045. 
675 Emil L. Smith to Bonica, January 24,1974, Bonica Papers, MS C 118, Box 67, Folder 5, 
Darling Library, UCLA. 
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interest in China or Chinese medicine, made repeated attempts to obtain 
permission to go witness acupuncture in the PRC before he was allowed to join a 
delegation sponsored by the Committee on Scholarly Communication?676 Isabelle 
Baszanger has drawn connections between Bonica's desire to go to China and his 
ambitions to create a specialised field of pain research and treatment. She has 
suggested that the spotlight on acupuncture, and, by extension, on the problem of 
pain, gave "a useful impetus" to Bonica' s project of creating "a world of pain. ,,677 
1 agree with Baszanger that it was no coincidence that Bonica, now memorialised 
as the "founding father" of the modem "pain movement," was actively involved 
in various initiatives on acupuncture. 1 will examine this involvement in more 
detail, and show how his efforts to promotea rigorous evaluation of 
acupuncture's pain-relieving efficacy were also meant to draw attention to the 
problem of pain, stimulate the development of pain research and claim special 
expertise for pain researchers. 
Bonica' s appointment as the chairman of the NIH Ad Hoc Committee 
yoked the study of acupuncture to the emerging field of pain research and 
treatment. This ~ppointment indeed deserves sorne attention. Bonica was neither a 
specialist in Chinese medicine or surgical anaesthesia. Instead, his reputation was 
based on the development of regional anaesthetic techniques and the development 
of a new mode! for the treatment of chronic pain. Describing his strategy for 
creating the Committee, Stetten explained: "We get together a group of scientists, 
presumably people who know what controlled experiments are. At my suggestion, 
Dr. Marston invited Dr. John Bonica as chairman ofthis committee. He is the 
chairman of the Department of Anesthesiology at the U of W A in Seattle. He runs 
in addition a very large and successful research clinic for chronic pain. ,,678 
676John Bonica, chairman of the NIH Ad Hoc Committee on Acupuncture had been trying to get 
into China since at least October of 1972, see: "Doctors Eye China Visit," New Haven Register 
(Oct 4 1972) in Bonica Papers, MS C 118, Box 67, Folder 9, Darling Library, UCLA. 
677 Isabelle Baszanger, lnventing Pain Medicine From the Laboratory ta the Clinic (New 
Brunswick, N.J: Rutgers University Press, 1998),63. 
678Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations FY /974, House of Representatives, Part 4- NIH, (US 
Govemment printing office, Washington OC: 1973), 793-4. 
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Bonica's model ofthe multidisciplinary pain c1inic was c10sely tied to his 
concept of chronic pain. In a 1953 manual on pain management, Bonica had 
begun to argue that persistent pain should be approached as a target of treatment, 
rather than as a symptom of an underlying condition.679 Bonica explained that 
pain persisting beyond an initial periodoftreatment and healing (usually defined 
as six months) shifted from its original function as a symptom of injury or disease 
to become a pathology in itself. Pathological pain no longer served a useful 
purpose as a waming signal or protective mechanism. Chronic pain was a multi-
dimensional condition affecting the "whole person," and al wayS involving sorne 
psychological component. Its treatment thus required the combined expertise and 
knowledge of a multi-disciplinary team that inc1uded psychologists and . 
psychiatrists, within a setting dedicated to this problem. While Bonica's manual 
helped articulate a conceptual model of chronic pain, in 1960 he was able to 
concretise a clinical model for its treatment when he became Director of the 
Department of Anesthesia at the University of Washington. From 1962, Bonica 
began to campaign for support from NIH and dedicated himself to the 
establishment of a "world of pain": the expansion of specialised chronic pain 
treatment facilities, the creation professional pain networks, the recognition of 
chronic pain as a serious national health problem, and increased funding for pain 
research.680 
By 1972, it seems that Bonica finally began to get the attention of the 
NIR The same year as he was appointed to the Ad Hoc Committee on 
Acupuncture, he was also invited to a symposium on trauma organised by the 
National Institute for General Medical Sciences (NIGMS), and was promised 
funding for a symposium on pain (this never came through).681 It is difficult to 
know how, exactly, Bonica's achievements and ambitions motivated his 
appointment to the Ad Hoc Committee on Acupuncture. What is clear, however, 
679 John J. Bonica, The Management of Pain With Special Emphasis on the Use of Analgesie Black 
in Diagnosis, Prognosis, and Therapy (Philadelphia: Lea & Febiger, 1953); Baszanger, Inventing 
Pain Medicine, 26-31 
680 Baszanger, Inventing Pain Medicine, 65 
681 Baszanger, Inventing Pain Medicine, 65. 
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is that he seized the occasions offered by this and other official positions in 
acupuncture initiatives to pursue his ambitions for the advancement of pain 
resea~ch and treatment as an effective and legitimate field within American 
niedicine. He did this in several ways. 
First, Bonica used the opportunity of public addresses and interviews to 
link the need for a proper evaluation of acupuncture to the importance of the 
problem of chronic pain. For example, in the testimony he prepared for hearings 
on acupuncture legislation in the State of Washington, Bonica introduced the 
issue of chronic pain as "a serious national health problem.,,682 Offering a 
potential solution to such a serious problem, acupuncture deserved serious 
evaluation, particularly because chronic sufferers, desperate for relief, were 
vulnerable to the false promises of quacks and entrepreneurs. As Bonica affirmed 
during the discussion at an NIH conference on acupuncture research: "1 really 
sense a great need for these studies. There is tremendous public interest in 
acupuncture, and many people in sever~ pain view it as their last hope. Is it truly 
helpful or is it a false hope ... 1 sincerely hope we will mount serious and well-
controlled trials ... ,,683 In addition, Bonica told a journalist: "American medicine is 
particularly eager to assess acupuncture because present methods cannot relieve 
the CP which many patients endure ( ... ) Unfortunately there are sorne who are 
ready to exploit the public ... " 684 Until its efficacy was determined, Bonica added 
in a radio interview, "unscrupulous practitioners may exploit this interest [in 
acupuncture] to the detriment of the American people." 685 Bonica also explained 
that a proper evaluation of acupuncture's efficacy would require more research on 
pain. In his summary statement on the NIGMS conference on acupuncture 
research, Bonica explained that "one of the se rio us problems in evaluating 
682 Acupuncture notes, ms., n.d., in "Acupuncture Legislation, Washington State, 1974," Bonica 
Papers, MS C 118, Box 66, Folder 20, Darling Library, UCLA. 
683Howard P. Jenerick, ed. Proceedings of the NIH Acupuncture Research Conference 
(Washington, D. c., VS Department of Health, Education and Welfare: 1973), 135. 
684AI Dieffenbach, "Doctors mulllong-range research on acupuncture," Seattle Times (Feb Il, 
1973) in Bonica Papers, MS C 118, Box 41, Folder 27, Darling Library, VCLA. 
685 "Transcript" in Bowen 1. Hosford to John J. Bonica, Apr 25, 1973, Bonica Papers, MS C 1 18, 
Box 21, Folder 21, Darling Library, VCLA: Enclosed is also a transcript of an interview between 
"NIH announcer" and members of the AD Hoc Committee including Bonica, that was to be 
broadcast "on radio stations around the country." 
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acupuncture for the relief of pain is that pain itself is a complex phenomenon 
which also should receive greater scientific research efforts,,,686 a point he also 
emphasised in interviews and conference discussions.687 Throughout his· 
discussion of acupuncture, Bonica emphasised the need for specialised expertise 
on pain. He presented his own credentials in acupuncture matters with respect to 
his longstanding interest in pain and its treatment.688 
Bonica also used his influence in the selection of the membership for 
committees and conferences to begin developing professional networks between 
researchers with an interest in pain. When Bonica sought to obtain permission for 
the entry into China for a small delegation to study ofacupuncture, the travel 
companions he chose were similarly invested in the field of pain research and in 
the psychological dimensions of pain. The names he suggested were Patrick Wall 
and Ronald Melzack, authors of the groundbreaking gate-theory ofpain and 
respected authorities on the psychology and neurophysiology of pain; Donald 
Katz, an anaesthesiologist with experience using hypnosis as a surgical 
anaesthetic and in neurophysiologic research; and Wilbert Fordyce, a colleague in 
the pain clinic and expert in the behavioural aspects of chronic pain. These 
researchers were also members-probably because they were invited by Bonica-
of the NIH Ad Hoc Committee on Acupuncture. However, other members of the 
Committee who were more interested in acupuncture itself or in physiology were 
not suggested. 
Bonica failed to obtain permission for this particular group to visit China. 
In 1974, however, a specialised group was formed to investigate acupuncture in 
China: the American Acupuncture Anesthesia Study Group (AAASG). Bonica 
was asked for his opinion on the selection of members for this group, and his 
686 John J. Bonica, "Summary Statement on NIGMS Acupuncture Research Conference, Feb 28-
Mar 1 1973," in Praceedings afthe NIH Acupuncture Research Conference, ed. Jenerick, 
(Washington, D. c., US Departrnent of Health, Education and Welfare: 1973), vi. 
687 ""Transcript" in Bowen 1. Hosford to John 1. Bonica, Apr 25, 1973, Bonica Papers, MS C 118, 
Box 21, Folder 21, Darling Library, UCLA: In which Bonica is reported to have said: "[ think 
sorne of the painful conditions are sn comple~ and it will take several years before we get any 
useful information that will suggest trends." 
688 "Acupuncture" notes, ms., n.d., in "Acupuncture Legislation, Washington State, 1974," Bonica 
Papers, MS C 118, Box 66, Folder 20, Darling Library, VCLA 
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recommendations can, similarly, be read as a wish-list for an aH-star pain research 
cast. They included the neurophysiologists Edward Perl, who had done 
"outstanding work on pain;" Fred Kerr, who was involved in the neurosurgical 
relief of pain; Ronald Dubner, who would become a leading authority on dental 
pain; Vernon Mountcastle, "one of the most respected neurophysiologists with an 
interest in pain in the U. S.;" and Arthur Taub, the director of a pain diagnostic 
and treatment unit at Yale University School of Medicine. Bonica also 
recommended psychologist Richard Chapman, "one of the brightest young 
psychologists doing se rio us research on pain," and anaesthesiologist Ephraim 
Siker, who had experience in analgesic evaluation.689 Many of Bonica's 
suggestions (Chapman, Taub, Dubner, Kerr, Siker) were followed, while a few 
others who would become respected authorities on pain research were added to 
the list: Jerome Modell and Kenneth Casey. The priority of the selection 
committee was clearly to prioritise expertise in pain research and treatment.690 
In addition to those who were recruited by Bonica and by others to 
participate in the evaluation of acupuncture, sorne researchers also took advantage 
of opportunities acupuncture offered to conduct their own trials on chronic pain 
sufferers. A handful of research grants were awarded by the NIH for acupuncture 
studies, and there were also opportunities to present results of trials on chronic 
pain in conferences, workshops, and in the news media. Sorne who had already 
established pain treatment facilities set up trials of acupuncture, thus showing that 
these could become useful research settings. 
For various reasons, then, the membership of the NIH Ad Hoc Committee 
on Acupuncture, the AAASG, and of the NIGMS conference on acupuncture 
research brought together individuals who would, just a few years later, be at the 
forefront of the institutionalisation of pain research. They would participate in 
689 Bonica to Denise Emery, February l, 1974, Delegation to the People's Republic of China: 
Acupuncture Membership, General, 1974, National Academy of Sciences Archives (NASA): 
690 Emil L. Smith to Bonica, January 24, 1974, Bonica Papers, MS C 118, Box 67, Folder 5, 
Darling Library, VCLA: According to Smith, chairman of the Committee for Scholarly 
Communication, the objectives of the AAASG would be to "interact with their Chinese colleagues 
at the research level. This is one of the few fields in which a kind of mutual study and leaming is 
possible. [t is, therefore, important that the delegation include members who have an experimental 
background on the mechanism of pain." 
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meetings (World Congresses on Pain), professional organisations (the 
International Association of the Study of Pain and the American Pain Society),and 
publications (Pain) and contribute to the expansion of pain clinics. Acupuncture 
evaluation may have offered sorne of these researchers their tirst opportunity to 
work together as pain experts. 
Whether or not these pain researchers hoped, one day, to offer their 
patients the option of acupuncture therapy, they unanimously insisted on the need 
for the most rigorous evaluation process. If acupuncture was to be made widely 
accessible, it shouid be approved by pain experts using the trusted methods of 
scientific medicine. If it was proved to be ineffective, chronic pain patients shouid 
be protected from faise-and potentially expensive-hopes, while increased 
funding should be channelled into pain research in search of more effective 
solutions. Indeed, Bonica, oftenjoined by colleagues, did not seem to lose any 
opportunity-from the reports of his visit to China to his recommendations to the 
NIH and his comments in various meetings-to call for more, well-controlled 
trials of acupuncture.69l 
The repeated appeals for caution, patience, and further research 
formulated by pain experts were also mobilised by the spokespersons of 
professional organisations. For them, calling for a rigorous evaluation of 
acupuncture was a means of lobbying for legislation that would keep acupuncture 
under the control of state medical and dentallicensing boards. Sorne ofthese 
boards, as well as national organisations, were active in pushing for legislation 
that would define acupuncture as the practice of medicine, and thus stipulate that 
acupuncture could only be practiced by, or under the supervision of, a qualitied 
medical professional. The FDA had taken early legislative measures in defining 
acupuncture apparatus-needles and stimulators-as experimental devices. This 
implied that any device sold in interstate commerce would have to display a 
691 For example: "An eye on the needle: a suggested approach to acupuncture," 1972, Bonica 
Papers, MS C 118, Box 66, Folder 6, Darling Library, UCLA; "Addition by Dr Bonica to 
Acupuncture Legislation," Draft 4, December 6, 1973, Bonica Papers, MS C 118, Box 66, Folder 
11, Darling Library, UCLA; Bonica, "Acupuncture Anesthesia in the People's Republic of China: 
Implications for American Medicine," Journal a/the American Medical Association 229, no. 10 
(1974): 1317-25. 
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warning label, and that the following conditions would be imposed on its use: The. 
deviceshould be used by qualified physicians or dentists, under a research 
protocol which had been reviewed by a peer cornrnittee on human research, and 
on subjects from who informed consent had been obtained.692 Until states 
regulated acupuncture practice, however, the FDA ruling would have little 
impact. Many state societies and boards issued position statements, while sorne 
took more direct action either by proposing their own restrictive bills on the 
practice of acupuncture, or by speaking against regulations they saw as overly lax. 
Though sorne attempts were made to support the restriction of acupuncture 
on the grounds of safety, the more common and seemingly more persuasive 
strategy was to argue that its efficacy had not been proven. The statements of 
researchers like Bonica were used to support this position, while Bonica was also 
invited to testify in hearings on proposed acupuncture bills in the State of 
Washington. Sorne ofthose who lobbied for this legislative position may have 
honestly hoped that acupuncture would one day be proved effective and legalised 
as a legitimate therapy. However, the immediate consequence of such legislation 
was to enable tight control over its practice. The definition of acupuncture as an 
experimental therapy usually entailed specifYing the conditions under which it 
could be practiced: in appropriate research settings, such as teaching hospitals; 
under the supervision of a medical research; and according to an appropriate 
research protoco1.693 
For the boards, such legislation meant restricting the practice of 
acupuncture, but for researchers it was also an opportunity to spell out the 
conditions for a proper evaluation of its efficacy. Bonica, for example, proposed, 
in an addition to a State of Washington bill, that, "in order to obtain meaningful 
692 "Report on acupuncture- NIH/FDA Meeting, September 22, 1972," Bonica Papers, MS C 1 18, 
Box 66, Folder 12, Darling Library, ueLA. 
693See, for example: James N. Benedict, Albert J. Pirro and Joseph R. Pisani, "Acupuncture: The 
Practice of Medicine?" Albany Legal Review 38 (1974): 633-90: On July 26 1972, the New York 
State Board of Medicine issued this statement: "Acupuncture is not an accepted medical procedure 
in the S ofNY at the present time. The NYSBM regards acupuncture involving the human body as 
an experimental procedure." The board recognizes the need for further research and "believes 
[acupuncture research] should be performed only in medical centers and teaching hospitals which 
have committees on human research. This would pro vide the necessary peer review ofprotocols 
and appropriate monitoring of acupuncture studies." 
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data, it will be necessary to have a uniform protocol, a special record keeping 
system, and a central agency for the collection and analysis of the data." In 
addition, controlled clinical trials "required adhering to strict scientific princip les 
of:" controlling, blinding, and statistical analysis.694 Thus, Bonica saw legislation 
as a potential means of guiding and standardising the evaluation of acupuncture. 
Another anaesthesiologist, M. T. Jenkins, had testified before the Texas Board of 
Medical Examiners in 1974 that acupuncture should be defined an investigational 
procedure, to be investigated only by full-fledged members of an Acupuncture 
Study Group, organised by each medical school in the state, under a uniform 
protocol. The investigator would then submit her data for review, collat_~on, and 
statistical analysis to a "special record-keeping system.,,695 
Because of various political and professional reasons-Congress' 
responsibility to the American people, Chinese-American relations, the 
constitution of a "world of pain" and the protection of the practice of medicine-
the evaluation of acupuncture became a serious and visible issue, leading to the 
creation of forums in which researchers could discuss how best to judge the 
effects of acupuncture on pain. 
No precise answers, however, came out ofthese discussions. Researchers 
usually recommended, rather vaguely, that well-controlled experiments should be 
conducted. When they did specify further how these should be conducted, they 
mentioned placebos, blinding, and statistical analysis, sometimes adding large-
scale coordination, uniform protocols, as well as centralised data collection and 
analysis. These conditions are hardly surprising if we consider that controlled 
clinical trials had become standard for the evaluation of drug therapiès, and, in the 
early 1970s, were being extended to new therapies such as surgery. 
If researchers were rather vague about the designs of experiments on 
acupuncture, they were quite specific about the reasons why experimental 
694 "Addition by Dr Bonica to Acupuncture Legislation, Draft 4, December 6, 1973," Bonica 
Papers, MS C 118, Box 66, Folder Il, Darling Library, UCLA. 
695Committee on Science and Technology, United States-China Science Cooperation Hearings 
before the Subcommittee on Science, Research and Technology U. S. House of Representatives, 
May 7,8, la; June 22, 1979 (U. S. Govemment Printing Office Washington: 1979),223-6: 
testimony of M. T. Jenkins. 
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technologies were necessary, and about what experimental technologies should 
"do" with respect to eliminating certain kinds of error and bias. These researchers 
were, at the same time, insisting that it was impossible to determine whether 
acupuncture was effective in relieving pain without these technologies. This 
necessity, as we will see, did not go undisputed. Many argued that it was possible, 
on the basis of individual, unmediated experiences of pain and suffering, to tell 
whether acupuncture worked. 
As Harry Marks has shown, trust in the methodological devices of 
controlled clinical experimentation-placebo-controlling, randomization, 
blinding, and statistical analys'is-was promoted by emphasising the 
untrustworthiness of certain figures-pharmaceutical firms, nurses, and even 
investigators. Therapeutic reformers insisted that these "figures of mistrust" were 
threats to the objective evaluation of therapeutic efficacy, on which both good 
medical practice and professional autonomy rested.696 In the context of the 
acupuncture debate, however, these "contraIs" were given new meanings. They 
were endowed, for example, with the power to protect therapeutic evaluation 
against the influence of new figures of mistrust: "brainwashed': Chinese patients 
and doctors; desperate and gullible chronic pain sufferers; charismatic and 
enterprising acupuncturists; the pervasive influence of the media; and, to a certain 
extent, medical researchers themselves, especially if they were not experts on 
pam. 
Medical researchers appealed to the need for large-scale, well-controlled 
clinical experimentation by describing the ways in which these figures-by their 
interests or susceptibilities--could distort the evaluation of acupuncture. In 
pronouncing these figures biased, researchers were, at the same time, rejecting 
certain forms of evidence (anecdotal, testimonial, individual, observational) in 
favour of others (experimental, clinical, controlled, statistical). Researchers 
justified mistrust in these figures with reference to the particular nature of pain, 
especially of chronic pain. Hence, the necessary conditions for objective 
696 Harry Marks, "Trust and Mistrust in the Marketplace: Statistics and Clinical Research, 1945-
1960," Histary afScience 38 (2000): 343-55. 
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evaluation described by members of acupuncture committees and study groups. 
The need for certain criteria to control the evaluation of acupuncture was closely 
connected to a portrayal of pain, and its relief, as an experience that was open to 
certain kinds ofsocial, mental, physical and even political influences. These 
criteria had implications in deciding who should, and more importantly, who 
should not, have authority injudging the pain-relieving efficacy of acupuncture. 
7.2 Pain, Objectivity, and Figures of Mistrust in the Acupuncture Debate 
In calling for more controlled evaluations of acupuncture's analgesic efficacy, 
researchers were criticizing the reliability of various different sources and forms 
of evidence. They rejected the "anecdotal evidence" provided by non-experts-
journalists and physicians-in the first reports from China. When "experts" such 
as Bonica and the members of the AAASG reported on their own trips to China, 
they complained that the political and cultural conditions under which 
acupuncture was practiced in China made both Chinese patients and doctors 
unreliable indicators of acupuncture's efficacy. In addition,their lack of access to 
information and results from properly controlled trials made it impossible for 
them to make their ownjudgments. Bonica declared that only well-controlled 
trials on American patients could resolve the question of acupuncture's efficacy. 
Even Americans, however, had been exposeq to potentially biasing influences: 
media hype; the wide publicity given to "testimonial" evidence; arid the promises 
of acupuncturists. In addition, given the nature of chronic pain, their suffering 
was, in sorne measure, amplified by the psychological consequences of this 
condition, and thus susceptible to the psychological modulation of strong 
suggestive influences.697 The subjectivity and openness of pain made individual 
experience an unreliable indicator ofanalgesic efficacy. The evaluation ofthis 
experience had to be subjected to the control of certain psychological influences, 
697 It is important to note that the "psychological" maladjustement that accompanied chronic pain 
was believed by many pain experts to be a result, rather than a cause, of persistent bodily 
suffering. 
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and compared to multiple other experiences. Finally, as we have seen, knowledge 
about pain was said to be helpful in the evaluation of acupuncture's efficacy. 
Researchers with knowledge about pain were encouraged to get involved in the 
evaluation of acupuncture, while calls were made for more funding for research 
onpam. 
The first doctors and joumalists who wrote about acupuncture in China 
emphasised the visual nature of their encounter with the technique and its 
wondrous effects. These observers circulated evocative photographs and verbal 
images of patients' behaviours under acupuncture anaesthesia, describing what 
they had seen, and sometimes heard, inside the operating room. "l'm writing only 
about what 1 actually saw," cautioned Walter' Tkach in Today's Health, and 
concluded that "seeing is believing.,,698 "1 Have Seen the Past and It Works," was 
the title of Samuel Rosen's article in the New York Times.699 Galston and Singer 
assured they had "personally witnessed the incisions made and operations 
performed." 700 They also saw the inserti~m of a few slim needles into strategic 
points on patients' bodies, and that patients were chattering, sippingjuice, eating 
fruit, and clutching little red books701 while one "layon his stomach with a vast 
gaping hole in his back, through which you could see the gasping of the 
remaining lung ... ,,702 Another patient's surgeon "picked up [her] beating heart and 
held it in his hand.,,703 They saw enough to ascertain that patients were conscious, 
that they had really been operated on and that they appeared to be pain-free. But, 
their critics soon began to ask, could this apparent efficacy be an illusion? Might 
698For example, W. Tkach, "1 Have Seen," 50-6; Us. Relations with the Poeple 's Republic of 
China, CrS-NO: 72-S381-8, Committee on Foreign Relations. Senate, Hearing, June 24-25-28-29, 
July 20, 1971, 119: testimony of Galston. 
699 Samuel Rosen, "1 Have Seen the Past and It Works," New York Time (l November, 1971),41, 
writes: "What 1 have to tell is, 1 know, not going to be believed. r know this because a Chinese 
surgeon, chiefat the major metropolitan hospital in Canton, told me that he had not believed it 
himself -- until he had seen it many times over." 
700E. Singer and A. W. Galston, "Education and Science in China," 15-23. 
701Collections of quotations by Chairman Mao that were distributed during the Cultural 
Revolution. To observers, they could be taken as signs of the pervasiveness ofpolitical ideo10gy in 
Chinese society. 
702Reston, "A View," 3. 
703 Topping, "Chinese Use Acupuncture," 10. Early reports written by physicians (Dimond, Ros~n, 
Tkach), contained similar graphie imagery. 
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residual pain, or non-acupunctural sources of relief, have remained invisible to 
these observers? 
Many invisible forces, American cri tics suggested, could have created a 
false appearance of efficacy. At tirst, it seems, sorne suspected a trick had been 
played on naïve American visitors. Perhaps patients had been secretly medicated 
or hypnotised before the American observers arrived.704 But soon, such 
intentional and straightforward deception on the part of the Chinese was no longer 
mentioned, at least not in published statements.705 Yet, critics continued to suspect 
that a more subtle form of deception was taking place. A recurring hypothesis was 
that acupuncture worked, or appeared to work, in China because of the social, 
political, and cultural conditions peculiar to the Chinese people. This hypothesis 
took several variations. Sorne critics supposed that a cultural tendency towards 
stoicism made Chinese patients less likely to express pain than American patients 
under the same conditions, because they were less sensitive, ready to accept more 
discomfort without suffering, or simply inexpressive. 706 Indeed, references to 
Chinese stoicism, or to culturally-conditioned responses to pain, were not 
infrequent in discussions about the evaluation of acupuncture. 707 Many others 
704See n.9 above. 
7051n private exchanges, sorne doctors were less diplomatic.D. Effler to J. J. Bonica, August 19, 
1974 Bonica Papers, MS C 118, Box 66, Folder 10, Darling Library, UCLA: Effler writes: r will 
try to speak with utmost frankness ... Medicine in China is playing a desperate game of catch-up, 
and the majority of papers that l read were obvious propaganda by the central government and 
scarcely qualified as scientific in nature ... " 
706 Harold R. Isaacs, Scratches on our Minds: American Images of China and India (New York: 
The John Day Company, 1958). [saacs' sociological investigation into American attitudes towards 
the Chinese traces a long history of Western representations ofChinese and Asian people as being 
stoical. Isaacs tells this history as an oscillation of positive and negative representations back to 
the eighteenth century. The positive attributes given to the Chine se were those of Pearl Buck's 
novels: peaceful, hardworking, endurant of hardships. But there was also another set of images of 
cruelty and barbarism, of the Chinese as "binders of women' s feet" and "torturers of a thousand 
cuts" whose indifference to pain was "nerveless." Thus, there was a "vast lore" attributing to the 
Chinese an "absence of nerves", which was either a tribute to their strength" and endurance or a 
way of dehumanizing the Chine se on the basis oftheir apparent disregard for pain, be it their own 
suffering or that inflicted on others 
707"Doctors Fear Quackery: Acupuncture Hit," Washington Star, (Aug 4, 1974) A-l and A-8 in 
Delegation to the PRC: Acupuncture, General, 1973-76, NASA, reports on the trip of an AMA 
delegation to China. The delegation statement reportedly specified "[n the opinion ofthree 
Western trained surgeons and one anesthesiologist who are members of our delegation, it seems 
unlikely that acupuncture analgesia will be widely accepted by Western patients, who tend to have 
relatively lower pain thresholds than do their stoic Oriental brethren." 
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supposed that a potent ideological indoctrination, apparent in the pervasive 
presence of Maoist ideology, produced a belief in acupuncture that was so strong 
it provided Chinese patients with the relief of surgical pain.708 They noted that 
Chinese patients were often found clutching "little red books"-collections of the 
citations of Chairman Mao-and exclaiming "long live Chairman Mao!" on the 
operation table.709 At least one author likened this phenomenon to hypnotism, and 
pointed out that hypnotism could effectively block pain, while others saw it as a 
type of placebo effect.710 It was also suggested, more rarely, that patients did not 
say they had felt sorne pain for political reasons. 711 
Kenneth McCracken, "After China Visit- Dr Kerr Reports Acupuncture Benefit" Rochester Post-
Bulletin Thurday June 6 1974, Delegation to the PRC: Acupuncture, General, 1973-76, NASA: 
"They are indeed stoical people," Dr Kerr said, "but when there is no response From even 
involuntary muscle to severe trauma to tissue as in major surgery, it's hard to believe something 
isn't happening"; "Americans Study Acupuncture as Anesthetie" Gainesville Sun (June 28, 1974) 
in Delegation to the PRC: Acupuncture, General, 1973-76, NASA: Walter Modeft is quoted to 
have said: "An important question which remains to be answered is whether or not the Chinese, in 
general, have greater tolerance to pain than Arnerieans"; "Acupuncture (Editorial)," Journal of the 
American Medical Association 223, no. 1 (1973): 77-8, "Of course, there are skepti.cs who have 
sent letters to THE JOURNAL and to American Medical News denouncing acupuncture 
aneshtesia as a hoax. Most ofthern believe that Chinese stoicisrn plus hypnosis are what makes 
acupuncture anesthesia seem to work." 
708 "Acupuncture: When You Need a Little Needling," New York Times, (2 May 1971), sec. 
Science/Medicine, p. E7: "While Western physicians are apt to be highly skeptical of acupuncture, 
many believe that it should not b di~rnissed out ofhand. Sorne have suggested that acupuncture 
works because of its patients' faith in it, that it is a form of psychosomatic medicine ... " 
709 "[nside Look at Chinese Medicine" American Medical News (Oct II 1971) in Boniea Papers, 
MS C 118, Box 41, Folder 17, Darling Library, UCLA, in which Dirnond reported that "after the 
patient's neck was sewn up, he sat up with a srnile. He picked up the little red book of Chairman 
Mao's thoughts, waved it, and sa id: 'Long Live Chairman Mao. Welcome to our Arnerican 
friends ... "; Reston, "A View": "One troubling diversion in all this for a visitor is that the 
impressive objective evidence of the rnedieal uses of acupuncture is always mixed up here with 
subjective psychiatrie and even ideological explanations. For example, ail the patients we saw on 
the operating table were clutching their little red books of Chairman Mao Tse-Tung's philosophic 
and moral teachings. And the doctors and surgeons, after partieipating in the operations, were 
explaining that the success ofthis system depended importantly on trust between doctor and 
patient and on a cornrnon faith in 'Mao Tse-Tung thought. '" Rosen, "[ Have Seen," 41, described 
patients leaving "the opearting roorn or the dentist's chair alert ... and waving his 'Quotations From 
Chainnan Mao Tsc-tung. '" 
710 W. S. Kroger, "Acupuncture Analgesia: lt Explanation by Conditioning Theory, Autogenic 
Training, and Hypnosis," AmericanJournal ofPsychiatry 130, no. 855-60 (1973); Kroger, 
"Hypnotism and Acupuncture," Journal of the American Medical Association 220 (1972): 1012-
13; Kroger, "The Scientific Rationale for Acupunctural Analgesia," Psychosomatics 14 (1973): 
191-4. 
711 Bud Gordon, "Why Sorne People Feel Pain More than Others," National Enquirer (1974) 
Bonica Papers, MS C 118, Box 66, Folder 31, Darling Library, UCLA: reports Bonica's words as: 
"Sorne showed facial expressions, shivering, groaning, and other signs that they felt pain .... But 
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These various hypotheses were made plausible was a view of pain as a 
bodily experience that was particularly open to social influences, which acted on 
experience through the medium of a malleable mind. The influences did not 
necessarily produce bodily changes, yet they were strong enough to make 
normally excruciating surgical procedures relatively painless. Such explanations 
were also made more believable by an American view of Chinese communist 
society, and of a Chinese cultural essence, which together produced a relationship 
between body, mind, and society that was radically different from the American 
one. The Chinese were portrayed as being particularly susceptible to the influence 
of collective ideology but relatively indifferent to individual bodily experience. 
Similar ideas informed the complaints of visiting "experts"-such as 
Bonica and the members of the AAASG-in their reports on the conditions under 
which they observed acupuncture in China. In their reports and publications, these 
experts, for example, commented on the political origins of acupuncture 
anaesthesia, a practice born from a directive issued by Mao himself and revived in 
the fervour of the Cultural Revolution. 712 A journalist reported, for example, that 
"Bonica [hadJ suggested that Chairman Mao-Tse Tung's strong advocacy of the 
technique and the political and religion popularity of Mao might have something 
to do with acupuncture's succesS.,,713 The AAASG report even suggested that "the 
des ire of sorne patients to withhold evidence of pain cannot be entirely 
they denied they felt pain because they'd been indoctrinated to believe that acupuncture is 
painless." 
712 Bonica, "Acupuncture Anesthesia in the People's Republic of China: Implications for American 
Medicine." Journal o/the American Medical Association 229, no. 10 (1974): 1318, tells how 
acupuncture was reintroduced during the Cultural Revolution as part of Mao's movement to fully 
integrate Western and traditional medicine. Almost ail the articles he had read on acupuncture 
"emphasized the fact that Acupuncture Anaesthesia is the product ofChairman Mao"s genius and 
policies. After reading ail this, 1 agree with Geiger. .. that in China, Acupuncture Anaesthesia is 
more than a medical and scientific subject, but one which involves national pride, health policy 
and political implications." 
AAASG, Acupuncture Anesthesia, 23, "The raIe ofpeer acceptance and national pride on the part 
of the patients were believed to be important factors by sorne of our colleagues ... " 
713 N. Rosenberg, "Acupuncture in Doctor's Grip," Milwaukee Journal (Feb 12 1973) [Box 67, 
Folder 9] John J. Bonica Papers, Manuscript collection number 118, Louise M. Darling 
Biomedical Library, History & Special Collections Division, University ofCalifornia, Los 
Angeles. 
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discounted.,,714 The influence of factors such as national pride on the apparent 
efficacy of acupuncture was impossible to detect through observation, or even 
physiological measurements, under uncontrolled conditions. 
These experts also complained that they had access to insufficient 
information about acupuncture to make informed judgments about the causes of 
its efficacy. They were disappointed not to be able to find out more about how 
patients were selected and prepared to undergo surgery under acupuncture 
anaesthesia. "To the best of the study group's knowledge," the members of the 
AAASG wrote tentatively, "coercion is not employed," while they were only 
"relatively certain" that "no effort to condition the patient or to induce hypnosis or 
posthypnotic suggestion was made.,,715 They also suspected that doctors and 
scientists did not, for political reasons, reveal the whole truth about the extent to 
which acupuncture was practiced, nor their real opinions about its efficacy. 
Bonica, for example, made sorne calculations indicating that acupuncture was 
used much less frequently as a surgical anaesthetic than had been reported by the 
aùthorities. 
Finally, Bonica and the members of the AAASG repeatedly pointed out 
the absence of controlled clinical trials in China.716 Bonica also noted that the 
Chinese disregard for placebo-controlling and statistical analysis extended more 
broadly than the evaluation of acupuncture. For example, Bonica underlined 
passages about the deficiencies in Chinese mechanisms of therapeutic evaluation 
in his fellow delegates' report oftheir trip. In Bonica's copy of Myron E. 
714AAASG, Acupuncture Anesthesia, 24. In their original manuscript of the report, the members of 
the AAASG had expressed their doubts slightly differently: "With regard to motivational factors, 
the possibility could be considered that the des ire of the patients to present this authentic Chinese 
disco very in the best possible light, while at the same time preserving 'face', might be sufficiently 
compelling factors for them to endure pain stoically. This possibility cannot be discarded lightly, 
especially when we review our records and find notes to the effect that the patient moaned softly, 
winced, grimaced, clenched fists or squirmed, yet when questioned directly after the operation, 
stated that he/she felt no pain. This should not be construed as deception but related to cultural and 
social factors which are important to the Chinese people." See, "NE1M: mis review "acupuncture 
hypalgesia ... PRC", 1975, Bonica Papers, MS C 118, Box 66, Folder 35, Darling Library, UCLA 
715 AAASG, Acupuncture Anesthesia, 23. 
716Bonica, "Therapeutic Acupuncture in the People's Republic of China: Implications for 
American Medicine," Journal of the American Medical Association 228, no. \2 (1974): \544-5\: 
"Unfortunately, no c1inical trials have been done, and ail of the reports c1aiming high percentage 
ofefficacy of acupuncture in relieving pain are anecdotal."AAASG, Acupuncture Anesthesia. 
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Wegman's report on the use oftraditional medicines, the foUowing was 
underlined: " ... unfortunately, the reaction against critical statistical analysis that 
took place during the cultural revolution is impeding proper evaluation of such 
experiments ... " In his copy of Lynchcott's report on child development, Bonica 
had apparently drawn attention to the following passage: "{ am left with the 
impression that the Chinese have put a very low priority, if any, in modem 
systems of collecting biostatistical information for the country at large. 1 would 
hasten to add, however, that 1 am sure they have the expertise and organization to 
accomplish this." These markings, which correlate with Bonica's own 
comments,717 seem to suggest that h~ shared his colleague's impression that the 
Chinese did not share Arnericans' understanding and practices of objectivity.718 
Various factors thus conspired, according to American medical 
researchers, to make it impossible to untangle mate rial causes of pain relief from 
psycho-cultural and psycho-social ones on the basis of observations in China. The 
view of Chinese society reflected in both general news coverage and discussions 
of acupuncture anaesthesia was one in which individual actions were 
indissociable from the thick ideological web that synchronised the actions of each 
ofits parts.719 The nature of pain made patients' experiences ofreliefunder 
acupuncture open to the influence of this collusion, regardless of whether it was 
considered to be the result of voluntary consensual cornplicity, unconscious 
717See, for example: "John J. Bonica notes on trip to China, 1973," Bonica Papers, MS C 118, Box 
66, Folder 52, Darling Library, UCLA, Bonica wrote: "Question about c1inical trials- they 
indicated that they do use controls and study groups but the answer was very vague and it is 
doubtful that this is the case." AI Dieffenbach, "Doctors mull," Bonica Papers, MS C 118, Box 41, 
Folder 27, Darling Library, UCLA: "Unfortunately, [Bonica] said, the ban on publishing in China 
has left no recent body of scientific reports that might have served as a basis for the expected 
American study of the procedure." 
718 Leo Orleans, "China's Statistics: the System and Its Problems," Public Data U~e 1 (1973): 17-
?, in Bonica Papers, MS C 118, Box 66, Folder 49, Darling Library, UCLA Bonica also kept in his 
papers this article about the different cultural and political attitude of the Chinese towards exact 
quantification and the establishment of a viable statistical system. 
719This image is present in W. S. Kroger, "The Scientific Rationale," 191-4, in which the author 
compares Chinese society to Skinnerian operant conditioning: "There are the cultural factors of a 
more than 3000 year beliefsystem which in a regimented society, readily bring about compliant 
behavior without avert cooperation being necessary. Such compliance will be obtained in Western 
society only if strong reward inducements are offered such as those outline in Mao's new thaught 
directives. Also, too, Mao is regarded as a deity and his words are accepted as gospel.... Mao's 
sociopolitical exhortations which are part ofChinese life induce an exquisite receptivity to mold 
the thinking of the masses." 
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brainwashing or totalitarian control. Chinese physicians were similarly caught 
within the tight social net, unable to think for themselves or to reveal that they 
did. 720 
Given widespread remarks on the limited utility of Chinese statements, 
and of observations made in China, it is not surprising that the Ad Hoc Committee 
on Acupuncture recommended that acupuncture should be experimented in 
priority on American subjects.721 American chronic pain sufferers,. however, had 
their own biases requiring careful control through the use of experimental devices. 
In addition, the nature of their pain sometimes created difficulties for the 
implementation of trials and the interpretation of results. 
Americans had easy access to descriptions of, and opinions about 
acupuncture, which were widely diffused through the news media. Sorne 
researchers complained that it was impossible to recruit naïve subjects, and even 
that "publicity given by press, radio and television to acupuncture in the United 
States has preconditioned our population to the same extent as people in China 
who believe in acupuncture because oftheir cultural heritage.,,722 Furthermore, 
72°Boyce Rensberger, "U. S. Doctors Are Skeptical of Acupuncture in Treatment of Purely 
Physical Diseases," New York Times (7 October 1971),42, reports the opinion ofseveral 
American physicians (Henry Beecher,Vemon Mountcastle, Janet Travell) who express doubts 
about whether Chinese physicians are telling the truth about acupuncture. Reston, "Now, About," 
1: "While 1 have no way ofknowing the validity of the reports, the Faith even of the professionally 
qualified doctors at the AI hospital is impressive. Maoism itself has obviously become an 
infectious disease, even among many of the we!l-educated urban citizens who had a hard time 
during the Cultural Revolution." 
721"An eye on the needle: a suggested approach to acupuncture," 1972, Bonica Papers, MS C 118, 
Box 66, Folder 6, Darling Library, UCLA. 
722While testing of acupuncture in American patients had initia!ly been seen as a way to control for 
psychological factors, namely Chinese ideological influences, this view did not hold for long. The 
following view was quite common: E. R. Kepes, M. Chen, M. Schapira, "A critical evaluation of 
acupuncture in the treatme,nt of chronic pain," Unpublished, n.d. in Bonica Papers, MS C 118, 
Box 66, Folder 46, Darling Library, UeLA: "In order to do research on new therapeutic 
modalities, one has to separate the bias on the part of the therapist and the bias of the paitnet from 
the actual effect of a new method. This is difficult to do with acupuncture. The publicity given by 
press, radio and television to acupuncture in the United States has preconditioned our population 
to the same extent as people in China who believe in acupuncture because oftheir cultural 
heritage. We have met very few patients who did not believe in it~ efficacy before their tirst 
experience with acupuncture treatment." 
See also: RJ Beebe, TW Andersen, HM Perkins, V A Hospital and U of Florida Coll of Med 
"Preliminary findings with acupuncture treatment of pain" in Proceedings of the NIH, 1-2: 
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these overly enthusiastic subjects were "failures from conventional medicine," 
and were thus more likely to be sensitive to the "novelty effect" of acupuncture, 
which might heighten the placebo effect. 723 The definition of acupuncture as 
experimental made it difficult, according to ethical guidelines, to recruit subjects 
who were not refractory to other therapies.724 Sorne researchers argued this factor 
required additional controls, while others argued that any significant relief 
obtained with acupuncture, even if it fell "within the placebo range," might be a 
sign of success in a patient population that had found no relief elsewhere. 725 
Researchers also expressed the need to control for acupuncturists' 
expertise and charisma. Experienced acupuncturists could not be "blinded" to the 
use of "placebo acupuncture," and sorne preferred to use trained technicians to 
deliver test therapies, despite the difficulties this involved and the arguments 
made for the importance of skill in acupuncture efficacy.726 Others suspected 
acupuncturists of infectious enthusiasm, even if they spoke no English, which 
made it difficult to protect double or even single blind controls.727 Sorne 
investigators even conducted trials comparing the efficacy of Asian-Iooking and 
Caucasian-looking acupuncturists.728 
The vulnerability of American sufferers to various influences-media 
publicity, acupuncturists' beliefs, and the hardships oftheir own suffering-
Despite results indicating that acupuncture was effective for the relief of chronic pain, the authors 
called for caution in part because: "the patients' expectations were high due to the widespread 
publicity." 
723 Praceedings afthe NI H, 130-131. 
724 F. F. Foldes in Praceedings afthe NIH, 135. 
725 Praceedings afthe NIH, 130: "Dr Foldes: The overall results ... seem t be surprisingly close ta 
the placebo effect... Dr Katz: [ would object to an overall comparison of percent 
effectiveness ... Many ofthese patients in the acupuncture trials are failures from conventional 
therapy. Dr Moore: l would underscore that particular point. Our patients come to the pain clinic 
with intractable pain." 
726 Gerald L. Looney, "Response ofOsteoarthritis to Acupuncture" in Proceedings afthe NIH, 18. 
727 Gene M. Smith, "Acupuncture and experimentally-induced ischemic pain," in Proceedings of 
the NIH, 64: "Even though the acupuncturist does not speak English this does not preclude the 
possibility ofbias, since there are many sources of non-verbal signalling available." The 
acupuncturist appeared "more expectant, more interested" in true than placebo trials, thus making 
it difficult ta "blind" the study. 
728 E. R. Kepes, M. Chen and M. Schapira, "A critical evaluation of acupuncture in the treatment 
of chronic pain," Unpublished, n.d. in Bonica Papers, MS C 118, Box 66, Folder 46, Darling 
Library, UCLA, one of the questions this study aimed to answer was: "Do the therapeutic results 
differ when acupuncture is administered by Chinese or Caucasian physicians?" 
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justified the need for well-controlled experiments, and for additional research on 
the possible presence of phenomena such as hypnotism or responses to the 
appearance of the acupuncturist. In addition, this image undermined the value of 
the "testimonial" evidence these sufferers presented in letters and legislative 
hearings. It was not so much that patients themselves could not be trusted to be 
truthful about their experience, but that individual experience could not be trusted. 
To become collectively val id, this experience had to be multiplied, compiled, and 
compared under the supervision of a medical researcher, preferably one who 
knew something about pain. Large numbers were imperative. The purpose of 
amassing and comparing data was not just to increase the level of certainty in 
evaluating acupuncture; it was a necessary means of controlling for the power, 
and malleability, of the mind in experiencing pain. 
7.3 Experience versus Experimentation: the Challenge to Medical Control 
While the popular response to acupuncture had reportedly stimulated a demand, 
through Congress and the NIH, for the serious medical evaluation of acupuncture, 
many grew impatient with, disappointed in or suspicious of the medical 
establishment's response. The authority of medical researchers' ideal evaluation 
through controlled experimentation was challenged. Sufferers, who had 
experienced the pain-relieving effects of acupuncture and who believed in the 
validity of their individual experience, testified in the media and in legislative 
hearings that acupuncture worked. They also criticised the medical "takeover" of 
acupuncture's evaluation, pointing out that the insistence on the exdusivity of 
controlled experimentation was just another means of keeping acupuncture within 
medical control. These daims were diffused widely with the help of journalists 
and editors, who published individual testimonies in newspapers; pro-acupuncture 
lobbyists, who arranged demonstrations and testimonies at legislative hearings, 
and also wrote to newspapers; and occasionally family members, who wrote 
lettersabout their kin's' experiences with acupuncture. 
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The mass media was an active player in the acupuncture debate. In a 
month-Iong survey ofhow frequently acupuncture was making the news, Bonica 
had reportedly collected 1,100 newspaper clippings.729 A computerised search of 
the archives of the New York Times and the Wall Street Journal using ProQuest 
confirms that articles, letters, and even short poe ms on acupuncture were printed 
by the hundreds between 1971 and 1974. The television and radio listings in these 
newspapers also indicate an omnipresent discussion of the acupuncture topic. 
Information about acupuncture, medical experts' opinions, research 
efforts, and regulatory debates was easily accessible to many Americans. The 
media also provided a channel for expressions of mistrust towards medical 
interests in, and methods of, evaluating acupuncture, and to praise for its efficacy. 
Testimonies of dramatic recoveries from disabling pain were reported in 
journalists' coverage of legislative hearings, interview citations, and in the letters 
sent by sufferers and their families to the editor of various newspapers. 730 
Newspaper articles also provided evidence of popular enthusiasm by relating the 
success of the acupuncture business. 731 Indeed, "extravagant media attention" 
would, in the 1980s, be accused of having distorted the real extent of 
acupuncture' s limited practice in the early 1970s.732 The media also related 
doctors' fears of uncontrolled spread of quackery and their concerns about the 
unethical exploitation of sufferers' desperation and gullibility, and traced the 
729 Al Dieffenbach, "Doctors mulliong-range research on acupuncture," Seattle Times (Feb Il, 
1973) in Box 41, Folder 27; Bonica to John Andes, December Il, 1972 in Bonica Papers, MS C 
118, Box 66, Folder 31, Darling Library, UCLA, in which Bonica reports that he had collected 
"hundreds of c\ippings" on acupuncture. 
730For example: Boyce Rensberger, "Acupuncture 'Wonderful' to a Patient," New York Times, 
(May 31, 1972),43; S. M. Gottlieb, "An Acupuncture Testimonial (Ietter to the editor)," New York 
nmes, (July 6 1974), 16; M. Schumach, "CouncilDelves lnto Acupuncture," New York Times 
(December 8, 1972),49; "Hearings Started on Acupuncture: Witnesses Tell State Panel the 
Therapy Cured them after Doctors Failed," New York Times (March 13, 1973),82. 
731"Acupuncture Patients Fear Ban," New York Times (Sep 5 1972), 1; "Acupuncture Clinic Here 
Closes Down,"New York Times (July 20, 1972),29. 
732Ginger McRae, "A Critical Overview ofU. S. Acupuncture Regulation," Journal ofHealth 
Politics, Policy and Law 7, no. 1 (1982): 163: "If acupuncture seemed rampant and ubiquitous, it 
was because of extravagant media attention and the tendency of the medical profession to 
exaggerate the dimensions of acupuncture practice." 
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evolution of medical research efforts.733 Articles, many bearing titles apparently 
in competition for the most imaginative "needling" puns 734, were not only 
records, but also vehicles, of rising tensions between a pro-acupuncture lobby and 
the medical establishment. Articles such as "Doctors Fear Quackery: Acupuncture 
Hit,,,735 "A Doc Deflates Acupuncture,,,736 "MD's Criticism of Acupuncture 
Disputed,,737 may even have exaggerated the animosity between lay acupuncture 
supporters and their medical critics. 
Nevertheless, these sources-along with letters sent directly to researchers 
and records of legislative and congressional hearings--do seem to reflect a real 
tension between elite researchers and those who believed there was sufficient 
evidence of efficacy to make acupuncture therapy immediately and widely 
accessible. Researchers' appeal to the authority of experimentation-in which 
individual subjectivity was interrogated under controlled conditions and then 
submerged in large numbers of data-was opposed by sufferers' appeal to the 
authority of individual experience-in which their own bodily knowledge was 
more valuable that the knowledge of experts. Medical institutional responses to 
acupuncture were also accused of bearing the biases of the medical profession, 
whose professional interests and biomedical close-mindedness would preclude a 
fair evaluation. 
Legislative hearings were the main sites of competition between 
experience and experimentation as sources of evidence for acupuncture's efficacy. 
Testimonies and demonstrations were admitted to legislative hearings on 
733 For example, see: "Medical Panel Asks Acupuncture Study to Evaluate Merits," New York 
Times (March 3, 1973),8; Lawrence K. Altman, "Interest in Acupuncture Rises in U. S.: Doctors 
Test Old Chinese Technique," New York Times (June 12, 1972), 1; Boyce Rensberger, "U.S. to 
Evaluate Acupuncture for Safety and Effectiveness," New York Times, (July 28, 1972), 1. 
734"Acupuncture: When You Need a Little Needling," New York Times (May 2, 1971), E7; R. R. 
Leger, "It May Needle Sorne, But Acupuncture Is On the Way in Nevada," Wall Street Journal 
(April 17, (973), 1; "Acupuncture Craze Gets Sharp Poke in Medical Report," Wall Street Jaurnal 
(June 18 1974),21; "A Needle for the Doctors," Wall StreetJournal (Apr Il 1972),22; C. K. 
Dorland, "Pointed Replies (letter to the editor), " Wall Street Journal, 14. 
735Bonica papers, in Washington Star, Sunday Aug 4, 1974, A-I and A-8 in NASA: Delegation to 
the PRC: Acupuncture, General, 1973-76. 
736 E. Nelson, Daily News, (June 18, 1974) in Bonica Papers, MS C 118, Box 66, Folder 31, 
Darling Library, UCLA. 
737 A. H. Kao, Honolulu Advertis~r, (Mar 22 1974)in Bonica Papers, MS C 118, Box 66, Folder 
31, Darling Library, UCLA. 
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acupuncture bills, as well as sorne congressional hearings. In a New Jersey 
hearing, a man was said to have testified while carrying his discarded crutches 
and back brace. 738 A Nevada bill was approved after weeks of demonstrations on 
hundreds of patients by a Hong Kong acupuncturist, including twenty legislators, 
according to one account. 739 One demonstration wàs even conducted during the 
hearings of a congressional sub-committee on Chinese-American Cooperation, 
using as its experimental subject, its chairman Mf. Brown.74o 
Legislators seem to have been more willing than medical authorities to 
consider types of evidence other than clinical trial results.741 Medical researchers, 
as we have seen, testified that the only possible source of valid information about 
acupuncture's efficacy was a coordinated set ofwell-controlled experiments. 
They urged that "testimonial" and "anecdotal" evidence should be purged from 
the acupuncture policymaking process. Yet, individuals-often backed by more 
influential acupuncture enthusiasts-persisted in presenting their own bodies as 
evidence for the efficacy of acupuncture. According to sorne observers, it worked. 
In a 1982 article presenting a "Critical Overview of U. S. Acupuncture 
Regulation," Ginger Mac Rae argued that "laws favoring the nonphysician 
acupuncturist generally are the fruit of activity by persistent and vocal state 
lobbies comprising nonphysician acupuncturists, patients who have benefited 
738 W. H. Waggoner, "Hearings Started on Acupuncture: Witnesses Tell State Panel the Therapy 
Cured Them After Doctors Failed," New York Times (March 13, 1973),82; W. H. Waggoner, 
"Chief Medical Officer, in Shift, Backs Acupuncture by Nondoctors," New York Times (May 8, 
1974),96. 
739 Associated Press, "Acupuncture Law in Nevada," New York Times (ApriI21, 1973),25; Leger, 
"It May Needle Sorne, 1; UPI, "Nevada legislature Backs an Acupuncture System," New York 
Times (April 10, 1973),40; UPI, "Acupuncture in Nevada," New York Times (March 11, 1973), 
28. This last one says that Hong Kong acupuncturist was invited because officiaIs trom the Senate 
Committee on Health and Welfare said they had requested a demonstration of acupuncture. 
Another article ("It May Needle Sorne") stated that the demonstrations were organised by New 
York attorney and real estate developer Arthur Steinberg who had been leading an active 
campaign to publicize and legalize the practice of acupuncture. 
See also: W. M. Edwards, "Acupuncture in Nevada," The Western Journal of Medicine 120 
(1974): 507-512; F. M. Anderson, "Instant Acupuncture for Nevada (editorial)," Western Journal 
of Medicine 120 (1974): 487-8. 
740 Cornrnittee on Science and Technology, United States-China Science Cooperation Hearings 
before the Subcommittee on Science, Research and Technology U S. House of Representatives, 
May 7,8, la; June 22, 1979 (U. S. Govemrnent Printing Office, Washington: 1979), 196-204. 
741McRae, "A Critical Overview,"163-96. My impression from reading congressional hearings and 
news coverage of state hearings tends to confirm this. 
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from acupuncture treatment and Western physicians well-disposed toward 
acupuncture." Mac Rae added, in a note, that "patients excel at presenting the 
kind of 'testimonial and anecdotal' evidence on behalf of acupuncture that is 
persistently belittled by the medical profession, but is persuasive to legislators.,,742 
Sufferers and acupuncture enthusiasts also contested researchers' denial of 
the validity of observational evidence. A widely diffused Associated Press 
summary of an article by Bonica on his observations in China that was published 
in JAMA drew so many angry responses and "poison pen" letters that Bonica felt 
compelled to issue a statement to correct the misconception that he was 
condemning acupuncture.743 In these letters, individuals told Bonica about the 
reliefthat they, or their close ones, had obtained from acupuncture; disputed the 
medical establishment's right to control access to a useful therapy; and questioned 
doctors' competence in evaluating its efficacy. Anthony Kao, the president of 
Acupuncture Services, Inc., accused Bonica of racism in implying that the 
Chinese felt less pain than did Americans, and of protecting the interests of the 
medical profession.744 Franz Z. Warren, President of the National Acupuncture 
Research Society, wrote Bonica an open letter c1aiming that his overly cautious 
tone would harm the cause of giving acupuncture a fair trial through well-funded 
and rigorous research programs. He added that this caution seemed unfounded: 
"The most confusing aspects of your report were the disparities in what you 
observed and how you translated your own eye-witnessed findings. If you really 
did see what you saw, how then interpret it as you did with your statement that 
acupuncture is no better or worse than hypnosis or placebo ... " Warren added: 
"When has there ever been any incontrovertible evidence in the areas of pain, 
hypnosis, anaesthesia theory and so on?,,745 
742McRae, "A Critical Overview," 196. 
743 Associated Press, "Report Claims Acupuncture Overrated," in (Box 66, Folder 29]; Bonica to 
New York Post, Washington Post, Los Angeles Times, June 28, 1974 (Box 67, Folder 9] John J. 
Bonica Papers, Manuscript collection number 118, Louise M. Darling Biomedical Library, History 
& Special Collections Division, University ofCalifomia, Los Angeles. 
744 A. H. Kao, "MD'sCriticism of Acupuncture Disputed" Honolulu Advertiser (March 22, 1974) 
in Bonica Papers, MS C 118, Box 66, Folder 31, Darling Library, UCLA. 
745 "An open letter to Dr John Bonica, chairman of the Advisory Committee on Acupuncture for 
the ASA- his remarks in a recent AMA article contained damaging implications to our society and 
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As we can see from these responses, there was a readiness not only to 
assert the value of non-experimental evidence, but also to dispute the legitimacy 
of medical control over the evalùation of acupuncture. In a hearing on the 
appropriation offunds to the NIH, in which Congressional representatives were 
demanding that the NIH take the evaluation of acupuncture seriously, Flood 
expressed particular concern about an article published in the Washington Star 
entitled "Acupuncture Deserves Wider Trial." "The question," the author 
declared, "is, how it is to be tested and by whom? And when tested, how valid 
will be the results? Doctors, of course, say that only they should be involved ... " 
The author concluded convinced that "the biases of the medical profession and its 
often arrogant pretended omniscience might weIl botch the job": "As long as M. 
D.'s hold aIl the cards, no one will really know what is valuable about 
acupuncture therapy and what should be rejected.,,746 Flood and Magnuson were 
apparently worried that ifNIH didn't act fast on acupuncture, the American 
public would not only lack reliable evidence about acupuncture, but would likely 
to lose its trust in medical researchers' willingness and capacity to produce such 
evidence. 747 
Such expressions of distrust were often directed towards the AMA, and 
may even have provoked reluctance among AMA representatives to get officially 
involved in the acupuncture debate, preferring to leave licensing issues to the state 
boards.748 By late 1972, the AMA had.not yet adopted an official position on 
acupuncture. When the AMA finaIly did appoint an Ad Hoc Committee on 
to acupuncture in general, and in the interest offaimess require a printed rebuttal, " in Frank Z. 
Warren to Bonica, August 8, 1974 in Bonica Papers, MS C 118, Box 66, Folder 29, Darling 
Library, UCLA. See also: Cecile E. MacTaggart, "Letter to the Editor 1-- No Title," New York 
Times (August 18, 1972), 30, "Is it likely that Dr. Walter Tkach, personal physician to the 
President of the U. S. would write an article in the July issue of Today's Health that was 'purely 
anectodal'? After ail, )le saw operations perfonned in China with his own eyes ... " 
746J. Randal, "Acupuncture de serves Wider Trial," Washington Star (June 8, 1972) cited in 
Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of the 
Committee on Appropriations FY 1974, House of Representatives, Part 4- NIH, (US Govemment 
printing office, Washington DC: 1973), 791-2 . 
. 747Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations FY 1974, House of Representatives, Part 4- NIH, (US 
Govemment printing office, Washington OC: 1973), 793. 
74S"Report on Acupuncture: NIH/FDA Meeting, September 22, 1972 in Bonica Papers, MS C 118, 
Box 66, Folder 12, Darling Library, UCLA. 
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Acupuncture/49 in February of 1974, Jenkins expressed concern that the purpose 
of the committee "could be misinterpreted as protection of the financial interests 
of physicians," and noted that there was "a danger than an AMA statement would 
be construed to be self serving." 750 J enkins may have feared a similar response to 
the statement issued by the American Society of Anesthesiologists, which called 
for acupuncture to be submitted to the scientific standards of American medicine. 
When this staternent had been summarised in the Chicago Sun Times, one reader 
promptlyresponded: "it will be interesting to see how long it takes the medical 
establishment to either 1) stifle [acupuncture] or 2) monopolise it for the further 
enrichment of physicians. The tirst indications may come at San Francisco this 
month when the AMA stages its annual re-enactment of King Canute's effort to 
stop the rising tide.,,75 1 Jenkins may also have received letters sirnilar to the one 
C. R. Wilson sent to Bonica: "Whether the AMAapproves of acupuncture or not 
is unimportant. In fact, if the AMA disapproves, there must be sorne validity to 
the treatrnent. As long as the AMA can keep a closed mind on sornething which 
has 5,000 years of operation behind it, it will encourage the unscrupulous, the 
unqualitied and the incornpetents to engage in surreptitious practice of 
t ,,752 acupunc ure... . 
Historians and sociologists of medicine have described the 1960s and 
1970s as a time of "crisis of legitirnacy" in Arnerican medicine, when distrust of 
medical authority was expressed in critiques of medical professional power, the 
emergence of "patient movements," and a growing involvement of the rnass 
media in health issues.753 This criticism was associated with broader social 
749 "AMA Grams," Journal of the American Medical Association 227, no. 12 (Mar 25) (1974): 
1393. During its January meeting the AMA board oftrustees authorised the establishment ofa 5 
member committee to study and report on.the state of acupuncture. 
750 "Ad Hoc Committee on Acupuncture, the Brown Palace Hotel, Denver, September 12-13, 
1974," in Bonica Papers, MS C 118, Box 66, Folder 22, Darling Library, veLA. 
751 "Medical group hits acupuncture" Chicago Sun Times, (June 3, 1972); "Acupuncture and the 
doctors" Chicago Sun Times (June 7 1972) in Bonica Papers, MS C 118, Box 66, Folder 31, 
Darling Library, UCLA. 
752 C. R. Wilson to Bonica, June 18, 1974, in Bonica Papers, MS C 118, Box 66, Folder 12, 
Darling Library, UCLA. 
753 Paul Starr, The Social Transformation of American Medicine (New York: Basic Books, 1982), 
379-393; Mike Saks, "Medicine and the Counter Culture,"in Companion to Medicine in the 20th 
Century. eds Roger Cooter, and John Pickstone, (London: Routledge, 2000) 113-23. 
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movements such as feminism and civil rights activism. Two of its aims were to 
reclaim lay control over health issues, and tovalidate sick persons' own 
knowledge and experience of their bodies. 
The debate about acupuncture thus reflects a more widespread willingness 
to contest biomedical authority, expertise, and exclusivity. While researchers 
claimed that the subjective and individual nature of pain made it especially 
difficult to evaluate the effects of acupuncture, for sufferers these effects were 
obviously and immediately perceptible. They didn't see the need for expensive 
and complex technologies to tell them what they already knew. In addition, many 
who had experienced several therapeutic failures had good reason to lose faith in 
biomedicine and its actors and to be enthusiastic about a therapy that seemed to 
procure relief. 
Pain experts such as Bonica agreed that medicine had failed to 
satisfactorily address problems of chronic pain, and that pain should be defined as 
what patients themselves experienced and defined as pain. Indeed, these were 
crucial comerstones in his campaign to create a specialised "pain medicine." 
However, for Bonica, the best collective long-term solution was to improve 
medicine rather than reject it" by developing, through increased research funding, 
properly controlled therapeutic experimentation, and by establishing new types of 
clinical models, a new kind of medicine within medicine. 
The failure to concretise Bonica's envisioned program of acupuncture 
evaluation was probably not directly due to "popular" or "pro-acupuncture" 
opposition. The AMA may have been reluctant to take a strong public stance on 
the need for an evaluation program controlled by medical researchers, but this 
doesn't explain the lack of actual research. The actions of pro-acupuncture lobbies 
in the legislative arena may have been a more concrete obstacle to the realisation 
ofresearchers' ambitions, in that it impeded rulings that may have'provided 
authorityand financial support for the establishment of coordinated research 
programs at the state level. 754 1 suggest, however, that acupuncture research faced 
754 Jackson W. Riddle, "Report of the New York State Commission on Acupuncture," American 
Journal ofChinese Medicine 2 (1974), 317-318: the draft ofproposed legislation incIuded, section 
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more immediate and practical obstacles arising from tensions and gaps within the 
medical establishment, which prevented the allocation of suffi cie nt resources for 
the implementation of valid and large-scale clinical trials. 
7.4 A Divided House of Pain: the Challenge from Within 
1 have argued in previous chapters that the successful implementation of pain-
measuring technologies usually depends on the use of certain social and material 
resources that include money, labour, authority, agreement, and the 
standardisation of definitions and techniques. Was there a lack of crucial 
resources for the implementation of technologies to evaluate the pain-relieving 
effects of acupuncture? 
NIH officiaIs asserted, in their response to the inquiries of Congressional 
representatives, that "the deficit here, sir seems not to be the lack of funds, but the 
lack of fundable research applications." 755 Researchers' own discussions of the 
difficulties they, and others, faced in designing and implementing acupuncture 
trials lead me to ask two questions: Why were good experimentai designs for the 
evaluation of acupuncture so hard to come by? Was there really enough money? 
In 1974, the NIH had reportedly given out five grants for acupuncture 
research amounting to "in excess" of $200,000.756 Perhaps, this couid have 
produced sorne reiatively persuasive evidence about therapeutic efficacy in a field 
in which researchers had aiready agreed on what was a good experiment. This 
was not the case either for acupuncture or chronic pain. While sorne researchers 
complained that NIH funding for acupuncture evaluation was inadequate and 
6: "the sum oftwo hundred fifty thousand dollars ($250,000), or so much thereof as may be 
necessary is hereby appropriated to the state boards for medicine and dentistry ... in carrying out 
the provisions ofthis act." These provisions included the creation of state-wide mechanism of data 
collection and evaluation to determine the efficacy of acupuncture. 
755 Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations FY 1975, House of Representatives, Part 7, (US Government 
printing office, Washington OC: 1974),2045. 
756Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations FY 1975, House of Representatives, Part 7, (US Government 
printing office, Washington OC: 1974), 2045. 
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inaccessible,757 l would argue that this was especially the case if we consider the 
amount of work that was needed to achieve some agreement on methodological 
details or, as some others suggested, to establish some centralised mechanism 
with sufficient authority to impose a standard protocol on a large scale. To this 
suggestion, Bonica had replied: "The committee considered this and did 
recommend a national collaborative effort wherein the study designs are similar 
and coordinated. l'm not sure this can be brought off in the face of current 
funding.,,758 
The novelty of acupuncture, and important ways in which it was different 
from the drug therapies for which clinical study designs had been refined, made it 
difficult to agree on a standard design. Acupuncture itself was difficult to 
standardise as a therapy because, according to many, it required skill, 
individualisation, and patient participation (for locating appropriate spots). There 
were difficult questions to answer, on which researchers disagreed, about how to 
deliver placebo acupuncture and how to achieve double-blind conditions. This 
was illustrated in a "controversial correspondence about double-blind studies of 
acupuncture" that took place over nearly two years through letters to the editor of 
lAMA.759 A parallel exchange of letters debated the importance of skill and of 
757Department of Labor and Health, Education and Welfare, Hearings before a Subcommittee of 
the Committee on Appropriations Fr 1975, House of Representatives, Part 7, (US Govemment 
printing office, Washington DC: 1974),256, Statement of Dr Herman Platt: "1 don't know the 
precise figure for acupuncture research funding was with respect ôfthe recent NIH involvement. 
However, it must be a mere pittance because 1 have known a number of these researchers and 
there is no way that they can conduct their work in a meaningful way."; Committee on Science 
and Technology, United States-China Science Cooperation Hearings before the Subcommittee on 
Science, Research and Technology U S. House of Representatives, May 7,8, la; June 22, 1979 (U. 
S. Government Printing Office Washington: 1979),205: Testimony of R. Coan, "Ertel: Does 
anyone finance your study, such as the NIH or the National Science Foundation, or any other 
groups at this time? Coan: l'm glad you asked that question. No is the naswer. 1 was told by Dr. 
Harold Jenerick, who has something to do with the Institute of General Medical Science of NfH 
that my chances of getting funds to do this would be 1 in 5,000; that is, to do acupuncture 
research." 
758 Bonica in Proceedings of the NIH, 137. 
759 B. D. Adler, "Acupuncture (Letter to the Editor)," Journal of the American Medical 
Association 222, no. 7 (1972): 833, called for well-controlled double-blind studies of acupuncture: 
in half ofthe patients, the needles would be placed in their proper position, but the other half 
would have needles placed in the approximate location, but a short distance away from the 
approved site( ... ) By this method, the role of suggestion can be easily determined." 
L. C. Mark, "Acupuncture and Suggestion (Letter to the Editor)," Journal of the American 
Medical Association 223, no. 8 (1973): 922, replied to Adler that placebo-acupuncture was 
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exact needle placement in obtaining acupuncture effects.76o Similar issues came 
up at the NIGMS Conference on Acupuncture Research in 1973.761 
While dis agreements about acupuncture certainly posed an obstacle to the 
rapid and cheap implementation of a successful program of evaluatiort, my focus 
in this section will be on the issue of pain-measurement. 1 will suggest that the 
novelty and instability both of chronic pain as an object, and of the professional 
networks concerned with its study, can explain why such a program was never 
realised. 
We've already seen that discussions about the evaluation of acupuncture 
were used as an opportunity to draw attention to the problem of chronic pain. 
impossible since the correct placement of the needles required the collaboration of the subject in 
identifying distinctive sensations. Nevertheless, "despite the inapplicability of the simplistic 
double-blind approach, meticulous scrutiny by careful investigators should pro vide the basis for a 
reasoned appraisal." 
E. Y. M. Chein and A. K. Schapiro, "Evaluation of Acupuncture (Letter ta the Editor)," Journal of 
the American Medical Association 224, no. 11 (1973): 1533-4, suggested that electrically 
stimulated needles could be made to elicit such sensations regardless of the correct placement of 
the needles. . 
759 L. C. Mark, "Double-Blind Studies of Acupuncture," Journal of the American Medical 
Association 225, no. 12 (1973): 1532, replied to Chein and Schapiro that needles tirst had to be 
placed, before they could be stimulated, and this tirst step could not "be counterfeited." 
Chein and Shapiro, "A Mini-Symposium on Acupuncture (Letter to the editor," Journal of the 
American Medical Association 227 (1974): 1122, continued to insist that controlling for the 
"powerful placebo effect" of acupuncture was essential, and proposed sorne new solutions. 
Perhaps two true acupuncture points could be chosen, but one would be irrelevant to the condition 
being treated and thus servé as the placebo. To make this double-blind, however, naive 
acupuncture technicians would have to be briefly trained, and only naive subjects recruited. Such a 
design, ifreplicated andrepeated in different conditions and by different investigators, could 
establish a "powerfu1 case ... for the efficacy of acupuncture." . 
760R. Macintosh, "Acupuncture (Letler to the Editor)," Journal of the American Medical 
Association 226, no. Il (1973): 1360, "A few weeks ago 1 expressed the opinion that in 
acupuncture for surgery, success depends on the suggestibility of the patient and not on the skill of 
the acupuncturist in placing the needles accurately. My beliefis strengthened by the contradictions 
in the accounts ofthyroidectomy by recent visitors to China." Macintosh is referring to variations 
in needle placement in different accounts of acupuncture surgeries. 
T. O. Cheng, " A Mini-Symposium on Acupuncture (letter to the editor)," Journal of the American 
Medical Association 227 (1974): 1122, in response to Macintosh, Cheng maintained that exact 
point do es not have to be the same on each patient, because different points are interconnected. 
Argues that it is necessary to understand the principles on which the points are based to practicc 
acupuncture effectively. "Success fo acupunctural anaesthesia indeed de pends on the skill of the 
acupuncturists in accurate placement of the needles, and not on the suggestibility of the patient." 
John R. Tack., "A Mini-Symposium on Acupuncture (letter to the editor)," Journal of the 
American Medical Association 227 (1974), also in response ta MacIntosh: "Dr MacIntosh seems 
to imply that the effect is due ta suggestion because it can be achieved by placing the needles in a 
wide variety of points. Erythromycin can be given topicaHy, orally, or intravenously. ShaH we 
attribute its effect to suggestion also?" 
761 For example: Looney in Proceedings of the NIH, 13-18. 
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Indeed, Bonica's position as chair of the NIH Ad Hoc Committee was probably 
instrumental in defining acupuncture as a therapy for chronic pain, and thus also 
defining chronic pain as a specific type of condition. First, Bonica and his 
committee's recommendations prioritised the evaluation of acupuncture's effects 
on pain rather than other conditions said to be responsive to the therapy, such as 
deafness and paralysis. In addition, they subdivided research priorities into two 
categories: anaesthesia, and chronic pain. Various types of conditions, such as 
migraine, cancer pain and various forms of arthritis, were newly assembled under 
a common label. There had been little previous discussion, however, about how 
what these conditions had in common, and little or no research specifically funded 
as primarily investigating chronic pain. 762 
Researchers from different areas-psychiatry, anaesthesiology, 
rheumatology, etc.-who may not have been accustomed to working together 
were brought to work on this poody defined common object. As we've also seen, 
the constitution of committees and conferences was used as a means of creating 
new professional networks, but these newly formed networks had had little 
chance to stabilise. Researchers had had little time and few organised 
opportunities to discuss how they might define or measure chronic pain, or to 
identify or create a mechanism to standardise measurement practices. 
It is true that previous initiatives had succeeded in effectively 
implementing clinical trials to determine analgesic efficacy. As we saw in the 
previous chapter, however, the trials sponsored by the Committee on Drug 
Addiction (CDAN) and the Veterans' Administration (VA) required long-term 
funding and close coordination in order to produce consistent and reliable results. 
Another cooperative clinical trial project, which was suggested as a model for 
acupuncture evaluation, was that developed by the Arthritis Foundation and the 
American Rheumatism Association. In 1958, the ARA had created a Committee 
on Diagnostic and Therapeutic Criteria and a Cooperating Clinics Committee 
(CCC) to resolve problems of precision and quality in arthritis drug evaluation. 
From 1959, the CCC began conducting multi-site controlled trials of arthritis 
762 Baszanger, lnventing Pain Medicine, 65. 
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trèatments, and was able to demonstrate that previous uncontrolled had led to 
faise impressions of therapeutic efficacy for sorne drugs, such as indomethacin. 
The use of multiple sites enabled the selection of sufficiently large and uniform 
samples of subjects and long-term, careful observation of each subject that \Vere 
necessary to overcome the variability of rheumatic diseases and perform the 
"detailed objective assessments required" made such conditions indispensable. 
Each study was performed under the same protocol, and data was analysed 
centrally.763 Like the CDAN and V A trials, the CCC trials had required central 
coordination and concerted work on a specifie target of measurement in order to 
produce valid results. No large institution was interested in overseeing, funding, 
and coordinating a long-term evaluation of acupuncture. 
Bonica's and others' appeals for more research on pain can be seen as a 
way of saying that the current state of knowledge and agreement about chronic 
pain was not sufficient to resolve the question of acupuncture's efficacy. Of. 
course, Bonica also had his own agenda in calling for more funding for pain 
research. Yet his position seems to be confirmed by the lack of agreement about 
what chronic pain was, and how it could be measured, that was clearly evident in 
the proceedings of the NIGMS Acupuncture Research Conference. In 1973, most 
of the researchers who had an interest in acupuncture got together to present their 
findings and discuss further research. These researchers came from various 
disciplines and research areas, bringing different ideas about pain-measurement 
from sensory psychology, rehabilitation medicine, arthritis research, analgesic 
assessment, anaesthesiology and psychophysics to bear on the evaluation of 
acupuncture. Almost every trial they reported used a different method for 
measuring improvements in pain due to acupuncture. In the discussion of each 
presentation, the various methods used to rate pain and its relief were frequently 
criticised. In addition, it was not dear, given the particularly tenacious nature of 
subjects' pain, how much relief should be considered significant. Given, also, the 
763Department of Labor, Health and Welfare, Hearings of the Senate Subcommittee on Heath of 
the Committee on Labor and Public Welfare on the National Arthritis Act, (U. S. Govemment 
Printing Office, Washington D. c.: 1974),535, annex: "A History of the Cooperating Clinics 
Committee. 
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susceptibility of pain to placebo effects, what was a rate of effectiveness "within 
the placebo range" supposed to mean? 764 
Four different types of pain-measuring instruments were used in the 
acupuncture trials described at the conference, or suggested in discussion: 1) 
Physiological tools that measured autonomic somatic responses to strong 
stimulation such as skin temperature, skin resistance, blood pressure, evoked 
potentials; 2) psychophysical tools that measured sensory thresholds, such as the 
dolorimeter; 3) self-reporting rating tools that presented a series of quantifiable 
options that subjects could choose to rate their impression of suffering or relief; 
and 4) behaviour-rating tools used by observers or subjects to record the 
frequency of certain types of "pain behaviours" such as time spent lying down, 
complaining, or limping. 
Each of these tools was associated with different models of pain and of 
objectivity. Physiological instruments could give very precise quantitative 
measurements and offered a high level of mechanical objectivity, since they did 
not require the participation of either the' subject or the observer to pro duce 
numbers. Their disadvantage, however, is that they did not actually measure pain; 
what they measured was a bodily response to stimulation and its perception. The 
discussions reported in the conference proceedings show that meeting participants 
disagreed about what these indicators meant, in part because of a lack of 
knowledge about pain. For example, the use of evoked potential responses to 
measure the outcome of acupuncture in one study was questioned as to how it was 
"a real ineasurement of pain," to which the investigator responded that they 
"didn't say it is a measure of pain relief.,,765 
Psychophysical instruments also offered a fairly high level of quantitative 
precision, and partial mechaniçal objectivity, since they required subjects to make 
sensory judgments. We have already seen, in Chapter 5, that the use of 
764 Proceedings of the NIH, 130:" Dr Foldes: The overall results ... seemed to be surprisingly close 
to the placebo effect... Dr Katz: 1 would object to an overall comparison of percent 
effectiveness ... Many ofthese patients in the acupuncture trials are failures from convention al 
therapy. Dr Moore: 1 would underscore that particular point. Our patients come to the pain clinic 
with intractable pain." 
765 Proceedings of the NIH, 34. 
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instruments like the dolorimeter for analgesic testing was criticised by Beecher. 
The use of such instruments for the evaluation of acupuncture was similarly 
criticised: they focused on the sensory aspects of pain, only one, and not 
necessarily the most important, of various components, including the emotional 
and cognitive, which made up the unitary experience of pain. In the NIGMS 
conference, for example, Chapman remarked: "in recent years, it has become 
evident that pain should not be studied as a simple sensory experience.,,766 The 
use of such instruments to measure the effectiveness of a therapy for chronic 
pain-such as acupuncture-was especially difficult to justify for those, like 
Bonica and many others, who believed that chronic pain was even more 
psychologically complex than acute pain. 
Self-reporting rating instruments, as we have seen in Chapter 6, became 
standard in the analgesic clinical trials sponsored by the Committee on Drug 
Addiction and Narcotics during the 1950s and 1960s, and continued to be widely 
used. They offered little quantitative precision and the numbers they produced 
were, at the individuallevel, arbitrary and subjective. When used in a large group 
of patients, under controlled conditions, they were thought to give reliable and 
consistent results. They had the advantage ofmeasuring what subjectsfelt, which 
was, according to sorne pain researchers, the only legitimate way of measuring 
pain. For those accustomed to physiological and sensory research, such subjective 
measures may have seemed absurdo In conference discussions, however, the most 
vocal critic of such measures for acupuncture evaluation did not oppose them to 
physiological or sens ory instruments, but instead advocated that pain should be 
measured as a form of behaviour. 
The behaviour-rating instruments that were proposed offered no 
mechanical objectivity, in that they were usually forms or diaries filled out either 
by observers or patients. They were nevertheless considered by sorne to be more 
objective than the self-reporting rating scales because they measured what 
subjects did rather than what they felt. More importantly, however, they were 
justified by a different definition of chronic pain and of therapeutic improvement. 
766 Richard C. Chapman in Proceedings afthe NIH, 52. 
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This conception of chronic pain as a set of leamed behaviours was developed by 
Wilbert Fordyce, a rehabilitation specialist at the University of Washington, 
where he was also a member of Bonica's multidisciplinary pain clinic as weIl as 
of the NIH Ad Hoc Committee on Acupuncture. In the late 60s, Fordyce had 
developed an innovative and controversial approach to the treatment of pain based 
on the principles ofbehaviour-modification. In its most radical formulation, this 
approach held that chronic pain could be defined as a set of pain behaviours, 
without reference to physiological disorders. These could be modified by 
reinforcing activity and discouraging expressions of suffering: limping, sitting, 
complaining, ètc. The outcome of therapy could only be evaluated by measuring 
changes in observed or self-reported behaviours, not by what a patient might 
"reaIly" be feeling "inside," nor by somatic changes.767 
During the NIH conference on acupuncture research, Fordyce often 
questioned the validity of presenters' self-reported rating scales. For instance, he 
advised Kepes: "Your criteria are still constrained by verbal reports, since the 
patients tell you how they fee!. 1 urge that you consider adding some relatively 
simple behavioral measures ofwhat, in fact, they can do. For example, have them 
keep diary forms showing the distribution of their time spent reclining, sitting, 
standing, and walking across a 24-hour period. This is a very valuable tool in 
evaluating the effects ofvarious modes oftherapy.,,768 Fcirdyce similarly prodded 
his colleague, Richard Chapman, who had used a combination of self-reporting 
pain scales and psychological tests: "1 did not hear you mention behavioral 
measures of pain. Are you contemplating using any ofthese?,,769 Chapman, 
however, urged his colleagues to use multiple measures of pain, and to use 
available statistical consulting services in order to succeed in "look[ing] at pain in 
a global fashion" and evaluate it "more meaningfully.,,77o 
767 Oral History Interview with Wilbert E. Fordyce, 10 July 1993 (Ms. Coll. no. 127.1), John C. 
Liebeskind History of Pain Collection, History & Special Collections Division, Louise M. Darling 
Biomedical Library, University ofCalifomia, Los Angeles. 
768 Proceedings of the NI H, 10. 
769 proceedings afthe NIH, 53. 
770 Proceedings of the NIH, 137. 
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There were two sources of tension among the conference participants that 
seemed to make it difficult to agree on val id measures of pain-relieving efficacy. 
The first was a lack of common reference points between researchers who had not 
previously met as "pain researchers." There was also another division between 
those who had already begun defining themselves as pain experts, but who either 
believed that chronic pain should be defined and measured according to what 
patients experienced (the "pain experientalists") and those who asserted that 
chronic pain was a behavioural issue that should be treated and measured as such. 
The tension surrounding the acupuncture question foreshadowed the further 
institutionalisation of this division in pain clinics offering two different types of 
treatment approaches. A detailed description of these approaches and their 
implications for the conceptualisation of pain and of suffering persons can be 
found in Isabelle Baszanger's work.771 
Given the apparent underdevelopment of, and budding tensions within, 
pain medicine, it seems obvious that a much more extensive process of 
consultation and research was necessary in order to evaluate acupuncture-
defined as a therapy for chronic pain-than had been envisaged by NIH officiaIs. 
Coming back to the question of "was there really enough money," we have to 
consider that a program of evaluation that would be recognised as valid first 
required agreement about basic methodological issues, such as measuring pain 
and creating placebo-acupuncture. Such agreement-whether obtained by 
acquiring more knowledge, providing opportunities for communication and 
discussion among researchers, or the authoritative imposition of a standard 
protocol-could not be produced without the help of more material resources and 
time than the NIH provided. 
771 Isabelle Baszanger, "Pain Physicians: Ali Alike, Ali Different," in Differences in Medicine: 
Unraveling Practices, Techniques, and Bodies ed. Marc Berg, and Annemarie Mol (Durham and 
London: Duke University Press, 1998), 119-143, Baszanger analyses the differences between 
these approaches at the level oftherapeutic practices, noting that one attempts to cure pain through 
the use of "techniques" and the other instead "manages" pain through behaviour-modification. She 
does not mention the implications for the evaluation oftreatment on the level of experience or of 
behaviour. A more detailed description of the two treatment approaches can be found in the 
second part of lnventing Pain Medicine. 
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The NIH initiative may have been more motivated by a concern to show 
Congress and the public that "something was being done" about the acupuncture 
question than by a concern to produce knowledge about acupunéture and chronic 
pain. Though Bonica urged that chronic pain be seen as a serious national health 
problem, his sense of urgency does not seem to have been widely shared by 
sponsors, and indeed, this continued to be a poorly funded area of research. Nor 
did acupuncture carry the promise of great benefit for those who had sufficient 
resources to mobilise a large-scale evaluation program. Listing the factors that 
contributed to the failure to resolve controversies about the efficacy of 
acupuncture, one researcher remarked in 2005, and this was also true in the 
1970s: "the relative lack of funding to perform large controlled acupuncture 
treatment studies as compared to the resources backing the launch of new 
analgesic drugs should not be forgotten as an additional factor.,,772 
The successful evaluation of acupuncture' s efficacy indeed seems to have 
been impeded by a lack of material resources, and by a lack of agreement and 
authority required to standardise and validate a technology for the measurement 
of acupuncture's painrelieving efficacy. 1 have suggested that this lack of 
material and social resources stemmed, at least in part, from the youth and 
fragility of pain research. The lack of previously established professional 
networks, meetings, common' definitions, knowledge, and accepted measurement 
tools or authorities relating to chronic pain made it impossible to launch an 
immediately successful evaluation program. Such a pro gram would have required, 
according to most researchers, the large-scale implementation of similar or 
complementary study designs to produce large amounts of commensurable data. 
The low priority given to chronic pain as a research topic may have been a reason 
why NIH, or other institutions, was unwilling to provide researchers will 
sufficient material resources to create the necessary standardising mechanisms for 
this. There was another division, however, within the small core of chronic pain 
experts, which may not have been so easily resolved. Tensions between 
behaviourist and experientalist chronic pain experts continued to animate debates 
772Sengt H. Sjolund, "Acupuncture or Acupuncture?" Pain 114, no. 3 (2005): 311-12. 
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about pain treatment, measurement and compensation throughout the 1970s and 
1980s.773 
Conclusion 
Although individual patients and doctors surely made up their own minds about 
whether acupuncture worked, it seems that the question of its pain-relieving 
efficacy was never formally resolved on a collective level. Yet after 1974, it was 
no longer a hot issue. The lack of controlled clinical studies of acupuncture was 
still bemoaned in 1979.774 Yet no further effort was made to launch any large-
scale evaluation program, although individual studies continued to be published. 
Acup~ncture had not, as sorne pain experts and representatives of professional 
organisations had feared, slipped far out of their control. As Ginger Mac Rae 
reported in 1982, acupuncture had failed to flourish; it was still regarded largely 
as a quack remedy, an option of last resort, to which few Americans had access. 
Mac Rae suggests that this failure was due to a shortage of services offered, due, 
1 
at least in part, to restrictive legislation. 775 Medicallobbyists had indeed managed 
to pass legislation in sorne states that specified that acupuncture should remain an 
experimental therapy until there was adequate proof of its efficacy. But perhaps it 
was not so much the legislation as the lack of acupuncturists (it may not have 
been as lucrative as sorne researchers supposed), or the lack of demand (in sorne 
are as of the U. S.), that halted the uncontrolled expansion of acupuncture. In 
addition, sorne chronic sufferers may have turned towards increasingly numerous 
pain clinics to seek treatment. 776 Sorne of these clinics even offered acupuncture, 
77J United States. Commission on the Eval~ation of Pain. Report of the Commission on the 
Evaluation of Pain ed. Kathleen Foley (Washington, OC: U. S Department of Health and Human 
Services, Social Security Administration, Office of Disability, 1987), see the minority report. 
774 Committee, on Science and Technology, United States-China Science Cooperation Hearings 
before the Subcommittee on Science, Research and Technology U. S. House of Representatives, 
May 7,8,10; June 22, 1979 (U. S. Government Printing Office Washington: 1979). 
775McRae, "A Critical Overview," 163-96. 
776 Baszanger, lnventing Pain Medicine, 3, notes that before 1960, there were only 3 pain 
treatment centres and, though there are no figures available for the 1960s, the development was 
not rapid during that decade. A major impulse was a meeting on pain organised by Bonica in 
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alongside therapies such as nerve blocks, physiotherapy, electrotherapy and 
biofeedback. 777 
Newly-defined pain experts also became less dependent on the 
acupuncture question to draw attention to chronic pain. With the impulse they 
were given by the acupuncture "episode," they were able to begin, in the mid-
1970s, to create their own professional networks through organisations, meetings, 
and journals. By the 1980s, they had begun participating in serious national and 
international policy debates on the evaluation of chronic pain as a disability and 
the treatment of cancer pain. 778 
Among themselves, however, pain experts have continued to perform 
occasional trials of acupuncture and to argue about the necessary conditions for a 
valid evaluation. A recent (2005) editorial in Pain has continued the long-tradition 
of pleas for improved trials of acupuncture. The "improvement" described by the 
author, however, seems to indicate a change in emphasis that is perhaps more in 
line with how acupuncture is actually used in the treatment of complex pain 
conditions and complex patients for whom there is no magic solution. Even if 
acupuncture was sometimes only partly effective, and not for every kind of pain, 
this was "not an argument against using it" since it was " what we do with both 
pharmacological and psychological pain management techniques. The crucial 
question is how to select the patients and the conditions suitable to treat, a 
problem that is still within the art of medicine ... ,,779 
Discussions about how to evaluate acupuncture reveal a model of pain as 
an experience not primarily situated in the body, but in a mind permeable to the 
influence of social relations, ideas, and psychological predispositions. This fits 
with the process of psychologisation and disembodiment of pain that 1 have been 
tracing in the past three chapters. Since the 1940s, instruments for collecting 
1973. In 1977, date of the first census, there were 327 pain clinics worldwide and at least 60% of 
these were in the U. S. 
777Jeanette Ezzo, Brian Berman, Victoria A. Hadhazy, Alejandro R. Jadad, Lixing Lao, and Betsy 
B. Singh. "Is Acupuncture Effective for the Treatment of Chronic Pain? A Systematic Review," 
Pain 86, no. 3 (2000): 217-25. 
778 U.S. Commission on the Evaluation of Pain, Report of the Commission; World Health 
Organisation, Cancer Pain Relief(Geneva: World Health Organisation, 1986). 
779 Sjolund, "Acupuncture," 311-12. 
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evidence of pain from within the body were increasingly rejected in favour of 
methods that rested on obtaining psychological, organisational, and statistical 
control over experimental conditions. 
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Conclusion 
People often look puzzled when they hear that l research the history of pain-
measuring technologies, they've looked puzzled: "But how do you measure 
pain?," they asked, exclaiming something about pain being so personal, or 
subjective, or variable. At first, l thought this was the wrong question. "Why has 
anyone ever wanted or needed to measure pain?," seemed, to me, to be a much 
more obvious and historically relevant question. l soon realised, however, that the 
question of how was in fact a rather interesting one to ask, and that it was closely 
connected to the question of why. In each of my chapters, l have tried to make 
links between the reasons behind demands for pain-measuring technologies, the 
types of resources invested in their creation and implementation, the realities of 
pain-measuring practices, and, finally, the theoretical and empirical validation of 
these technologies. In this conclusion, l will further discuss the question: What is 
the secret of successful pain measurement? 
A number of scientists and clinicians, since the 19th century, have searched 
for the answer in the construction of various types of pain-measuring 
technologies. They thought the evaluation of pain should be made quantitative 
because numbers were precise, comparable, communicable and impersonal. 780 
However, the value of precision, comparability, communicability and 
impersonality has taken different meanings depending whether pain was being 
measured to classifY human types or to produce a better analgesic. These pain 
measurers evidently believed that sorne sort oftechnological mediation was 
necessary to make the evaluation of pain quantitative and objective. They 
produced various sorts ofnon-human entities, such as meters, scales, protocols, 
etc., designed (by humans) and operated (by humans) to reduce or eliminate 
human variability and error from the evaluation process. 
What made a pain-mca~uring technology good? Sorne of the people who 
have invented such technologies have explained that the secret in designing a 
good pain-measuring technology was to correctly identify the "true" nature of 
780 Ted Porter, Trust in Numbers. 
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pain. Ronald Melzack, for example, in an essay on "Concepts of Pain 
Measurement" published in 1983, explained that a better understanding of the 
motivational-affective dimension of pain had recently led to the. creation of more 
accurate measuring tools. The previous "sensory approach to pain," however, had 
"fail[ed] to provide a complete picture of pain processes.,,78 1 The adoption of 
"more complex models of information processing in the nervous system" and 
recognition of the "active 'noisy' brain," had led researchers to more fully 
consider the role of motivational and affective processes that gave rise to pain. A 
new theory, the "gate control theory" now explained how signais could be 
"blocked or modulated by cognitive activities," that is, by learning, past 
experience and thought, before it gave rise to the experience of pain. On the basis 
of this theory, a new, more effective pain-measuring technology had been 
developed: the McGill Pain Questionnaire, which used word categories and 
numbers to tate the sensory, affective and evaluative dimensions of pain. 
Before this, however, the Cornell team had insisted that it was crucial, in 
order to quantify pain, to recognise that outward expressions of pain were the 
product oftwo internai processes: "sensation" and "reaction." Pure sensation 
involved only the sensory, perceptive and discriminative functÏons of the nervous 
system, while reaction was cognitive and affective. The reason the dolorimeter 
succeeded in giving such precise and consistent results was because it was able to 
isolate the sensory from the emotional components of pain. 
Beecher pointed out that the dolorimeter did not produce consistent and 
accurate results when it was used under appropriate experimental conditions (as 
defined by Beecher). Discrepancies produced by the dolorimeter, Beecher 
explained, resulted from the impossibility, in practice, of dividing the pain 
sensation from the pain reaction. The implication ofthis reality was that pain was 
inevitably. an idiosyncratic and emotional cxperience. It was impossible to 
eliminate subjectivity or to control for variability at the level of the individual, but 
it was possible to obtain consistency, accuracy and validity at the coHective level. 
78\ Ronald Melzack, "Concepts of Pain Measurement," In Pain Measurement and Assessment, ed. 
Ronald Melzack (New York: Raven Press, 1983),3. 
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Therefore, in order to measure analgesic effect, it would be necessary to approach 
pain relief at a population level, using appropriate statistical controls. 
Melzack, Hardy-Wolff-Goodell, Beecher and their colleagues each, in 
their ways, have suggested that once the "true" nature of pain had been 
apprehended, it became possible to create the technology able to control for bias 
and variability, and to reliably quantify sorne essential component(s) of pain and 
its relief. In addition, however, as they themselves may weIl acknowledge, 
knowledge about pain was also often acquired through the use of measuring 
technologies. 1 have given examples of this throughout this thesis. Analgesia 
clinical trials were used to obtain information about how, and why, a certain 
proportion of the population responded to placebos for the relief of pain, as weIl 
as to measure this proportion. The dolorimeter was used to better understand the 
psychophysical patterns of pain perception. Various algometers were used to find 
out how biological, social and psychological factors influenced the intensity of 
pam expenence. 
The technical capacities of pain-measuring instruments therefore shaped 
possible ways of thinking about pain: about how pain experience was produced 
within the body and the mind, and how it was modulated by internaI and external 
factors. While this suggests a more dynamic model of interaction between the 
technical and theoretical principles of pain-measuring technologies, it also 
suggests ways in which social and material conditions can enable certain kinds of 
pain-measuring practices and thus enable ways of thinking about pain. Obtaining 
control over pain and the conditions in which it was measured depended not only 
on the technical capacities of the instruments themselves, but the coordination of 
the actions and abilities of the people who operated them. 
As 1 have also shown in this thesis, and as pain measurers would also 
probably acknowledge, human effort and judgment were necessary to make pain-
measuring technologies work. The instruments did not, by themselves, ensure the 
precision, consistency and validity of the results they produced. These qualities 
also depended on the efforts, abilities, attentiveness and knowledge of the 
individuals who operated these technologies. 
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As we have seen, the proper functioning of the dolorimeter depended on the 
ability of subjects to recognise the pain threshold accurately. The analgesic 
clinical trial depended on the coordination of many actors, and more specifically 
on the good judgment of observers, statisticians and subject-selectors, as weIl as 
the ability of subjects to be decisive, alert to differences in levels of pain intensity, 
and their willingness to gi ve their pain a number. 
Thus, while pain measurers have generally tended to emphasize the 
theoretical knowledge and technical control necessary for the successful 
measurement of pain, my own investigation of pain-measuring practices has led 
me to conclude that creating a valid technology of pain measurement also depends 
on the success of social processes. These are not separate processes: The technical 
capacities and theoretical underpinnings of measuring technologies interact 
dynamically with the social and material conditions of measurement practices. 
While pain measurers have often neglected, at least in print, to give importance to 
the broader social and material networks in whichcertain kinds of "measurable" 
pain become practicable and valuable, my own interpretation of pain-measuring 
technologies would be partial if it did not take into account these actors' technical 
and theoretical explanations of whether, and why, they worked. 
When 1 say that creating a "measurable pain" is, in large part, a social 
achievement, 1 mean this in several ways. First, 1 suggest that the value given to 
pain measurement by sociological groups, for reasons that are often political, 
economic, or social, drives the creation of pain-measuring technologies, defines 
their function, and influences the determination oftheir validity. In other words, 
what pain-measuring technologies are considered to be useful for, and by who, 
may influence whether they will work (and, obviously, whether they wiil be 
created in the first place). Second, 1 would argue that obtaining consistent, 
accurate and valid measurements of pain, or pain relief, requires social, as much 
as technical control over the conditions and practices of pain-measurement. That 
is, to eliminate the influence of irrelevant variables, it is necessary to be able, to 
sorne extent, to predict and control people's actions (and thoughts). Finally, the 
use of pain-measuring technologies has a social impact They can alter the 
307 
308 
relations and the distribution of authority and of resources among people both 
within the immediate clinical or experimental context, and beyond that context. 
When pain measurers report on the design or validity of pain-measuring 
technologies, they sometimes mention, usually briefly, the utility of these 
methods. They tell us that sorne technology may be useful for clinical diagnosis or 
for therapeutic evaluation. Sometimes they simply let us assume pain-measuring 
instruments will, in sorne vague way, contribute to the human struggle against 
pain. Such omissions seem to imply that the validity of pain-measuring 
technologies has nothing to do with their purpose. The history of pain-measuring 
technologies, however, shows that the importance they have been given, for the 
fulfilment of a specific purpose, can influence their chance of working. When 
specific technologies were seen to have a greater economic and professional 
importance, such as the analgesic clinical trials sponsored by CDAN, they were 
supported with greater social and material resources. As we have seen, in 6, larger 
grants translated into salaries for full-time observers and fees for statistical 
consultants who transformed the practice of the clinical trial and made it a much 
more effective technology. In chapter 7, however, we saw that small and scattered 
grants for investigations of acupuncture analgesia made it impossible to 
implement the kind of mechanism necessary to coordinate research on a 
sufficiently largl? scale to obtain consistent and comparable results. 
In addition, the reason for which pain was being measured also entered 
into consideration in the evaluation of the validity of a particular technology. For 
example, algometers were thought to be highly reliable when they were used to 
measure stable inter- or intraindividual differences in sensitivity in the early 
twentieth century, but the variation in their results was judged to be too erratic for 
the purpose of measuring analgesic efficacy in the 1910s. At that time, making 
analgesic testing objective was not a high priority, and no efforts were invested 
towards the creation of pain-measuring technologies that were more appropriate 
for this purpose until the mid 1930s. 
We can also look at the evolution of self-reporting pain scales and 
questionnaires. In the 1950s, these were considered to be valid for the 
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measurement of therapeutic effect when used within the context of a clinical trial, 
but do not seem to have been used to evaluate the pain of disease or injury within 
individual therapeutic encounters. A few decades earlier, such scales might well 
have seemed absurd to clinicians such as Libman and Behan, for whom the ideal 
type of technology would bypass patients' own expressions of pain, which could 
be distorted by emotions, insensibility or conscious lying. It was also unclear that 
such tools would have been relevant for answering early to mid century questions 
about the evaluation and treatment of pain. In the last decades of the 20th century, 
however, self-reporting scales and questionnaires became widely used for clinical 
pain evaluation, at least in North America. The new uses for which these tools 
have come to be seen as relevant and valid appear to be linked to the emergence 
of new kinds of debates about the treatment and compensation of pain, 
particularly of chronic pain, that have appeared with the institutionalisation of 
"pain medicine" and the development of a "culture of pain." Within the context of 
these debates, self-reporting pain scales and questionnaires are se en as 
contributing relevant information about the effectiveness of different types of pain 
clinics, the distribution of disability benefits and equitable access to appropriate 
pain relief. For these purposes, it was important not to eliminate patients' 
emotions, but to fully integrate them into the evaluative process. In addition, by 
this time, malingering was widely considered to be rare and insignificant, and thus 
not an obstacle to giving patients control over the assessment of their pain. 
Thus, the social, economic and political function of pain evaluation-
whether it be to serve the development of the analgesic drug industry, to detect 
the presence of a "real" physical disability or to promote equitable access to pain 
relief-have shaped ideas about how pain should be evaluated, and thus of what 
pain-measuring technologies should do. In addition, the relative importance 
accorded to such functions influenced the amount of effort, time, money and 
interest that were invested towards the improvement of pain measurement at 
particular times. Both types of dynamics suggest links between the historically-
specific and socially defined functions of pain-measuring technologies, their 
design and the judgmept of their theoretical and empirical validity. 
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How exactly does the investment of resources into the development and 
use of pain-measuring technologies improve their validity? What type of resource 
did it take to make these technologies work? As l have shown, different types of 
technologies required different amounts and types of resources in order to 
produce accurate and consistent results, and did so on different scales. Mechanical 
technologies such as the dolorimeter, or the fMRI technology l mentioned in the 
introduction, seem to require mainly material resources to obtain control over the 
variables that could distort the evaluation of pain, and to increase the precision of 
measurement. As we have seen, however, instruments such as the dolorimeter 
worked weIl when they were used in certain ways, which implies that successful 
measurement required sorne control over the behaviours and attitudes of the 
people who used it. To obtain this control, investigators needed the right type of 
subject and time for training, in addition to a reliable instrument. Though it was 
fairly cheap, the dolorimeter seemed to yield consistent results only on a fairly 
smaIl scale. When more money was invested in analgesic testing, however, it 
became possible to obtain control on a larger scale. In particular, the hiring of 
full-time observers and access to large sources of hospital patients made it 
possible to obtain abundant and comparable data. This kind of large-scale control 
also made it possible to define pain as an incorrigibly idiosyncratic experience 
rather than attempt to transform it into something more stable. These case studies 
suggest that both material and human resources, that is, certain types of people, of 
labour and authority, were required to make pain-measuring technologies work. In 
addition, these resources were required not only to obtain technical control but 
also social control (by predicting and prescribing behaviours) over the conditions 
and practices of measurement in arder to achieve accuracy, consistency and 
precISIOn. 
When it became necessary to validate certain kinds of statements about 
pain on a larger scale-for instance, that acupuncture was effective in the relief of 
surgical or chronic pain-it was also necessary to coordinate measurement 
practices on a larger scale, and thus ta obtain access to more resources and 
authority. For example, elite researchers suggested that the design and results of 
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individual trials of acupuncture be coordinated at a state and nationallevel in 
order to accumulate sufficient, and sufficiently comparable, evidence to determine 
its pain relieving efficacy. It proved impossible, however, to obtain sufficient 
money and authority to create and implement such mechanisms of control over 
the design and implementation of technologies of acupuncture evaluation. 
When pain-measuring technologies were implemented, they reconfigured 
the distribution of authority over the evaluation of pain. Both within and beyond 
the immediate context of measurement, pain-measuring technologies have 
transformed social relations. Consider the analgesic clinical trial. Its use changed 
working relations between researchers, hospital staff and patients. It appeared to 
give patients more authority over the judgment of their own experience of pain, 
and it is probable that a 1950s surgical patient was more often asked for their 
opinion about the effectiveness of a treatment if they were participating in a 
clinical trial than during the course of normal postoperative care. On the other 
hand, their individual statements would be given little credibility in the final 
evaluation of the efficacy of a drug. Nurses' and doctors' opinions about the 
effectiveness of drugs were given no weight in the evaluation process. 
The contrast between early and late 20th century technologies, and the 
authority they were meant to eliminate, is also instructive. Aigometers were 
originally, around the turn of the 20th century, designed to bypass the conscious, 
wilful and idiosyncratic interpretation of pain by individual patients, and thus to 
eliminate their authority over the evalùation of pain. The American Pain Society's 
1990s campaign of "Pain: The Fifth Vital Sign," however, promoted clinical pain 
scales as a means of giving every patients' pain a voice, and reducing physicians' 
discretionary power to decide which patients should be asked about their pain, 
and how their pain should be taken into consideration. 
Certain kinds of technologies also empowered those who controlled their 
use. For example, responsibility for, and expertise in, the running of analgesic 
clinical trials benefited the professional status of anaesthesiologists and clinical 
pharmacologists. As we saw in chapter 7, elite researchers were accused of taking 
over the evaluation of acupuncture because they insisted on the exclusive validity 
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oftesting technologies such as the analgesic clinical trial. Disputes about whose 
authority it would be to pronounce acupuncture effective or ineffective-be!ween 
elite American researchers, various Chinese figures, acupuncturists, legislators 
and American chronic pain sufferers-may have hampered the ability of these 
researchers to insist on the validity of any single technology of pain-measurement 
for the evaluation ofthis controversial therapy. 
The outcome of acupuncture's evaluation-whether it was approved or 
dismissed- would also have had different implications for each group of actors 
involved. In the case of CDAN-sponsored trial, however, everyone agreed on the 
importance of the goal that was pursued through evaluation: the creation and 
approval of lucrative, safe and effective analgesics. More recently, disagreements 
over the ways in which social security disability benefits should be distributed to 
chronic pain sufferers has delayed the introduction of measuring technologies into 
American disability evaluation. 
The close and complex connections between the changing social value of 
"measurable pain" and the uses and validity of pain-measuring technologies have 
continued to be evident in recent debates and practices. 8eginning in the mid 
1970s, the landscape of pain-measurement was dramatically altered. The 
institutionalisation of "pain medicine" in professional organisations, meetings, 
joumals and dinics created new demands for new types of pain-measuring 
technologies, new spaces in which they could be circulated, and new conditions 
for their use. For various reasons, pain-measuring technologies have acquired new 
uses and have been circulated increasingly widely during the past four decades. 1 
believe that a doser examination of the conditions and consequences oftheir use 
can reveal a lot about the issues and practices that affect how sufferers have been 
managed and treated during this period. My hope is that my thesis has offered 
new ways of interrogating the issues surrounding the measurement of pain that 
will be useful for understanding both the narrow and broad implications of these 
technologies for healthcare professionals and people in pain. 
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